curated_by,bao_format,assay_category,assay_type,assay_strain,src_id,assay_organism,confidence_score,relationship_type,variant_id,doc_id,tid,cell_id,tissue_id,assay_tissue,assay_tax_id,src_assay_id,assay_id,description,assay_subcellular_fraction,assay_test_type,assay_cell_type,chembl_id
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7524,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,In vivo,,CHEMBL618647
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7525,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,In vivo,,CHEMBL618648
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7526,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,In vivo,,CHEMBL618649
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7527,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,In vivo,,CHEMBL618650
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7528,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,In vivo,,CHEMBL618651
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7529,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,In vivo,,CHEMBL876497
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2048.0,Lung,10116.0,,7530,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,In vivo,,CHEMBL618652
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2048.0,Lung,10116.0,,7531,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,In vivo,,CHEMBL618653
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2048.0,Lung,10116.0,,7532,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,In vivo,,CHEMBL618654
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6351,50597,,,,10116.0,,7533,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,,,CHEMBL618655
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1465,50597,,,,10116.0,,7534,Compound was tested for solubility in water,,,,CHEMBL618656
Intermediate,BAO_0000100,,P,,1,,0,U,,5182,22229,,,,,,7535,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,,CHEMBL618657
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17847,50597,,,,10116.0,,7536,Solubility was determined,,,,CHEMBL618658
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15339,50597,,,,10116.0,,7537,solubility in water (ug/mL) at 37 degree C.,,,,CHEMBL618659
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5202,50597,,,,10116.0,,7538,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,,,CHEMBL618660
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1088,50597,,,,10116.0,,7539,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,,,CHEMBL618661
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,7540,Half life in rats,,,,CHEMBL873807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5353,50597,,,,10116.0,,7541,Half life in Dawley rat,,,,CHEMBL618662
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2864,50597,,,,10116.0,,7542,Half life period after 3 mg/kg iv administration,,In vivo,,CHEMBL618663
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2864,50597,,,,10116.0,,7543,Half life period after 3 mg/kg iv administration in rat,,In vivo,,CHEMBL618664
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2864,50597,,,,10116.0,,7544,Half life period after 3 mg/kg iv administration in the rat,,In vivo,,CHEMBL618665
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6362,50597,,,,10116.0,,7545,Half life period in female Sprague-Dawley rats,,,,CHEMBL876498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6249,50597,,,,10116.0,,7546,Half life period in rat,,,,CHEMBL618666
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,7547,Half-life in rats was determined,,,,CHEMBL620440
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,7548,Half-life in rats with metabolic oxidation,,,,CHEMBL620441
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,7549,Half-life in rats,,,,CHEMBL620442
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7550,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,In vivo,,CHEMBL620443
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7551,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,In vivo,,CHEMBL620444
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7552,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,In vivo,,CHEMBL620445
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7553,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,In vivo,,CHEMBL620446
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,1969.0,Plasma,10116.0,,7554,Biological half-life measured in plasma of rat,,,,CHEMBL620447
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,1969.0,Plasma,10116.0,,7555,Biological half-life measured in plasma of rat; 22-25,,,,CHEMBL621129
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,1969.0,Plasma,10116.0,,7556,Biological half-life measured in plasma of rat; 9-16,,,,CHEMBL621130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3184,50597,,,,10116.0,,7557,Compound was evaluated for its half life when administered intravenously in rat,,In vivo,,CHEMBL873808
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4891,50597,,,,10116.0,,7558,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,In vivo,,CHEMBL876598
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,7559,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,In vivo,,CHEMBL621131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,7560,Half life (T1/2) after oral administration in rat,,In vivo,,CHEMBL621132
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4413,50597,,,,10116.0,,7561,Half life of compound after iv administration of 20 mg/kg dose in rat,,In vivo,,CHEMBL621133
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,7562,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,In vivo,,CHEMBL621312
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17267,50597,,,,10116.0,,7563,Half life of compound was determined in rat,,,,CHEMBL621313
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,178.0,Blood,10116.0,,7564,Half life of compound was determined in rat blood,,,,CHEMBL621314
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,,,10116.0,,7565,Half life at 1 mg/kg was determined in rat,,In vivo,,CHEMBL621315
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,,,10116.0,,7566,Half life at 10 mg/kg was determined in rat,,In vivo,,CHEMBL621316
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,401,50597,,,,10116.0,,7567,Half life in rats,,,,CHEMBL621317
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4942,50597,,,,10116.0,,7568,Half life in rats in hours,,,,CHEMBL621318
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17735,50597,,,,10116.0,,7569,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,In vivo,,CHEMBL621319
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6056,50597,,,,10116.0,,7570,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,In vivo,,CHEMBL621377
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5213,50597,,,,10116.0,,7571,Half life was determined,,,,CHEMBL621378
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6616,50597,,,,10116.0,,7572,Half life after i.v. administration,,In vivo,,CHEMBL876599
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5937,50597,,,,10116.0,,7573,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,In vivo,,CHEMBL621379
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5819,50597,,1969.0,Plasma,10116.0,,7574,Half life in rat plasma,,,,CHEMBL621380
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5819,50597,,1969.0,Plasma,10116.0,,7575,Half life in rat plasma; Not detected,,,,CHEMBL621381
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6803,50597,,,,10116.0,,7576,Half life in rats,,,,CHEMBL618515
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,7577,Half life period of compound was determined after peroral administration,,In vivo,,CHEMBL618516
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,7578,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,In vivo,,CHEMBL618517
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5948,50597,,,,10116.0,,7579,Half life period in rat,,,,CHEMBL618518
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,,,10116.0,,7580,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,In vivo,,CHEMBL618519
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,,,10116.0,,7581,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,In vivo,,CHEMBL618698
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,,,10116.0,,7582,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,In vivo,,CHEMBL618862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,,,10116.0,,7583,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL618863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,7584,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,In vivo,,CHEMBL618864
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,7585,Half life time in rat the dose of 2 mg/kg,,In vivo,,CHEMBL618865
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,7586,Half-life 24 hr after 10 mg/kg iv administration in rats,,In vivo,,CHEMBL618866
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,7587,Half-life 24 hr after 2 mg/kg iv administration in rats,,In vivo,,CHEMBL618867
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,,,10116.0,,7588,Half-life consistent with the observed metabolic steady state in rats,,,,CHEMBL875828
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17735,50597,,,,10116.0,,7589,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,In vivo,,CHEMBL618868
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,,,10116.0,,7590,Half-life for oxidative metabolic stability was determined using male human,,,,CHEMBL618869
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17670,50597,,,,10116.0,,7591,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,In vivo,,CHEMBL618870
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1696,50597,,1969.0,Plasma,10116.0,,7592,Half-life in rat plasma,,,,CHEMBL618871
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1742,50597,,1969.0,Plasma,10116.0,,7593,Half-life in rat plasma was determined,,,,CHEMBL618872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17800,50597,,,,10116.0,,7594,Half-life in rats was determined,,,,CHEMBL873816
Autocuration,BAO_0000218,,A,,1,,0,U,,12923,22224,,,,,,7595,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,,CHEMBL618873
Autocuration,BAO_0000019,,A,,1,,0,U,,11954,22224,,,,,,7596,Area under curve after oral dose of 0.1 mg//kg,,,,CHEMBL621602
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,7597,Area under curve after oral dose of 0.3 mg/kg,,,,CHEMBL621603
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,7598,Area under curve after oral dose of 1 mg/kg,,,,CHEMBL621604
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,7599,Area under curve after oral dose of 10 mg/kg,,,,CHEMBL621605
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,7600,Area under curve after oral dose of 23.4 mg/kg,,,,CHEMBL621606
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,7601,Area under curve after oral dose of 3 mg/kg,,,,CHEMBL621607
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,7602,Area under curve after oral dose of 3.87 mg/kg,,,,CHEMBL621608
Autocuration,BAO_0000019,,A,,1,,0,U,,5237,22224,,,,,,7603,Area under curve was determined,,,,CHEMBL621609
Autocuration,BAO_0000218,,A,,1,,0,U,,4026,22224,,,,,,7604,Area under curve at a dose of 10 mg/kg,,,,CHEMBL621610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5237,50597,,,,10116.0,,7605,Area under curve was determined; ND=No data,,,,CHEMBL621611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7606,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,,CHEMBL621612
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7607,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,,CHEMBL622308
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7608,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,,CHEMBL622309
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7609,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,,,CHEMBL622310
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7610,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,,CHEMBL622311
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7611,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,,,CHEMBL622312
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7612,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,,CHEMBL622931
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,7613,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,,,CHEMBL622932
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7614,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,,CHEMBL622736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7615,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,,CHEMBL622737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7616,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,,CHEMBL622738
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7617,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,,,CHEMBL622739
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7618,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,,CHEMBL622740
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7619,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,,,CHEMBL622741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7620,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,,CHEMBL622742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,7621,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,,,CHEMBL622743
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11637,50594,,1969.0,Plasma,10090.0,,7622,AUC in mice,,,,CHEMBL622744
Autocuration,BAO_0000019,,A,,1,,0,U,,11149,22224,,,,,,7623,Area under curve was measured from the graph obtained from concentration Vs time,,,,CHEMBL624134
Autocuration,BAO_0000019,,A,,1,,0,U,,10016,22224,,,,,,7624,Area under curve value of compound per hour after oral administration,,,,CHEMBL624135
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,7625,Area under curve was determined after oral administration in rats,,,,CHEMBL624136
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,7626,Area under curve was determined after oral administration in rats; No data,,,,CHEMBL624137
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,7627,Area under curve was determined after oral administration in rats;No data,,,,CHEMBL624320
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12923,50588,,,,9615.0,,7628,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,,CHEMBL624321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7629,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,,,CHEMBL624322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7630,Area under curve was determined for the compound after iv dose of 5.06 in rats,,,,CHEMBL624323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7631,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,,,CHEMBL624324
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7632,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,,,CHEMBL624325
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7633,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,,,CHEMBL624326
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7634,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,,,CHEMBL624327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,7635,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,,,CHEMBL624328
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14169,50588,,,,9615.0,,7636,Area under curve was determined in Dogs after peroral administration,,,,CHEMBL627848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14169,50597,,,,10116.0,,7637,Area under curve was determined in Rats after peroral administration,,,,CHEMBL627849
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14258,50597,,,,10116.0,,7638,Area under curve was determined in carotid blood of rat when administered intradermally,,,,CHEMBL627850
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14258,50597,,,,10116.0,,7639,Area under curve was determined in portal blood of rat when administered intradermally,,,,CHEMBL627851
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7640,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,,CHEMBL627852
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7641,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,,CHEMBL627853
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7642,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,,CHEMBL627854
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7643,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,,CHEMBL627855
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7644,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,,,CHEMBL627856
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7645,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,,CHEMBL875339
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7646,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,,,CHEMBL627857
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2106.0,Spleen,10116.0,,7647,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,In vivo,,CHEMBL627858
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,178.0,Blood,10116.0,,7648,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,,,CHEMBL627859
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,955.0,Brain,10116.0,,7649,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,,,CHEMBL627860
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,948.0,Heart,10116.0,,7650,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,,,CHEMBL627019
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2107.0,Liver,10116.0,,7651,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,,,CHEMBL627020
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2048.0,Lung,10116.0,,7652,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,,,CHEMBL627021
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2385.0,Muscle tissue,10116.0,,7653,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,,,CHEMBL627022
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,,,10116.0,,7654,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,,,CHEMBL627023
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2106.0,Spleen,10116.0,,7655,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,,,CHEMBL627024
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2046.0,Thyroid gland,10116.0,,7656,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,,,CHEMBL627025
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2113.0,Kidney,10116.0,,7657,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,,,CHEMBL627026
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,178.0,Blood,10116.0,,7658,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,,,CHEMBL627027
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,955.0,Brain,10116.0,,7659,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,,,CHEMBL627028
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,948.0,Heart,10116.0,,7660,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,,,CHEMBL627029
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2113.0,Kidney,10116.0,,7661,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,,,CHEMBL627030
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2107.0,Liver,10116.0,,7662,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,,,CHEMBL627031
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2048.0,Lung,10116.0,,7663,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,,,CHEMBL627032
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2385.0,Muscle tissue,10116.0,,7664,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,,,CHEMBL627033
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,,,10116.0,,7665,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,,,CHEMBL627034
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2106.0,Spleen,10116.0,,7666,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,,,CHEMBL627035
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2046.0,Thyroid gland,10116.0,,7667,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,,,CHEMBL627036
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,178.0,Blood,10116.0,,7668,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,,,CHEMBL875340
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,948.0,Heart,10116.0,,7669,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,,,CHEMBL627037
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2113.0,Kidney,10116.0,,7670,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,,,CHEMBL627038
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2107.0,Liver,10116.0,,7671,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,,,CHEMBL627039
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2385.0,Muscle tissue,10116.0,,7672,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,,,CHEMBL627040
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2106.0,Spleen,10116.0,,7673,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,,,CHEMBL624663
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2046.0,Thyroid gland,10116.0,,7674,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,,,CHEMBL625963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,955.0,Brain,10116.0,,7675,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,,,CHEMBL876799
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,2048.0,Lung,10116.0,,7676,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,,,CHEMBL626133
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,,,10116.0,,7677,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,,,CHEMBL626134
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6295,50597,,,,10116.0,,7678,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,,CHEMBL626135
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6296,50597,,,,10116.0,,7679,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,,CHEMBL626136
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6296,50597,,,,10116.0,,7680,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,,,CHEMBL626137
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6295,50597,,,,10116.0,,7681,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,,CHEMBL626138
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6296,50597,,,,10116.0,,7682,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,,CHEMBL626139
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7683,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,In vivo,,CHEMBL626140
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7684,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,In vivo,,CHEMBL626141
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,7685,C24h in rat p.o. at 20 mg/kg concentration,,,,CHEMBL626142
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,7686,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,In vivo,,CHEMBL627930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,7687,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,In vivo,,CHEMBL627931
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,7688,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,In vivo,,CHEMBL627932
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,7689,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,In vivo,,CHEMBL627933
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,7690,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,In vivo,,CHEMBL627934
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,7691,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,In vivo,,CHEMBL627935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7692,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,In vivo,,CHEMBL627936
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7693,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL627937
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7694,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,In vivo,,CHEMBL627938
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7695,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,In vivo,,CHEMBL627939
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7696,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,In vivo,,CHEMBL627940
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7697,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,In vivo,,CHEMBL627941
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7698,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,In vivo,,CHEMBL876800
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7699,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL627942
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7700,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,In vivo,,CHEMBL627943
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7701,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,In vivo,,CHEMBL627944
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7702,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,In vivo,,CHEMBL627945
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7703,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,In vivo,,CHEMBL628584
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7704,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,In vivo,,CHEMBL628585
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7705,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,In vivo,,CHEMBL628586
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7706,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,In vivo,,CHEMBL628587
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7707,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,In vivo,,CHEMBL628588
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7708,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,In vivo,,CHEMBL628589
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7709,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,In vivo,,CHEMBL625304
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7710,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,In vivo,,CHEMBL625305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7711,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,In vivo,,CHEMBL625306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7712,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,In vivo,,CHEMBL625307
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7713,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,In vivo,,CHEMBL625308
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7714,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,In vivo,,CHEMBL627740
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7715,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,In vivo,,CHEMBL627741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7716,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,In vivo,,CHEMBL627742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7717,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL627743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,178.0,Blood,10116.0,,7718,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL627744
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7719,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL627745
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7720,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,In vivo,,CHEMBL627746
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7721,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,In vivo,,CHEMBL627747
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7722,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,In vivo,,CHEMBL876810
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7723,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,In vivo,,CHEMBL627748
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7724,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,In vivo,,CHEMBL627749
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7725,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,In vivo,,CHEMBL627750
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7726,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL618728
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7727,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,In vivo,,CHEMBL618729
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7728,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,In vivo,,CHEMBL618730
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7729,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,In vivo,,CHEMBL618731
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7730,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,In vivo,,CHEMBL618732
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7731,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,In vivo,,CHEMBL618733
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7732,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,In vivo,,CHEMBL618734
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7733,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,In vivo,,CHEMBL618735
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7734,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,In vivo,,CHEMBL876602
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7735,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,In vivo,,CHEMBL618736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7736,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,In vivo,,CHEMBL618737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7737,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,In vivo,,CHEMBL618738
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7738,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,In vivo,,CHEMBL618739
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7739,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,In vivo,,CHEMBL618740
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7740,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,In vivo,,CHEMBL618741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7741,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL618742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,10000001.0,Bone,10116.0,,7742,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL618743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,1969.0,Plasma,10116.0,,7743,Half-life from rat plasma at a single oral dose of 25 mg/kg,,In vivo,,CHEMBL618744
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5610,50597,,,,10116.0,,7744,Half-life in male rat,,,,CHEMBL618745
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,7745,Half-life in rat after peroral administration at 10 mg/kg concentration,,In vivo,,CHEMBL620479
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,7746,Half-life in rat after peroral administration at 5 mg/kg concentration,,In vivo,,CHEMBL620480
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17771,50597,,,,10116.0,,7747,Half-life in rat at a dose of 3 mg/kg,,In vivo,,CHEMBL620481
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1974,50597,,,,10116.0,,7748,Half-life was evaluated in rats,,,,CHEMBL620482
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4239,50597,,,,10116.0,,7749,Half-life was measured in rat,,,,CHEMBL876603
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6681,50597,,,,10116.0,,7750,Half-life period for the compound was determined in rats at 50 mg/kg dose,,In vivo,,CHEMBL620483
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,,,10116.0,,7751,Half-life period in rats after intravenous administration at 5 mg/kg,,In vivo,,CHEMBL620484
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6046,50597,,,,10116.0,,7752,Half-life period in rat at 10 mg/kg,,In vivo,,CHEMBL620485
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,7753,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,In vivo,,CHEMBL620486
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,7754,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,In vivo,,CHEMBL620487
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,7755,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,In vivo,,CHEMBL620488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,7756,Half-life time in rat the dose of 2 mg/kg,,In vivo,,CHEMBL620489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1088,50597,,,,10116.0,,7757,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,In vivo,,CHEMBL620490
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5610,50597,,,,10116.0,,7758,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,In vivo,,CHEMBL620491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3032,50597,,1969.0,Plasma,10116.0,,7759,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,In vivo,,CHEMBL876604
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,,,10116.0,,7760,Oral half life was determined,,In vivo,,CHEMBL620492
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,7761,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,In vivo,,CHEMBL620493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4408,50597,,,,10116.0,,7762,Pharmacokinetic property (t1/2) in rat,,In vivo,,CHEMBL620494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2552,50597,,1969.0,Plasma,10116.0,,7763,Plasma elimination half-life was determined,,,,CHEMBL620495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,1969.0,Plasma,10116.0,,7764,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,In vivo,,CHEMBL620496
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,7765,Plasma half life was observed after intravenous administration in rat,,In vivo,,CHEMBL620497
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1465,50597,,1969.0,Plasma,10116.0,,7766,Plasma half-life was determined,,,,CHEMBL620498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1446,50597,,1969.0,Plasma,10116.0,,7767,Plasma half-life following oral administration in Fisher rats,,In vivo,,CHEMBL620499
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6824,50597,,1969.0,Plasma,10116.0,,7768,Plasma half-life in rat,,,,CHEMBL620500
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17533,50597,,1969.0,Plasma,10116.0,,7769,Plasmatic Half-life after intravenous administration to rat,,In vivo,,CHEMBL873809
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5979,50597,,,,10116.0,,7770,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,In vivo,,CHEMBL620501
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,7771,Terminal half life after intravenous administration (1 mg/kg) in rat,,In vivo,,CHEMBL620502
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,7772,Terminal half life in Rat at a oral dose of 5 mg/kg,,In vivo,,CHEMBL620503
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2463,50597,,,,10116.0,,7773,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,In vivo,,CHEMBL620504
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,7774,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,In vivo,,CHEMBL876605
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,7775,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,In vivo,,CHEMBL620505
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,7776,plasma half life was observed after intravenous administration in rat,,In vivo,,CHEMBL873811
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,7777,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,In vivo,,CHEMBL624016
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,7778,Half life of compound determined in rat,,,,CHEMBL624017
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,7779,Mean residence time determined in rat,,,,CHEMBL624018
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,7780,Plasma half life determined in rat,,,,CHEMBL624019
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,955.0,Brain,10116.0,,7781,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,In vivo,,CHEMBL624020
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4891,50597,,,,10116.0,,7782,Compound was evaluated for pharmacokinetic parameter maximum time period,,In vivo,,CHEMBL624201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,7783,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,In vivo,,CHEMBL872528
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,7784,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,7785,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,7786,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624350
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,7787,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL621320
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,7788,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,In vivo,,CHEMBL621321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,7789,Maximum time (Tmax) required to reach Cmax in rats,,,,CHEMBL621322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,,,10116.0,,7790,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL621323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6571,50597,,,,10116.0,,7791,Maximum time of clearance of compound in rats after peroral administration,,In vivo,,CHEMBL621324
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,7792,Maximum time at the dose of 2 mg/kg in rat,,,,CHEMBL621325
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,1969.0,Plasma,10116.0,,7793,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,In vivo,,CHEMBL875837
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,1969.0,Plasma,10116.0,,7794,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,In vivo,,CHEMBL621326
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14465,50597,,,,10116.0,,7795,Tmax in Guinea pig (PO dose),,In vivo,,CHEMBL621327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,7796,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,In vivo,,CHEMBL621328
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5960,50597,,,,10116.0,,7797,Pharmacokinetic parameter (Tmax) in rat,,In vivo,,CHEMBL621329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5022,50597,,,,10116.0,,7798,Pharmacokinetic parameter (Tmax) was estimated,,In vivo,,CHEMBL621330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4408,50597,,,,10116.0,,7799,Pharmacokinetic property (Tmax) in rat,,In vivo,,CHEMBL621331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5983,50597,,,,10116.0,,7800,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,In vivo,,CHEMBL621332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,7801,T max in Rat at a oral dose of 5 mg/kg,,In vivo,,CHEMBL621333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,7802,T max was determined at 10 mg/kg po dose in rats,,In vivo,,CHEMBL621334
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,7803,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,,,CHEMBL621335
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14180,50588,,,,9615.0,,7804,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,,,CHEMBL621336
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14180,50597,,,,10116.0,,7805,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,,,CHEMBL621337
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,7806,Area under curve was measured after i.v. administration into Beagle dog.,,,,CHEMBL621338
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,7807,Area under curve was measured after iv administration into Beagle dog,,,,CHEMBL875838
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,7808,Area under curve was measured after po administration into Beagle dog,,,,CHEMBL621339
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,7809,Area under curve was measured after po administration into Beagle dog.,,,,CHEMBL621340
Autocuration,BAO_0000218,,A,,1,,0,U,,15675,22224,,,,,,7810,Area under curve was measured at peroral dose of 3 mg/kg,,,,CHEMBL621341
Autocuration,BAO_0000019,,A,,1,,0,U,,12706,22224,,,,,,7811,Area under curve was measured by using concentration Vs time,,,,CHEMBL621342
Autocuration,BAO_0000019,,A,,1,,0,U,,12706,22224,,,,,,7812,Area under curve was measured by using concentration Vs time; not tested,,,,CHEMBL621343
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9750,50594,,,,10090.0,,7813,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,,,CHEMBL621344
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9750,50594,,,,10090.0,,7814,Area under curve(AUC) was measured in mice after oral administration.,,,,CHEMBL621345
Autocuration,BAO_0000019,,A,,1,,0,U,,14691,22224,,,,,,7815,Area under curve(AUC) value of the compound,,,,CHEMBL621346
Autocuration,BAO_0000218,,A,,1,,0,U,,14691,22224,,,,,,7816,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,,CHEMBL621347
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14691,50588,,,,9615.0,,7817,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,,,CHEMBL621348
Autocuration,BAO_0000019,,A,,1,,0,U,,2939,22224,,178.0,Blood,,,7818,Area under curve(carotid artery) was determined by the availability in blood,,,,CHEMBL621349
Autocuration,BAO_0000019,,A,,1,,0,U,,2939,22224,,178.0,Blood,,,7819,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,,CHEMBL621350
Autocuration,BAO_0000019,,A,,1,,0,U,,2939,22224,,178.0,Blood,,,7820,Area under curve(carotid artery) was determined by the availability in blood; No data,,,,CHEMBL875839
Autocuration,BAO_0000019,,A,,1,,0,U,,2939,22224,,178.0,Blood,,,7821,Area under curve(portal vein) was determined by the availability in blood,,,,CHEMBL620211
Autocuration,BAO_0000019,,A,,1,,0,U,,2939,22224,,178.0,Blood,,,7822,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,,CHEMBL620212
Autocuration,BAO_0000019,,A,,1,,0,U,,2939,22224,,178.0,Blood,,,7823,Area under curve(portal vein) was determined by the availability in blood; No data,,,,CHEMBL620213
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,9552,50797,,1969.0,Plasma,9544.0,,7824,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,,CHEMBL620214
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,9552,50797,,1969.0,Plasma,9544.0,,7825,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,,CHEMBL620215
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,9552,50797,,1969.0,Plasma,9544.0,,7826,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,,,CHEMBL620216
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9552,50588,,1969.0,Plasma,9615.0,,7827,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,,,CHEMBL620888
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9552,50588,,1969.0,Plasma,9615.0,,7828,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,,,CHEMBL620889
Autocuration,BAO_0000019,,A,,1,,0,U,,9552,22224,,1969.0,Plasma,,,7829,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,,CHEMBL620890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11911,50597,,1969.0,Plasma,10116.0,,7830,Area under plasma time curve determined in male rat,,,,CHEMBL620891
Autocuration,BAO_0000019,,A,,1,,0,U,,16618,22224,,,,,,7831,Area under the MAP curve measured over 5 min.,,,,CHEMBL620892
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14387,50594,,,,10090.0,,7832,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,,,CHEMBL621079
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14387,50594,,,,10090.0,,7833,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,,,CHEMBL621080
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12836,50588,,,,9615.0,,7834,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,,,CHEMBL621081
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,12836,100712,,,,10026.0,,7835,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,,,CHEMBL621082
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12836,50597,,,,10116.0,,7836,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,,,CHEMBL621083
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14339,50588,,,,9615.0,,7837,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,,,CHEMBL621084
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14339,50588,,,,9615.0,,7838,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,,,CHEMBL621085
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14339,50588,,,,9615.0,,7839,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,,,CHEMBL621086
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,10524,50588,,,,9615.0,,7840,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,,CHEMBL621087
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9994,50588,,,,9615.0,,7841,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,,,CHEMBL622607
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,11325,50588,,,,9615.0,,7842,Serum AUC in marmosets (IV dose),,,,CHEMBL622608
Autocuration,BAO_0000019,,A,,1,,0,U,,12536,22224,,,,,,7843,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,,CHEMBL624481
Autocuration,BAO_0000019,,A,,1,,0,U,,12536,22224,,,,,,7844,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,,CHEMBL624482
Autocuration,BAO_0000019,,A,,1,,0,U,,12536,22224,,,,,,7845,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,,CHEMBL624483
Autocuration,BAO_0000019,,A,,1,,0,U,,12536,22224,,,,,,7846,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,,CHEMBL624484
Autocuration,BAO_0000019,,A,,1,,0,U,,12536,22224,,,,,,7847,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,,CHEMBL624485
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15556,50597,,,,10116.0,,7848,Area under the curve for fumarate salt was evaluated in F344 Rats.,,,,CHEMBL624486
Autocuration,BAO_0000019,,A,,1,,0,U,,2809,22224,,,,,,7849,Area under the curve for the compound was calculated.,,,,CHEMBL624487
Autocuration,BAO_0000019,,A,,1,,0,U,,9511,22224,,,,,,7850,Area under the curve in concentration/ time,,,,CHEMBL624488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12818,50597,,,,10116.0,,7851,Area under the curve administered intraintestinal in rats.,,,,CHEMBL624489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12818,50597,,,,10116.0,,7852,Area under the curve administered intravenously in rats.,,,,CHEMBL625184
Autocuration,BAO_0000019,,A,,1,,0,U,,15118,22224,,,,,,7853,Area under the curve during intravenous administration,,,,CHEMBL625185
Autocuration,BAO_0000019,,A,,1,,0,U,,15118,22224,,,,,,7854,Area under the curve during intravenous administration; Not determined,,,,CHEMBL875954
Autocuration,BAO_0000019,,A,,1,,0,U,,15118,22224,,,,,,7855,Area under the curve during systemic administration,,,,CHEMBL625186
Autocuration,BAO_0000019,,A,,1,,0,U,,15118,22224,,,,,,7856,Area under the curve during systemic administration; Not determined,,,,CHEMBL625187
Autocuration,BAO_0000019,,A,,1,,0,U,,2632,22224,,,,,,7857,Area under the curve was calculated for the compound.,,,,CHEMBL625188
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14346,50588,,,,9615.0,,7858,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,,,CHEMBL625189
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14346,50588,,,,9615.0,,7859,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,,,CHEMBL625190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,7860,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,,,CHEMBL621733
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,7861,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,,,CHEMBL621734
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11149,50597,,,,10116.0,,7862,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,,,CHEMBL621735
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,1969.0,Plasma,10116.0,,7863,Clearance of the drug was measured in the plasma of rat; No data,,,,CHEMBL621736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5247,50597,,1969.0,Plasma,10116.0,,7864,The pharmacokinetic parameter plasma clearance in vivo in rats,,,,CHEMBL621737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,7865,Plasma clearance at the dose of 2 mg/kg in rat,,,,CHEMBL621738
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,7866,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,In vivo,,CHEMBL622806
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,7867,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,In vivo,,CHEMBL623519
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,7868,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,In vivo,,CHEMBL623520
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17065,50597,,,,10116.0,,7869,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,In vivo,,CHEMBL623521
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17671,50597,,,,10116.0,,7870,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,In vivo,,CHEMBL623522
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6672,50597,,,,10116.0,,7871,Clearance rate in rat,,In vivo,,CHEMBL623523
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6673,50597,,,,10116.0,,7872,Clearance rate in rat,,In vivo,,CHEMBL623690
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,7873,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL623691
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,7874,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL623692
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,7875,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL623693
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,7876,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL623694
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4413,50597,,,,10116.0,,7877,Clearance of compound after iv administration of 20 mg/kg dose in rat,,In vivo,,CHEMBL623695
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,7878,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,In vivo,,CHEMBL623696
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,7879,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,In vivo,,CHEMBL623697
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,0,U,,5005,22224,,1969.0,Plasma,9544.0,,7880,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,In vivo,,CHEMBL623698
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,5005,22224,,1969.0,Plasma,10116.0,,7881,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,In vivo,,CHEMBL623699
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,7882,Mean (%CV) PK parameters for CL(mL/min/kg).,,In vivo,,CHEMBL623700
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3747,50597,,,,10116.0,,7883,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,In vivo,,CHEMBL623701
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,1969.0,Plasma,10116.0,,7884,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,In vivo,,CHEMBL623702
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,7885,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,In vivo,,CHEMBL623703
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17267,50597,,,,10116.0,,7886,Plasma clearance in rat was determined,,In vivo,,CHEMBL623704
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,7887,Plasma clearance in rat after administration of 2 mg/kg iv,,In vivo,,CHEMBL623705
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,7888,Plasma clearance in rat after administration of 2 mg/kg iv,,In vivo,,CHEMBL623706
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,7889,Plasma clearance was determined,,In vivo,,CHEMBL623707
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5960,50597,,,,10116.0,,7890,Plasma clearance in rat,,In vivo,,CHEMBL623708
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5937,50597,,,,10116.0,,7891,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,In vivo,,CHEMBL623709
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5871,50597,,,,10116.0,,7892,Plasma clearance in rat by iv administration,,In vivo,,CHEMBL623710
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5874,50597,,,,10116.0,,7893,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,In vivo,,CHEMBL623711
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6504,50597,,,,10116.0,,7894,Plasma clearance in rat p.o.,,In vivo,,CHEMBL623712
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6803,50597,,,,10116.0,,7895,Plasma clearance in rats,,In vivo,,CHEMBL623713
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,7896,Plasma clearance was determined; ND denotes no data,,In vivo,,CHEMBL623714
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,7897,Plasma clearance was determined; ND denotes not determined,,In vivo,,CHEMBL623715
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,,,10116.0,,7898,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,In vivo,,CHEMBL623716
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,,,10116.0,,7899,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,In vivo,,CHEMBL622980
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,7900,Plasma administration to rats,,In vivo,,CHEMBL622981
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6362,50597,,,,10116.0,,7901,Plasma clearance of the compound in female Sprague-Dawley rats,,In vivo,,CHEMBL622982
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,7902,Plasma clearance was observed after intravenous administration in rat,,In vivo,,CHEMBL622983
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6215,50597,,,,10116.0,,7903,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,In vivo,,CHEMBL622984
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,,,10116.0,,7904,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,In vivo,,CHEMBL622985
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,7905,plasma clearance was observed after intravenous administration in rat,,In vivo,,CHEMBL623631
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,7906,In vivo CL/F determined,,In vivo,,CHEMBL623632
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,1969.0,Plasma,10116.0,,7907,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,In vivo,,CHEMBL623633
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,1969.0,Plasma,10116.0,,7908,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,In vivo,,CHEMBL623634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5213,50597,,,,10116.0,,7909,Compound was tested for the lower blood clearance in rat,,In vivo,,CHEMBL623635
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4687,50597,,,,10116.0,,7910,Evaluated for the low clearance in rat (in vivo),,In vivo,,CHEMBL621195
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3371,50597,,,,10116.0,,7911,Pharmacokinetic property (CLb)of the compound was determined in rat,,In vivo,,CHEMBL621196
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4690,50597,,,,10116.0,,7912,Rapid clearance after intravenous administration in rat was determined,,In vivo,,CHEMBL875287
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5702,50597,,,,10116.0,,7913,Clearance measured in rat,,In vivo,,CHEMBL621197
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,740,50597,,1969.0,Plasma,10116.0,,7914,Compound was evaluated for plasma clearance in rat,,In vivo,,CHEMBL621198
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,1969.0,Plasma,10116.0,,7915,Low plasma clearance was calculated in rat,,In vivo,,CHEMBL621199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5789,50597,,,,10116.0,,7916,Pharmacokinetic property (Clp) in rat,,In vivo,,CHEMBL621200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,7917,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,In vivo,,CHEMBL621201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,7918,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,In vivo,,CHEMBL621202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,7919,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,In vivo,,CHEMBL621203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,7920,Plasma clearance after IV dosing at 1 mg/kg in rat,,In vivo,,CHEMBL621204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7921,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,In vivo,,CHEMBL621205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7922,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL621206
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7923,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,In vivo,,CHEMBL621207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7924,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,In vivo,,CHEMBL621208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7925,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,In vivo,,CHEMBL621209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7926,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,In vivo,,CHEMBL876484
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7927,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,In vivo,,CHEMBL621210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7928,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL621211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7929,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,In vivo,,CHEMBL621212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7930,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,In vivo,,CHEMBL621213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7931,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,In vivo,,CHEMBL621214
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7932,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,In vivo,,CHEMBL621215
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7933,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,In vivo,,CHEMBL621216
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7934,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,In vivo,,CHEMBL621217
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7935,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,In vivo,,CHEMBL621218
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7936,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,In vivo,,CHEMBL621219
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7937,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,In vivo,,CHEMBL621220
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7938,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,In vivo,,CHEMBL621221
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7939,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,In vivo,,CHEMBL621222
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7940,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,In vivo,,CHEMBL621223
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7941,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,In vivo,,CHEMBL876485
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7942,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,In vivo,,CHEMBL621224
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7943,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL621225
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,948.0,Heart,10116.0,,7944,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL621226
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7945,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL621227
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7946,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,In vivo,,CHEMBL621228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7947,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,In vivo,,CHEMBL621229
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7948,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,In vivo,,CHEMBL621230
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7949,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,In vivo,,CHEMBL621231
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7950,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,In vivo,,CHEMBL621232
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7951,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,In vivo,,CHEMBL621233
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7952,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL621234
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7953,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,In vivo,,CHEMBL621235
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7954,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,In vivo,,CHEMBL621236
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7955,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL621237
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2113.0,Kidney,10116.0,,7956,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL876486
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,160.0,Intestine,10116.0,,7957,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,In vivo,,CHEMBL622436
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,160.0,Intestine,10116.0,,7958,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,In vivo,,CHEMBL622437
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,160.0,Intestine,10116.0,,7959,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,In vivo,,CHEMBL622438
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7960,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,In vivo,,CHEMBL622439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7961,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,In vivo,,CHEMBL622440
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7962,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL622441
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7963,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,In vivo,,CHEMBL622442
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7964,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL622443
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7965,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,In vivo,,CHEMBL622444
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7966,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,In vivo,,CHEMBL622445
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7967,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,In vivo,,CHEMBL622446
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7968,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,In vivo,,CHEMBL622447
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7969,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL622448
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7970,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,In vivo,,CHEMBL622449
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7971,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,In vivo,,CHEMBL622450
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7972,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,In vivo,,CHEMBL622451
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7973,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,In vivo,,CHEMBL622452
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7974,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,In vivo,,CHEMBL622453
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7975,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,In vivo,,CHEMBL622454
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7976,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,In vivo,,CHEMBL622455
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,7977,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,In vivo,,CHEMBL876024
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,7978,T max was determined at 3 mg/kg po dose in rats,,In vivo,,CHEMBL622456
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,7979,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL622457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,7980,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL622458
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,7981,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,,,CHEMBL622459
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,7982,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,,,CHEMBL873343
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,7983,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,,,CHEMBL622460
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,1969.0,Plasma,10116.0,,7984,Time for maximum plasma concentration determined in rat,,,,CHEMBL622461
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6681,50597,,1969.0,Plasma,10116.0,,7985,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,In vivo,,CHEMBL622462
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,7986,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,In vivo,,CHEMBL622463
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,7987,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,In vivo,,CHEMBL622464
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,7988,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,In vivo,,CHEMBL622465
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,7989,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,In vivo,,CHEMBL622466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,7990,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,In vivo,,CHEMBL622467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6824,50597,,1969.0,Plasma,10116.0,,7991,Time of maximum plasma concentration in rat,,,,CHEMBL622468
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,1969.0,Plasma,10116.0,,7992,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,,CHEMBL876025
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,1969.0,Plasma,10116.0,,7993,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,,CHEMBL622469
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,1969.0,Plasma,10116.0,,7994,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,,CHEMBL622470
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,7995,Time required to reach maximum concentration (Cmax) after oral administration in rat,,In vivo,,CHEMBL622471
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1742,50597,,1969.0,Plasma,10116.0,,7996,Time required to reach maximum concentration in rat plasma,,,,CHEMBL622472
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2774,50597,,1969.0,Plasma,10116.0,,7997,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,In vivo,,CHEMBL622473
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,1969.0,Plasma,10116.0,,7998,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,In vivo,,CHEMBL624282
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,7999,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,In vivo,,CHEMBL624283
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,8000,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,In vivo,,CHEMBL624284
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,1969.0,Plasma,10116.0,,8001,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,In vivo,,CHEMBL624285
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,8002,Time to reach Cmax after oral administration to rats,,In vivo,,CHEMBL624286
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,,,10116.0,,8003,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,In vivo,,CHEMBL624287
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,216,50597,,,,10116.0,,8004,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,,,CHEMBL624288
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,1969.0,Plasma,10116.0,,8005,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,In vivo,,CHEMBL624289
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,1969.0,Plasma,10116.0,,8006,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,In vivo,,CHEMBL873344
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6215,50597,,,,10116.0,,8007,Tmax after peroral administration (10 mg/kg) was determined in rat,,In vivo,,CHEMBL619623
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,8008,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,In vivo,,CHEMBL621399
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,8009,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,In vivo,,CHEMBL621400
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17670,50597,,,,10116.0,,8010,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,In vivo,,CHEMBL621401
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1465,50597,,,,10116.0,,8011,Tmax was determined,,,,CHEMBL621402
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2552,50597,,,,10116.0,,8012,Tmax was determined,,,,CHEMBL621403
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,8013,Tmax after oral administration in rat,,In vivo,,CHEMBL621121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,8014,Tmax after peroral administration in rats at 2.4 uM/kg,,In vivo,,CHEMBL872525
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5610,50597,,,,10116.0,,8015,Tmax in male rat,,,,CHEMBL621122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6046,50597,,,,10116.0,,8016,Tmax in rat at 10 mg/kg,,In vivo,,CHEMBL621123
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5874,50597,,,,10116.0,,8017,Tmax in rat by po administration at a dose of 40 mg/kg,,In vivo,,CHEMBL621124
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,,,10116.0,,8018,Tmax in rats,,,,CHEMBL621125
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,8019,Tmax was measured in rats after peroral administration at 5 mg/kg,,In vivo,,CHEMBL621126
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,,,10116.0,,8020,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,In vivo,,CHEMBL621127
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2959,50597,,,,10116.0,,8021,Tmax value after administration of 20 mg/Kg oral dose in rat,,In vivo,,CHEMBL621128
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,8022,Tmax value at a dose of 10 mg/kg in male SD rats,,In vivo,,CHEMBL618263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,8023,Tmax value at a dose of 100 mg/kg in male SD rats,,In vivo,,CHEMBL618264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,8024,Tmax value at a dose of 50 mg/kg in male SD rats,,In vivo,,CHEMBL618265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4186,50597,,1969.0,Plasma,10116.0,,8025,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,In vivo,,CHEMBL618266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,8026,time required to reach maximum concentration (Cmax) after oral administration in rat,,In vivo,,CHEMBL618267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,1088.0,Urine,10116.0,,8027,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,,,CHEMBL618450
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,1088.0,Urine,10116.0,,8028,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,,,CHEMBL618451
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5546,50597,,,,10116.0,,8029,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,,CHEMBL618452
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3173,50597,,1088.0,Urine,10116.0,,8030,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,,,CHEMBL618453
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3173,50597,,1088.0,Urine,10116.0,,8031,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,,,CHEMBL618454
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3173,50597,,1088.0,Urine,10116.0,,8032,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,,,CHEMBL618455
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4257,50597,,,,10116.0,,8033,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,In vivo,,CHEMBL618456
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6011,50597,,,,10116.0,,8034,Compound distribution in rat tissues was determined,,In vivo,,CHEMBL618457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,8035,Volume of distribution was evaluated in rat,,In vivo,,CHEMBL618458
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8036,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,,,CHEMBL618459
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8037,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,,,CHEMBL876733
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14346,50588,,,,9615.0,,8038,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,,,CHEMBL618460
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8039,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,,,CHEMBL618461
Autocuration,BAO_0000019,,A,,1,,0,U,,15469,22224,,,,,,8040,Area under the curve was determined after oral administration (300 uM/Kg),,,,CHEMBL618462
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8041,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,,,CHEMBL618463
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8042,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,,,CHEMBL618464
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8043,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,,,CHEMBL618465
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8044,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,,,CHEMBL618466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,8045,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,,,CHEMBL618467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,8046,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,,,CHEMBL618468
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12935,50588,,1969.0,Plasma,9615.0,,8047,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,,,CHEMBL618469
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12935,50588,,1969.0,Plasma,9615.0,,8048,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,,,CHEMBL618470
Autocuration,BAO_0000218,,A,,1,,0,U,,14813,22224,,,,,,8049,Plasma drug AUC in rat (PO dose),,,,CHEMBL618471
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15792,50594,,,,10090.0,,8050,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,,,CHEMBL618472
Autocuration,BAO_0000218,,A,,1,,0,U,,3579,22224,,,,,,8051,Area under was determined at a dose of 30 mg/kg,,,,CHEMBL618473
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,12487,50506,,,,9669.0,,8052,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,,,CHEMBL621699
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12487,50597,,,,10116.0,,8053,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,,,CHEMBL621700
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12487,50597,,,,10116.0,,8054,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,,,CHEMBL621701
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,12487,50506,,,,9669.0,,8055,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,,,CHEMBL621702
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12487,50588,,,,9615.0,,8056,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,,,CHEMBL621703
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12487,50588,,,,9615.0,,8057,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,,,CHEMBL621704
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8058,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,,,CHEMBL624259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8059,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,,,CHEMBL624260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8060,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,,,CHEMBL624430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8061,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,,,CHEMBL624431
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8062,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,,,CHEMBL624432
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8063,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,,,CHEMBL624433
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8064,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,,,CHEMBL624434
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,8065,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,,,CHEMBL624435
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8066,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,,,CHEMBL618570
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8067,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,CHEMBL618571
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8068,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,,,CHEMBL618572
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8069,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,CHEMBL618573
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8070,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,,,CHEMBL619267
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8071,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,CHEMBL619431
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8072,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,,,CHEMBL619432
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,8073,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,CHEMBL619433
Autocuration,BAO_0000218,,A,,1,,0,U,,13298,22224,,1969.0,Plasma,,,8074,AUC in mice after oral dose (50 mg/kg),,,,CHEMBL619434
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12226,50594,,1977.0,Serum,10090.0,,8075,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,,,CHEMBL619435
Autocuration,BAO_0000019,,A,,1,,0,U,,12634,22224,,1969.0,Plasma,,,8076,AUC (0-4 hr) ug/ml/h,,,,CHEMBL619436
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14810,50597,,,,10116.0,,8077,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,,,CHEMBL619437
Autocuration,BAO_0000218,,A,,1,,0,U,,13889,22224,,,,,,8078,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,,CHEMBL619438
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10018,50594,,,,10090.0,,8079,Compound was evaluated for Area under curve in mice,,,,CHEMBL619439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8758,50597,,,,10116.0,,8080,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,CHEMBL619440
Autocuration,BAO_0000218,,F,,1,,0,U,,8758,22224,,,,,,8081,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,CHEMBL619441
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8758,50597,,,,10116.0,,8082,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,,CHEMBL619442
Autocuration,BAO_0000019,,A,,1,,0,U,,2249,22224,,,,,,8083,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,,CHEMBL875156
Autocuration,BAO_0000019,,A,,1,,0,U,,2249,22224,,,,,,8084,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,,CHEMBL619443
Autocuration,BAO_0000019,,A,,1,,0,U,,2249,22224,,,,,,8085,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,,CHEMBL619444
Autocuration,BAO_0000019,,A,,1,,0,U,,2249,22224,,,,,,8086,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,,CHEMBL623464
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15115,50594,,,,10090.0,,8087,Compound was evaluated for area under curve when administered through oral route in mouse,,,,CHEMBL623465
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,8088,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,In vivo,,CHEMBL623466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,8089,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,In vivo,,CHEMBL623467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6249,50597,,,,10116.0,,8090,Plasma clearance in rat,,In vivo,,CHEMBL623468
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2463,50597,,,,10116.0,,8091,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,In vivo,,CHEMBL622660
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4969,50597,,,,10116.0,,8092,Plasma clearance rate in Sprague-Dawley rats,,In vivo,,CHEMBL622661
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,17720,50597,,,,10116.0,,8093,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL622662
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3457,50597,,,,10116.0,,8094,Pharmacokinetic property (total body clearance) in rat,,In vivo,,CHEMBL622663
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5983,50597,,,,10116.0,,8095,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,In vivo,,CHEMBL622664
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6295,50597,,,,10116.0,,8096,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,,CHEMBL622665
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6296,50597,,,,10116.0,,8097,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,,CHEMBL622666
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,8098,Cl in rat i.v. at 2 mg/kg concentration,,In vivo,,CHEMBL621615
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,8099,Clearance of compound after intravenous administration in rats at 24 uM/kg,,In vivo,,CHEMBL621616
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5503,50597,,,,10116.0,,8100,Clearance was determined,,In vivo,,CHEMBL621617
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4368,50597,,,,10116.0,,8101,Clearance by intravenous administration of 3.4 mg/kg in rat,,In vivo,,CHEMBL621618
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6005,50597,,,,10116.0,,8102,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,In vivo,,CHEMBL621619
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5031,50597,,,,10116.0,,8103,Clearance rate after i.v. administration in rats,,In vivo,,CHEMBL621620
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,,,10116.0,,8104,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL621786
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,8105,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,In vivo,,CHEMBL621787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5979,50597,,,,10116.0,,8106,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,In vivo,,CHEMBL621788
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,8107,Clearance (Cl) after oral administration in rat,,In vivo,,CHEMBL621789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,8108,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,In vivo,,CHEMBL621790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4839,50597,,1969.0,Plasma,10116.0,,8109,Compound was tested for plasma clearance in rat,,In vivo,,CHEMBL621791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,8110,In vitro microsome metabolism clearance in rat was determined,Microsomes,In vitro,,CHEMBL621792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,8111,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Microsomes,In vitro,,CHEMBL621793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8112,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL621794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5496,50597,,1969.0,Plasma,10116.0,,8113,In vivo plasma clearance was determined,,In vivo,,CHEMBL621795
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5739,50597,,,,10116.0,,8114,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,In vivo,,CHEMBL621796
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5676,50597,401.0,2107.0,Liver,10116.0,,8115,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,In vivo,Hepatocyte,CHEMBL621797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4239,50597,,,,10116.0,,8116,Pharmacokinetic property (Plasma clearance) was measured in rat,,In vivo,,CHEMBL621798
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5676,50597,,,,10116.0,,8117,Pharmacokinetic property (clearance) in rat i.v.,,In vivo,,CHEMBL621799
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1918,50597,,,,10116.0,,8118,"Plasma Clearance was evaluated in rats, iv",,In vivo,,CHEMBL621800
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17800,50597,,,,10116.0,,8119,Plasma clearance (in vivo) in rats was determined,,In vivo,,CHEMBL621801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6056,50597,,,,10116.0,,8120,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,In vivo,,CHEMBL621802
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5496,50597,,,,10116.0,,8121,Plasma clearance was determined,,In vivo,,CHEMBL618596
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,8122,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,In vivo,,CHEMBL618597
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,8123,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,In vivo,,CHEMBL618598
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,,,10116.0,,8124,Plasma clearance in rats,,In vivo,,CHEMBL618599
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,8125,Plasma clearance rate determined in rat,,In vivo,,CHEMBL618600
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6011,50597,,,,10116.0,,8126,Plasma clearance was determined in rat,,In vivo,,CHEMBL618601
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,8127,Plasma clearance was determined,,In vivo,,CHEMBL618602
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5948,50597,,,,10116.0,,8128,Plasma clearance value in rat,,In vivo,,CHEMBL618603
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6125,50597,,2107.0,Liver,10116.0,,8129,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,Ex vivo,,CHEMBL618604
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4839,50597,,,,10116.0,,8130,Clearance in rat,,In vivo,,CHEMBL618605
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,8131,Total body clearance in rat i.v. at 2 mg/kg concentration,,In vivo,,CHEMBL618606
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6571,50597,,,,10116.0,,8132,Clearance of compound in rats after intravenous administration,,In vivo,,CHEMBL618607
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3364,50597,,,,10116.0,,8133,Clearance after iv administration to rats,,In vivo,,CHEMBL618608
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8134,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,In vivo,,CHEMBL618609
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8135,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,In vivo,,CHEMBL618610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8136,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,In vivo,,CHEMBL618611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8137,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,In vivo,,CHEMBL618612
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8138,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,In vivo,,CHEMBL618613
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8139,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,In vivo,,CHEMBL621076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8140,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,In vivo,,CHEMBL621077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17670,50597,,,,10116.0,,8141,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,In vivo,,CHEMBL621078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5970,50597,,,,10116.0,,8142,Clearance in rat,,In vivo,,CHEMBL621251
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,8143,Clearance in rat after oral administration at 10 mg/kg,,In vivo,,CHEMBL621252
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4590,50597,,,,10116.0,,8144,Clearance in rat.,,In vivo,,CHEMBL621253
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6193,50597,,,,10116.0,,8145,Clearance rate following an oral dose of 20 mg/kg in rats,,In vivo,,CHEMBL621254
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2832,50597,,,,10116.0,,8146,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,In vivo,,CHEMBL621255
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1052,50597,,1969.0,Plasma,10116.0,,8147,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,In vivo,,CHEMBL621256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8148,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,In vivo,,CHEMBL621257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8149,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,In vivo,,CHEMBL621258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8150,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,In vivo,,CHEMBL621259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8151,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,In vivo,,CHEMBL621260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8152,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,In vivo,,CHEMBL876494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8153,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,In vivo,,CHEMBL621261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8154,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,In vivo,,CHEMBL621262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8155,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,In vivo,,CHEMBL621263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2107.0,Liver,10116.0,,8156,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL621264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8157,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL621265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8158,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,In vivo,,CHEMBL621266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8159,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,In vivo,,CHEMBL621267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8160,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL621268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8161,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,In vivo,,CHEMBL621269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8162,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,In vivo,,CHEMBL621270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8163,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,In vivo,,CHEMBL621271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8164,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,In vivo,,CHEMBL621272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8165,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,In vivo,,CHEMBL621273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8166,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,In vivo,,CHEMBL621274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8167,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,In vivo,,CHEMBL876495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8168,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,In vivo,,CHEMBL621275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8169,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL621276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2385.0,Muscle tissue,10116.0,,8170,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL621277
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,160.0,Intestine,10116.0,,8171,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,In vivo,,CHEMBL621278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,160.0,Intestine,10116.0,,8172,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,In vivo,,CHEMBL621279
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,160.0,Intestine,10116.0,,8173,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,In vivo,,CHEMBL621280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8174,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,In vivo,,CHEMBL621281
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8175,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,In vivo,,CHEMBL621282
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8176,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,In vivo,,CHEMBL621283
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8177,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,In vivo,,CHEMBL621284
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8178,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,In vivo,,CHEMBL621285
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8179,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,In vivo,,CHEMBL621286
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8180,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,In vivo,,CHEMBL623220
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8181,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,In vivo,,CHEMBL623221
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,2106.0,Spleen,10116.0,,8182,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,In vivo,,CHEMBL876029
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,945.0,Stomach,10116.0,,8183,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,In vivo,,CHEMBL623222
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,945.0,Stomach,10116.0,,8184,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,In vivo,,CHEMBL623223
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9866,50597,,945.0,Stomach,10116.0,,8185,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,In vivo,,CHEMBL621445
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,178.0,Blood,10116.0,,8186,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621446
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,178.0,Blood,10116.0,,8187,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621447
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,178.0,Blood,10116.0,,8188,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619681
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,178.0,Blood,10116.0,,8189,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619682
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,178.0,Blood,10116.0,,8190,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619683
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,955.0,Brain,10116.0,,8191,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619684
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,955.0,Brain,10116.0,,8192,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619685
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,955.0,Brain,10116.0,,8193,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619686
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,955.0,Brain,10116.0,,8194,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619687
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,955.0,Brain,10116.0,,8195,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,948.0,Heart,10116.0,,8196,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619689
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,948.0,Heart,10116.0,,8197,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619690
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,948.0,Heart,10116.0,,8198,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619691
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6062,50597,,,,10116.0,,8199,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,In vivo,,CHEMBL619692
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,8200,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,CHEMBL619693
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,,,10116.0,,8201,Vc value after IV dose at a dose of 5 mg/kg in rats.,,In vivo,,CHEMBL619694
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,,,10116.0,,8202,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,In vivo,,CHEMBL619695
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4891,50597,,,,10116.0,,8203,Compound was evaluated for pharmacokinetic parameter volume of distribution,,In vivo,,CHEMBL619696
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,740,50597,,,,10116.0,,8204,Compound was evaluated for volume of distribution in rat,,In vivo,,CHEMBL619697
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,,,10116.0,,8205,Steady state volume distribution was determined; steady state(ss),,In vivo,,CHEMBL619698
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3364,50597,,,,10116.0,,8206,Steady state volume of distribution after iv administration to rats,,In vivo,,CHEMBL619699
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2552,50597,,,,10116.0,,8207,Steady state volume of distribution dosing at 3 mg/kg iv,,In vivo,,CHEMBL619700
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,406,50597,,,,10116.0,,8208,The compound was evaluated for volume of distribution in rat,,In vivo,,CHEMBL619701
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12500,50597,,,,10116.0,,8209,The compound was tested for volume of distribution in rat,,In vivo,,CHEMBL619702
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12500,50597,,,,10116.0,,8210,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,In vivo,,CHEMBL620335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,8211,Volume distribution (VD) after oral administration in rat,,In vivo,,CHEMBL620336
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17671,50597,,,,10116.0,,8212,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,In vivo,,CHEMBL620337
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1094,50597,,,,10116.0,,8213,Volume distribution in rat,,In vivo,,CHEMBL620520
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5833,50597,,,,10116.0,,8214,Volume distribution in rat,,In vivo,,CHEMBL620521
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,8215,Volume distribution in rat after peroral administration at 10 mg/kg,,In vivo,,CHEMBL875825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,8216,Volume distribution in rat after peroral administration at 5 mg/kg,,In vivo,,CHEMBL620522
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6005,50597,,,,10116.0,,8217,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,In vivo,,CHEMBL620523
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1696,50597,,,,10116.0,,8218,Volume of distribution in rat.,,In vivo,,CHEMBL620524
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6672,50597,,,,10116.0,,8219,Volume of distribution in rat,,In vivo,,CHEMBL620525
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6673,50597,,,,10116.0,,8220,Volume of distribution in rat,,In vivo,,CHEMBL620526
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5871,50597,,,,10116.0,,8221,Volume of distribution in rat by iv administration,,In vivo,,CHEMBL620527
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6803,50597,,,,10116.0,,8222,Volume of distribution in rats,,In vivo,,CHEMBL620528
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,,,10116.0,,8223,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,In vivo,,CHEMBL620529
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,8224,Volume distribution at the dose of 2 mg/kg in rat,,,,CHEMBL620530
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,8225,Steady state volume of distribution was determined,,In vivo,,CHEMBL620531
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,0,U,,5005,22224,,,,9544.0,,8226,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,In vivo,,CHEMBL620532
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,5005,22224,,,,10116.0,,8227,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,In vivo,,CHEMBL620533
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,5005,22224,,,,10116.0,,8228,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,In vivo,,CHEMBL620534
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,8229,Mean (%CV) PK parameters for Vdss(mL/kg).,,In vivo,,CHEMBL620535
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,8230,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,In vivo,,CHEMBL875826
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,8231,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,In vivo,,CHEMBL620536
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8232,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,In vivo,,CHEMBL620537
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8233,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,In vivo,,CHEMBL618526
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5739,50597,,,,10116.0,,8234,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,In vivo,,CHEMBL618527
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5789,50597,,,,10116.0,,8235,Pharmacokinetic property (Vdss) in rat,,In vivo,,CHEMBL618528
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4239,50597,,,,10116.0,,8236,Pharmacokinetic property (vdss) was measured in rat,,In vivo,,CHEMBL618529
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4709,50597,,,,10116.0,,8237,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,In vivo,,CHEMBL618530
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6642,50597,,,,10116.0,,8238,Volume of distribution in rat,,In vivo,,CHEMBL618531
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5247,50597,,,,10116.0,,8239,The pharmacokinetic parameter volume of distribution in vivo in rats,,In vivo,,CHEMBL618532
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,17720,50597,,,,10116.0,,8240,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL618533
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,8241,Vdss in rat i.v. at 2 mg/kg concentration,,In vivo,,CHEMBL618534
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,8242,Volume distribution after intravenous administration (1 mg/kg) in rat,,In vivo,,CHEMBL618535
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,8243,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,In vivo,,CHEMBL618536
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,8244,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,In vivo,,CHEMBL618537
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,8245,Volume distribution at a dose of 10 uM/kg in rat was determined,,In vivo,,CHEMBL618538
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4521,50597,,,,10116.0,,8246,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,In vivo,,CHEMBL618539
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,8247,Volume distribution was calculated in rat,,In vivo,,CHEMBL618540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,8248,Volume distribution was determined,,In vivo,,CHEMBL618541
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2938,50597,,,,10116.0,,8249,Volume of distribution after intravenous administration was evaluated in rat,,In vivo,,CHEMBL618542
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6679,50597,,,,10116.0,,8250,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,In vivo,,CHEMBL622544
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,8251,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,In vivo,,CHEMBL622545
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,8252,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,In vivo,,CHEMBL622546
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,8253,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,In vivo,,CHEMBL622547
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5145,50597,,,,10116.0,,8254,Volume of distribution in steady state was determined in rat,,In vivo,,CHEMBL622548
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6467,50597,,,,10116.0,,8255,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,In vivo,,CHEMBL622549
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6467,50597,,,,10116.0,,8256,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,In vivo,,CHEMBL622550
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15115,50594,,,,10090.0,,8257,Compound was evaluated for area under curve when administered through oral route to mouse,,,,CHEMBL622551
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8758,50597,,,,10116.0,,8258,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,CHEMBL622552
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8758,50597,,,,10116.0,,8259,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,,CHEMBL622553
Autocuration,BAO_0000218,,F,,1,,0,U,,8267,22224,,,,,,8260,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,In vivo,,CHEMBL622554
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8267,50588,,,,9615.0,,8261,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,,,CHEMBL622555
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14239,50594,,,,10090.0,,8262,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,,,CHEMBL622556
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14239,50594,,,,10090.0,,8263,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,,,CHEMBL622557
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,8264,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,,,CHEMBL622558
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,8265,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,,,CHEMBL622559
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,10754,50588,,,,9615.0,,8266,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,,,CHEMBL622560
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14681,50597,,,,10116.0,,8267,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,,CHEMBL622561
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14681,50597,,,,10116.0,,8268,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,,,CHEMBL622562
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14681,50597,,,,10116.0,,8269,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,,CHEMBL622563
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,8270,Concentration of compound in Central nervous system,,,,CHEMBL622564
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,8271,Concentration of compound in Central nervous system; Not detectable,,,,CHEMBL622565
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13318,50594,,,,10090.0,,8272,"Concentration of diester in the blood, following oral administration in mice",,,,CHEMBL622566
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13318,50594,,,,10090.0,,8273,"Concentration of monoester in the blood, following oral administration in mice",,,,CHEMBL624515
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13318,50594,,,,10090.0,,8274,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,,,CHEMBL624516
Autocuration,BAO_0000019,,A,,1,,0,U,,15692,22224,,,,,,8275,Evaluated for Pharmacokinetic property: Area under the curve,,,,CHEMBL624517
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8276,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,,,CHEMBL624518
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8277,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,,,CHEMBL624519
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8278,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,,,CHEMBL624520
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8279,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,,,CHEMBL624521
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8280,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,,,CHEMBL624522
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8281,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,,,CHEMBL624523
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8282,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,,CHEMBL624409
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8283,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,,,CHEMBL624410
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8284,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,,CHEMBL624411
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8285,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,,,CHEMBL623531
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8286,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,,,CHEMBL623532
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8287,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,,,CHEMBL623533
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,8288,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,,CHEMBL623534
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8289,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,,,CHEMBL623535
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8290,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,,,CHEMBL623536
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8291,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,,,CHEMBL623537
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8292,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,,,CHEMBL623538
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8293,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,,,CHEMBL623539
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8294,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,,,CHEMBL623540
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8295,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,,,CHEMBL623541
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8296,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,,,CHEMBL623542
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8297,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,,,CHEMBL623543
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8298,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,,,CHEMBL623544
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8299,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,,,CHEMBL623545
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,8300,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,,,CHEMBL623546
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,1969.0,Plasma,10116.0,,8301,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL623547
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6827,50597,,,,10116.0,,8302,High i.v. clearance in Dawley rats,,In vivo,,CHEMBL623548
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,2107.0,Liver,10116.0,,8303,In vitro clearance in rat liver microsomes,Microsomes,In vitro,,CHEMBL623549
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6331,50597,,2107.0,Liver,10116.0,,8304,Intrinsic clearance in rat liver microsomes was determined,Microsomes,In vitro,,CHEMBL623550
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5948,50597,401.0,2107.0,Liver,10116.0,,8305,Intrinsic clearance in rat hepatocytes was determined,,In vitro,Hepatocyte,CHEMBL875276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,8306,Plasma Clearance was determined,,In vivo,,CHEMBL621872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6647,50597,,,,10116.0,,8307,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,In vivo,,CHEMBL621873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1696,50597,,,,10116.0,,8308,Plasma clearance in rat.,,In vivo,,CHEMBL621874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,,,10116.0,,8309,Plasma clearance in rats,,In vivo,,CHEMBL621875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,347,50597,,,,10116.0,,8310,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,In vivo,,CHEMBL621876
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,8311,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,In vivo,,CHEMBL621877
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,,,10116.0,,8312,Plasma clearance was measured in rat,,In vivo,,CHEMBL621878
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,8313,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,In vivo,,CHEMBL621879
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5328,50597,,1969.0,Plasma,10116.0,,8314,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,In vivo,,CHEMBL621880
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5160,50597,,,,10116.0,,8315,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,In vivo,,CHEMBL621881
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,8316,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,In vivo,,CHEMBL621882
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,,,10116.0,,8317,Total clearance at 1 mg/kg was determined in rat,,In vivo,,CHEMBL875283
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,,,10116.0,,8318,Total clearance at 10 mg/kg was determined in rat,,In vivo,,CHEMBL621883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6596,50597,,,,10116.0,,8319,Clearance in rat,,In vivo,,CHEMBL621884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4796,50597,,,,10116.0,,8320,Plasma clearance rate determined in rats,,In vivo,,CHEMBL621885
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6850,50597,,,,10116.0,,8321,Clearance of compound in rat was evaluated,,In vivo,,CHEMBL621886
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5932,50597,,1969.0,Plasma,10116.0,,8322,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,In vivo,,CHEMBL621887
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3371,50597,,,,10116.0,,8323,Pharmacokinetic property (blood clearance) in rat,,In vivo,,CHEMBL621888
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2083,50597,,,,10116.0,,8324,Plasma clearance in rat,,In vivo,,CHEMBL621889
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4942,50597,,,,10116.0,,8325,Plasma clearance in rats,,In vivo,,CHEMBL621890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6838,50597,,2107.0,Liver,10116.0,,8326,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Microsomes,In vitro,,CHEMBL621891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5353,50597,,,,10116.0,,8327,Clearance in Dawley rat,,In vivo,,CHEMBL621892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,8328,Clearance rat,,In vivo,,CHEMBL621893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,8329,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,In vivo,,CHEMBL621894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,8330,Clearance rat; Not determined,,In vivo,,CHEMBL621895
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,8331,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,In vivo,,CHEMBL875284
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,8332,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,In vivo,,CHEMBL618699
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,8333,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,In vivo,,CHEMBL618700
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6211,50597,,,,10116.0,,8334,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,In vivo,,CHEMBL618701
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,8335,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,In vivo,,CHEMBL876600
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,8336,Clearance of compound in rat after 1 mg/kg i.v. administration,,In vivo,,CHEMBL618702
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3341,50597,,,,10116.0,,8337,Compound was evaluated for Hepatic clearance in rat,,In vivo,,CHEMBL618703
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4891,50597,,,,10116.0,,8338,In vivo clearance after 5 mg/kg dose,,In vivo,,CHEMBL618704
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1094,50597,,1969.0,Plasma,10116.0,,8339,Compound was tested for plasma clearance in rats,,In vivo,,CHEMBL618705
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2938,50597,,,,10116.0,,8340,Hepatic clearance after intravenous administration was evaluated in rat,,In vivo,,CHEMBL618706
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17853,50597,,,,10116.0,,8341,Lower clearance in rat (i.v.) at 0.5 mpk,,In vivo,,CHEMBL618707
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6049,50597,,1969.0,Plasma,10116.0,,8342,Pharmacokinetic parameter expressed as plasma clearance in rat,,In vivo,,CHEMBL618708
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5789,50597,,,,10116.0,,8343,Pharmacokinetic property (Clp) in rat,,In vivo,,CHEMBL618709
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,,,10116.0,,8344,Plasma clearance in Sprague-Dawley rats,,In vivo,,CHEMBL618710
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6448,50597,,,,10116.0,,8345,Plasma clearance (Clp) in rat,,In vivo,,CHEMBL618711
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6062,50597,,,,10116.0,,8346,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,In vivo,,CHEMBL618712
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5710,50597,,,,10116.0,,8347,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,In vivo,,CHEMBL618713
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4709,50597,,,,10116.0,,8348,Plasma clearance after intravenous administration of 1 mg/kg in rat,,In vivo,,CHEMBL618714
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4521,50597,,,,10116.0,,8349,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,In vivo,,CHEMBL618715
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1742,50597,,,,10116.0,,8350,Plasma clearance in rat was determined,,In vivo,,CHEMBL618716
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,8351,Plasma clearance measured in rat,,In vivo,,CHEMBL876601
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,8352,Plasma clearance was calculated in rat,,In vivo,,CHEMBL618717
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5145,50597,,,,10116.0,,8353,Plasma clearance in rat,,In vivo,,CHEMBL618718
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5833,50597,,,,10116.0,,8354,Plasma clearance in rat,,In vivo,,CHEMBL618719
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6453,50597,,,,10116.0,,8355,Plasma clearance in rat,,In vivo,,CHEMBL618720
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,8356,Plasma clearance in rat,,In vivo,,CHEMBL618721
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6305,50597,,,,10116.0,,8357,Plasma clearance in rats,,In vivo,,CHEMBL621477
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6642,50597,,,,10116.0,,8358,Plasma clearance in rat,,In vivo,,CHEMBL621478
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,8359,Plasma clearance was evaluated in rat,,In vivo,,CHEMBL621479
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,8360,Plasma clearance was evaluated in rat; Not tested,,In vivo,,CHEMBL621480
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5144,50597,,,,10116.0,,8361,Plasma clearance rate was determined for the compound in rat,,In vivo,,CHEMBL621481
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,8362,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,In vivo,,CHEMBL621482
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,8363,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,In vivo,,CHEMBL621483
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,8364,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,In vivo,,CHEMBL621484
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,948.0,Heart,10116.0,,8365,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621485
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,948.0,Heart,10116.0,,8366,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621486
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,160.0,Intestine,10116.0,,8367,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621487
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,160.0,Intestine,10116.0,,8368,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,160.0,Intestine,10116.0,,8369,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,160.0,Intestine,10116.0,,8370,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621490
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,160.0,Intestine,10116.0,,8371,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2113.0,Kidney,10116.0,,8372,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621492
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2113.0,Kidney,10116.0,,8373,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2113.0,Kidney,10116.0,,8374,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2113.0,Kidney,10116.0,,8375,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2113.0,Kidney,10116.0,,8376,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621496
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2107.0,Liver,10116.0,,8377,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621497
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2107.0,Liver,10116.0,,8378,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2107.0,Liver,10116.0,,8379,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL621499
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2107.0,Liver,10116.0,,8380,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL618634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2107.0,Liver,10116.0,,8381,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL618635
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2048.0,Lung,10116.0,,8382,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL618636
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2048.0,Lung,10116.0,,8383,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2048.0,Lung,10116.0,,8384,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL619738
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2048.0,Lung,10116.0,,8385,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2048.0,Lung,10116.0,,8386,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2385.0,Muscle tissue,10116.0,,8387,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2385.0,Muscle tissue,10116.0,,8388,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2385.0,Muscle tissue,10116.0,,8389,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2385.0,Muscle tissue,10116.0,,8390,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624334
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2385.0,Muscle tissue,10116.0,,8391,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL624335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2106.0,Spleen,10116.0,,8392,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620016
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2106.0,Spleen,10116.0,,8393,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620169
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2106.0,Spleen,10116.0,,8394,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620170
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2106.0,Spleen,10116.0,,8395,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2106.0,Spleen,10116.0,,8396,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620172
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,945.0,Stomach,10116.0,,8397,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620173
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,945.0,Stomach,10116.0,,8398,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620174
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,945.0,Stomach,10116.0,,8399,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620175
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,945.0,Stomach,10116.0,,8400,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620176
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,945.0,Stomach,10116.0,,8401,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,In vivo,,CHEMBL620177
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2037.0,Cerebellum,10116.0,,8402,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620178
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2037.0,Cerebellum,10116.0,,8403,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620179
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,,,10116.0,,8404,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620180
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,8405,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,In vivo,,CHEMBL620181
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6571,50597,,,,10116.0,,8406,Volume of distribution of compound in rats after intravenous administration,,In vivo,,CHEMBL620182
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6453,50597,,,,10116.0,,8407,Volume of distribution in rat,,In vivo,,CHEMBL620183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,8408,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,In vivo,,CHEMBL620184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,8409,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,In vivo,,CHEMBL620185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,8410,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,In vivo,,CHEMBL620186
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5353,50597,,,,10116.0,,8411,Volume of distribution was determined in Dawley rat,,In vivo,,CHEMBL620187
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8412,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,In vivo,,CHEMBL620188
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8413,Volume of distribution was reported in Sprague-Dawley rat,,In vivo,,CHEMBL620189
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,8414,Volumes of distribution in rat after peroral administration,,In vivo,,CHEMBL620190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,8415,Volumes of distribution in rat after po administration,,In vivo,,CHEMBL620191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,8416,Volumes of distribution in rat after po administration; Not determined,,In vivo,,CHEMBL620192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5676,50597,,,,10116.0,,8417,Pharmacokinetic property (Volume) in rat i.v.,,In vivo,,CHEMBL620193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,8418,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,In vivo,,CHEMBL620194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17670,50597,,,,10116.0,,8419,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,In vivo,,CHEMBL876730
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,8420,Volume distribution in rat after oral administration at 10 mg/kg,,In vivo,,CHEMBL620195
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,,,10116.0,,8421,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL620196
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,8422,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,In vivo,,CHEMBL620197
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6647,50597,,,,10116.0,,8423,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,In vivo,,CHEMBL620198
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,8424,Volume of distribution in rats,,In vivo,,CHEMBL620199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,8425,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,In vivo,,CHEMBL620200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,8426,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,In vivo,,CHEMBL620201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8427,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL620202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8428,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL620203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8429,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,In vivo,,CHEMBL620204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8430,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL620205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5960,50597,,,,10116.0,,8431,Pharmacokinetic parameter (Vss) in rat,,In vivo,,CHEMBL624664
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5676,50597,,,,10116.0,,8432,Pharmacokinetic property (Volume) in rat i.v.,,In vivo,,CHEMBL624665
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5948,50597,,,,10116.0,,8433,Pharmacokinetic property (Vss) in rat,,,,CHEMBL624666
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5979,50597,,,,10116.0,,8434,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,In vivo,,CHEMBL624667
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,8435,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL624668
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,8436,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL624669
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,8437,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL624670
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,8438,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL624671
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6448,50597,,,,10116.0,,8439,Steady state volume distribution in rat,,In vivo,,CHEMBL624672
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,8440,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,In vivo,,CHEMBL624673
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,8441,Steady state volume of distribution determined in rat,,In vivo,,CHEMBL624674
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,8442,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,In vivo,,CHEMBL624675
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,,,10116.0,,8443,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,In vivo,,CHEMBL621728
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,8444,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,,,CHEMBL621729
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,8445,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,,,CHEMBL621730
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,8446,Volume distribution in rat after administration of 2 mg/kg iv,,In vivo,,CHEMBL621731
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,8447,Volume distribution in rat after administration of 2 mg/kg iv,,In vivo,,CHEMBL621732
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,8448,Volume in steady state distribution value was determined,,In vivo,,CHEMBL621908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,8449,Volume in steady state distribution value was determined; ND denotes no data,,In vivo,,CHEMBL875347
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,8450,Volume in steady state distribution value was determined; ND denotes not determined,,In vivo,,CHEMBL621909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17065,50597,,,,10116.0,,8451,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,In vivo,,CHEMBL621910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,,,10116.0,,8452,Volume of distribution at steady state was evaluated in rats,,In vivo,,CHEMBL621911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,8453,Volume of distribution at steady state was observed after intravenous administration in rat,,In vivo,,CHEMBL621912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6485,50597,,,,10116.0,,8454,Volume of distribution in steady state was determined in rat,,In vivo,,CHEMBL621913
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,,,10116.0,,8455,Volume of distribution in steady state was determined in rat,,In vivo,,CHEMBL621914
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6616,50597,,,,10116.0,,8456,Volume of distribution after i.v. administration,,In vivo,,CHEMBL621915
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,,,10116.0,,8457,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,In vivo,,CHEMBL621916
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2107.0,Liver,10090.0,,8458,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,In vivo,,CHEMBL621917
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2107.0,Liver,10090.0,,8459,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,In vivo,,CHEMBL621918
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8460,Biodistribution of compound (oxidized form) in spleen tissue,,In vivo,,CHEMBL621919
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8461,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,In vivo,,CHEMBL621920
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8462,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,In vivo,,CHEMBL621921
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8463,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL622401
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8464,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,In vivo,,CHEMBL875348
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8465,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,In vivo,,CHEMBL622402
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,178.0,Blood,10090.0,,8466,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,In vivo,,CHEMBL622403
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,178.0,Blood,10090.0,,8467,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL622404
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,955.0,Brain,10090.0,,8468,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,In vivo,,CHEMBL622405
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,955.0,Brain,10090.0,,8469,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,In vivo,,CHEMBL622406
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,955.0,Brain,10090.0,,8470,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL622407
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,948.0,Heart,10090.0,,8471,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,In vivo,,CHEMBL622408
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,948.0,Heart,10090.0,,8472,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,In vivo,,CHEMBL622409
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,948.0,Heart,10090.0,,8473,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL622410
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2113.0,Kidney,10090.0,,8474,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,In vivo,,CHEMBL622411
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2113.0,Kidney,10090.0,,8475,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,In vivo,,CHEMBL627864
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2113.0,Kidney,10090.0,,8476,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL627865
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2107.0,Liver,10090.0,,8477,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,In vivo,,CHEMBL627866
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2107.0,Liver,10090.0,,8478,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL627751
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8479,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,In vivo,,CHEMBL627752
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8480,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,In vivo,,CHEMBL627753
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16438,50594,,2106.0,Spleen,10090.0,,8481,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,In vivo,,CHEMBL627754
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12467,50594,,,,10090.0,,8482,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,,,CHEMBL627755
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,955.0,Brain,10090.0,,8483,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627756
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,955.0,Brain,10090.0,,8484,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627757
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,955.0,Brain,10090.0,,8485,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627758
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,955.0,Brain,10090.0,,8486,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627759
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,955.0,Brain,10090.0,,8487,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627760
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,955.0,Brain,10090.0,,8488,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627761
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,948.0,Heart,10090.0,,8489,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL876811
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,948.0,Heart,10090.0,,8490,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627762
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,948.0,Heart,10090.0,,8491,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627763
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,948.0,Heart,10090.0,,8492,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627764
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,948.0,Heart,10090.0,,8493,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627765
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,948.0,Heart,10090.0,,8494,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627766
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2113.0,Kidney,10090.0,,8495,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627767
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2113.0,Kidney,10090.0,,8496,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627768
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2113.0,Kidney,10090.0,,8497,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL628422
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2113.0,Kidney,10090.0,,8498,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL628423
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5089,50597,,,,10116.0,,8499,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,In vivo,,CHEMBL628424
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5089,50597,,,,10116.0,,8500,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,In vivo,,CHEMBL628425
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4257,50597,,,,10116.0,,8501,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,In vivo,,CHEMBL628426
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6679,50597,,,,10116.0,,8502,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,In vivo,,CHEMBL628427
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5546,50597,,,,10116.0,,8503,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,In vivo,,CHEMBL626938
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6141,50597,,,,10116.0,,8504,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,In vivo,,CHEMBL626939
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8505,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,In vivo,,CHEMBL626940
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8506,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,In vivo,,CHEMBL626941
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,8507,Plasma clearance was reported in Sprague-Dawley rat,,In vivo,,CHEMBL626942
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,8508,Plasma clearance after intravenous administration (1 mg/kg) in rat,,In vivo,,CHEMBL876812
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6848,50597,,,,10116.0,,8509,Plasma clearance of compound in rats was evaluated,,In vivo,,CHEMBL626943
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6848,50597,,,,10116.0,,8510,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,In vivo,,CHEMBL626944
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6467,50597,,,,10116.0,,8511,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,In vivo,,CHEMBL626945
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6467,50597,,,,10116.0,,8512,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,In vivo,,CHEMBL626946
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4956,50597,,,,10116.0,,8513,Plasma clearance rate in Sprague-Dawley rats,,In vivo,,CHEMBL626856
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5529,50597,,,,10116.0,,8514,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,In vivo,,CHEMBL626857
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,406,50597,,1969.0,Plasma,10116.0,,8515,The compound was evaluated for plasma clearance in rat,,In vivo,,CHEMBL626858
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,1969.0,Plasma,10116.0,,8516,Total plasma clearance in rat,,In vivo,,CHEMBL627018
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3293,50597,,178.0,Blood,10116.0,,8517,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,In vivo,,CHEMBL625331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4075,50597,,178.0,Blood,10116.0,,8518,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,In vivo,,CHEMBL625332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,8519,C max was determined at 10 mg/kg po dose in rats,,In vivo,,CHEMBL877590
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,8520,C max was determined at 3 mg/kg po dose in rats,,In vivo,,CHEMBL625333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,,,10116.0,,8521,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,In vivo,,CHEMBL625334
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,,,10116.0,,8522,Cmax after single intravenous bolus of 1 mg/kg in rats,,In vivo,,CHEMBL625335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4762,50597,,,,10116.0,,8523,Cmax of compound at 5 mg/kg after po administration was determined in rat,,In vivo,,CHEMBL625336
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,8524,Cmax 24 hr after 10 mg/kg oral administration in rats,,In vivo,,CHEMBL625337
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,8525,Cmax 24 hr after 2 mg/kg oral administration in rats,,In vivo,,CHEMBL625338
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,1969.0,Plasma,10116.0,,8526,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,In vivo,,CHEMBL625339
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,8527,Cmax in rat after administration of 2 mg/kg iv,,In vivo,,CHEMBL625340
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,8528,Cmax in rat after administration of 2 mg/kg iv,,In vivo,,CHEMBL625341
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,8529,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,In vivo,,CHEMBL622687
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6515,50597,,1969.0,Plasma,10116.0,,8530,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,In vivo,,CHEMBL622688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11149,50597,,178.0,Blood,10116.0,,8531,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,In vivo,,CHEMBL622689
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11149,50597,,178.0,Blood,10116.0,,8532,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,In vivo,,CHEMBL620295
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17858,50597,,,,10116.0,,8533,Cmax after 10 mg/kg oral administration in rat,,In vivo,,CHEMBL620296
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,8534,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,In vivo,,CHEMBL620297
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,8535,Cmax after IV dosing at 1 mg/kg in rat; no data,,In vivo,,CHEMBL620298
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,8536,Cmax after oral administration at 20 mpk in rats,,In vivo,,CHEMBL620299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,8537,Cmax after oral administration at 20 mpk in rats; Not performed.,,In vivo,,CHEMBL620300
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,8538,Cmax after oral administration at 20 mpk in rats d; Not performed.,,In vivo,,CHEMBL620301
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,8539,Cmax after oral administration in rat,,In vivo,,CHEMBL620302
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,8540,Cmax after oral administration at a dose of 2 mg/kg in rat,,In vivo,,CHEMBL620303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,8541,Cmax after oral administration at a dose of 4 mg/kg in rat,,In vivo,,CHEMBL620304
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6113,50597,,,,10116.0,,8542,Cmax in rats after 20 mg/kg oral dose,,In vivo,,CHEMBL620305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,8543,Cmax after peroral administration in rats at 2.4 uM/kg,,In vivo,,CHEMBL620306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,8544,Cmax at the dose of 2 mg/Kg administered perorally in rats,,In vivo,,CHEMBL620307
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,8545,Cmax at the dose of 5 mg/Kg administered perorally in rats,,In vivo,,CHEMBL620308
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6402,50597,,,,10116.0,,8546,Cmax by administering at 20 mg/kg p.o. in rats,,In vivo,,CHEMBL620309
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5610,50597,,,,10116.0,,8547,Cmax in male rat,,In vivo,,CHEMBL620310
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5207,50597,,,,10116.0,,8548,Cmax in rat,,In vivo,,CHEMBL620311
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6011,50597,,,,10116.0,,8549,Cmax in rat,,In vivo,,CHEMBL620312
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6504,50597,,,,10116.0,,8550,Cmax in rat,,In vivo,,CHEMBL620313
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6046,50597,,,,10116.0,,8551,Cmax in rat at 10 mg/kg,,In vivo,,CHEMBL620314
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6504,50597,,,,10116.0,,8552,Cmax in rat at the dose of 1 mg/kg i.v.,,In vivo,,CHEMBL620315
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5874,50597,,,,10116.0,,8553,Cmax in rat by po administration at a dose of 40 mg/kg,,In vivo,,CHEMBL620316
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,8554,Cmax in rat p.o. at 20 mg/kg concentration,,In vivo,,CHEMBL620317
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5836,50597,,,,10116.0,,8555,Cmax in rats,,In vivo,,CHEMBL620318
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,,,10116.0,,8556,Cmax in rats,,In vivo,,CHEMBL620319
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,8557,Cmax was evaluated after 20 uM/kg of peroral administration,,In vivo,,CHEMBL620320
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,8558,Cmax was measured in rats after peroral administration at 3 mg/kg,,In vivo,,CHEMBL620321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,,,10116.0,,8559,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,In vivo,,CHEMBL620322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,,,10116.0,,8560,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,1870.0,Frontal cortex,10116.0,,8561,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620324
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,1870.0,Frontal cortex,10116.0,,8562,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620325
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,10000000.0,Hippocampus,10116.0,,8563,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620326
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,10000000.0,Hippocampus,10116.0,,8564,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,,,10116.0,,8565,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620328
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,,,10116.0,,8566,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,1891.0,Midbrain,10116.0,,8567,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,1891.0,Midbrain,10116.0,,8568,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL875286
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,,,10116.0,,8569,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,,,10116.0,,8570,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2435.0,Striatum,10116.0,,8571,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13950,50597,,2435.0,Striatum,10116.0,,8572,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,CHEMBL620334
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8573,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL621015
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8574,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL621016
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8575,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL621191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8576,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL621192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8577,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL621193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8578,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL621194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8579,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL624204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8580,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL624205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8581,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL624206
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8582,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL624207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8583,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL624208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8584,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL624209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8585,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL624210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8586,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL624211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8587,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL624212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8588,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL624213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8589,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL876611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8590,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL624214
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,178.0,Blood,10116.0,,8591,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL624215
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8592,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL624216
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8593,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL624217
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8594,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL624218
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8595,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL624219
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8596,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL624220
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,178.0,Blood,10116.0,,8597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL624221
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8598,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL624222
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8599,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL624223
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8600,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL624224
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8601,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL624225
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,8602,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,In vivo,,CHEMBL622420
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5031,50597,,,,10116.0,,8603,Volume of steady state distribution after i.v. administration in rats,,In vivo,,CHEMBL622421
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6215,50597,,,,10116.0,,8604,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,In vivo,,CHEMBL622422
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17671,50597,,,,10116.0,,8605,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,In vivo,,CHEMBL622423
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,,,10116.0,,8606,Vss was determined,,In vivo,,CHEMBL622424
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6596,50597,,,,10116.0,,8607,Vss in rat,,In vivo,,CHEMBL622425
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,8608,Vss was evaluated after 10 uM/kg of intra arterial administration,,In vivo,,CHEMBL876612
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,8609,volume of distribution at steady state was observed after intravenous administration in rat,,In vivo,,CHEMBL622426
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6062,50597,,,,10116.0,,8610,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,In vivo,,CHEMBL622427
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5874,50597,,,,10116.0,,8611,Pharmacokinetic (PK) parameter Vz in rat,,In vivo,,CHEMBL622428
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4942,50597,,,,10116.0,,8612,Volume distribution in rats,,In vivo,,CHEMBL622429
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,8613,Volume of distribution in rat; No data,,In vivo,,CHEMBL622430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,,,10116.0,,8614,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL622431
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,2116.0,Ileum,10116.0,,8615,% absorption predicted from in vitro rat ileum transport studies,,,,CHEMBL622432
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8616,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,In vivo,,CHEMBL622433
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8617,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,In vivo,,CHEMBL622434
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8618,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,In vivo,,CHEMBL622435
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8619,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,In vivo,,CHEMBL618748
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8620,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,In vivo,,CHEMBL618749
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8621,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,In vivo,,CHEMBL618750
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8622,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,In vivo,,CHEMBL618751
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13569,50597,,,,10116.0,,8623,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,In vivo,,CHEMBL618752
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,8624,Oral bioavailability in rat,,In vivo,,CHEMBL618753
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,750,50597,,1969.0,Plasma,10116.0,,8625,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,In vivo,,CHEMBL618754
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,750,50597,,,,10116.0,,8626,Oral bioavailability in rat,,In vivo,,CHEMBL618755
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4590,50597,,,,10116.0,,8627,Oral bioavailability in rat,,In vivo,,CHEMBL618756
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1716,50597,,,,10116.0,,8628,Oral bioavailability in rat,,In vivo,,CHEMBL618757
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1974,50597,,,,10116.0,,8629,Bioavailability in rat,,In vivo,,CHEMBL618758
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4502,50597,,,,10116.0,,8630,Oral bioavailability in rat (dose 30 mg/kg),,In vivo,,CHEMBL621088
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3371,50597,,,,10116.0,,8631,Pharmacokinetic property (cLogP) in rat,,,,CHEMBL621089
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,9099,50597,,178.0,Blood,10116.0,,8632,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,,,CHEMBL621090
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,9099,50597,,178.0,Blood,10116.0,,8633,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,,,CHEMBL621091
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4590,50597,,,,10116.0,,8634,Clearance in rat.,,In vivo,,CHEMBL876731
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3184,50597,,,,10116.0,,8635,Compound was evaluated for its clearance when administered intravenously in rat,,In vivo,,CHEMBL621092
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16456,50597,,,,10116.0,,8636,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,In vivo,,CHEMBL621093
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,8637,Blood: Brain distribution ratio is determined in rat,,,,CHEMBL621094
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,8638,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,,,CHEMBL621095
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,8639,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,,,CHEMBL621096
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2113.0,Kidney,10116.0,,8640,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL621097
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,8641,Percent dose excreted in 0-48 hours administered ip to male rat,,,,CHEMBL621098
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2037.0,Cerebellum,10116.0,,8642,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621099
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2037.0,Cerebellum,10116.0,,8643,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621100
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2037.0,Cerebellum,10116.0,,8644,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,,CHEMBL621101
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2037.0,Cerebellum,10116.0,,8645,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621102
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2037.0,Cerebellum,10116.0,,8646,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL876732
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8647,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621103
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8648,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621104
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8649,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,,CHEMBL621105
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8650,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621106
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8651,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621107
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8652,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621108
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8653,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL621109
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2113.0,Kidney,10090.0,,8654,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL621110
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2113.0,Kidney,10090.0,,8655,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL621111
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2107.0,Liver,10090.0,,8656,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL622541
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2107.0,Liver,10090.0,,8657,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL622542
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2107.0,Liver,10090.0,,8658,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL622543
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2107.0,Liver,10090.0,,8659,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624412
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2107.0,Liver,10090.0,,8660,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624413
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2107.0,Liver,10090.0,,8661,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624414
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2048.0,Lung,10090.0,,8662,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624415
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2048.0,Lung,10090.0,,8663,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624416
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2048.0,Lung,10090.0,,8664,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624417
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2048.0,Lung,10090.0,,8665,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624418
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2048.0,Lung,10090.0,,8666,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624419
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2048.0,Lung,10090.0,,8667,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624420
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2385.0,Muscle tissue,10090.0,,8668,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624421
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2385.0,Muscle tissue,10090.0,,8669,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624422
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2385.0,Muscle tissue,10090.0,,8670,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL624423
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2385.0,Muscle tissue,10090.0,,8671,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL625123
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2385.0,Muscle tissue,10090.0,,8672,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL625124
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2385.0,Muscle tissue,10090.0,,8673,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL625125
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,14.0,Zone of skin,10090.0,,8674,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL625126
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,14.0,Zone of skin,10090.0,,8675,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626947
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,14.0,Zone of skin,10090.0,,8676,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626948
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,14.0,Zone of skin,10090.0,,8677,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626949
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,14.0,Zone of skin,10090.0,,8678,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626950
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,14.0,Zone of skin,10090.0,,8679,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626951
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2106.0,Spleen,10090.0,,8680,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626952
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2106.0,Spleen,10090.0,,8681,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626953
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2106.0,Spleen,10090.0,,8682,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626954
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2106.0,Spleen,10090.0,,8683,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626955
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2106.0,Spleen,10090.0,,8684,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626956
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,2106.0,Spleen,10090.0,,8685,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626957
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,178.0,Blood,10090.0,,8686,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626958
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,178.0,Blood,10090.0,,8687,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626959
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,178.0,Blood,10090.0,,8688,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626960
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,178.0,Blood,10090.0,,8689,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL626961
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,178.0,Blood,10090.0,,8690,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627589
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17208,50594,,178.0,Blood,10090.0,,8691,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,In vivo,,CHEMBL627590
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3132,50594,,,,10090.0,,8692,Time taken for EC90 was determined when tested in mouse,,,,CHEMBL627591
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3132,50594,,,,10090.0,,8693,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,,,CHEMBL627592
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,16597,50594,,,,10090.0,,8694,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,In vivo,,CHEMBL627593
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5727,50594,,,,10090.0,,8695,Half life in mice,,,,CHEMBL627594
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5302,50594,,,,10090.0,,8696,Half life period in mouse after 10 mg/Kg dose,,In vivo,,CHEMBL876813
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5302,50594,,,,10090.0,,8697,Half life period in mouse after 10 mg/kg dose,,In vivo,,CHEMBL627595
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,6348,50594,,,,10090.0,,8698,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,In vivo,,CHEMBL627596
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5964,50597,,,,10116.0,,8699,Cmax value at 5 mg/kg po was determined in rat,,In vivo,,CHEMBL627597
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,8700,Cmax value evaluated in rat,,In vivo,,CHEMBL627598
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5206,50597,,955.0,Brain,10116.0,,8701,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,In vivo,,CHEMBL627599
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2959,50597,,,,10116.0,,8702,Cmax value after administration of 20 mg/Kg oral dose in rat,,In vivo,,CHEMBL627600
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5964,50597,,,,10116.0,,8703,Cmax value at 1 mg/kg po in rat,,In vivo,,CHEMBL627601
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5964,50597,,,,10116.0,,8704,Cmax value at 5 mg/kg po in rat,,In vivo,,CHEMBL627776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,8705,Cmax value at a dose of 10 mg/kg in male SD rats,,In vivo,,CHEMBL627777
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,8706,Cmax value at a dose of 100 mg/kg in male SD rats,,In vivo,,CHEMBL627778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,8707,Cmax value at a dose of 50 mg/kg in male SD rats,,In vivo,,CHEMBL627779
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17617,50597,,,,10116.0,,8708,Cmax value in rats at 10 mg/kg,,In vivo,,CHEMBL876814
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1445,50597,,,,10116.0,,8709,Cmax value was evaluated in rats at a dose of 20 mg/kg,,In vivo,,CHEMBL627780
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6082,50597,,,,10116.0,,8710,Cmax value was determined after peroral administration of 20 mg/kg in rat,,In vivo,,CHEMBL627781
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1446,50597,,,,10116.0,,8711,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,In vivo,,CHEMBL627782
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5407,50597,,1969.0,Plasma,10116.0,,8712,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,In vivo,,CHEMBL627783
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2690,50597,,1969.0,Plasma,10116.0,,8713,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,In vivo,,CHEMBL627784
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,8714,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,In vivo,,CHEMBL627785
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,8715,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,In vivo,,CHEMBL627786
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4891,50597,,1969.0,Plasma,10116.0,,8716,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,In vivo,,CHEMBL627787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2807,50597,,1969.0,Plasma,10116.0,,8717,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,In vivo,,CHEMBL627788
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2807,50597,,1969.0,Plasma,10116.0,,8718,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,In vivo,,CHEMBL626579
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2807,50597,,1969.0,Plasma,10116.0,,8719,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,In vivo,,CHEMBL626580
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3634,50597,,,,10116.0,,8720,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,In vivo,,CHEMBL876815
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1881,50597,,1969.0,Plasma,10116.0,,8721,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,In vivo,,CHEMBL626581
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1881,50597,,1969.0,Plasma,10116.0,,8722,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,In vivo,,CHEMBL626582
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,8723,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,In vivo,,CHEMBL626583
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8724,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL626205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8725,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL626206
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8726,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL626207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,8727,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL623882
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,8728,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,In vivo,,CHEMBL623883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,8729,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,In vivo,,CHEMBL623884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3032,50597,,1969.0,Plasma,10116.0,,8730,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,In vivo,,CHEMBL623885
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6295,50597,,1969.0,Plasma,10116.0,,8731,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,In vivo,,CHEMBL623886
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6619,50597,,,,10116.0,,8732,Maximal concentration in rat was determined,,In vivo,,CHEMBL623887
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6616,50597,,,,10116.0,,8733,Maximal concentration after i.v. administration,,In vivo,,CHEMBL623888
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3249,50597,,1969.0,Plasma,10116.0,,8734,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,In vivo,,CHEMBL623889
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,1969.0,Plasma,10116.0,,8735,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,In vivo,,CHEMBL623890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,1969.0,Plasma,10116.0,,8736,Cmax in rat plasma after oral dose (50 mg/Kg),,In vivo,,CHEMBL623891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1360,50597,,1969.0,Plasma,10116.0,,8737,Maximal plasma concentration was determined.,,In vivo,,CHEMBL623892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2552,50597,,1969.0,Plasma,10116.0,,8738,Maximal plasma drug concentration was determined,,In vivo,,CHEMBL623893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6571,50597,,,,10116.0,,8739,Maximal concentration in rats after peroral administration,,In vivo,,CHEMBL877616
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,8740,Maximum concentration in rat after 2 mg/kg peroral administration,,In vivo,,CHEMBL623894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6567,50597,,1969.0,Plasma,10116.0,,8741,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,In vivo,,CHEMBL623895
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3031,50597,,,,10116.0,,8742,Maximum concentration of compound in rat was evaluated.,,In vivo,,CHEMBL623896
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3436,50597,,,,10116.0,,8743,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,In vivo,,CHEMBL623897
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3436,50597,,,,10116.0,,8744,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,In vivo,,CHEMBL623898
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2083,50597,,,,10116.0,,8745,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,In vivo,,CHEMBL623899
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3436,50597,,,,10116.0,,8746,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,In vivo,,CHEMBL623900
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,8747,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,In vivo,,CHEMBL623901
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1974,50597,,,,10116.0,,8748,Maximum concentration was evaluated in rats,,In vivo,,CHEMBL623902
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3307,50597,,1359.0,Cerebrospinal fluid,10116.0,,8749,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,In vivo,,CHEMBL623903
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3307,50597,,1969.0,Plasma,10116.0,,8750,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,In vivo,,CHEMBL623904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,1969.0,Plasma,10116.0,,8751,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,In vivo,,CHEMBL877617
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1500,50597,,,,10116.0,,8752,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,In vivo,,CHEMBL623905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1500,50597,,,,10116.0,,8753,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,In vivo,,CHEMBL623906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4186,50597,,1969.0,Plasma,10116.0,,8754,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,In vivo,,CHEMBL623907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8755,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL623908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8756,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL623909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8757,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL623910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8758,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL623911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8759,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL623912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8760,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL624616
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8761,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL624617
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8762,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL624618
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8763,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL624619
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8764,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL624794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8765,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL624795
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8766,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL623921
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8767,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL623922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8768,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL623923
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,8769,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL623924
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8770,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL623925
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8771,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL623926
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8772,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL623927
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8773,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL623928
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8774,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL623929
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,8775,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL623930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8776,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL623931
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8777,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL622165
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8778,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL621249
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8779,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL621250
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8780,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL621448
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8781,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL621449
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8782,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL621450
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8783,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL621451
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8784,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL621452
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8785,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL621453
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8786,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL621454
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8787,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL621455
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8788,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL621456
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8789,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL625145
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8790,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL875847
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8791,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL625146
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8792,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL625147
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8793,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL625148
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,955.0,Brain,10116.0,,8794,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL625149
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8795,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL625150
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8796,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL625151
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8797,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL625152
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8798,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL625153
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8799,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL625154
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,955.0,Brain,10116.0,,8800,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL625155
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8801,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,,CHEMBL625156
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,8802,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624354
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,10000000.0,Hippocampus,10116.0,,8803,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624355
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,10000000.0,Hippocampus,10116.0,,8804,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624356
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,10000000.0,Hippocampus,10116.0,,8805,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624357
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,10000000.0,Hippocampus,10116.0,,8806,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624358
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2435.0,Striatum,10116.0,,8807,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624359
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2435.0,Striatum,10116.0,,8808,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624360
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2435.0,Striatum,10116.0,,8809,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,,CHEMBL624361
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2435.0,Striatum,10116.0,,8810,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624362
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2435.0,Striatum,10116.0,,8811,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,CHEMBL624363
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,178.0,Blood,10116.0,,8812,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL624364
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,178.0,Blood,10116.0,,8813,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL624365
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,178.0,Blood,10116.0,,8814,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL624366
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,178.0,Blood,10116.0,,8815,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL624367
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,955.0,Brain,10116.0,,8816,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL624368
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,955.0,Brain,10116.0,,8817,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL624369
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,955.0,Brain,10116.0,,8818,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL624370
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,955.0,Brain,10116.0,,8819,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625069
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,955.0,Brain,10116.0,,8820,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625070
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,948.0,Heart,10116.0,,8821,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626051
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,948.0,Heart,10116.0,,8822,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626052
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,948.0,Heart,10116.0,,8823,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL626053
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,948.0,Heart,10116.0,,8824,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626054
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,948.0,Heart,10116.0,,8825,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626055
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2113.0,Kidney,10116.0,,8826,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626056
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2113.0,Kidney,10116.0,,8827,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626057
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2113.0,Kidney,10116.0,,8828,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2113.0,Kidney,10116.0,,8829,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2107.0,Liver,10116.0,,8830,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625195
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2107.0,Liver,10116.0,,8831,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625196
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2107.0,Liver,10116.0,,8832,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL625197
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2107.0,Liver,10116.0,,8833,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625198
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2107.0,Liver,10116.0,,8834,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL627929
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2048.0,Lung,10116.0,,8835,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL627074
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2048.0,Lung,10116.0,,8836,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL627075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2048.0,Lung,10116.0,,8837,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL627076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2048.0,Lung,10116.0,,8838,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL627077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2048.0,Lung,10116.0,,8839,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL627078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2385.0,Muscle tissue,10116.0,,8840,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL627079
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,4573,50594,,,,10090.0,,8841,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,In vivo,,CHEMBL873824
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3132,50594,,1969.0,Plasma,10090.0,,8842,Half life in mouse plasma was determined at dose 25 mg/kg,,In vivo,,CHEMBL627080
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17718,50594,,,,10090.0,,8843,Half life was determined,,,,CHEMBL627081
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17728,50594,,,,10090.0,,8844,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,In vivo,,CHEMBL627082
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5961,50594,,,,10090.0,,8845,Half-life in male mice after 1 mg/kg intravenous dose,,In vivo,,CHEMBL627083
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17731,50594,,1969.0,Plasma,10090.0,,8847,Half life in mice plasma,,,,CHEMBL627085
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17592,50594,,,,10090.0,,8848,Half life in mouse,,,,CHEMBL627086
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3132,50594,,1969.0,Plasma,10090.0,,8849,Half life in mouse plasma at dose 25 mg/kg,,In vivo,,CHEMBL627087
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17729,50594,,,,10090.0,,8850,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,In vivo,,CHEMBL627088
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17729,50594,,,,10090.0,,8851,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,In vivo,,CHEMBL627089
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17729,50594,,,,10090.0,,8852,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,In vivo,,CHEMBL627090
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3277,50594,,,,10090.0,,8853,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,In vivo,,CHEMBL627091
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3760,50594,,,,10090.0,,8854,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,In vivo,,CHEMBL627092
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,3760,50594,,,,10090.0,,8855,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,In vivo,,CHEMBL876785
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,2862,50594,,,,10090.0,,8856,Half-life by iv administration in mouse,,In vivo,,CHEMBL627093
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,2862,50594,,,,10090.0,,8857,Half-life by oral administration in mouse,,In vivo,,CHEMBL627094
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5980,50594,,,,10090.0,,8858,Half-life in mice,,,,CHEMBL627095
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,6159,50594,,955.0,Brain,10090.0,,8859,Half-life using mouse brain homogenate,,,,CHEMBL627096
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,6254,50594,,,,10090.0,,8860,Half-life was measured in mice,,,,CHEMBL627097
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,6062,50594,,,,10090.0,,8861,Half-life was measured in mouse after an iv dose of 1 mg/kg,,In vivo,,CHEMBL627098
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,1574,50594,,178.0,Blood,10090.0,,8862,Half-life period was determined in mouse blood,,,,CHEMBL627099
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,56,50594,,955.0,Brain,10090.0,,8863,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,,,CHEMBL627100
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,993,50594,,1969.0,Plasma,10090.0,,8864,Plasma half life in mouse,,,,CHEMBL627101
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,6652,50594,,,,10090.0,,8865,Stability of the peptide in the presence of mouse serum,,,,CHEMBL627102
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17852,50594,,,,10090.0,,8866,Terminal half life of compound was determined in mouse,,,,CHEMBL627103
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,2675,50594,,,,10090.0,,8867,Terminal half life was evaluated in mice after intravenous administration,,In vivo,,CHEMBL627104
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,2675,50594,,,,10090.0,,8868,Terminal half life was evaluated in mice after oral administration,,In vivo,,CHEMBL627105
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,499,50594,,,,10090.0,,8869,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,,,CHEMBL876786
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,499,50594,,,,10090.0,,8870,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,,,CHEMBL873825
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,499,50594,,,,10090.0,,8871,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,,,CHEMBL627106
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14239,50594,,,,10090.0,,8872,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,In vivo,,CHEMBL626336
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5506,50594,,,,10090.0,,8873,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,In vivo,,CHEMBL877462
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,5506,50594,,,,10090.0,,8874,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,In vivo,,CHEMBL626337
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17734,50594,,,,10090.0,,8875,Half life after intraperitoneal administration of 100 mg/kg in mice,,,,CHEMBL626338
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17728,50594,,,,10090.0,,8876,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,In vivo,,CHEMBL626339
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17728,50594,,,,10090.0,,8877,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,In vivo,,CHEMBL626340
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17728,50594,,,,10090.0,,8878,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,In vivo,,CHEMBL625377
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17728,50594,,,,10090.0,,8879,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,In vivo,,CHEMBL625378
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,17728,50594,,,,10090.0,,8880,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,In vivo,,CHEMBL625379
Autocuration,BAO_0000251,,A,,1,Sus scrofa,0,U,,14294,22224,,,,9823.0,,8881,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,,,CHEMBL625380
Autocuration,BAO_0000251,,A,,1,Sus scrofa,0,U,,14294,22224,,,,9823.0,,8882,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Microsomes,,,CHEMBL625381
Autocuration,BAO_0000019,,A,,1,Sus scrofa,0,U,,6056,22224,,,,9823.0,,8883,Stability to porcine renal DHP-I,,,,CHEMBL625382
Autocuration,BAO_0000218,,A,,1,Sus scrofa,0,U,,1317,22224,,,,9823.0,,8884,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,In vivo,,CHEMBL873828
Autocuration,BAO_0000218,,A,,1,Sus scrofa,0,U,,1317,22224,,,,9823.0,,8885,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,In vivo,,CHEMBL625383
Autocuration,BAO_0000019,,A,,1,Sus scrofa,0,U,,5229,22224,,,,9823.0,,8886,Half-life of the parent prodrug in porcine esterase solution,,,,CHEMBL625384
Autocuration,BAO_0000019,,A,,1,Sus scrofa,0,U,,4231,22224,,,,9823.0,,8887,"First order rate constant, k was determined in in pig liver Esterase",,,,CHEMBL625385
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,4231,22224,,2107.0,Liver,9823.0,,8888,Half life of the in pig liver Esterase,,,,CHEMBL625386
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,5318,22224,,2107.0,Liver,9823.0,,8889,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,,,CHEMBL623571
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,5318,22224,,2107.0,Liver,9823.0,,8890,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,,,CHEMBL623572
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,5318,22224,,2107.0,Liver,9823.0,,8891,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,,,CHEMBL623573
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,3305,22224,,2107.0,Liver,9823.0,,8892,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,,,CHEMBL623574
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,3305,22224,,2107.0,Liver,9823.0,,8893,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,,,CHEMBL623575
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,2842,22224,,2107.0,Liver,9823.0,,8894,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,,,CHEMBL623749
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,2842,22224,,2107.0,Liver,9823.0,,8895,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,,,CHEMBL623750
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,889,22224,,2107.0,Liver,9823.0,,8896,Half-life in vitro in pig liver,,In vitro,,CHEMBL623751
Autocuration,BAO_0000221,,A,,1,Sus scrofa,0,U,,1904,22224,,2107.0,Liver,9823.0,,8897,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,,,CHEMBL623752
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4186,50597,,1969.0,Plasma,10116.0,,8898,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,In vivo,,CHEMBL623753
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2774,50597,,1969.0,Plasma,10116.0,,8899,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,In vivo,,CHEMBL623754
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1742,50597,,1969.0,Plasma,10116.0,,8900,Maximum concentration in rat plasma was determined,,In vivo,,CHEMBL623755
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,8901,Maximum concentration in rats,,In vivo,,CHEMBL623756
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,8902,Maximum concentration in rats at 1-2 hours,,In vivo,,CHEMBL623757
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2081,50597,,,,10116.0,,8903,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,In vivo,,CHEMBL623758
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3307,50597,,955.0,Brain,10116.0,,8904,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,In vivo,,CHEMBL623759
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,8905,Maximum concentration at the dose of 2 mg/kg in rat,,In vivo,,CHEMBL623760
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,,,10116.0,,8906,Maximum concentration was evaluated in rats,,In vivo,,CHEMBL623761
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,1969.0,Plasma,10116.0,,8907,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,In vivo,,CHEMBL623762
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,1969.0,Plasma,10116.0,,8908,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,In vivo,,CHEMBL877594
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,1969.0,Plasma,10116.0,,8909,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,In vivo,,CHEMBL623763
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,1969.0,Plasma,10116.0,,8910,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,In vivo,,CHEMBL623764
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,1969.0,Plasma,10116.0,,8911,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,In vivo,,CHEMBL623765
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2591,50597,,178.0,Blood,10116.0,,8912,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,In vivo,,CHEMBL623766
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2591,50597,,178.0,Blood,10116.0,,8913,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,In vivo,,CHEMBL623767
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2591,50597,,178.0,Blood,10116.0,,8914,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,In vivo,,CHEMBL623768
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8915,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623769
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8916,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623770
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8917,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623771
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8918,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623772
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8919,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623773
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8920,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623774
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,1969.0,Plasma,10116.0,,8921,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,In vivo,,CHEMBL623775
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14465,50597,,,,10116.0,,8922,Cmax in rat (PO dose),,In vivo,,CHEMBL623776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,1969.0,Plasma,10116.0,,8923,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,In vivo,,CHEMBL622191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,1969.0,Plasma,10116.0,,8924,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,In vivo,,CHEMBL622192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,1969.0,Plasma,10116.0,,8925,Maximum plasma concentration determined in rat,,In vivo,,CHEMBL622193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,8926,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,In vivo,,CHEMBL622194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,8927,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,In vivo,,CHEMBL622195
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6824,50597,,1969.0,Plasma,10116.0,,8928,Maximum plasma concentration in rat,,In vivo,,CHEMBL622196
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17065,50597,,1969.0,Plasma,10116.0,,8929,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,In vivo,,CHEMBL622197
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2932,50597,,1969.0,Plasma,10116.0,,8930,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,In vivo,,CHEMBL622198
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2932,50597,,1969.0,Plasma,10116.0,,8931,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,In vivo,,CHEMBL622199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,1969.0,Plasma,10116.0,,8932,Maximum plasma concentration of compound was measured in rat,,In vivo,,CHEMBL622200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2864,50597,,1969.0,Plasma,10116.0,,8933,Maximum plasma concentration after 20 mg/kg oral administration in rat,,In vivo,,CHEMBL622201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,1969.0,Plasma,10116.0,,8934,Maximum plasma concentration after oral administration to rats,,In vivo,,CHEMBL623990
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,1969.0,Plasma,10116.0,,8935,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,In vivo,,CHEMBL623991
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,1969.0,Plasma,10116.0,,8936,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,In vivo,,CHEMBL623992
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,1969.0,Plasma,10116.0,,8937,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,In vivo,,CHEMBL623993
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,1969.0,Plasma,10116.0,,8938,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,In vivo,,CHEMBL623994
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,8939,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL623995
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,8940,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL623996
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,8941,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL623997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4516,50597,,1969.0,Plasma,10116.0,,8942,Maximum plasma concentration dosed orally in rats,,In vivo,,CHEMBL623998
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4516,50597,,1969.0,Plasma,10116.0,,8943,Maximum plasma concentration dosed orally in rats after 6 hours,,In vivo,,CHEMBL623999
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4516,50597,,1969.0,Plasma,10116.0,,8944,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,In vivo,,CHEMBL624000
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,1969.0,Plasma,10116.0,,8945,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,In vivo,,CHEMBL624001
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,1969.0,Plasma,10116.0,,8946,Maximum plasma concentration in rat after po administration,,In vivo,,CHEMBL624002
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,1969.0,Plasma,10116.0,,8947,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,In vivo,,CHEMBL624003
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,1969.0,Plasma,10116.0,,8948,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,In vivo,,CHEMBL624004
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8949,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL624005
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8950,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL624006
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8951,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL624007
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8952,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL624008
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8953,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL624009
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8954,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL874387
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8955,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL624010
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8956,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL624011
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8957,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL624012
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8958,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL624013
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8959,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL624736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8960,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL624737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8961,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL624738
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8962,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL624739
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,948.0,Heart,10116.0,,8963,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL624740
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8964,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL624896
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8965,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL624897
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8966,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL624108
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8967,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL624109
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8968,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL624110
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8969,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL624111
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8970,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL624112
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8971,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL624113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8972,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL619709
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,948.0,Heart,10116.0,,8973,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL619710
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8974,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL619711
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8975,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL619712
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8976,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL619713
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8977,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL619714
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8978,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL619715
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8979,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL619716
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8980,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL619717
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8981,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL619718
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8982,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL619719
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8983,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL875329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8984,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL619720
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8985,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL619721
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8986,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL619722
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8987,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL619723
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8988,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL619724
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8989,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL619725
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8990,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL619726
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8991,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL619727
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2113.0,Kidney,10116.0,,8992,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL619728
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,8993,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL619729
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2385.0,Muscle tissue,10116.0,,8994,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL619730
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2385.0,Muscle tissue,10116.0,,8995,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL619731
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2385.0,Muscle tissue,10116.0,,8996,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL619732
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2385.0,Muscle tissue,10116.0,,8997,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL619733
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2385.0,Muscle tissue,10116.0,,8998,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL619734
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,14.0,Zone of skin,10116.0,,8999,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL619735
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,14.0,Zone of skin,10116.0,,9000,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL875330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,14.0,Zone of skin,10116.0,,9001,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL628465
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,14.0,Zone of skin,10116.0,,9002,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL628466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,14.0,Zone of skin,10116.0,,9003,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL628467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2106.0,Spleen,10116.0,,9004,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL628468
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2106.0,Spleen,10116.0,,9005,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL628469
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2106.0,Spleen,10116.0,,9006,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL628470
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2106.0,Spleen,10116.0,,9007,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL628471
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2106.0,Spleen,10116.0,,9008,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL628472
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2046.0,Thyroid gland,10116.0,,9009,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2046.0,Thyroid gland,10116.0,,9010,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL625192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2046.0,Thyroid gland,10116.0,,9011,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,In vivo,,CHEMBL875337
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2046.0,Thyroid gland,10116.0,,9012,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626341
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2046.0,Thyroid gland,10116.0,,9013,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL626342
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,2107.0,Liver,10116.0,,9014,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,In vivo,,CHEMBL621943
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3748,50597,,,,10116.0,,9015,Half life in rats,,,,CHEMBL621944
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,9016,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,,,CHEMBL621945
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4871,50597,,,,10116.0,,9017,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,,,CHEMBL621946
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4871,50597,,,,10116.0,,9018,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,,CHEMBL621947
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4872,50597,,,,10116.0,,9019,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,,,CHEMBL621948
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4872,50597,,,,10116.0,,9020,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,,CHEMBL621949
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5413,50597,,,,10116.0,,9021,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,,,CHEMBL621950
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5413,50597,,,,10116.0,,9022,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,,,CHEMBL621951
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15272,50597,,178.0,Blood,10116.0,,9023,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,In vivo,,CHEMBL621952
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,2107.0,Liver,10116.0,,9024,Stability (%) in rat liver microsomes,,,,CHEMBL621953
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,9025,Area under curve was calculated after intravenous administration,,,,CHEMBL621954
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,9026,Area under the curve was calculated after iv administration in rat,,,,CHEMBL621955
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,9027,Area under the curve was calculated in rat after peroral administration,,,,CHEMBL621956
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6211,50597,,,,10116.0,,9028,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,,CHEMBL621957
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5710,50597,,,,10116.0,,9029,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,,,CHEMBL621958
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5710,50597,,,,10116.0,,9030,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,,,CHEMBL621959
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17853,50597,,,,10116.0,,9031,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,,,CHEMBL621960
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17853,50597,,,,10116.0,,9032,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,,,CHEMBL621961
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,9033,p value of the compound,,,,CHEMBL621962
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,9034,p value of the compound,,,,CHEMBL876787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,9035,p value of the compound,,,,CHEMBL621963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9036,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL622637
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9037,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL622638
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9038,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL626561
Autocuration,BAO_0000019,,F,,1,Oryctolagus cuniculus,0,U,,7991,22224,,,,9986.0,,9039,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,,,CHEMBL626562
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,,,9986.0,,9040,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,,,CHEMBL626563
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,,,9986.0,,9041,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,,,CHEMBL626564
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,6253,22224,,,,9986.0,,9042,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,In vivo,,CHEMBL626565
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,6253,22224,,,,9986.0,,9043,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,In vivo,,CHEMBL626566
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,3615,22224,,,,9986.0,,9044,Clearance rate in rabbits,,In vivo,,CHEMBL626567
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,4059,22224,,,,9986.0,,9045,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,In vivo,,CHEMBL626568
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,,,9986.0,,9046,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,In vivo,,CHEMBL626569
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,,,9986.0,,9047,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,In vivo,,CHEMBL626570
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,,,9986.0,,9048,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,In vivo,,CHEMBL626571
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,,,9986.0,,9049,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,In vivo,,CHEMBL626572
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,4059,22224,,1969.0,Plasma,9986.0,,9050,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,In vivo,,CHEMBL626573
Autocuration,BAO_0000251,,A,,1,Oryctolagus cuniculus,0,U,,9659,22224,,2107.0,Liver,9986.0,,9051,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Microsomes,,,CHEMBL626574
Autocuration,BAO_0000251,,A,,1,Oryctolagus cuniculus,0,U,,9659,22224,,2107.0,Liver,9986.0,,9052,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Microsomes,,,CHEMBL626575
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,3639,22224,,,,9986.0,,9053,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,,,CHEMBL626576
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,3639,22224,,,,9986.0,,9054,Dose at which bioavailability of perorally administered compound was tested in rabbit,,,,CHEMBL626577
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,3639,22224,,,,9986.0,,9055,The compound was tested for its bioavailability in rabbit (by oral dosage).,,In vivo,,CHEMBL626578
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,,,9986.0,,9056,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,In vivo,,CHEMBL625263
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,,,9986.0,,9057,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,In vivo,,CHEMBL625264
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,,,9986.0,,9058,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,In vivo,,CHEMBL625265
Autocuration,BAO_0000251,,A,,1,Oryctolagus cuniculus,0,U,,14294,22224,,,,9986.0,,9059,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,,,CHEMBL625266
Autocuration,BAO_0000251,,A,,1,Oryctolagus cuniculus,0,U,,14294,22224,,,,9986.0,,9060,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Microsomes,,,CHEMBL876796
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,,,9986.0,,9061,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,In vivo,,CHEMBL625267
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,1969.0,Plasma,9986.0,,9062,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,In vivo,,CHEMBL625268
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,1969.0,Plasma,9986.0,,9063,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,In vivo,,CHEMBL625269
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,5124,22224,,1969.0,Plasma,9986.0,,9064,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,In vivo,,CHEMBL624689
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,,,9986.0,,9065,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,In vivo,,CHEMBL624690
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,1088.0,Urine,9986.0,,9066,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,,,CHEMBL624691
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,429,22224,,1088.0,Urine,9986.0,,9067,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,,,CHEMBL624692
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,4059,22224,,,,9986.0,,9068,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,In vivo,,CHEMBL624693
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,4137,22224,,,,9986.0,,9069,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,In vivo,,CHEMBL624694
Autocuration,BAO_0000221,,A,,1,Oryctolagus cuniculus,0,U,,11672,22224,,,,9986.0,,9070,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,In vitro,,CHEMBL877596
Autocuration,BAO_0000019,,A,,1,Oryctolagus cuniculus,0,U,,12886,22224,,,,9986.0,,9071,Time within which only 10% of the drug was degraded,,,,CHEMBL624695
Autocuration,BAO_0000221,,A,,1,Oryctolagus cuniculus,0,U,,3853,22224,,2107.0,Liver,9986.0,,9072,Half life period in rabbit liver homogenate,,,,CHEMBL624696
Autocuration,BAO_0000019,,A,,1,Oryctolagus cuniculus,0,U,,3615,22224,,,,9986.0,,9073,Half life value in rabbits,,,,CHEMBL624697
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,6253,22224,,178.0,Blood,9986.0,,9074,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,In vivo,,CHEMBL624698
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,6253,22224,,178.0,Blood,9986.0,,9075,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,In vivo,,CHEMBL624699
Autocuration,BAO_0000218,,A,,1,Oryctolagus cuniculus,0,U,,6077,22224,,,,9986.0,,9076,Half-life period in rabbits following intravenous administration at 2 mg/kg,,In vivo,,CHEMBL624700
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17617,50597,,1969.0,Plasma,10116.0,,9077,AUC 0-8 hr value in rats at 10 mg/kg,,,,CHEMBL622903
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,1969.0,Plasma,10116.0,,9078,AUC after administration at 2000 mg/kg/day in rats,,,,CHEMBL622904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6149,50597,,1969.0,Plasma,10116.0,,9079,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,,,CHEMBL622905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,1969.0,Plasma,10116.0,,9080,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,,CHEMBL622906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,1969.0,Plasma,10116.0,,9081,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,,CHEMBL622907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,1969.0,Plasma,10116.0,,9082,AUC in rat after oral administration at 10.5 mg/kg dose,,,,CHEMBL622908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,1969.0,Plasma,10116.0,,9083,AUC in rat after oral administration at 11.2 mg/kg dose,,,,CHEMBL622909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,1969.0,Plasma,10116.0,,9084,AUC in rat after oral administration at 9.7 mg/kg dose,,,,CHEMBL622910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,955.0,Brain,10116.0,,9085,AUC in rat brain after oral administration at 10 mg/kg,,,,CHEMBL622911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6504,50597,,1969.0,Plasma,10116.0,,9086,AUC in rat p.o.,,,,CHEMBL622912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,1969.0,Plasma,10116.0,,9087,AUC in rat p.o. at 20 mg/kg concentration,,,,CHEMBL622913
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,1969.0,Plasma,10116.0,,9088,AUC in rat plasma after oral administration at 10 mg/kg,,,,CHEMBL622914
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,216,50597,,1969.0,Plasma,10116.0,,9089,AUC in rats,,,,CHEMBL622915
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,1969.0,Plasma,10116.0,,9090,AUC value after IV dose at a dose of 5 mg/kg in rats.,,,,CHEMBL622916
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,1969.0,Plasma,10116.0,,9091,AUC value after oral dose at a dose of 10 mg/kg in rats.,,,,CHEMBL622917
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,1969.0,Plasma,10116.0,,9092,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,In vivo,,CHEMBL622918
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,216,50597,,1969.0,Plasma,10116.0,,9093,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,In vivo,,CHEMBL622919
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6049,50597,,1969.0,Plasma,10116.0,,9094,Maximum plasma concentration was evaluated in rat,,In vivo,,CHEMBL622920
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2463,50597,,1969.0,Plasma,10116.0,,9095,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,In vivo,,CHEMBL622921
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6679,50597,,1969.0,Plasma,10116.0,,9096,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,In vivo,,CHEMBL622922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6681,50597,,1969.0,Plasma,10116.0,,9097,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,In vivo,,CHEMBL622923
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,1969.0,Plasma,10116.0,,9098,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL877604
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,1969.0,Plasma,10116.0,,9099,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,In vivo,,CHEMBL622924
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,1969.0,Plasma,10116.0,,9100,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,In vivo,,CHEMBL622925
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,1969.0,Plasma,10116.0,,9101,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,In vivo,,CHEMBL622926
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6227,50597,,1969.0,Plasma,10116.0,,9102,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,In vivo,,CHEMBL623625
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,1969.0,Plasma,10116.0,,9103,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,In vivo,,CHEMBL623626
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1465,50597,,1969.0,Plasma,10116.0,,9104,Maximum plasma drug concentration was determined,,In vivo,,CHEMBL623627
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4368,50597,,,,10116.0,,9105,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,In vivo,,CHEMBL623628
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,9106,Mean peak plasma concentration was observed after intravenous administration in rat,,In vivo,,CHEMBL623629
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,9107,Mean peak plasma concentration was observed after oral administration in rat,,In vivo,,CHEMBL623630
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9108,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,In vivo,,CHEMBL623804
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9109,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,In vivo,,CHEMBL623805
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1567,50597,,1969.0,Plasma,10116.0,,9110,Peak oral plasma concentration was determined in rats by oral administration,,In vivo,,CHEMBL623806
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,1969.0,Plasma,10116.0,,9111,Peak plasma concentration (Cmax) was determined,,In vivo,,CHEMBL623807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6193,50597,,1969.0,Plasma,10116.0,,9112,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,In vivo,,CHEMBL623808
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,1969.0,Plasma,10116.0,,9113,Peak plasma concentration (Cmax) in rats,,In vivo,,CHEMBL623809
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6485,50597,,1969.0,Plasma,10116.0,,9114,Peak plasma concentration at 1 mg/kg peroral administration,,In vivo,,CHEMBL623810
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,1969.0,Plasma,10116.0,,9115,Peak plasma concentration in rat,,In vivo,,CHEMBL623811
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,1969.0,Plasma,10116.0,,9116,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,In vivo,,CHEMBL623812
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5394,50597,,,,10116.0,,9117,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,In vivo,,CHEMBL877605
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4408,50597,,,,10116.0,,9118,Pharmacokinetic property (Cmax) in rat,,In vivo,,CHEMBL623813
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5983,50597,,,,10116.0,,9119,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,In vivo,,CHEMBL623814
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4878,50597,,,,10116.0,,9120,Cmax in rat after 3mg/kg oral dose,,In vivo,,CHEMBL623815
Intermediate,BAO_0000218,,A,Sprague-Dawley,1,Rattus norvegicus,1,N,,5862,50597,,,,10116.0,,9121,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,In vivo,,CHEMBL623816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4517,50597,,,,10116.0,,9122,Cmax in rats after 20 mg/kg oral dose,,In vivo,,CHEMBL623145
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5932,50597,,1969.0,Plasma,10116.0,,9123,Cmax in rat plasma after 30mg/kg oral dose,,In vivo,,CHEMBL623146
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5436,50597,,1969.0,Plasma,10116.0,,9124,Plasma concentration after oral administration of 100 mg/kg to rats,,In vivo,,CHEMBL623147
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,955.0,Brain,10116.0,,9125,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,In vivo,,CHEMBL623042
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4950,50597,,,,10116.0,,9126,Tested for the Cmax in rat at 10 mg/kg per orally,,In vivo,,CHEMBL623043
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9127,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL623044
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9128,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL623045
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3360,50597,,,,10116.0,,9129,Bioavailability as oral Cmax in rats at 30 mins,,In vivo,,CHEMBL623046
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3360,50597,,,,10116.0,,9130,Bioavailability as oral Cmax in rats at 6hr,,In vivo,,CHEMBL623226
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,9131,The maximum concentration of compound was measured at the dose of 100 umol/kg,,In vivo,,CHEMBL623227
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,9132,The maximum concentration of compound was measured at the dose of 300 umol/kg,,In vivo,,CHEMBL623228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,9133,The maximum concentration of compound was measured at the dose of 30 umol/kg,,In vivo,,CHEMBL623229
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5160,50597,,1969.0,Plasma,10116.0,,9134,The maximum plasma levels for the compounds were determined by LC-MS.,,In vivo,,CHEMBL623230
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,9135,mean peak plasma concentration was observed after intravenous administration in rat,,In vivo,,CHEMBL623231
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,1969.0,Plasma,10116.0,,9136,mean peak plasma concentration was observed after oral administration in rat,,In vivo,,CHEMBL623232
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4709,50597,,,,10116.0,,9137,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,,,CHEMBL623233
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3535,50597,,,,10116.0,,9138,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,,,CHEMBL623234
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3535,50597,,,,10116.0,,9139,Concentration in plasma (portal) following oral dose in rats at 1 hr,,,,CHEMBL623235
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3535,50597,,,,10116.0,,9140,Concentration in plasma (portal) following oral dose in rats at 2 hr,,,,CHEMBL623236
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3535,50597,,,,10116.0,,9141,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,,,CHEMBL623237
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3535,50597,,,,10116.0,,9142,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,,,CHEMBL623238
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3535,50597,,,,10116.0,,9143,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,,,CHEMBL623239
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,5005,22224,,1969.0,Plasma,10116.0,,9144,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,In vivo,,CHEMBL623240
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6326,50597,,1898.0,Hypothalamus,10116.0,,9145,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,,,CHEMBL623241
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6326,50597,,1898.0,Hypothalamus,10116.0,,9146,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,,,CHEMBL623242
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6326,50597,,,,10116.0,,9147,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,,,CHEMBL874394
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6326,50597,,,,10116.0,,9148,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,,,CHEMBL623243
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9149,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL623244
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,9150,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL623245
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,9151,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL623246
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,9152,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL623247
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,9153,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL623248
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2113.0,Kidney,10116.0,,9154,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL623249
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9155,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL625072
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9156,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL625073
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9157,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL625074
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9158,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL625075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9159,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL625076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9160,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL625077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9161,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL625078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9162,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL874395
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9163,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL625079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9164,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL625080
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9165,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL625081
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9166,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL625082
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9167,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL625083
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9168,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL625084
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9169,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL625085
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9170,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL625086
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9171,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL625087
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9172,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL625088
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2107.0,Liver,10116.0,,9173,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL622205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9174,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL622206
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9175,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL622207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9176,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL622366
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9177,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL622367
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9178,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL875331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2107.0,Liver,10116.0,,9179,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL622368
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9180,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL622369
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9181,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL622370
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9182,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL622371
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9183,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL622372
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9184,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL622373
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9185,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL622374
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9186,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL622375
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9187,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL622376
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9188,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL622377
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9189,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL622378
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9190,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL622379
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9191,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL622380
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9192,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL622381
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9193,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL622382
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9194,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL622383
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9195,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL875332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9196,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL622384
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9197,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL622385
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6175,50597,,945.0,Stomach,10116.0,,9198,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,,CHEMBL622386
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,,,10116.0,,9199,The compound was tested for the plasma binding in rat,,,,CHEMBL622387
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16459,50597,,,,10116.0,,9200,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,,,CHEMBL622388
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16459,50597,,,,10116.0,,9201,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,,,CHEMBL622389
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16459,50597,,,,10116.0,,9202,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,,,CHEMBL622390
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16459,50597,,,,10116.0,,9203,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,,,CHEMBL622391
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16459,50597,,,,10116.0,,9204,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,,,CHEMBL622392
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16459,50597,,,,10116.0,,9205,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,,,CHEMBL622393
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3278,50597,,,,10116.0,,9206,Plasma level at 2 hr after administration of the compound,,,,CHEMBL622394
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3278,50597,,,,10116.0,,9207,plasma level at 2 hr after administration of the compound,,,,CHEMBL622395
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9208,Stability in rat serum measured as % recovery at 1 min,,,,CHEMBL622396
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9209,Stability in rat serum measured as % recovery at 10 min,,,,CHEMBL624894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9210,Stability in rat serum measured as % recovery at 10 mins,,,,CHEMBL624895
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9211,Stability in rat serum measured as % recovery at 2 hr,,,,CHEMBL624058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9212,Stability in rat serum measured as % recovery at 3 min,,,,CHEMBL624059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9213,Stability in rat serum measured as % recovery at 3 mins,,,,CHEMBL624060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9214,Stability in rat serum measured as % recovery at 5 min,,,,CHEMBL624061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4684,50597,,1977.0,Serum,10116.0,,9215,Stability in rat serum measured as % recovery at 5 mins,,,,CHEMBL624062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16456,50597,,,,10116.0,,9216,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,In vivo,,CHEMBL624063
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16456,50597,,,,10116.0,,9217,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,In vivo,,CHEMBL624064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,723,50597,,1969.0,Plasma,10116.0,,9218,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,,,CHEMBL624065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,723,50597,,1969.0,Plasma,10116.0,,9219,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,,,CHEMBL624066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5160,50597,,,,10116.0,,9220,Half life tested in mature male rat at a dose of 30 mg/kg,,In vivo,,CHEMBL877490
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4709,50597,,,,10116.0,,9221,Half life after intravenous administration of 1 mg/kg in rat,,In vivo,,CHEMBL874442
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5633,50597,,,,10116.0,,9222,Half life period after administration (30 mg/kg) in rat,,In vivo,,CHEMBL626890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5302,50597,,,,10116.0,,9223,Half life period in rat after 5 mg/Kg dose,,In vivo,,CHEMBL626891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5302,50597,,,,10116.0,,9224,Half life period in rat after 5 mg/kg dose,,In vivo,,CHEMBL626892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9225,Half life period was determined,,,,CHEMBL626893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9226,Half life period was evaluated in rat,,,,CHEMBL626894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9227,Half life period was evaluated in rat; 0.5-1.0,,,,CHEMBL626895
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9228,Half life period was evaluated in rat; 5.9-7.5,,,,CHEMBL626896
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14512,50597,,1969.0,Plasma,10116.0,,9229,Half-life in rat plasma,,,,CHEMBL626897
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6230,50597,,,,10116.0,,9230,Half-life time in rat was determined,,,,CHEMBL626898
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3364,50597,,,,10116.0,,9231,Terminal half-life after iv administration to rats,,In vivo,,CHEMBL626899
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6874,50597,,,,10116.0,,9232,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,In vivo,,CHEMBL626900
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,857,50597,,,,10116.0,,9233,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,,,CHEMBL626901
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,858,50597,,,,10116.0,,9234,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,In vivo,,CHEMBL626902
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,858,50597,,,,10116.0,,9235,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,In vivo,,CHEMBL626903
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9236,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,In vivo,,CHEMBL874443
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9237,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,In vivo,,CHEMBL626904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6305,50597,,,,10116.0,,9238,Half life in rats,,,,CHEMBL626905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13501,50597,,1969.0,Plasma,10116.0,,9239,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,In vivo,,CHEMBL873830
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,,,10116.0,,9240,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,In vivo,,CHEMBL626906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4186,50597,,1969.0,Plasma,10116.0,,9241,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,In vivo,,CHEMBL631076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2932,50597,,1969.0,Plasma,10116.0,,9242,Biological half-life was measured in plasma of rats,,,,CHEMBL631077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17065,50597,,,,10116.0,,9243,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,In vivo,,CHEMBL631078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,9244,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,In vivo,,CHEMBL631079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2713,50597,,,,10116.0,,9245,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,In vivo,,CHEMBL631080
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,9246,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,In vivo,,CHEMBL631081
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,9247,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,In vivo,,CHEMBL631239
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,740,50597,,1969.0,Plasma,10116.0,,9248,Compound was evaluated for plasma half life in rat,,,,CHEMBL631240
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,1969.0,Plasma,10116.0,,9249,AUC value at a dose of 5 mg/kg (p.o.) in rats,,,,CHEMBL631241
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2959,50597,,1969.0,Plasma,10116.0,,9250,AUC value after administration of 20 mg/Kg oral dose in rat,,,,CHEMBL631242
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,1969.0,Plasma,10116.0,,9251,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,,,CHEMBL631243
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,1969.0,Plasma,10116.0,,9252,AUC0-96 after administration at 50 mg/kg,,,,CHEMBL874444
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,1969.0,Plasma,10116.0,,9253,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,,,CHEMBL631244
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3293,50597,,,,10116.0,,9254,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,,,CHEMBL631245
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,9255,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,,,CHEMBL627162
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,9256,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,,,CHEMBL627163
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6757,50597,,,,10116.0,,9257,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,,,CHEMBL627164
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5979,50597,,2113.0,Kidney,10116.0,,9258,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,,,CHEMBL627165
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5979,50597,,,,10116.0,,9259,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,,,CHEMBL627166
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5979,50597,,,,10116.0,,9260,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,,,CHEMBL627167
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,9261,Area under curve (AUC) at a dose of 30 mg/kg in rats,,,,CHEMBL627822
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9262,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,,CHEMBL627823
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9263,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,,,CHEMBL627824
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5355,50597,,,,10116.0,,9264,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,,CHEMBL627825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5633,50597,,,,10116.0,,9265,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,,,CHEMBL627826
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1716,50597,,,,10116.0,,9266,Area under curve (Pharmacokinetic property) was determined,,,,CHEMBL627827
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1716,50597,,,,10116.0,,9267,Area under curve (Pharmacokinetic property) of the compound; Not determined,,,,CHEMBL627828
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,9268,Area under curve after intravenous administration (1 mg/kg) in rat,,,,CHEMBL627829
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,9269,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,,,CHEMBL627830
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,9270,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,,,CHEMBL627831
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,9271,Area under curve in male SD rats was observed after oral administration in rat,,,,CHEMBL627832
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4413,50597,,,,10116.0,,9272,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,,,CHEMBL627833
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,9273,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,CHEMBL627834
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,9274,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,,,CHEMBL628004
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5964,50597,,,,10116.0,,9275,Area under curve at 5 mg/kg po was determined in rat,,,,CHEMBL628005
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,9276,Area under curve in Rat at a oral dose of 5 mg/kg,,,,CHEMBL628006
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4186,50597,,,,10116.0,,9277,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,,CHEMBL628007
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,9278,Area under curve was determined,,,,CHEMBL625676
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17858,50597,,,,10116.0,,9279,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,,,CHEMBL631309
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,9280,Area under curve after intravenous administration at 3 mg/kg,,,,CHEMBL631310
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6106,50597,,,,10116.0,,9281,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,,,CHEMBL631311
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5964,50597,,,,10116.0,,9282,Area under curve at 4 hr in rat,,,,CHEMBL631312
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,9283,Area under curve at a dose of 30 mg/kg,,,,CHEMBL631313
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,9284,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,,,CHEMBL631314
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,9285,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,,,CHEMBL631315
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5862,50597,,,,10116.0,,9286,Area under curve for a 2-mpk po dose in SD rats,,,,CHEMBL631316
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5862,50597,,,,10116.0,,9287,Area under curve in SD rats,,,,CHEMBL631317
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,9288,Area under curve in rat after oral administration at 13 mg/kg dose,,,,CHEMBL874471
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5871,50597,,,,10116.0,,9289,Area under curve in rat by po administration at 0-24 hr,,,,CHEMBL631318
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5919,50597,,1969.0,Plasma,10116.0,,9290,Area under curve in rat plasma,,,,CHEMBL631319
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,9291,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,,,CHEMBL631320
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,9292,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,,,CHEMBL631321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10,50597,,,,10116.0,,9293,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,,,CHEMBL631322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11149,50597,,,,10116.0,,9294,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,,,CHEMBL631323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5302,50597,,,,10116.0,,9295,Area under curve value in rat at a dose of 5 mg/kg,,,,CHEMBL631324
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,9296,Area under curve was determined after oral administration in rats,,,,CHEMBL631325
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,,,10116.0,,9297,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,,CHEMBL631326
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6011,50597,,,,10116.0,,9298,Area under curve was determined after peroral administration in rat,,,,CHEMBL631327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5375,50597,,,,10116.0,,9299,Area under curve was determined at a dose 30 mpk administered orally.,,,,CHEMBL631328
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,9300,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,,,CHEMBL631329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4368,50597,,,,10116.0,,9301,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,,,CHEMBL627217
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5610,50597,,,,10116.0,,9302,Area under curve was determined in male rat,,,,CHEMBL626352
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5833,50597,,,,10116.0,,9303,Area under curve was determined in rat after PO administration,,,,CHEMBL626353
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4257,50597,,,,10116.0,,9304,Area under curve was determined in rat after a 3 mg/kg of oral dose,,,,CHEMBL626354
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5937,50597,,,,10116.0,,9305,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,,,CHEMBL626355
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5932,50597,,,,10116.0,,9306,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,,,CHEMBL626356
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5932,50597,,,,10116.0,,9307,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,,,CHEMBL626357
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9308,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL626358
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9309,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL626359
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17771,50597,,1969.0,Plasma,10116.0,,9310,Peak plasma concentration in rat at a dose of 3 mg/kg,,,,CHEMBL626360
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1628,50597,,,,10116.0,,9311,Plasma concentration at 2 hr in rats was evaluated.,,,,CHEMBL626361
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1628,50597,,,,10116.0,,9312,Plasma concentration at 2 hr in rats was evaluated; Not available,,,,CHEMBL626362
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9313,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL626363
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,9314,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL626970
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,9315,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL626971
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,1969.0,Plasma,10116.0,,9316,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL626972
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,1969.0,Plasma,10116.0,,9317,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL626973
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,1969.0,Plasma,10116.0,,9318,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL626974
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,1969.0,Plasma,10116.0,,9319,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL874592
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,9320,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,,,CHEMBL626975
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,9321,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,,,CHEMBL626976
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,9322,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,,,CHEMBL626977
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,9323,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,,,CHEMBL626978
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16427,50597,,,,10116.0,,9324,PK study was carried to determine the relative absorption ranking in rat.,,,,CHEMBL626979
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,1969.0,Plasma,10116.0,,9325,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,In vivo,,CHEMBL626980
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,178.0,Blood,10116.0,,9326,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,,,CHEMBL626981
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,178.0,Blood,10116.0,,9327,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,,,CHEMBL626982
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,178.0,Blood,10116.0,,9328,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,,,CHEMBL626983
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,178.0,Blood,10116.0,,9329,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,,,CHEMBL622522
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,178.0,Blood,10116.0,,9330,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,,,CHEMBL622523
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,178.0,Blood,10116.0,,9331,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,,,CHEMBL622524
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,955.0,Brain,10116.0,,9332,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,,,CHEMBL622525
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,955.0,Brain,10116.0,,9333,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,,,CHEMBL622526
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,955.0,Brain,10116.0,,9334,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,,,CHEMBL619849
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,955.0,Brain,10116.0,,9335,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,,,CHEMBL619850
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,955.0,Brain,10116.0,,9336,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,,,CHEMBL623864
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,955.0,Brain,10116.0,,9337,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,,,CHEMBL623865
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,948.0,Heart,10116.0,,9338,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,,,CHEMBL623866
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,948.0,Heart,10116.0,,9339,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,,,CHEMBL623867
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,948.0,Heart,10116.0,,9340,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,,,CHEMBL877615
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,948.0,Heart,10116.0,,9341,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,,,CHEMBL623868
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,948.0,Heart,10116.0,,9342,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,,,CHEMBL623869
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,948.0,Heart,10116.0,,9343,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,,,CHEMBL623870
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9344,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL623871
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2048.0,Lung,10116.0,,9345,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL623872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9346,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL622129
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9347,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL622130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9348,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL622131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9349,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL622132
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9350,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL622133
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9351,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL622134
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9352,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL622135
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2048.0,Lung,10116.0,,9353,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL622136
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9354,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL622137
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9355,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL622138
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9356,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL623017
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9357,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL623018
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9358,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL623019
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9359,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL623020
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9360,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL623021
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9361,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL623022
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9362,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL623023
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9363,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL623024
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9364,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL623025
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9365,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL620545
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9366,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL620546
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9367,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL620547
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9368,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL620548
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9369,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL620549
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9370,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL620550
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9371,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL620551
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2385.0,Muscle tissue,10116.0,,9372,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL620552
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9373,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL620553
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9374,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL620554
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9375,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL875845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9376,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL620555
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9377,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL620556
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2385.0,Muscle tissue,10116.0,,9378,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL620557
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9379,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL620558
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9380,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL620559
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9381,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL622939
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9382,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL622940
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9383,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL622941
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9384,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL622942
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9385,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL622943
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9386,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL622944
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9387,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL622945
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9388,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL622946
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3341,50597,,,,10116.0,,9389,Compound was evaluated for terminal half life in rat,,,,CHEMBL622947
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3634,50597,,1969.0,Plasma,10116.0,,9390,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,In vivo,,CHEMBL622948
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3634,50597,,1969.0,Plasma,10116.0,,9391,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,In vivo,,CHEMBL622949
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4839,50597,,,,10116.0,,9392,Compound was tested for its half life in rat,,,,CHEMBL622950
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,0,U,,5005,22224,,1969.0,Plasma,9544.0,,9393,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,In vivo,,CHEMBL622951
Intermediate,BAO_0000366,,A,,1,Rattus norvegicus,0,U,,5005,22224,,1969.0,Plasma,10116.0,,9394,Compound was tested for its plasma half life in Sprague Dawley rats,,,,CHEMBL622952
Intermediate,BAO_0000366,,A,,1,Rattus norvegicus,0,U,,5005,22224,,1969.0,Plasma,10116.0,,9395,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,,,CHEMBL622953
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1094,50597,,1969.0,Plasma,10116.0,,9396,Compound was tested for plasma half-life period in rat,,,,CHEMBL873818
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5031,50597,,,,10116.0,,9397,Elimination half life after i.v. administration of compound in rats,,In vivo,,CHEMBL622954
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,9398,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,In vivo,,CHEMBL622955
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,9399,Elimination half-life after IV dosing at 1 mg/kg in rat,,In vivo,,CHEMBL875229
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,9400,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,In vivo,,CHEMBL622956
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,9401,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,In vivo,,CHEMBL622957
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,955.0,Brain,10116.0,,9402,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,In vivo,,CHEMBL622958
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,1969.0,Plasma,10116.0,,9403,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,In vivo,,CHEMBL622959
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,955.0,Brain,10116.0,,9404,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,In vivo,,CHEMBL622960
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,1969.0,Plasma,10116.0,,9405,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,In vivo,,CHEMBL622961
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4687,50597,,,,10116.0,,9406,Evaluated for the half life in rat (in vivo),,In vivo,,CHEMBL622962
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,9407,Hafl life in rat,,,,CHEMBL622963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,9408,Hafl life rat,,,,CHEMBL622964
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,9409,Hafl life rat,,,,CHEMBL622965
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,9410,Hafl life rat; Not determined,,,,CHEMBL622966
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,9411,Hafl life rat; Not determined,,,,CHEMBL622967
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,2113.0,Kidney,10116.0,,9412,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,In vivo,,CHEMBL622968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,2107.0,Liver,10116.0,,9413,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,In vivo,,CHEMBL622969
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,2048.0,Lung,10116.0,,9414,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,In vivo,,CHEMBL875327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,9415,Half life in rat after 1 mg/kg i.v. administration,,In vivo,,CHEMBL628638
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,9416,Half life in rat after 2 mg/kg peroral administration,,In vivo,,CHEMBL628639
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9417,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,In vivo,,CHEMBL625840
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4722,50597,,,,10116.0,,9418,Half life of 10 mg/kg oral dose determined in rats,,In vivo,,CHEMBL625841
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9419,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL625842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9420,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL625843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9421,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL625844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9422,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL873822
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9423,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL625845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9424,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL627059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9425,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL627060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,9426,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL627061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4762,50597,,,,10116.0,,9427,Half life of compound at 5 mg/kg after po administration was determined in rat,,In vivo,,CHEMBL627709
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5327,50597,,,,10116.0,,9428,Half life of compound determined after intravenous administration to rat,,In vivo,,CHEMBL627710
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4847,50597,,,,10116.0,,9429,Half life of compound was determined in rat,,,,CHEMBL627711
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,9430,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL627712
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9431,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,In vivo,,CHEMBL627713
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9432,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,In vivo,,CHEMBL627714
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,0,U,,4256,22224,,,,9541.0,,9433,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,In vivo,,CHEMBL627889
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,4256,22224,,,,10116.0,,9434,Half life determined in rat by intravenous administration,,In vivo,,CHEMBL627890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4722,50597,,,,10116.0,,9435,Half life determined in rats after iv administration,,In vivo,,CHEMBL627891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,1969.0,Plasma,10116.0,,9436,Half life in rat plasma after administration of 2 mg/kg iv,,In vivo,,CHEMBL627892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,1969.0,Plasma,10116.0,,9437,Half life in rat plasma after administration of 2 mg/kg iv,,In vivo,,CHEMBL627893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1435,50597,,1969.0,Plasma,10116.0,,9438,Half life in rat plasma was determined,,,,CHEMBL627894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1435,50597,,1969.0,Plasma,10116.0,,9439,Half life in rat plasma was determined; NA means not applicable,,,,CHEMBL627895
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5206,50597,,,,10116.0,,9440,Half life in rat was tested,,,,CHEMBL627896
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6080,50597,,1969.0,Plasma,10116.0,,9441,Half life measured in rat plasma,,,,CHEMBL627897
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4449,50597,,,,10116.0,,9442,Half life recorded in rats,,,,CHEMBL627898
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,9443,Half life was calculated,,,,CHEMBL627899
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,9444,Half life was calculated in rat,,,,CHEMBL873823
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3747,50597,,,,10116.0,,9445,Half life was determined,,,,CHEMBL627900
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17858,50597,,,,10116.0,,9446,Half life after 10 mg/kg oral administration in rat,,In vivo,,CHEMBL627901
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9447,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,In vivo,,CHEMBL627902
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9448,Half life after administering orally a dose of 30 mg/kg,,In vivo,,CHEMBL627903
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5031,50597,,,,10116.0,,9449,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,,,CHEMBL627904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4722,50597,,,,10116.0,,9450,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,,,CHEMBL627905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,9451,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,,,CHEMBL627906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,9452,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,,,CHEMBL627907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,9453,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,,,CHEMBL876783
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,9454,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,,,CHEMBL627908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17065,50597,,,,10116.0,,9455,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,,CHEMBL627909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1353,50597,,,,10116.0,,9456,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,,,CHEMBL627910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1353,50597,,,,10116.0,,9457,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,,,CHEMBL627911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1353,50597,,,,10116.0,,9458,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,,,CHEMBL627912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1353,50597,,,,10116.0,,9459,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,,,CHEMBL627913
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1353,50597,,,,10116.0,,9460,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,,,CHEMBL627914
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,9461,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,,,CHEMBL627915
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,9462,Area under the curve was evaluated after 20 uM/kg of peroral administration,,,,CHEMBL627916
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6062,50597,,,,10116.0,,9463,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,,,CHEMBL627917
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6056,50597,,,,10116.0,,9464,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,,,CHEMBL627918
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,9465,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,,,CHEMBL627919
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,9466,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,,,CHEMBL627920
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,9467,Area under the curve was evaluated at an oral dose of 30 mg/kg,,,,CHEMBL627921
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9468,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,CHEMBL627922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9469,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,CHEMBL876784
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9470,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,CHEMBL627923
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9471,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,CHEMBL626208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9472,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,CHEMBL626209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,9473,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,CHEMBL626210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2463,50597,,1969.0,Plasma,10116.0,,9474,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,,CHEMBL627994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4709,50597,,,,10116.0,,9475,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,,,CHEMBL627995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4075,50597,,,,10116.0,,9476,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,,,CHEMBL627996
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5394,50597,,,,10116.0,,9477,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,,,CHEMBL627997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,9478,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,,,CHEMBL627998
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,9479,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,,,CHEMBL628640
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,9480,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,,,CHEMBL628641
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,9481,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,,,CHEMBL628642
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9482,Compound was evaluated for area under the curve expressed as (h*ug/ml),,,,CHEMBL628643
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2591,50597,,,,10116.0,,9483,Compound was tested for area under curve in rat,,,,CHEMBL628644
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6567,50597,,,,10116.0,,9484,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,,,CHEMBL628645
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6211,50597,,,,10116.0,,9485,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,,CHEMBL628646
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5529,50597,,,,10116.0,,9486,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,,,CHEMBL628647
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,,,10116.0,,9487,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,,CHEMBL628648
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,,,10116.0,,9488,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,,CHEMBL625358
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,,,10116.0,,9489,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,,CHEMBL625359
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5408,50597,,,,10116.0,,9490,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,,CHEMBL625360
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,9491,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,,,CHEMBL625361
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,9492,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,,,CHEMBL625362
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,9493,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,,,CHEMBL625363
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4796,50597,,,,10116.0,,9494,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,,CHEMBL625364
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,9495,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,CHEMBL625365
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,9496,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,CHEMBL625366
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,9497,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,,CHEMBL625367
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2113.0,Kidney,10116.0,,9498,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,,,CHEMBL625368
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2113.0,Kidney,10116.0,,9499,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,,,CHEMBL625369
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2113.0,Kidney,10116.0,,9500,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,,,CHEMBL625370
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2113.0,Kidney,10116.0,,9501,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,,,CHEMBL625371
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2113.0,Kidney,10116.0,,9502,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,,,CHEMBL625372
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2113.0,Kidney,10116.0,,9503,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,,,CHEMBL625373
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2107.0,Liver,10116.0,,9504,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,,,CHEMBL625374
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2107.0,Liver,10116.0,,9505,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,,,CHEMBL877593
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2107.0,Liver,10116.0,,9506,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,,,CHEMBL625375
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2107.0,Liver,10116.0,,9507,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,,,CHEMBL625376
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2107.0,Liver,10116.0,,9508,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,,,CHEMBL621973
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2107.0,Liver,10116.0,,9509,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,,,CHEMBL621974
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2048.0,Lung,10116.0,,9510,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,,,CHEMBL621975
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2048.0,Lung,10116.0,,9511,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,,,CHEMBL622166
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2048.0,Lung,10116.0,,9512,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,,,CHEMBL622167
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2048.0,Lung,10116.0,,9513,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,,,CHEMBL622168
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2048.0,Lung,10116.0,,9514,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,,,CHEMBL622169
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2048.0,Lung,10116.0,,9515,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,,,CHEMBL622170
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9516,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,,,CHEMBL622171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9517,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,,,CHEMBL622172
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9518,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,,,CHEMBL622173
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9519,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,,,CHEMBL622174
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9520,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,,,CHEMBL622175
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9521,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,,,CHEMBL622176
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9522,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,,,CHEMBL622177
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9523,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,,,CHEMBL622178
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9524,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,,,CHEMBL622179
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9525,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,,,CHEMBL622180
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9526,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL622181
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9527,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL622182
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9528,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL622183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9529,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL622184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9530,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL622185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9531,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL622186
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9532,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL622187
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9533,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL625002
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9534,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL622090
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9535,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL622091
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9536,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL622092
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9537,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL622093
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9538,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL622094
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9539,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL622095
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9540,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL622264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9541,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL622265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9542,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL622266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9543,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL622267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9544,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL622268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9545,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL622269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9546,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL625071
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9547,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL621621
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9548,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL621622
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9549,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL621623
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9550,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL621624
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9551,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL621625
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9552,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL621626
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9553,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL621627
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9554,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL621628
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9555,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL875328
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9556,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL621629
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9557,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL621630
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9558,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL621631
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,2106.0,Spleen,10116.0,,9559,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL621632
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9560,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL621633
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9561,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL621634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9562,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL621635
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9563,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL621636
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9564,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL621637
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,2106.0,Spleen,10116.0,,9565,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL621638
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9566,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL618883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9567,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,CHEMBL618884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9568,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL628627
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9569,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL628628
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9570,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,CHEMBL628629
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9571,Half life after administering orally a dose of 3 mg/kg,,In vivo,,CHEMBL628630
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9572,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,In vivo,,CHEMBL628631
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9573,Half life after administering intravenously a dose of 1 mg/kg,,In vivo,,CHEMBL628632
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,526,50597,,,,10116.0,,9574,Half life after oral dosing in rats,,In vivo,,CHEMBL628633
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9575,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,In vivo,,CHEMBL628634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4368,50597,,,,10116.0,,9576,Half life by intravenous administration of 3.4 mg/kg in rat,,In vivo,,CHEMBL627789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3371,50597,,,,10116.0,,9577,Half life in rat,,,,CHEMBL627790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6448,50597,,,,10116.0,,9578,Half life in rat,,,,CHEMBL627791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6453,50597,,,,10116.0,,9579,Half life in rat,,,,CHEMBL627792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,,,10116.0,,9580,Half life in rat after intravenous administration of the compound,,In vivo,,CHEMBL627793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,1969.0,Plasma,10116.0,,9581,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,In vivo,,CHEMBL627794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,,,10116.0,,9582,Half life in rat after po administration of the compound,,In vivo,,CHEMBL627795
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,,,10116.0,,9583,Half life in rat after po administration of the compound; ND means Not determined,,In vivo,,CHEMBL627796
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,1969.0,Plasma,10116.0,,9584,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,In vivo,,CHEMBL875335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,1969.0,Plasma,10116.0,,9585,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,In vivo,,CHEMBL627797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5789,50597,,,,10116.0,,9586,Half life in rat i.v.,,In vivo,,CHEMBL627798
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,9587,Half life in rat i.v. at 2 mg/kg concentration,,In vivo,,CHEMBL627799
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,9588,Half life in rats,,,,CHEMBL627800
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,484,50597,,,,10116.0,,9589,Half life in rats after intravenous administration,,In vivo,,CHEMBL627801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6467,50597,,,,10116.0,,9590,Half life in rats at the dose of 1.0 mpk by i.v. administration,,In vivo,,CHEMBL627802
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6642,50597,,,,10116.0,,9591,Half life in rat,,,,CHEMBL627803
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,9592,Half life was evaluated after intravenous administration to rats,,In vivo,,CHEMBL873820
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1369,50597,,,,10116.0,,9593,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,,,CHEMBL627804
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,9594,Half life was evaluated in rat,,,,CHEMBL627805
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6049,50597,,,,10116.0,,9595,Half life was evaluated in rat,,,,CHEMBL627806
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,9596,Half life was evaluated in rat; Not tested,,,,CHEMBL627107
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,,,10116.0,,9597,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,In vivo,,CHEMBL627108
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11149,50597,,,,10116.0,,9598,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,In vivo,,CHEMBL627109
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11149,50597,,178.0,Blood,10116.0,,9599,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,In vivo,,CHEMBL627110
Intermediate,BAO_0000218,,A,,1,Primates,0,U,,2891,22224,,,,9443.0,,9600,Half life was measured in monkey at dose of 10 mg/kg by po administration,,In vivo,,CHEMBL627111
Intermediate,BAO_0000218,,A,,1,Primates,0,U,,2891,22224,,,,9443.0,,9601,Half life was measured in monkey at dose of 10 mg/kg by po administration,,In vivo,,CHEMBL627112
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,2891,22224,,,,10116.0,,9602,Half life was measured in rat at dose of 30 mg/kg by iv administration,,In vivo,,CHEMBL627113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,2891,22224,,,,10116.0,,9603,Half life was measured in rat at dose of 30 mg/kg by po administration,,In vivo,,CHEMBL627114
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,9604,Half life (t1/2) was determined,,,,CHEMBL627115
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,9605,Half life period at a dose of 10 uM/kg in rat was determined,,,,CHEMBL627116
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,9606,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,In vivo,,CHEMBL627117
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5503,50597,,,,10116.0,,9607,Half life period was determined,,,,CHEMBL627118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,9608,Half life period after intravenous administration at 20 mpk in rats,,In vivo,,CHEMBL627119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,9609,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,In vivo,,CHEMBL627120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6109,50597,,,,10116.0,,9610,Half life period after intravenous administration in rat,,In vivo,,CHEMBL626922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,9611,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,In vivo,,CHEMBL626923
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,9612,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,In vivo,,CHEMBL626924
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4755,50597,,1969.0,Plasma,10116.0,,9613,Half life period in 80% rat plasma at 37 degree Centigrade,,,,CHEMBL626925
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5862,50597,,,,10116.0,,9614,Half life period in SD rats,,,,CHEMBL626926
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9615,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,,,CHEMBL626927
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9616,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,,,CHEMBL626928
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9617,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,,CHEMBL626929
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9618,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,,CHEMBL626930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5960,50597,,,,10116.0,,9619,Half life period in rat,,,,CHEMBL626931
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6103,50597,,,,10116.0,,9620,Half life period in rat,,,,CHEMBL626932
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6317,50597,,,,10116.0,,9621,Half life period in rat,,,,CHEMBL626933
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,9622,Half life period in rat after oral administration at 10.5 mg/kg dose,,In vivo,,CHEMBL873826
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,9623,Half life period in rat after oral administration at 11.2 mg/kg dose,,In vivo,,CHEMBL626934
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,9624,Half life period in rat after oral administration at 13 mg/kg dose,,In vivo,,CHEMBL626935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,9625,Half life period in rat after oral administration at 9.7 mg/kg dose,,In vivo,,CHEMBL626936
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,9626,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,CHEMBL626937
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6295,50597,,,,10116.0,,9627,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,,CHEMBL625906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6296,50597,,,,10116.0,,9628,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,,CHEMBL625907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16427,50597,,,,10116.0,,9629,PK study was carried to determine AUC (area under curve) value in rat,,,,CHEMBL625908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,9630,Pharmacokinetic parameter AUC after intravenous administration to rats,,,,CHEMBL625909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,9631,Pharmacokinetic parameter AUC after oral administration to rats,,,,CHEMBL625910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9632,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,,,CHEMBL625911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9633,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,,,CHEMBL625912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9634,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,,,CHEMBL626538
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9635,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,,,CHEMBL876794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9636,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,,,CHEMBL626539
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,9637,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,,,CHEMBL626540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5394,50597,,,,10116.0,,9638,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,,,CHEMBL626541
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5394,50597,,,,10116.0,,9639,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,,,CHEMBL626542
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,9640,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,,,CHEMBL626543
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,9641,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,,,CHEMBL626544
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,9642,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,,,CHEMBL626545
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,9643,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,,,CHEMBL626546
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,9644,Pharmacokinetic parameter area under curve was reported,,,,CHEMBL626547
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4408,50597,,,,10116.0,,9645,Pharmacokinetic property (AUC) in rat,,,,CHEMBL626548
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5983,50597,,,,10116.0,,9646,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,,,CHEMBL626549
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4397,50597,,,,10116.0,,9647,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,,,CHEMBL626550
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4397,50597,,,,10116.0,,9648,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,,,CHEMBL626551
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5491,50597,,,,10116.0,,9649,Pharmacokinetic property was determined,,,,CHEMBL623777
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5491,50597,,,,10116.0,,9650,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,,,CHEMBL623778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5491,50597,,,,10116.0,,9651,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,,,CHEMBL623779
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,1969.0,Plasma,10116.0,,9652,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,,CHEMBL623780
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,1969.0,Plasma,10116.0,,9653,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,,,CHEMBL622015
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,1969.0,Plasma,10116.0,,9654,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,,,CHEMBL622016
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5173,50597,,,,10116.0,,9655,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,,,CHEMBL622017
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5173,50597,,,,10116.0,,9656,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,,,CHEMBL622018
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5173,50597,,,,10116.0,,9657,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,,,CHEMBL622019
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5173,50597,,,,10116.0,,9658,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,,,CHEMBL622020
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,,,10116.0,,9659,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,,,CHEMBL622021
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,,,10116.0,,9660,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,,,CHEMBL622022
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5327,50597,,,,10116.0,,9661,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,,,CHEMBL622023
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6681,50597,,,,10116.0,,9662,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,,,CHEMBL622024
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,,,10116.0,,9663,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,,,CHEMBL622693
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,,,10116.0,,9664,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,,,CHEMBL622694
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,9665,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,,CHEMBL622695
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,9666,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,,CHEMBL622696
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,9667,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,,,CHEMBL622697
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6619,50597,,,,10116.0,,9668,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,,,CHEMBL622874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6619,50597,,,,10116.0,,9669,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,,,CHEMBL622875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10363,50597,,,,10116.0,,9670,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,,CHEMBL622876
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4796,50597,,,,10116.0,,9671,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,,CHEMBL622877
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,9672,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,,CHEMBL622878
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,1969.0,Plasma,10116.0,,9673,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,,,CHEMBL622879
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4839,50597,,,,10116.0,,9674,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,,,CHEMBL877602
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9675,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL622880
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9676,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL622881
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9677,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL622882
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9678,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL622883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9679,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,,,CHEMBL622884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11450,50597,,2046.0,Thyroid gland,10116.0,,9680,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,,,CHEMBL622885
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,9681,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,,CHEMBL622886
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,9682,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,CHEMBL622887
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,1088.0,Urine,10116.0,,9683,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,,CHEMBL622888
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,178.0,Blood,10116.0,,9684,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622889
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,178.0,Blood,10116.0,,9685,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,178.0,Blood,10116.0,,9686,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,178.0,Blood,10116.0,,9687,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL877603
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,955.0,Brain,10116.0,,9688,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,955.0,Brain,10116.0,,9689,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,955.0,Brain,10116.0,,9690,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,955.0,Brain,10116.0,,9691,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622895
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,955.0,Brain,10116.0,,9692,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,In vivo,,CHEMBL622896
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,948.0,Heart,10116.0,,9693,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622897
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,948.0,Heart,10116.0,,9694,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622898
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,948.0,Heart,10116.0,,9695,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622899
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2113.0,Kidney,10116.0,,9696,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622900
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2113.0,Kidney,10116.0,,9697,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624114
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2113.0,Kidney,10116.0,,9698,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624115
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2113.0,Kidney,10116.0,,9699,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624116
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2107.0,Liver,10116.0,,9700,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624117
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2107.0,Liver,10116.0,,9701,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2107.0,Liver,10116.0,,9702,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2107.0,Liver,10116.0,,9703,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2048.0,Lung,10116.0,,9704,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2048.0,Lung,10116.0,,9705,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2048.0,Lung,10116.0,,9706,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624123
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2048.0,Lung,10116.0,,9707,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624124
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2385.0,Muscle tissue,10116.0,,9708,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624125
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2385.0,Muscle tissue,10116.0,,9709,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624126
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2385.0,Muscle tissue,10116.0,,9710,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624127
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2385.0,Muscle tissue,10116.0,,9711,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624128
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,14.0,Zone of skin,10116.0,,9712,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL624129
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,14.0,Zone of skin,10116.0,,9713,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL624130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,14.0,Zone of skin,10116.0,,9714,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622340
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,14.0,Zone of skin,10116.0,,9715,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622341
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,160.0,Intestine,10116.0,,9716,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622342
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,160.0,Intestine,10116.0,,9717,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622343
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,160.0,Intestine,10116.0,,9718,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622344
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,160.0,Intestine,10116.0,,9719,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622345
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2106.0,Spleen,10116.0,,9720,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622346
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2106.0,Spleen,10116.0,,9721,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622347
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2106.0,Spleen,10116.0,,9722,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622348
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2106.0,Spleen,10116.0,,9723,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622349
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9724,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,CHEMBL622350
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9725,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,CHEMBL622351
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9726,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,CHEMBL622352
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9727,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,CHEMBL622353
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9728,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,CHEMBL622354
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9729,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,CHEMBL622355
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9730,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,CHEMBL622356
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9731,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,CHEMBL622357
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9732,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,CHEMBL622358
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9733,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,CHEMBL622359
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9734,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,CHEMBL874393
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9735,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL622872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9736,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL622873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9737,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL623047
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9738,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL623048
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9739,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL623049
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9740,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL623050
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9741,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL623051
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9742,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL623052
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9743,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL626343
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9744,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,CHEMBL626344
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9745,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,CHEMBL626345
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9746,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,CHEMBL626346
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9747,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,CHEMBL626347
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9748,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,CHEMBL626348
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16434,50597,,,,10116.0,,9749,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,CHEMBL626349
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9750,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,CHEMBL626350
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9751,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,CHEMBL626351
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9752,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,CHEMBL627650
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9753,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,CHEMBL627651
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9754,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,CHEMBL627652
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16435,50597,,,,10116.0,,9755,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,CHEMBL627653
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9756,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,,,CHEMBL627654
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9757,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,,,CHEMBL627835
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9758,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,,,CHEMBL627836
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9759,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,,,CHEMBL627837
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9760,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,,,CHEMBL627838
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9761,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,,,CHEMBL875338
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9762,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,,,CHEMBL627839
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9763,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,,,CHEMBL627840
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9764,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,,,CHEMBL627841
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9765,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,,,CHEMBL627842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9766,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,,,CHEMBL627843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9767,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,,,CHEMBL627844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9768,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,,,CHEMBL627845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5874,50597,,,,10116.0,,9769,Half life period in rat by iv administration at a dose of 3 mg/kg,,In vivo,,CHEMBL627846
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9770,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,,,CHEMBL627847
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9771,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,,,CHEMBL873821
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9772,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,,CHEMBL626079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1515,50597,,1969.0,Plasma,10116.0,,9773,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,,CHEMBL626080
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5491,50597,,1969.0,Plasma,10116.0,,9774,Half life period was evaluated in rat plasma,,,,CHEMBL626081
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5491,50597,,1969.0,Plasma,10116.0,,9775,Half life period was evaluated in rat plasma; Not tested,,,,CHEMBL875344
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1918,50597,,,,10116.0,,9776,Half life period was evaluated in rats,,,,CHEMBL626082
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1918,50597,,,,10116.0,,9777,"Half life period was evaluated in rats, iv",,In vivo,,CHEMBL626250
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6113,50597,,,,10116.0,,9778,Half life period after intravenous administration at 5 mg/kg in rat,,In vivo,,CHEMBL626251
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5546,50597,,,,10116.0,,9779,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,In vivo,,CHEMBL626252
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5553,50597,,,,10116.0,,9780,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,In vivo,,CHEMBL626253
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4188,50597,,1969.0,Plasma,10116.0,,9781,Half life stability of compound was evaluated in rat plasma,,,,CHEMBL626254
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6215,50597,,,,10116.0,,9782,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,In vivo,,CHEMBL626255
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6141,50597,,,,10116.0,,9783,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,In vivo,,CHEMBL626256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,9784,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,In vivo,,CHEMBL626257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,9785,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,In vivo,,CHEMBL626258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5710,50597,,,,10116.0,,9786,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,In vivo,,CHEMBL626259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5789,50597,,,,10116.0,,9787,Half in rat i.v.,,In vivo,,CHEMBL626260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6011,50597,,,,10116.0,,9788,Half period in rat after intravenous administration,,In vivo,,CHEMBL875345
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17594,50597,,,,10116.0,,9789,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,In vivo,,CHEMBL626261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12357,50597,,2107.0,Liver,10116.0,,9790,Half-life measured in in vitro Cathepsin B assay in rat liver,,In vitro,,CHEMBL626262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5210,50597,,,,10116.0,,9791,Half-life of compound was determined in rats,,,,CHEMBL626263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,,,10116.0,,9792,Half-life at 10 mg/kg in rat upon intravenous administration,,In vivo,,CHEMBL625270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6672,50597,,,,10116.0,,9793,Half-life determined in rat,,,,CHEMBL625271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6673,50597,,,,10116.0,,9794,Half-life determined in rat,,,,CHEMBL625272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,955.0,Brain,10116.0,,9795,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,In vivo,,CHEMBL625273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3741,50597,,1969.0,Plasma,10116.0,,9796,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,,,CHEMBL625274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17671,50597,,,,10116.0,,9797,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,In vivo,,CHEMBL625275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,1969.0,Plasma,10116.0,,9798,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,In vivo,,CHEMBL625276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17537,50597,,1969.0,Plasma,10116.0,,9799,Half-life in rat plasma,,,,CHEMBL625277
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4965,50597,,1969.0,Plasma,10116.0,,9800,Half-life in rat plasma was determined,,,,CHEMBL625278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17537,50597,,1969.0,Plasma,10116.0,,9801,Half-life in rat plasma; Not tested,,,,CHEMBL625279
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6124,50597,,1977.0,Serum,10116.0,,9802,Half-life in rat serum,,,,CHEMBL625280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6124,50597,,1977.0,Serum,10116.0,,9803,Half-life in rat serum; na is not available,,,,CHEMBL876797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,9804,Half-life was calculated in rat,,,,CHEMBL625281
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17668,50597,,1969.0,Plasma,10116.0,,9805,Half-life was calculated in rat plasma,,,,CHEMBL873827
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3185,50597,,,,10116.0,,9806,Half-life was determined,,,,CHEMBL625282
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,9807,Half-life was determined,,,,CHEMBL625283
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2959,50597,,,,10116.0,,9808,Half-life after administration of 20 mg/Kg oral dose in rat,,In vivo,,CHEMBL625284
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4029,50597,,,,10116.0,,9809,Half-life after administration of 3.2 mg/kg intravenously in male rat,,In vivo,,CHEMBL625285
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4029,50597,,,,10116.0,,9810,Half-life after intravenous administration in female rat,,In vivo,,CHEMBL625286
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4029,50597,,,,10116.0,,9811,Half-life after intravenous administration in male rat,,In vivo,,CHEMBL625287
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6180,50597,,,,10116.0,,9812,Half-life after intravenous dose in rat,,In vivo,,CHEMBL625288
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1557,50597,,2107.0,Liver,10116.0,,9813,Half-life in a rat liver homogenate preparation,,,,CHEMBL625289
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12500,50597,,1969.0,Plasma,10116.0,,9814,Half-life in plasma of rat,,,,CHEMBL625290
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12500,50597,,1969.0,Plasma,10116.0,,9815,Half-life in plasma of rat at dose of 3-10 mgkg,,,,CHEMBL876798
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5064,50597,,,,10116.0,,9816,Half-life in rat,,,,CHEMBL625291
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5145,50597,,,,10116.0,,9817,Half-life in rat,,,,CHEMBL625292
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5147,50597,,,,10116.0,,9818,Half-life in rat,,,,CHEMBL625293
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5833,50597,,,,10116.0,,9819,Half-life in rat,,,,CHEMBL622832
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6596,50597,,,,10116.0,,9820,Half-life in rat,,,,CHEMBL622833
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,,,10116.0,,9821,Half-life in rat,,,,CHEMBL622834
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,9822,Half-life in rat after oral administration at 10 mg/kg,,In vivo,,CHEMBL622835
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,,,10116.0,,9823,Half-life in rat after po administration at a dose of 10 mg/kg,,In vivo,,CHEMBL622836
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,,,10116.0,,9824,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,In vivo,,CHEMBL622837
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10,50597,,,,10116.0,,9825,Half-life in rat at 3 mg/kg dose administered intravenously,,In vivo,,CHEMBL622838
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17669,50597,,955.0,Brain,10116.0,,9826,Half-life in rat brain homogenate,,,,CHEMBL622839
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17065,50597,,1969.0,Plasma,10116.0,,9827,Half-life in rat plasma,,,,CHEMBL622840
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4333,50597,,,,10116.0,,9828,Half-life in rats,,,,CHEMBL622841
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6827,50597,,,,10116.0,,9829,Half-life in Dawley rats,,,,CHEMBL622842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,889,50597,,1969.0,Plasma,10116.0,,9830,Half-life in vitro in rat plasma,,In vitro,,CHEMBL622843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,889,50597,,1969.0,Plasma,10116.0,,9831,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,In vitro,,CHEMBL622844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3747,50597,,,,10116.0,,9832,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,,,CHEMBL622845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,9833,The area under the curve of compound was measured at the dose of 100 umol/kg,,,,CHEMBL622846
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,9834,The area under the curve of compound was measured at the dose of 300 umol/kg,,,,CHEMBL622847
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,9835,The area under the curve of compound was measured at the dose of 30 umol/kg,,,,CHEMBL622848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3360,50597,,,,10116.0,,9836,Bioavailability as oral AUC in rats,,In vivo,,CHEMBL622849
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,1969.0,Plasma,10116.0,,9837,The plasma concentration versus time curve (AUC) was determined,,,,CHEMBL622850
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9838,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL876807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9839,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL622851
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9840,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL622852
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,9841,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,,,CHEMBL622853
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,9842,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,,,CHEMBL622854
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17411,50597,,,,10116.0,,9843,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,CHEMBL622855
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,1969.0,Plasma,10116.0,,9844,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,,,CHEMBL622856
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,1969.0,Plasma,10116.0,,9845,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,,,CHEMBL622857
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,1969.0,Plasma,10116.0,,9846,AUC in rat after po administration at a dose of 10 mg/kg,,,,CHEMBL622858
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,1969.0,Plasma,10116.0,,9847,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,,,CHEMBL622859
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,9848,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,,,CHEMBL622860
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,9849,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,,,CHEMBL622861
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,9850,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,,,CHEMBL622862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,9851,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,,,CHEMBL622863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,9852,Area under curve value 6 hr after po administration in rat,,,,CHEMBL623817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,9853,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,,CHEMBL623818
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,9854,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,,,CHEMBL623819
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,9855,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,,CHEMBL623820
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,9856,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,,,CHEMBL623821
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6642,50597,,1969.0,Plasma,10116.0,,9857,AUC normalized for dose (AUCN) in rat,,,,CHEMBL623822
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,9858,Area under curve in rat after p.o. administration,,,,CHEMBL623823
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,9859,Area under curve in rat after p.o. administration,,,,CHEMBL623824
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,9860,Area under curve in rat after p.o. administration; Not determined,,,,CHEMBL623825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,9861,Area under curve in rat after peroral administration,,,,CHEMBL622070
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3603,50597,,,,10116.0,,9862,Area under curve (carotid artery) value of the compound,,,,CHEMBL622071
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3550,50597,,,,10116.0,,9863,Bioavailability expressed as the area under curve of rat carotid artery,,,,CHEMBL622072
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,9864,Area under curve in male SD rats was observed after intravenous administration in rat,,,,CHEMBL622073
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17720,50597,,,,10116.0,,9865,Area under curve of the compound was determined,,,,CHEMBL622074
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5407,50597,,,,10116.0,,9866,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,,,CHEMBL622075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,1969.0,Plasma,10116.0,,9867,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,,,CHEMBL622076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,1969.0,Plasma,10116.0,,9868,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,,,CHEMBL622077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3603,50597,,,,10116.0,,9869,Area under curve (portal vein) value of the compound,,,,CHEMBL622078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3550,50597,,,,10116.0,,9870,Bioavailability expressed as the area under curve of rat portal vein,,,,CHEMBL622079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,1969.0,Plasma,10116.0,,9871,Area Under plasma concentration time curve in rat upon peroral administration,,,,CHEMBL622080
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,9872,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,,,CHEMBL877612
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,9873,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,,,CHEMBL622081
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9874,Compound was evaluated for oral bioavailability in rats,,,,CHEMBL622082
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9875,Compound was evaluated for oral bioavailability in rats after iv administration,,,,CHEMBL622083
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9876,Compound was evaluated for oral bioavailability in rats; 30-80,,,,CHEMBL622084
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9877,Compound was evaluated for oral bioavailability in rats; 50-60,,,,CHEMBL622085
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9878,Compound was evaluated for oral bioavailability in rats; no data,,,,CHEMBL622086
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17791,50597,,,,10116.0,,9879,Compound was evaluated for oral bioavailability in rats; peptide,,,,CHEMBL622087
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,9880,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,,,CHEMBL622088
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,9881,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,,,CHEMBL622089
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,9882,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,,,CHEMBL623685
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,9883,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,,,CHEMBL623686
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,945.0,Stomach,10116.0,,9884,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL623687
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,945.0,Stomach,10116.0,,9885,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL623688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,945.0,Stomach,10116.0,,9886,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL623689
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,945.0,Stomach,10116.0,,9887,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622485
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2046.0,Thyroid gland,10116.0,,9888,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622486
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2046.0,Thyroid gland,10116.0,,9889,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL877613
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2046.0,Thyroid gland,10116.0,,9890,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,In vivo,,CHEMBL622487
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2046.0,Thyroid gland,10116.0,,9891,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,948.0,Heart,10116.0,,9892,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,In vivo,,CHEMBL622489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,1088.0,Urine,10116.0,,9893,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,,CHEMBL622490
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,1088.0,Urine,10116.0,,9894,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,,CHEMBL622491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,2107.0,Liver,10116.0,,9895,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,,,CHEMBL622492
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,1088.0,Urine,10116.0,,9896,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,,CHEMBL622493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,1088.0,Urine,10116.0,,9897,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,,CHEMBL622494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8677,50597,,2385.0,Muscle tissue,10116.0,,9898,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,,CHEMBL622495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,,,10116.0,,9899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,,,CHEMBL622496
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6899,50597,,1088.0,Urine,10116.0,,9900,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,,CHEMBL622497
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2189,50597,,,,10116.0,,9901,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,,,CHEMBL622498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2189,50597,,1088.0,Urine,10116.0,,9902,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,,,CHEMBL624918
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2189,50597,,1088.0,Urine,10116.0,,9903,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,,,CHEMBL624919
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,178.0,Blood,10116.0,,9904,Biodistribution of compound in rat blood after 5 min of administration,,In vivo,,CHEMBL624920
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,178.0,Blood,10116.0,,9905,Biodistribution of compound in rat blood after 5 min of administration.,,In vivo,,CHEMBL624921
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,955.0,Brain,10116.0,,9906,Biodistribution of compound in rat brain after 5 min of administration,,In vivo,,CHEMBL624922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,948.0,Heart,10116.0,,9907,Biodistribution of compound in rat heart after 5 min of administration,,In vivo,,CHEMBL624923
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,948.0,Heart,10116.0,,9908,Biodistribution of compound in rat heart after 5 min of administration.,,In vivo,,CHEMBL624924
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2113.0,Kidney,10116.0,,9909,Biodistribution of compound in rat kidney after 5 min of administration,,In vivo,,CHEMBL624925
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2113.0,Kidney,10116.0,,9910,Biodistribution of compound in rat kidney after 5 min of administration.,,In vivo,,CHEMBL624926
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2107.0,Liver,10116.0,,9911,Biodistribution of compound in rat liver after 5 min of administration,,In vivo,,CHEMBL624927
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2107.0,Liver,10116.0,,9912,Biodistribution of compound in rat liver after 5 min of administration.,,In vivo,,CHEMBL874402
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2048.0,Lung,10116.0,,9913,Biodistribution of compound in rat lung after 5 min of administration,,In vivo,,CHEMBL624928
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2048.0,Lung,10116.0,,9914,Biodistribution of compound in rat lung after 5 min of administration.,,In vivo,,CHEMBL624929
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2385.0,Muscle tissue,10116.0,,9915,Biodistribution of compound in rat muscle after 5 min of administration,,In vivo,,CHEMBL624930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10839,50597,,2385.0,Muscle tissue,10116.0,,9916,Biodistribution of compound in rat muscle after 5 min of administration.,,In vivo,,CHEMBL624931
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,948.0,Heart,10116.0,,9917,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624932
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,948.0,Heart,10116.0,,9918,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624933
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,2107.0,Liver,10116.0,,9919,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624934
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,2107.0,Liver,10116.0,,9920,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,,,10116.0,,9921,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624936
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,,,10116.0,,9922,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624937
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,2106.0,Spleen,10116.0,,9923,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624938
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,2106.0,Spleen,10116.0,,9924,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624939
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,,,10116.0,,9925,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL624940
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4043,50597,,,,10116.0,,9926,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,CHEMBL874403
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1446,50597,,,,10116.0,,9927,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,,,CHEMBL624941
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9971,50597,,1088.0,Urine,10116.0,,9928,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,,,CHEMBL624942
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9971,50597,,1088.0,Urine,10116.0,,9929,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,,,CHEMBL624943
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5765,50597,,,,10116.0,,9930,% Bioavailability after 1 day of the drug administration in rats,,In vivo,,CHEMBL624944
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5765,50597,,,,10116.0,,9931,% Bioavailability after 4 day of the drug administration in rats,,In vivo,,CHEMBL624945
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4257,50597,,,,10116.0,,9932,Absolute bioavailability was evaluated in rat,,In vivo,,CHEMBL624946
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9933,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,,,CHEMBL624947
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9934,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,,,CHEMBL624948
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9935,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,,,CHEMBL624949
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2113.0,Kidney,10116.0,,9936,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,,,CHEMBL622025
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2113.0,Kidney,10116.0,,9937,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,,,CHEMBL622026
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2113.0,Kidney,10116.0,,9938,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,,,CHEMBL622027
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2113.0,Kidney,10116.0,,9939,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,,,CHEMBL622028
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2107.0,Liver,10116.0,,9940,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,,,CHEMBL622029
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2107.0,Liver,10116.0,,9941,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,,,CHEMBL622208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2107.0,Liver,10116.0,,9942,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,,,CHEMBL622209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2107.0,Liver,10116.0,,9943,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,,,CHEMBL622210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9944,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,,,CHEMBL622211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9945,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,,,CHEMBL622212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9946,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,,,CHEMBL622213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9947,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,,,CHEMBL874404
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9948,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,,,CHEMBL620452
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9949,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,,,CHEMBL620453
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9950,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,,,CHEMBL620454
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9951,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,,,CHEMBL624067
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9952,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,,,CHEMBL624068
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,992.0,Female gonad,10116.0,,9953,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,,,CHEMBL624069
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,992.0,Female gonad,10116.0,,9954,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,,,CHEMBL624070
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,992.0,Female gonad,10116.0,,9955,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,,,CHEMBL624071
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,995.0,Uterus,10116.0,,9956,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,,,CHEMBL624072
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,995.0,Uterus,10116.0,,9957,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,,,CHEMBL624073
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,995.0,Uterus,10116.0,,9958,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,,,CHEMBL624788
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,995.0,Uterus,10116.0,,9959,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,,,CHEMBL624789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9960,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,,,CHEMBL624790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9961,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,,,CHEMBL624791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9962,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,,,CHEMBL624792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,,,10116.0,,9963,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,,,CHEMBL624793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9964,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,,,CHEMBL877491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9965,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,,,CHEMBL624957
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9966,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,,,CHEMBL624958
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13091,50597,,2385.0,Muscle tissue,10116.0,,9967,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,,,CHEMBL624959
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11977,50597,,,,10116.0,,9968,Dissociation constant was determined,,,,CHEMBL624960
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,9969,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,,,CHEMBL624961
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9970,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL624962
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,9971,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL624963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4755,50597,,,,10116.0,,9972,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,,,CHEMBL624964
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,589,50597,,,,10116.0,,9973,LogP value was evaluated in the in situ rat gut perfusion assay,,,,CHEMBL624965
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,9974,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,In vivo,,CHEMBL624966
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5031,50597,,,,10116.0,,9975,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,In vivo,,CHEMBL624967
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,9976,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,In vivo,,CHEMBL624968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17720,50597,,,,10116.0,,9977,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,,,CHEMBL624969
Expert,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,2862,50597,,,,10116.0,,9978,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,,,CHEMBL624970
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,9979,Half-life was evaluated after 10 uM/kg of intra arterial administration,,,,CHEMBL624971
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,9980,Half-life was evaluated after 20 uM/kg of peroral administration,,In vivo,,CHEMBL624972
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6005,50597,,,,10116.0,,9981,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,In vivo,,CHEMBL624973
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2938,50597,,1969.0,Plasma,10116.0,,9982,Half-life was evaluated in plasma of rat,,,,CHEMBL624974
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,9983,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,In vivo,,CHEMBL624975
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,9984,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,In vivo,,CHEMBL877492
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6062,50597,,,,10116.0,,9985,Half-life was measured in rat after an iv dose of 1 mg/kg,,In vivo,,CHEMBL624976
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6571,50597,,,,10116.0,,9986,Half-life period of compound in rats after peroral administration,,In vivo,,CHEMBL624977
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3136,50597,,1969.0,Plasma,10116.0,,9987,Half-life period of compound was measured in rat plasma.,,,,CHEMBL626848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3136,50597,,1969.0,Plasma,10116.0,,9988,Half-life period of compound was measured in rat plasma; ND is not determined,,,,CHEMBL626849
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3136,50597,,1969.0,Plasma,10116.0,,9989,Half-life period of compound was measured in rat plasma; not determined,,,,CHEMBL626850
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4521,50597,,,,10116.0,,9990,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,In vivo,,CHEMBL626851
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5871,50597,,,,10116.0,,9991,Half-life period in rat by iv administration,,In vivo,,CHEMBL626852
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6077,50597,,,,10116.0,,9992,Half-life period in rats following intravenous administration at 2 mg/kg,,In vivo,,CHEMBL626853
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6679,50597,,,,10116.0,,9993,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,In vivo,,CHEMBL626854
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5144,50597,,,,10116.0,,9994,Half-life period was determined for the compound in rat,,,,CHEMBL627486
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4498,50597,,,,10116.0,,9995,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,In vivo,,CHEMBL627487
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4498,50597,,,,10116.0,,9996,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,In vivo,,CHEMBL627488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,,,10116.0,,9997,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,In vivo,,CHEMBL627489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6211,50597,,,,10116.0,,9998,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,In vivo,,CHEMBL627490
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5529,50597,,,,10116.0,,9999,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,In vivo,,CHEMBL873829
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,10000,Half-life was determined in rat at a dose of 1 mpk i.v.,,In vivo,,CHEMBL627655
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,10001,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,In vivo,,CHEMBL625994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6444,50597,,,,10116.0,,10002,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,In vivo,,CHEMBL625995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5207,50597,,,,10116.0,,10003,Half-life in rat,,,,CHEMBL625996
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,530,50597,,1969.0,Plasma,10116.0,,10004,In vitro half life in rat plasma,,In vitro,,CHEMBL625850
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1116,50597,,1969.0,Plasma,10116.0,,10005,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,In vitro,,CHEMBL625851
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3219,50597,,,,10116.0,,10006,In vitro half life in rat,,In vitro,,CHEMBL625852
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6109,50597,,,,10116.0,,10007,In vivo half life period after intravenous administration in rat,,In vivo,,CHEMBL625853
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,10008,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,In vivo,,CHEMBL625854
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,10009,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,In vivo,,CHEMBL874450
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10010,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL625855
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10011,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL625856
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10012,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL625857
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10013,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL873831
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17853,50597,,,,10116.0,,10014,Longer half-life in rat (i.v.) at 0.5 mpk,,In vivo,,CHEMBL625858
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17853,50597,,,,10116.0,,10015,Longer half-life in rat (p.o.) at 2.0 mpk,,In vivo,,CHEMBL625859
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3457,50597,,,,10116.0,,10016,Pharmacokinetic property (half life) in rat,,,,CHEMBL625860
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,10017,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,In vivo,,CHEMBL625861
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,10018,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,In vivo,,CHEMBL625862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,10019,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,In vivo,,CHEMBL625863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,10020,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,In vivo,,CHEMBL625864
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5739,50597,,,,10116.0,,10021,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,In vivo,,CHEMBL625865
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,10022,Pharmacokinetic half time was determined intravenously in rats.,,In vivo,,CHEMBL625866
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6567,50597,,1969.0,Plasma,10116.0,,10023,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,In vivo,,CHEMBL625867
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2448,50597,,1969.0,Plasma,10116.0,,10024,Plasma half life of hydrolysis of the compound,,,,CHEMBL625868
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5423,50597,,1969.0,Plasma,10116.0,,10025,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,In vivo,,CHEMBL625869
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,1969.0,Plasma,10116.0,,10026,Plasma half life period was calculated in rat,,,,CHEMBL874451
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,1969.0,Plasma,10116.0,,10027,Plasma half-life in Sprague-Dawley rats,,,,CHEMBL625870
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,1969.0,Plasma,10116.0,,10028,Plasma half-life in Sprague-Dawley rats; Not determined,,,,CHEMBL625871
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1500,50597,,1969.0,Plasma,10116.0,,10029,Plasma half-life in rats,,,,CHEMBL625872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1500,50597,,1969.0,Plasma,10116.0,,10030,Plasma half-life in rats; <MQL,,,,CHEMBL625873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,1969.0,Plasma,10116.0,,10031,Plasma half-life period (0-8 h) was determined,,,,CHEMBL625874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,1969.0,Plasma,10116.0,,10032,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,,,CHEMBL625875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,1969.0,Plasma,10116.0,,10033,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,In vivo,,CHEMBL625876
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,1969.0,Plasma,10116.0,,10034,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,In vivo,,CHEMBL631258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4956,50597,,1969.0,Plasma,10116.0,,10035,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,,,CHEMBL631259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4956,50597,,1969.0,Plasma,10116.0,,10036,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,,,CHEMBL631260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,10037,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,,,CHEMBL631261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,10038,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,,,CHEMBL631262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,178.0,Blood,10116.0,,10039,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,,,CHEMBL631263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10040,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,,,CHEMBL631264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10041,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,,,CHEMBL631265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10042,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,,,CHEMBL631266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10043,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,,,CHEMBL631267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10044,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,,,CHEMBL631268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10045,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,,,CHEMBL631269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,,,10116.0,,10046,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,,,CHEMBL631270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10047,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,,CHEMBL631271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10048,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,,,CHEMBL631272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10049,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,,,CHEMBL631273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10050,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,,,CHEMBL631274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10051,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,,,CHEMBL631275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10052,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,,,CHEMBL626984
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,948.0,Heart,10116.0,,10053,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,,,CHEMBL626985
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10054,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,,CHEMBL626986
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10055,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,,,CHEMBL626987
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10056,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,,,CHEMBL626988
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10057,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,,,CHEMBL626989
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10058,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,,,CHEMBL626990
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10059,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,,,CHEMBL626991
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2107.0,Liver,10116.0,,10060,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,,,CHEMBL626992
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10061,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,,,CHEMBL626993
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10062,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,,,CHEMBL874593
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10063,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,,,CHEMBL626994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10064,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,,,CHEMBL626995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10065,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,,,CHEMBL626190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10066,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,,,CHEMBL626191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2048.0,Lung,10116.0,,10067,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,,,CHEMBL626364
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10068,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,,,CHEMBL626365
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10069,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,,,CHEMBL626366
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10070,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,,,CHEMBL626367
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10071,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,,,CHEMBL626368
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10072,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,,,CHEMBL626369
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10073,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,,,CHEMBL626370
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4498,50597,,,,10116.0,,10074,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,In vivo,,CHEMBL626371
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4498,50597,,,,10116.0,,10075,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,In vivo,,CHEMBL626372
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3603,50597,,,,10116.0,,10076,Bioavailability after a dose of 10 mg/kg p.o.,,In vivo,,CHEMBL626373
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6215,50597,,,,10116.0,,10077,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,In vivo,,CHEMBL626374
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5710,50597,,,,10116.0,,10078,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,In vivo,,CHEMBL626375
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5710,50597,,,,10116.0,,10079,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,In vivo,,CHEMBL626376
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5676,50597,,,,10116.0,,10080,Bioavailability in rat po was determined,,In vivo,,CHEMBL626377
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17667,50597,,,,10116.0,,10081,Bioavailability of compound at 10 mg/kg in rat after oral administration,,In vivo,,CHEMBL626378
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17667,50597,,,,10116.0,,10082,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,In vivo,,CHEMBL626379
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6848,50597,,,,10116.0,,10083,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,In vivo,,CHEMBL626380
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6848,50597,,,,10116.0,,10084,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,In vivo,,CHEMBL626381
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17267,50597,,,,10116.0,,10085,Bioavailability in rat,,In vivo,,CHEMBL626382
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6362,50597,,,,10116.0,,10086,Bioavailability in rat (Sprague-Dawley) (female),,In vivo,,CHEMBL626383
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17671,50597,,,,10116.0,,10087,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,In vivo,,CHEMBL874652
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17671,50597,,,,10116.0,,10088,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,In vivo,,CHEMBL626384
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4333,50597,,,,10116.0,,10089,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,In vivo,,CHEMBL626385
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6077,50597,,,,10116.0,,10090,Bioavailability in rat at an oral dose of 2 mg/kg,,In vivo,,CHEMBL626386
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3278,50597,,,,10116.0,,10091,Bioavailability in rat,,In vivo,,CHEMBL626387
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5964,50597,,,,10116.0,,10092,Bioavailability in rat,,In vivo,,CHEMBL626388
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4884,50597,,,,10116.0,,10093,Bioavailability in rat,,In vivo,,CHEMBL626389
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4905,50597,,,,10116.0,,10094,Bioavailability in rat,,In vivo,,CHEMBL626390
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4884,50597,,,,10116.0,,10095,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,In vivo,,CHEMBL626391
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6850,50597,,,,10116.0,,10096,Bioavailability in rat,,In vivo,,CHEMBL626392
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2864,50597,,,,10116.0,,10097,Oral bioavailability in rat,,In vivo,,CHEMBL626393
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5780,50597,,,,10116.0,,10098,Bioavailability was determined in rat,,In vivo,,CHEMBL623026
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1465,50597,,,,10116.0,,10099,Bioavailability,,In vivo,,CHEMBL623027
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5199,50597,,,,10116.0,,10100,Bioavailability,,In vivo,,CHEMBL623028
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5765,50597,,,,10116.0,,10101,Bioavailability in rat after 1 day dosing,,In vivo,,CHEMBL623029
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5765,50597,,,,10116.0,,10102,Bioavailability in rat after 4 day dosing,,In vivo,,CHEMBL623030
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,10103,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,In vivo,,CHEMBL623031
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,10104,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,In vivo,,CHEMBL623032
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,10105,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,In vivo,,CHEMBL623033
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6518,50597,,,,10116.0,,10106,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,In vivo,,CHEMBL623034
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2083,50597,,,,10116.0,,10107,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,In vivo,,CHEMBL623035
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17260,50597,,,,10116.0,,10108,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,In vivo,,CHEMBL623036
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4956,50597,,,,10116.0,,10109,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,In vivo,,CHEMBL623037
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4368,50597,,,,10116.0,,10110,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,In vivo,,CHEMBL623038
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17752,50597,,1969.0,Plasma,10116.0,,10111,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,In vivo,,CHEMBL874385
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1446,50597,,,,10116.0,,10112,Bioavailability in rat (Fisher) (fasted),,In vivo,,CHEMBL623039
Intermediate,BAO_0000218,,A,,1,Primates,0,U,,2891,22224,,,,9443.0,,10113,Bioavailability in monkey after po administration of 10 mg/kg dose,,In vivo,,CHEMBL623040
Intermediate,BAO_0000218,,A,,1,Primates,0,U,,2891,22224,,,,9443.0,,10114,Oral bioavailability in monkey (dose 10 mg/kg),,In vivo,,CHEMBL623041
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6672,50597,,,,10116.0,,10115,Bioavailability in rat,,In vivo,,CHEMBL623741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6673,50597,,,,10116.0,,10116,Bioavailability in rat,,In vivo,,CHEMBL623742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,,,10116.0,,10117,Bioavailability in rat,,In vivo,,CHEMBL623743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,10118,Bioavailability in rat,,In vivo,,CHEMBL623744
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17853,50597,,,,10116.0,,10119,Bioavailability in rat (dose 2.0 mg/kg p.o.),,In vivo,,CHEMBL623745
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4521,50597,,,,10116.0,,10120,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,In vivo,,CHEMBL623746
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4940,50597,,,,10116.0,,10121,Oral bioavailability in rat (dose 5 mg/kg p.o.),,In vivo,,CHEMBL623747
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,2891,22224,,,,10116.0,,10122,Bioavailability in rat after po administration of 30 mg/kg dose,,In vivo,,CHEMBL623748
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,2891,22224,,,,10116.0,,10123,Bioavailability in rat after po administration of 30 mg/kg dose,,In vivo,,CHEMBL623916
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4521,50597,,,,10116.0,,10124,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,In vivo,,CHEMBL623917
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17686,50597,,,,10116.0,,10125,Bioavailability in rat (dose 2 mg/kg i.v.),,In vivo,,CHEMBL623918
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,10126,Bioavailability in rat,,In vivo,,CHEMBL874386
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,1969.0,Plasma,10116.0,,10127,Bioavailability in rat; Only traces detected in rat plasma,,In vivo,,CHEMBL623919
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5064,50597,,,,10116.0,,10128,Bioavailability in rat,,In vivo,,CHEMBL623920
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5147,50597,,,,10116.0,,10129,Bioavailability upon oral administration of compound,,In vivo,,CHEMBL623148
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1916,50597,,,,10116.0,,10130,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,In vivo,,CHEMBL623149
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6049,50597,,,,10116.0,,10131,Bioavailability in rat,,In vivo,,CHEMBL623150
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1445,50597,,,,10116.0,,10132,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,In vivo,,CHEMBL623151
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1445,50597,,,,10116.0,,10133,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,In vivo,,CHEMBL623152
Expert,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,2862,50597,,,,10116.0,,10134,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,,,CHEMBL623153
Expert,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,2862,50597,,,,10116.0,,10135,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,,,CHEMBL623154
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4194,50597,,,,10116.0,,10136,In vitro and metabolic stability was determined,,,,CHEMBL623155
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4194,50597,,,,10116.0,,10137,In vitro metabolic stability in rat hepatocytes,,,,CHEMBL623156
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5486,50597,,,,10116.0,,10138,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,,,CHEMBL623157
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,401.0,2107.0,Liver,10116.0,,10139,Metabolic rate for compound was observed in rat hepatocytes,,In vitro,Hepatocyte,CHEMBL623158
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5600,50597,,,,10116.0,,10140,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,,,CHEMBL623159
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14294,50597,,,,10116.0,,10141,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,,,CHEMBL874390
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14294,50597,,,,10116.0,,10142,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,,,CHEMBL623160
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14294,50597,,,,10116.0,,10143,Metabolism of compound in rat S9 microsomes; Trace,,,,CHEMBL623161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17847,50597,,,,10116.0,,10144,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,,,CHEMBL623162
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10145,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,,,CHEMBL623163
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10146,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,,,CHEMBL623164
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10147,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,,,CHEMBL623165
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10148,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,,,CHEMBL623166
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10149,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,,,CHEMBL624983
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10150,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,,,CHEMBL624984
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10151,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,,,CHEMBL624985
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10152,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,,,CHEMBL622970
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10153,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,,,CHEMBL622971
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10154,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,,,CHEMBL622972
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10155,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,,,CHEMBL622973
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10156,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,,,CHEMBL622974
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10157,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,,,CHEMBL622975
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10158,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,,,CHEMBL622976
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10159,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,,,CHEMBL622977
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10160,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,,CHEMBL624351
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10161,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,,,CHEMBL624352
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10162,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,,CHEMBL624353
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10163,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,,,CHEMBL622397
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10164,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,,,CHEMBL622398
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10165,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,,,CHEMBL622399
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10166,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,,CHEMBL622400
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10167,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,,CHEMBL628428
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10168,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,,,CHEMBL628590
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10169,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,,CHEMBL628591
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10170,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,,,CHEMBL628592
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10171,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,,CHEMBL628593
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10172,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,,,CHEMBL875333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10173,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,,CHEMBL628594
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4969,50597,,1969.0,Plasma,10116.0,,10174,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,,,CHEMBL628595
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6737,50597,,1969.0,Plasma,10116.0,,10175,Stability in rat plasma was determined,,,,CHEMBL628596
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6737,50597,,1969.0,Plasma,10116.0,,10176,Stability in rat plasma was determined; ND= no data,,,,CHEMBL628597
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5089,50597,,1969.0,Plasma,10116.0,,10177,Tested for plasma half life period in rat (0-8 hr),,,,CHEMBL628598
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5089,50597,,1969.0,Plasma,10116.0,,10178,Tested for plasma half life period in rat (0-8 hr); Not determined,,,,CHEMBL628599
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,,,10116.0,,10179,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,In vivo,,CHEMBL628600
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,,,10116.0,,10180,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,In vivo,,CHEMBL628601
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4950,50597,,,,10116.0,,10181,Tested for the half life in rat,,,,CHEMBL628602
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2412,50597,,,,10116.0,,10182,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,In vitro,,CHEMBL628603
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2412,50597,,,,10116.0,,10183,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,In vitro,,CHEMBL628604
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2412,50597,,,,10116.0,,10184,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,In vitro,,CHEMBL628605
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2412,50597,,,,10116.0,,10185,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,In vitro,,CHEMBL628606
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2412,50597,,,,10116.0,,10186,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,In vitro,,CHEMBL628607
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,10187,The biological half life the compound was measured at the dose of 100 umol/kg,,,,CHEMBL628608
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15022,50597,,,,10116.0,,10188,The biological half life the compound was measured at the dose of 30 umol/kg,,,,CHEMBL628609
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,406,50597,,1969.0,Plasma,10116.0,,10189,The compound was evaluated for plasma half life period in rat,,,,CHEMBL628610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,10190,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL873819
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,10191,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL628611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5247,50597,,,,10116.0,,10192,The pharmacokinetic parameter half-life period in vivo in rats,,In vivo,,CHEMBL628612
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,10193,"The pharmacokinetic property, Half-life was determined",,In vivo,,CHEMBL628613
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,10194,"The pharmacokinetic property, Half-life in rat in vivo",,In vivo,,CHEMBL628614
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,10195,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,In vivo,,CHEMBL628615
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,10196,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,In vivo,,CHEMBL628616
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3918,50597,,1969.0,Plasma,10116.0,,10197,The plasma half life period in rats,,,,CHEMBL627924
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2906,50597,,2107.0,Liver,10116.0,,10198,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,,,CHEMBL627925
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6467,50597,,,,10116.0,,10199,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,In vivo,,CHEMBL627926
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,10200,t1/2 (apparent elimination)of the compound was determined,,,,CHEMBL627927
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3788,50597,,,,10116.0,,10201,t1/2 value in rat,,,,CHEMBL627928
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17796,50597,,,,10116.0,,10202,Half life in rat,,,,CHEMBL627539
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,1969.0,Plasma,10116.0,,10203,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,In vivo,,CHEMBL876790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5983,50597,,,,10116.0,,10204,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,In vivo,,CHEMBL858186
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,10205,Half-life period in fasted rats,,,,CHEMBL627540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,10206,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,In vivo,,CHEMBL627541
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,10207,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,In vivo,,CHEMBL627715
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,429,50597,,,,10116.0,,10208,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,In vivo,,CHEMBL627716
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,,,10116.0,,10209,Maximum time required to achieve Cmax was determined in rat,,,,CHEMBL627717
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10210,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,In vivo,,CHEMBL627718
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10211,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,In vivo,,CHEMBL627719
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10212,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,In vivo,,CHEMBL627720
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,10213,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,In vivo,,CHEMBL627721
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,10214,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,In vivo,,CHEMBL627722
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10215,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL627723
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10216,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL626058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10217,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL626059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10218,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL626060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,10219,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL626061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,10220,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,In vivo,,CHEMBL876791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4723,50597,,,,10116.0,,10221,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,In vivo,,CHEMBL626062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,10222,Tmax at the dose of 2 mg/Kg administered perorally in rats,,In vivo,,CHEMBL626063
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,10223,Tmax at the dose of 5 mg/Kg administered perorally in rats,,In vivo,,CHEMBL626064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,10224,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL626065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17720,50597,,1969.0,Plasma,10116.0,,10225,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,In vivo,,CHEMBL626066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,,,10116.0,,10226,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,In vivo,,CHEMBL626067
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10227,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,,,CHEMBL626068
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10228,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,,,CHEMBL626069
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10229,Percent total excretion of 3-methoxyacetaminophen glucuronide,,,,CHEMBL626070
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10230,Percent total excretion of N-methoxyacetaminophen glucuronide,,,,CHEMBL626071
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10231,Percent total excretion of N-methoxyacetaminophen sulfate,,,,CHEMBL626072
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10232,Percent total excretion of acetaminophen,,,,CHEMBL626073
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7768,50597,,2046.0,Thyroid gland,10116.0,,10233,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,,,CHEMBL626741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17655,50597,,,,10116.0,,10234,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,,,CHEMBL626742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17735,50597,,,,10116.0,,10235,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,,,CHEMBL626743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5960,50597,,,,10116.0,,10236,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,,,CHEMBL876792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17735,50597,,,,10116.0,,10237,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,,CHEMBL626744
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7116,50597,,,,10116.0,,10238,Compound was tested for antidiuretic activity in rats,,,,CHEMBL626745
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4878,50597,,1969.0,Plasma,10116.0,,10239,AUC in rat after 3mg/kg oral dose,,In vivo,,CHEMBL626746
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,10240,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,,,CHEMBL626747
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,10241,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,,,CHEMBL626748
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16367,50597,,,,10116.0,,10242,Bioavailability administered orally at a dose of 10 mg/kg to rats,,,,CHEMBL626749
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16366,50597,,,,10116.0,,10243,Oral Bioavailability was determined,,,,CHEMBL626750
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,10244,Oral bioavailability in rat,,,,CHEMBL626751
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4426,50597,,,,10116.0,,10245,Oral bioavailability in rat; Not performed.,,,,CHEMBL626913
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,10246,Bioavailability,,,,CHEMBL626914
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5041,50597,,,,10116.0,,10247,Bioavailability was determined; ND denotes no data,,,,CHEMBL626915
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1500,50597,,,,10116.0,,10248,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,,,CHEMBL626916
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1500,50597,,,,10116.0,,10249,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,,,CHEMBL626917
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17409,50597,,,,10116.0,,10250,Binding towards rat plasma protein at 10 uM,,,,CHEMBL626918
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17409,50597,,,,10116.0,,10251,Binding towards rat plasma protein at 100 uM,,,,CHEMBL626919
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2959,50597,,,,10116.0,,10252,Bioavailability in rat (dose 20 mg/kg p.o.),,In vivo,,CHEMBL626920
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13501,50597,,,,10116.0,,10253,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,In vivo,,CHEMBL621976
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6567,50597,,,,10116.0,,10254,Bioavailability in rat after 5 mg/kg oral gavage,,In vivo,,CHEMBL877599
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6571,50597,,,,10116.0,,10255,Bioavailability in rat,,In vivo,,CHEMBL621977
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6715,50597,,,,10116.0,,10256,Bioavailability in rat (dose 1 mg/kg i.v.),,In vivo,,CHEMBL621978
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6715,50597,,,,10116.0,,10257,Bioavailability in rat (dose 3 mg/kg p.o.),,In vivo,,CHEMBL621979
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2932,50597,,,,10116.0,,10258,Oral bioavailability in rat,,In vivo,,CHEMBL621980
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4171,50597,,,,10116.0,,10259,Bioavailability of the compound in rats after administration of 30 mg/kg,,In vivo,,CHEMBL621981
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,10260,Bioavailability after administration of 10 mg/kg in rats,,In vivo,,CHEMBL621982
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17509,50597,,,,10116.0,,10261,Bioavailability after administration of 2 mg/kg in rats,,In vivo,,CHEMBL882953
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4527,50597,,,,10116.0,,10262,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,In vivo,,CHEMBL621983
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,10263,Bioavailability in dogs was determined; high,,In vivo,,CHEMBL621984
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6659,50597,,,,10116.0,,10264,Bioavailability in monkey after intravenous administration at 1 mpk,,In vivo,,CHEMBL621985
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6659,50597,,,,10116.0,,10265,Bioavailability in monkey after peroral administration at 10 mpk,,In vivo,,CHEMBL621986
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6659,50597,,,,10116.0,,10266,Bioavailability in rat after intravenous administration at 1 mpk,,In vivo,,CHEMBL621987
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,6659,50597,,,,10116.0,,10267,Bioavailability in rat after intravenous administration at 2 mpk,,In vivo,,CHEMBL877600
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6659,50597,,,,10116.0,,10268,Bioavailability in rat after peroral administration at 30 mpk,,In vivo,,CHEMBL621988
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,6659,50597,,,,10116.0,,10269,Bioavailability in rat after peroral administration at at 100 mpk,,In vivo,,CHEMBL621989
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6597,50597,,,,10116.0,,10270,Bioavailability in rats was evaluated,,In vivo,,CHEMBL621990
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1202,50597,,,,10116.0,,10271,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,In vivo,,CHEMBL621991
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1202,50597,,,,10116.0,,10272,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,In vivo,,CHEMBL621992
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1202,50597,,,,10116.0,,10273,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,In vivo,,CHEMBL621993
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1202,50597,,,,10116.0,,10274,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,In vivo,,CHEMBL621994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5207,50597,,,,10116.0,,10275,Bioavailability in rat,,In vivo,,CHEMBL621995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5970,50597,,,,10116.0,,10276,Bioavailability in rat,,In vivo,,CHEMBL621996
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,,,10116.0,,10277,Oral bioavailability in rat (dose 10 mg/kg),,In vivo,,CHEMBL621997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17538,50597,,,,10116.0,,10278,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,In vivo,,CHEMBL621998
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1466,50597,,,,10116.0,,10279,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,In vivo,,CHEMBL621999
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,,,10116.0,,10280,Oral bioavailability in rat,,In vivo,,CHEMBL622000
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,,,10116.0,,10281,Bioavailability was measured in rat after oral administration; 2-4,,In vivo,,CHEMBL622001
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2879,50597,,,,10116.0,,10282,Bioavailability was measured in rat after oral administration; 3-7,,In vivo,,CHEMBL622002
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3777,50597,,,,10116.0,,10283,Bioavailability in rat (intraduodenal administration),,In vivo,,CHEMBL622003
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3777,50597,,,,10116.0,,10284,Bioavailability in rat (intraduodenal administration),,In vivo,,CHEMBL877601
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3777,50597,,,,10116.0,,10285,Oral bioavailability in rat,,In vivo,,CHEMBL624871
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3777,50597,,,,10116.0,,10286,Oral bioavailability in rat,,In vivo,,CHEMBL622004
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5423,50597,,,,10116.0,,10287,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,In vivo,,CHEMBL882954
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,10288,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,In vivo,,CHEMBL622005
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16365,50597,,,,10116.0,,10289,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,In vivo,,CHEMBL622006
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4239,50597,,,,10116.0,,10290,Bioavailability was measured in rat,,In vivo,,CHEMBL622007
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5438,50597,,,,10116.0,,10291,Bioavailability was reported,,In vivo,,CHEMBL622008
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,10292,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,In vivo,,CHEMBL622009
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,10293,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,In vivo,,CHEMBL622010
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,10294,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,In vivo,,CHEMBL622011
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,10295,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,In vivo,,CHEMBL622012
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4199,50597,,,,10116.0,,10296,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,In vivo,,CHEMBL622013
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4890,50597,,,,10116.0,,10297,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,In vivo,,CHEMBL622014
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2792,50597,,,,10116.0,,10298,Bioavailability was determined at 3 mg/kg po dose in rats,,In vivo,,CHEMBL624749
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5529,50597,,,,10116.0,,10299,Oral bioavailability in rat (dose 2 mg/kg),,In vivo,,CHEMBL624750
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,10300,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,In vivo,,CHEMBL624751
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,10301,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,In vivo,,CHEMBL624752
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6685,50597,,,,10116.0,,10302,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,In vivo,,CHEMBL624753
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6005,50597,,,,10116.0,,10303,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,In vivo,,CHEMBL624754
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,10304,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,In vivo,,CHEMBL624755
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,10305,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,In vivo,,CHEMBL624756
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6103,50597,,,,10116.0,,10306,Bioavailability in rat,,In vivo,,CHEMBL624757
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,10307,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,In vivo,,CHEMBL624758
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6410,50597,,,,10116.0,,10308,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,In vivo,,CHEMBL622270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5353,50597,,,,10116.0,,10309,Bioavailability in rat (Sprague-Dawley),,In vivo,,CHEMBL622271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,10310,Bioavailability in rat at the dose of 2 mg/kg,,In vivo,,CHEMBL622272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,10311,Oral bioavailability in rat,,In vivo,,CHEMBL622273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5809,50597,,,,10116.0,,10312,Bioavailability in rat (cannulated) (dose 2 mg/kg),,In vivo,,CHEMBL622274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,10313,Bioavailability value of compound in rats was determined after peroral administration,,In vivo,,CHEMBL622275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3634,50597,,,,10116.0,,10314,Oral bioavailability in rat (dose 20 mg/kg),,In vivo,,CHEMBL622276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3341,50597,,,,10116.0,,10315,Oral bioavailability in rat,,In vivo,,CHEMBL622277
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2690,50597,,,,10116.0,,10316,Oral bioavailability in rat (dose 5 mg/kg),,In vivo,,CHEMBL622278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3184,50597,,,,10116.0,,10317,Oral bioavailability in rat,,In vivo,,CHEMBL622279
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,740,50597,,,,10116.0,,10318,Oral bioavailability in rat,,In vivo,,CHEMBL622280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1806,50597,,,,10116.0,,10319,Compound was evaluated for oral bioavailability in rats; 15-27 %,,In vivo,,CHEMBL624083
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4891,50597,,,,10116.0,,10320,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,In vivo,,CHEMBL624084
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3634,50597,,,,10116.0,,10321,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,In vivo,,CHEMBL624085
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,64,50597,,,,10116.0,,10322,Compound was tested for bioavailability in rats,,In vivo,,CHEMBL624086
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4839,50597,,,,10116.0,,10323,Bioavailability in rat,,In vivo,,CHEMBL624087
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1094,50597,,,,10116.0,,10324,Oral bioavailability in rat,,In vivo,,CHEMBL624088
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,0,U,,5005,22224,,,,9544.0,,10325,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,In vivo,,CHEMBL624089
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,5005,22224,,,,10116.0,,10326,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,In vivo,,CHEMBL624090
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4687,50597,,,,10116.0,,10327,Evaluated for the bioavailability in rat (in vivo),,In vivo,,CHEMBL624091
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17804,50597,,,,10116.0,,10328,F value of compound in rats was determined after peroral administration,,In vivo,,CHEMBL624092
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10329,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624093
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10330,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624094
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10331,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624095
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5974,50597,,,,10116.0,,10332,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,In vivo,,CHEMBL624096
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1088,50597,,,,10116.0,,10333,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,In vivo,,CHEMBL624097
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1742,50597,,,,10116.0,,10334,Maximum fall in carotid flow in rat,,In vivo,,CHEMBL624098
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4689,50597,,,,10116.0,,10335,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,In vivo,,CHEMBL874392
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2463,50597,,,,10116.0,,10336,Oral bioavailability in rat (dose 5 mg/kg),,In vivo,,CHEMBL624099
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,10337,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,In vivo,,CHEMBL624100
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5654,50597,,,,10116.0,,10338,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,In vivo,,CHEMBL624101
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6874,50597,,,,10116.0,,10339,Oral bioavailability in rat (male Wistar),,In vivo,,CHEMBL624102
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5633,50597,,,,10116.0,,10340,Oral bioavailability after administration (30 mg/kg) in rat; good,,In vivo,,CHEMBL624103
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5496,50597,,,,10116.0,,10341,Oral bioavailability at the dose of 2 mg/kg in rat,,In vivo,,CHEMBL624104
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2358,50597,,,,10116.0,,10342,Oral bioavailability determined in rats,,In vivo,,CHEMBL624105
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16456,50597,,,,10116.0,,10343,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,In vivo,,CHEMBL624106
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5302,50597,,,,10116.0,,10344,Oral bioavailability in rat (dose single 10 mg/kg),,In vivo,,CHEMBL624107
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5302,50597,,,,10116.0,,10345,Oral bioavailability in rat (dose single 10 mg/kg),,In vivo,,CHEMBL623943
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5302,50597,,,,10116.0,,10346,Oral bioavailability in rat (dose 5 mg/kg,,In vivo,,CHEMBL623944
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10347,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,,,CHEMBL623945
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10348,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,,,CHEMBL623946
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10349,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,,,CHEMBL623947
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10350,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,,,CHEMBL623948
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10351,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,,,CHEMBL623949
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10352,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,,,CHEMBL623950
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10353,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,,,CHEMBL874398
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10354,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,,,CHEMBL623951
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10355,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,,,CHEMBL623952
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10356,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,,,CHEMBL623953
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10357,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,,,CHEMBL623954
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10358,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,,,CHEMBL623955
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10359,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,,,CHEMBL623956
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10360,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,,,CHEMBL627807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10361,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,,,CHEMBL627808
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10362,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,,,CHEMBL627809
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10363,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,,,CHEMBL627810
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10364,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,,,CHEMBL627811
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10365,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,,,CHEMBL627812
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10366,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,,,CHEMBL627813
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10367,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,,,CHEMBL627814
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10368,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,,,CHEMBL875336
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10369,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,,,CHEMBL627815
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10370,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,,,CHEMBL627816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10371,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,,,CHEMBL627817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10372,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,,,CHEMBL627818
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10373,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,,,CHEMBL627819
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10374,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,,,CHEMBL627820
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10375,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,,,CHEMBL627821
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10376,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,,CHEMBL628464
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10377,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,,,CHEMBL626239
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10378,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,,,CHEMBL626240
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10379,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,,,CHEMBL626241
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10380,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,,,CHEMBL626242
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10381,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,,,CHEMBL626243
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10382,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,,CHEMBL626244
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10383,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,,,CHEMBL626907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10384,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,,CHEMBL626908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10385,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,,CHEMBL626909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10386,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,,CHEMBL626910
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10387,Percent total excretion of acetaminophen cysteine conjugate,,,,CHEMBL875342
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10388,Percent total excretion of acetaminophen glucuronide,,,,CHEMBL626911
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10389,Percent total excretion of acetaminophen sulfate,,,,CHEMBL626912
Intermediate,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,7449,50597,,,,10116.0,,10390,Percent total excretion of acetaminophen-mercapturic acid,,,,CHEMBL627065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3172,50597,,1088.0,Urine,10116.0,,10391,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,,,CHEMBL627066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16456,50597,,,,10116.0,,10392,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,In vivo,,CHEMBL627067
Autocuration,BAO_0000218,,A,,1,ratrat,0,U,,10839,22224,,2385.0,Muscle tissue,8656.0,,10393,Biodistribution of compound in rat muscle after 5 min of administration,,In vivo,,CHEMBL627068
Autocuration,BAO_0000218,,A,,1,ratrat,0,U,,10839,22224,,2385.0,Muscle tissue,8656.0,,10394,Biodistribution of compound in rat muscle after 5 min of administration.,,In vivo,,CHEMBL627069
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,,,9940.0,,10395,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL627070
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,,,9940.0,,10396,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL627071
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,,,9940.0,,10397,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL627072
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,,,9940.0,,10398,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL627073
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,,,9940.0,,10399,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL625387
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,,,9940.0,,10400,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL625388
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,1969.0,Plasma,9940.0,,10401,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL625389
Autocuration,BAO_0000218,,A,,1,Ovis aries,0,U,,5334,22224,,1969.0,Plasma,9940.0,,10402,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,In vivo,,CHEMBL875343
Intermediate,BAO_0000218,,A,,1,Serpentes,1,N,,1735,50497,,,,8570.0,,10403,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,,,CHEMBL876795
Intermediate,BAO_0000218,,A,,1,Serpentes,1,N,,1469,50497,,,,8570.0,,10404,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,,,CHEMBL626552
Intermediate,BAO_0000218,,A,,1,Serpentes,1,N,,1336,50497,,,,8570.0,,10405,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,,,CHEMBL626553
Autocuration,BAO_0000366,,A,,1,Homo sapiens,0,U,,12403,22224,,1969.0,Plasma,9606.0,,10406,The human biological plasma half life of the compound,,,,CHEMBL626554
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,1088.0,Urine,10116.0,,10407,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,,CHEMBL626555
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10408,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,,,CHEMBL626556
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10409,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,,,CHEMBL626557
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10410,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,,,CHEMBL626558
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10411,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,,,CHEMBL626559
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10412,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,,,CHEMBL626560
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10413,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,,,CHEMBL876803
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10414,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,,,CHEMBL627964
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10415,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,,,CHEMBL627965
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10416,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,,,CHEMBL627966
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10417,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,,,CHEMBL627967
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10418,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,,,CHEMBL627968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10419,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,,,CHEMBL627969
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,,,10116.0,,10420,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,,,CHEMBL627970
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,178.0,Blood,10116.0,,10421,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,,,CHEMBL627971
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8004,50597,,178.0,Blood,10116.0,,10422,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,,,CHEMBL627972
Expert,BAO_0000357,,B,,1,Homo sapiens,9,D,,15917,180,,,,9606.0,,10423,Dissociation constant against binding to human cyclophilin A,,,,CHEMBL856029
Expert,BAO_0000019,,B,,1,Bos taurus,8,H,,12396,11591,,,,9913.0,,10424,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,,,CHEMBL627973
Autocuration,BAO_0000019,,A,,1,,0,U,,7065,22224,,,,,,10425,-Log C was determined by performing the electroshock minimum test,,,,CHEMBL627974
Autocuration,BAO_0000019,,A,,1,,0,U,,7065,22224,,,,,,10426,-Log C was determined by performing the foot shock test,,,,CHEMBL627975
Autocuration,BAO_0000019,,A,,1,,0,U,,7065,22224,,,,,,10427,-Log C was determined by performing the incl screen test,,,,CHEMBL627976
Autocuration,BAO_0000019,,A,,1,,0,U,,7065,22224,,,,,,10428,-Log C was determined by performing the maximum electroshock test,,,,CHEMBL627977
Autocuration,BAO_0000019,,A,,1,,0,U,,7065,22224,,,,,,10429,-Log C was determined by performing the pentylenetetrazole test,,,,CHEMBL627978
Autocuration,BAO_0000019,,A,,1,,0,U,,12415,22224,,,,,,10430,Tested for experimental arotinoid inhibitory dose,,,,CHEMBL627979
Autocuration,BAO_0000019,,A,,1,,0,U,,10256,22224,,,,,,10431,Negative log transformed activity,,,,CHEMBL876804
Autocuration,BAO_0000019,,A,,1,,0,U,,7991,22224,,,,,,10432,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,,CHEMBL627980
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14342,50512,,,,10141.0,,10433,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,,,CHEMBL627981
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14342,50512,,,,10141.0,,10434,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,,,CHEMBL627982
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14342,50512,,,,10141.0,,10435,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,,,CHEMBL627983
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14342,50512,,2116.0,Ileum,10141.0,,10436,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,,,CHEMBL627984
Autocuration,BAO_0000100,,P,,1,,0,U,,6047,22229,,,,,,10437,Solubility in water was determined; values expressed as -log,,,,CHEMBL627985
Autocuration,BAO_0000019,,A,,1,,0,U,,17269,22224,,,,,,10438,Ratio of Kcat to that of Km was determined,,,,CHEMBL627986
Autocuration,BAO_0000019,,A,,1,,0,U,,10026,22224,,,,,,10439,Observed first order rate constant,,,,CHEMBL627987
Autocuration,BAO_0000019,,A,,1,,0,U,,14583,22224,,,,,,10440,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,,CHEMBL627988
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,10441,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,In vivo,,CHEMBL627989
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2661,50597,,,,10116.0,,10442,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,In vivo,,CHEMBL627990
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4029,50597,,,,10116.0,,10443,Oral Bioavailability after administration of 10 mg/kg in male rat,,In vivo,,CHEMBL876805
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17735,50597,,,,10116.0,,10444,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,In vivo,,CHEMBL627991
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4576,50597,,,,10116.0,,10445,Oral bioavailability in rat,,In vivo,,CHEMBL627992
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17582,50597,,,,10116.0,,10446,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,In vivo,,CHEMBL627993
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,,,10116.0,,10447,Oral bioavailability at 1 mg/kg was determined in rat,,In vivo,,CHEMBL622817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17651,50597,,,,10116.0,,10448,Oral bioavailability at 10 mg/kg was determined in rat,,In vivo,,CHEMBL622818
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17670,50597,,,,10116.0,,10449,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,In vivo,,CHEMBL622819
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5045,50597,,,,10116.0,,10450,Oral bioavailability in rat,,In vivo,,CHEMBL872267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1696,50597,,,,10116.0,,10451,Oral bioavailability in rat,,In vivo,,CHEMBL622820
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17764,50597,,,,10116.0,,10452,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,In vivo,,CHEMBL622821
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6448,50597,,,,10116.0,,10453,Oral bioavailability in rat,,In vivo,,CHEMBL622822
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6596,50597,,,,10116.0,,10454,Oral bioavailability in rat,,In vivo,,CHEMBL622823
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17547,50597,,,,10116.0,,10455,Oral bioavailability in rat,,In vivo,,CHEMBL622824
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17771,50597,,,,10116.0,,10456,Oral bioavailability in rat at a dose of 3 mg/kg,,In vivo,,CHEMBL622825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,10457,Oral bioavailability in rat after oral administration at 10 mg/kg,,In vivo,,CHEMBL622901
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4558,50597,,,,10116.0,,10458,Oral bioavailability in rat,,In vivo,,CHEMBL622902
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,,,10116.0,,10459,Oral bioavailability in rat,,In vivo,,CHEMBL621844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6827,50597,,,,10116.0,,10460,Oral bioavailability in Dawley rats,,In vivo,,CHEMBL621845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4026,50597,,,,10116.0,,10461,Oral bioavailability,,In vivo,,CHEMBL621846
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10,50597,,,,10116.0,,10462,Oral bioavailability in rat (dose 30 mg/kg),,In vivo,,CHEMBL621847
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10463,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,In vivo,,CHEMBL877609
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10464,Bioavailability in rat (dose 3 mg/kg i.v.),,In vivo,,CHEMBL621848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10465,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,In vivo,,CHEMBL621849
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10466,Oral bioavailability in rat (dose 60 mg/kg p.o.),,In vivo,,CHEMBL622030
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4796,50597,,,,10116.0,,10467,Percent oral bioavailability determined in rats,,In vivo,,CHEMBL622031
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,10468,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,In vivo,,CHEMBL622032
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2137,50597,,,,10116.0,,10469,The compound was evaluated for bioavailability in rats; 32-51,,In vivo,,CHEMBL622033
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2959,50597,,,,10116.0,,10470,Bioavailability in rat (dose 20 mg/kg p.o.),,In vivo,,CHEMBL622034
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1361,50597,,,,10116.0,,10471,Oral bioavailability in rat,,In vivo,,CHEMBL622035
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4727,50597,,,,10116.0,,10472,Bioavailability percent in rat at the dose of 2 mg/kg,,In vivo,,CHEMBL882966
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16423,50597,,,,10116.0,,10473,Bioavailability was evaluated after 20 uM/kg of peroral administration,,In vivo,,CHEMBL622036
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5206,50597,,,,10116.0,,10474,Oral bioavailability in rat,,In vivo,,CHEMBL622037
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6448,50597,,,,10116.0,,10475,Oral bioavailability in rat,,In vivo,,CHEMBL622038
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17723,50597,,,,10116.0,,10476,Bioavailability in rats,,In vivo,,CHEMBL622039
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,178.0,Blood,10116.0,,10477,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,In vivo,,CHEMBL622040
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,178.0,Blood,10116.0,,10478,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622041
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,178.0,Blood,10116.0,,10479,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622042
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,178.0,Blood,10116.0,,10480,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622043
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,178.0,Blood,10116.0,,10481,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622044
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,10000001.0,Bone,10116.0,,10482,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622045
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,10000001.0,Bone,10116.0,,10483,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622046
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,10000001.0,Bone,10116.0,,10484,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622047
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,10000001.0,Bone,10116.0,,10485,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL877610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,955.0,Brain,10116.0,,10486,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622048
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,955.0,Brain,10116.0,,10487,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622049
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,955.0,Brain,10116.0,,10488,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622050
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,955.0,Brain,10116.0,,10489,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622051
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,,,10116.0,,10490,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622052
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,,,10116.0,,10491,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622053
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,,,10116.0,,10492,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622054
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,,,10116.0,,10493,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622055
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5237,50597,,,,10116.0,,10494,Oral bioavailability in rats was determined; High,,In vivo,,CHEMBL622056
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5503,50597,,,,10116.0,,10495,Oral bioavailability in the rat was determined,,In vivo,,CHEMBL622057
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15765,50597,,,,10116.0,,10496,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,In vivo,,CHEMBL628008
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15660,50597,,,,10116.0,,10497,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,In vivo,,CHEMBL622058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10498,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL622059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10499,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL622060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10500,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL622061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5978,50597,,,,10116.0,,10501,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,In vivo,,CHEMBL622062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,10502,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,In vivo,,CHEMBL622063
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3598,50597,,,,10116.0,,10503,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,In vivo,,CHEMBL877611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4216,50597,,,,10116.0,,10504,Oral bioavailability of compound in Sprague Dawley rats,,In vivo,,CHEMBL622064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17839,50597,,,,10116.0,,10505,Oral bioavailability of compound in rat,,In vivo,,CHEMBL622065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6570,50597,,,,10116.0,,10506,Oral bioavailability in rat (dose 2 mg/kg),,In vivo,,CHEMBL622066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5334,50597,,,,10116.0,,10507,Oral bioavailability of compound in rat was determined,,In vivo,,CHEMBL622067
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6886,50597,,,,10116.0,,10508,Oral bioavailability of compound in rats,,In vivo,,CHEMBL622068
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5210,50597,,,,10116.0,,10509,Oral bioavailability of compound was determined in rats,,In vivo,,CHEMBL622069
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4170,50597,,,,10116.0,,10510,Oral bioavailability at a dose of 30 mg/kg in rats,,In vivo,,CHEMBL624796
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6028,50597,,,,10116.0,,10511,Oral bioavailability in rat (dose 10 mg/kg),,In vivo,,CHEMBL624797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6028,50597,,,,10116.0,,10512,Oral bioavailability in rat (dose 10 mg/kg),,In vivo,,CHEMBL623053
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,10513,Oral bioavailability evaluated in rat,,In vivo,,CHEMBL623054
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6168,50597,,,,10116.0,,10514,Oral bioavailability in fasted rat,,In vivo,,CHEMBL623055
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6168,50597,,,,10116.0,,10515,Oral bioavailability in fed rat,,In vivo,,CHEMBL623056
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5160,50597,,,,10116.0,,10516,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,In vivo,,CHEMBL623057
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,10517,Oral bioavailability in rat,,In vivo,,CHEMBL623058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,10518,Oral bioavailability in rat (dose 10 mg/kg p.o.),,In vivo,,CHEMBL623059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6535,50597,,,,10116.0,,10519,Oral bioavailability in rat after administration of 10 mg/kg po,,In vivo,,CHEMBL623060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4194,50597,,,,10116.0,,10520,Oral bioavailability in rat,,In vivo,,CHEMBL623061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6230,50597,,,,10116.0,,10521,Oral bioavailability in rat,,In vivo,,CHEMBL623062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6619,50597,,,,10116.0,,10522,Oral bioavailability in rat,,In vivo,,CHEMBL623063
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17607,50597,,,,10116.0,,10523,Oral bioavailability in rat,,In vivo,,CHEMBL623064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4942,50597,,,,10116.0,,10524,Oral bioavailability in ratrs,,In vivo,,CHEMBL623065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4942,50597,,,,10116.0,,10525,Oral bioavailability in rat,,In vivo,,CHEMBL623066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6646,50597,,,,10116.0,,10526,Oral bioavailability in rat,,In vivo,,CHEMBL623067
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5237,50597,,,,10116.0,,10527,Oral bioavailability in rats was determined; High,,In vivo,,CHEMBL623068
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6646,50597,,,,10116.0,,10528,Oral bioavailability in rat,,In vivo,,CHEMBL623069
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4449,50597,,,,10116.0,,10529,Oral bioavailability in rat,,In vivo,,CHEMBL623070
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6057,50597,,,,10116.0,,10530,Oral bioavailability was calculated in rat,,In vivo,,CHEMBL623071
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2552,50597,,,,10116.0,,10531,Oral bioavailability,,In vivo,,CHEMBL623072
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5496,50597,,,,10116.0,,10532,Oral bioavailability,,In vivo,,CHEMBL623073
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6484,50597,,,,10116.0,,10533,Oral bioavailability,,In vivo,,CHEMBL623074
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6485,50597,,,,10116.0,,10534,Oral bioavailability,,In vivo,,CHEMBL623075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6616,50597,,,,10116.0,,10535,Oral bioavailability after i.v. administration,,In vivo,,CHEMBL623076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4969,50597,,,,10116.0,,10536,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,In vivo,,CHEMBL623077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5862,50597,,,,10116.0,,10537,Oral bioavailability in rat (Sprague-Dawley),,In vivo,,CHEMBL623078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,,,10116.0,,10538,Oral bioavailability in Sprague-Dawley rats,,In vivo,,CHEMBL623079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,,,10116.0,,10539,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,In vivo,,CHEMBL623080
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,,,10116.0,,10540,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,In vivo,,CHEMBL623081
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5546,50597,,,,10116.0,,10541,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,In vivo,,CHEMBL623082
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6168,50597,,,,10116.0,,10542,Oral bioavailability in fasted rat,,In vivo,,CHEMBL874400
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6168,50597,,,,10116.0,,10543,Oral bioavailability in fed rat,,In vivo,,CHEMBL623083
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3624,50597,,,,10116.0,,10544,Oral bioavailability in rat,,In vivo,,CHEMBL623084
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5213,50597,,,,10116.0,,10545,Oral bioavailability in rat,,In vivo,,CHEMBL623085
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5496,50597,,,,10116.0,,10546,Oral bioavailability in rat,,In vivo,,CHEMBL623086
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5553,50597,,,,10116.0,,10547,Oral bioavailability in rat,,In vivo,,CHEMBL623087
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5833,50597,,,,10116.0,,10548,Oral bioavailability in rat,,In vivo,,CHEMBL623088
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5836,50597,,,,10116.0,,10549,Oral bioavailability in rat,,In vivo,,CHEMBL623089
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5865,50597,,,,10116.0,,10550,Oral bioavailability in rat,,In vivo,,CHEMBL623090
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5960,50597,,,,10116.0,,10551,Oral bioavailability in rat,,In vivo,,CHEMBL623091
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6249,50597,,,,10116.0,,10552,Oral bioavailability in rat,,In vivo,,CHEMBL623092
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6448,50597,,,,10116.0,,10553,Oral bioavailability in rat,,In vivo,,CHEMBL623093
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6453,50597,,,,10116.0,,10554,Oral bioavailability in rat,,In vivo,,CHEMBL874401
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,10555,Oral bioavailability in rat,,In vivo,,CHEMBL623094
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17607,50597,,,,10116.0,,10556,Oral bioavailability in rat,,In vivo,,CHEMBL623095
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,10557,Oral bioavailability in rat after peroral administration at 10 mg/kg,,In vivo,,CHEMBL623096
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5939,50597,,,,10116.0,,10558,Oral bioavailability in rat after peroral administration at 5 mg/kg,,In vivo,,CHEMBL624913
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6281,50597,,,,10116.0,,10559,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,In vivo,,CHEMBL624914
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5874,50597,,,,10116.0,,10560,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,In vivo,,CHEMBL624915
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5213,50597,,,,10116.0,,10561,Oral bioavailability in rat; Not measured,,In vivo,,CHEMBL624916
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4964,50597,,,,10116.0,,10562,Oral bioavailability in rat,,In vivo,,CHEMBL624917
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11020,50597,,,,10116.0,,10563,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,,,CHEMBL625157
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6251,50597,,2107.0,Liver,10116.0,,10564,In vitro metabolic potential in rat liver microsomes,,,,CHEMBL625158
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1568,50597,,,,10116.0,,10565,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,In vivo,,CHEMBL625159
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3032,50597,,,,10116.0,,10566,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,In vivo,,CHEMBL625160
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3748,50597,,,,10116.0,,10567,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,In vivo,,CHEMBL625161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,401,50597,,,,10116.0,,10568,Oral bioavailability in rat,,In vivo,,CHEMBL625162
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6512,50597,,,,10116.0,,10569,Oral bioavailability in rat,,In vivo,,CHEMBL625163
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17617,50597,,,,10116.0,,10570,Oral bioavailability in rats at 10 mg/kg,,In vivo,,CHEMBL625164
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6679,50597,,,,10116.0,,10571,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,In vivo,,CHEMBL625165
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6742,50597,,,,10116.0,,10572,Oral bioavailability in rat,,In vivo,,CHEMBL625166
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,589,50597,,,,10116.0,,10573,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,,,CHEMBL625167
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,589,50597,,,,10116.0,,10574,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,,,CHEMBL625168
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3185,50597,,,,10116.0,,10575,Plasma clearance of the compound,,In vivo,,CHEMBL625169
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17596,50597,,,,10116.0,,10576,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,In vivo,,CHEMBL626264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2713,50597,,,,10116.0,,10577,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,In vivo,,CHEMBL626265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12500,50597,,1969.0,Plasma,10116.0,,10578,The compound was tested for plasma clearance in rat,,In vivo,,CHEMBL626266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12500,50597,,1969.0,Plasma,10116.0,,10579,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,In vivo,,CHEMBL626267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2713,50597,,,,10116.0,,10580,Plasma concentration upon oral administration of 1 mg/Kg in rats,,,,CHEMBL626268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1446,50597,,,,10116.0,,10581,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,,,CHEMBL626269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6227,50597,,,,10116.0,,10582,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,,,CHEMBL626270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4709,50597,,,,10116.0,,10583,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,,,CHEMBL626271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,10584,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,,,CHEMBL626272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,10585,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,,CHEMBL626273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,10586,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,,CHEMBL875346
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5510,50597,,,,10116.0,,10587,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,,,CHEMBL626274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4514,50597,,,,10116.0,,10588,Compound was tested for protein binding in rat plasma,,,,CHEMBL626275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2713,50597,,,,10116.0,,10589,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,,,CHEMBL624646
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2713,50597,,,,10116.0,,10590,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,,,CHEMBL624647
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5340,50597,,2107.0,Liver,10116.0,,10591,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,,,CHEMBL624648
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12058,50597,,,,10116.0,,10592,Area under curve ratio was determined (po/iv) in rat,,,,CHEMBL624649
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,,,10116.0,,10593,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,,,CHEMBL624650
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,,,10116.0,,10594,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,,,CHEMBL624651
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,,,10116.0,,10595,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,,,CHEMBL624652
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6495,50597,,,,10116.0,,10596,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,,,CHEMBL624653
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6078,50597,,,,10116.0,,10597,Ratio of AUCbrain to AUCplasma,,,,CHEMBL624654
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5656,50597,,,,10116.0,,10598,Ratio of brain to plasma,,,,CHEMBL624655
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10599,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,,,CHEMBL624656
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10600,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,,CHEMBL624657
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10601,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,,CHEMBL624658
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,,,10116.0,,10602,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,,,CHEMBL624659
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,,,10116.0,,10603,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,,,CHEMBL624660
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10130,50597,,,,10116.0,,10604,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,,,CHEMBL624661
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5213,50597,,,,10116.0,,10605,Steady state brain :blood ratio was determined,,,,CHEMBL624662
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10606,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL625199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10607,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,,CHEMBL625200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10608,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,,CHEMBL625201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4910,50597,,,,10116.0,,10609,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,,CHEMBL625202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2083,50597,,,,10116.0,,10610,Percentage recovery after 3h incubation with rat hapatocytes was determined,,,,CHEMBL625203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2082,50597,,,,10116.0,,10611,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,,,CHEMBL625204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2082,50597,,,,10116.0,,10612,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,,,CHEMBL625205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6351,50597,,,,10116.0,,10613,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,,,CHEMBL625206
Autocuration,BAO_0000019,,A,,1,,0,U,,14583,22224,,,,,,10614,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,,CHEMBL625207
Autocuration,BAO_0000019,,A,,1,,0,U,,14583,22224,,,,,,10615,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,,CHEMBL625208
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,4608,50587,495.0,,,9606.0,,10616,In vivo absorption in Caco-2 cell line monolayers was determined,,,Caco-2,CHEMBL625209
Autocuration,BAO_0000100,,P,,1,,0,U,,13668,22229,,,,,,10617,Calculated partition coefficient (clogP),,,,CHEMBL625210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,10618,Area under curve was determine after peroral administration at 10 mpk in Rat,,,,CHEMBL625211
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,5669,50797,,,,9544.0,,10619,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,,,CHEMBL625212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,10620,Area under curve was determine after peroral administration at 160 mpk in Rat,,,,CHEMBL625213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,10621,Area under curve was determine after peroral administration at 20 mpk in Rat,,,,CHEMBL625214
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,10622,Area under curve was determine after peroral administration at 50 mpk in Rat,,,,CHEMBL874542
Autocuration,BAO_0000100,,P,,1,,0,U,,6472,22229,,,,,,10623,Calculated partition coefficient (clogP) (AlogP),,,,CHEMBL625215
Autocuration,BAO_0000019,,A,,1,,0,U,,15106,22224,,,,,,10624,Activated partial thromboplastin time measured,,,,CHEMBL625216
Autocuration,BAO_0000100,,P,,1,,0,U,,15207,22224,,,,,,10625,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,,CHEMBL625217
Autocuration,BAO_0000100,,P,,1,,0,U,,15207,22224,,,,,,10626,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,,CHEMBL625218
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13941,50588,,1969.0,Plasma,9615.0,,10627,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,,,CHEMBL622864
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13941,50597,,1969.0,Plasma,10116.0,,10628,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,,,CHEMBL622865
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13941,50597,,1969.0,Plasma,10116.0,,10629,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,,,CHEMBL622866
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13941,50588,,1969.0,Plasma,9615.0,,10630,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,,,CHEMBL622867
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,15240,50512,,1969.0,Plasma,10141.0,,10631,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,,,CHEMBL876808
Autocuration,BAO_0000019,,A,,1,,0,U,,10655,22224,,955.0,Brain,,,10632,AUC in brain,,,,CHEMBL627725
Autocuration,BAO_0000019,,A,,1,,0,U,,10655,22224,,1977.0,Serum,,,10633,AUC in serum,,,,CHEMBL627726
Autocuration,BAO_0000019,,A,,1,,0,U,,6504,22224,,1969.0,Plasma,,,10634,AUC was determined,,,,CHEMBL627727
Autocuration,BAO_0000019,,A,,1,,0,U,,10615,22224,,1969.0,Plasma,,,10635,AUC of the compound.,,,,CHEMBL627728
Autocuration,BAO_0000019,,A,,1,,0,U,,10353,22224,,1969.0,Plasma,,,10636,AUC value (0-4 hr),,,,CHEMBL627729
Autocuration,BAO_0000019,,A,,1,,0,U,,14907,22224,,1969.0,Plasma,,,10637,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,,CHEMBL627730
Autocuration,BAO_0000019,,A,,1,,0,U,,14907,22224,,1969.0,Plasma,,,10638,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,,CHEMBL627731
Autocuration,BAO_0000019,,A,,1,,0,U,,14907,22224,,1969.0,Plasma,,,10639,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,,CHEMBL627732
Autocuration,BAO_0000019,,A,,1,,0,U,,14907,22224,,1969.0,Plasma,,,10640,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,,CHEMBL627733
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16359,50597,,1969.0,Plasma,10116.0,,10641,AUC(area under curve) was determined after intravenous administration in rats,,,,CHEMBL627734
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16359,50597,,1969.0,Plasma,10116.0,,10642,AUC(area under curve) was determined after oral administration in rats,,,,CHEMBL627735
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,15240,50512,,1969.0,Plasma,10141.0,,10643,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,,,CHEMBL627736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15240,50597,,1969.0,Plasma,10116.0,,10644,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,,,CHEMBL876809
Autocuration,BAO_0000019,,A,,1,,0,U,,15469,22224,,,,,,10645,Area Under Curve after oral dosing of 100 uM/Kg,,,,CHEMBL627737
Autocuration,BAO_0000019,,A,,1,,0,U,,15469,22224,,,,,,10646,Area Under Curve after oral dosing of 30 uM/Kg,,,,CHEMBL627738
Autocuration,BAO_0000019,,A,,1,,0,U,,13520,22224,,,,,,10647,Area Under Curve was measured by ploting the graph between concentration verses time,,,,CHEMBL627739
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17025,50588,,,,9615.0,,10648,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,,,CHEMBL626143
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17025,22224,,,,314293.0,,10649,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,,,CHEMBL626144
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,,,9986.0,,10650,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,,,CHEMBL626145
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17025,50597,,,,10116.0,,10651,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,,,CHEMBL626146
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12032,50597,,178.0,Blood,10116.0,,10652,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,,,CHEMBL626147
Autocuration,BAO_0000019,,A,,1,,0,U,,10291,22224,,,,,,10653,Area under curve (AUC) was determined,,,,CHEMBL626148
Autocuration,BAO_0000218,,A,,1,,0,U,,5767,22224,,,,,,10654,Area under curve (AUC) following ip administration at 1 mg/kg,,,,CHEMBL626149
Autocuration,BAO_0000019,,A,,1,,0,U,,1434,22224,,,,,,10655,Area under curve (AUC) was determined; ND is Not determined,,,,CHEMBL626150
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14925,50588,,,,9615.0,,10656,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,,,CHEMBL626151
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14925,50588,,,,9615.0,,10657,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,,,CHEMBL626152
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14925,50588,,,,9615.0,,10658,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,,,CHEMBL626153
Autocuration,BAO_0000019,,A,,1,,0,U,,1434,22224,,,,,,10659,Area under curve (AUR) was determined,,,,CHEMBL626154
Autocuration,BAO_0000019,,A,,1,,0,U,,11883,22224,,,,,,10660,Area under curve at 1 uM/dg administered intravenously,,,,CHEMBL626155
Autocuration,BAO_0000019,,A,,1,,0,U,,11883,22224,,,,,,10661,Area under curve at 10 uM/dg administered perorally,,,,CHEMBL626156
Autocuration,BAO_0000019,,A,,1,,0,U,,11883,22224,,,,,,10662,Area under curve at 2 uM/dg administered intravenously,,,,CHEMBL626157
Autocuration,BAO_0000019,,A,,1,,0,U,,11883,22224,,,,,,10663,Area under curve at 20 uM/dg administered perorally,,,,CHEMBL626158
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15233,50588,,,,9615.0,,10664,Area under curve at a peroral dose of 3 mg/kg in dog,,,,CHEMBL626159
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15233,50597,,,,10116.0,,10665,Area under curve at a peroral dose of 3 mg/kg in rat,,,,CHEMBL626160
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15233,50588,,,,9615.0,,10666,Area under curve at an iv dose of 1 mg/kg in dog,,,,CHEMBL626161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15233,50597,,,,10116.0,,10667,Area under curve at an iv dose of 1 mg/kg in rat,,,,CHEMBL626162
Autocuration,BAO_0000019,,A,,1,,0,U,,12978,22224,,,,,,10668,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,,CHEMBL626163
Autocuration,BAO_0000019,,A,,1,,0,U,,12978,22224,,,,,,10669,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,,CHEMBL626164
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11355,50594,,,,10090.0,,10670,Area under curve measured as conc vs time after intravenous administration to mice.,,,,CHEMBL626165
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11355,50594,,,,10090.0,,10671,Area under curve measured as conc vs time after peroral administration to mice.,,,,CHEMBL626166
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12923,50588,,,,9615.0,,10672,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,,CHEMBL626167
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12923,50588,,,,9615.0,,10673,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,,,CHEMBL626168
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12923,50588,,,,9615.0,,10674,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,,,CHEMBL877463
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12923,50588,,,,9615.0,,10675,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,,,CHEMBL626169
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,948.0,Heart,10116.0,,10676,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL626170
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,948.0,Heart,10116.0,,10677,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL626171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,948.0,Heart,10116.0,,10678,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL626172
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,948.0,Heart,10116.0,,10679,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL626173
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2113.0,Kidney,10116.0,,10680,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,In vivo,,CHEMBL626174
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2113.0,Kidney,10116.0,,10681,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL626175
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2113.0,Kidney,10116.0,,10682,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL626176
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2113.0,Kidney,10116.0,,10683,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL626177
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2113.0,Kidney,10116.0,,10684,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622499
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2107.0,Liver,10116.0,,10685,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,In vivo,,CHEMBL622500
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2107.0,Liver,10116.0,,10686,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622501
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2107.0,Liver,10116.0,,10687,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL622502
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2107.0,Liver,10116.0,,10688,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL622503
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2107.0,Liver,10116.0,,10689,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL877614
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2048.0,Lung,10116.0,,10690,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL624839
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2048.0,Lung,10116.0,,10691,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL624840
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2048.0,Lung,10116.0,,10692,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL624841
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2048.0,Lung,10116.0,,10693,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL624842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2385.0,Muscle tissue,10116.0,,10694,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL624843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2385.0,Muscle tissue,10116.0,,10695,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,In vivo,,CHEMBL624844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2385.0,Muscle tissue,10116.0,,10696,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,In vivo,,CHEMBL624845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17738,50597,,2385.0,Muscle tissue,10116.0,,10697,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,In vivo,,CHEMBL621904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,178.0,Blood,10116.0,,10698,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,In vivo,,CHEMBL621905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,178.0,Blood,10116.0,,10699,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,In vivo,,CHEMBL874382
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,178.0,Blood,10116.0,,10700,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,In vivo,,CHEMBL621906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,955.0,Brain,10116.0,,10701,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,In vivo,,CHEMBL621907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,955.0,Brain,10116.0,,10702,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,In vivo,,CHEMBL622096
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,955.0,Brain,10116.0,,10703,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,In vivo,,CHEMBL622097
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,948.0,Heart,10116.0,,10704,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,In vivo,,CHEMBL622098
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,948.0,Heart,10116.0,,10705,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,In vivo,,CHEMBL622099
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,948.0,Heart,10116.0,,10706,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,In vivo,,CHEMBL622100
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2113.0,Kidney,10116.0,,10707,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,In vivo,,CHEMBL622101
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2113.0,Kidney,10116.0,,10708,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,In vivo,,CHEMBL622102
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2113.0,Kidney,10116.0,,10709,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,In vivo,,CHEMBL622103
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2107.0,Liver,10116.0,,10710,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,In vivo,,CHEMBL622104
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2107.0,Liver,10116.0,,10711,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,In vivo,,CHEMBL622105
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2107.0,Liver,10116.0,,10712,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,In vivo,,CHEMBL622106
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2048.0,Lung,10116.0,,10713,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,In vivo,,CHEMBL622107
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2048.0,Lung,10116.0,,10714,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,In vivo,,CHEMBL622108
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2048.0,Lung,10116.0,,10715,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,In vivo,,CHEMBL622109
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2385.0,Muscle tissue,10116.0,,10716,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,In vivo,,CHEMBL622110
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2385.0,Muscle tissue,10116.0,,10717,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,In vivo,,CHEMBL622111
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2385.0,Muscle tissue,10116.0,,10718,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,In vivo,,CHEMBL874383
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,14.0,Zone of skin,10116.0,,10719,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,In vivo,,CHEMBL622112
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,14.0,Zone of skin,10116.0,,10720,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,In vivo,,CHEMBL622113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,14.0,Zone of skin,10116.0,,10721,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,In vivo,,CHEMBL622114
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2106.0,Spleen,10116.0,,10722,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,In vivo,,CHEMBL622115
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11195,50597,,2106.0,Spleen,10116.0,,10723,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,In vivo,,CHEMBL622116
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6193,50597,,,,10116.0,,10724,Oral bioavailability in rat,,In vivo,,CHEMBL622117
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6803,50597,,,,10116.0,,10725,Oral bioavailability in rat,,In vivo,,CHEMBL622118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6647,50597,,,,10116.0,,10726,Oral bioavailability in rats at 6 mg/kg,,In vivo,,CHEMBL622119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6647,50597,,,,10116.0,,10727,Oral bioavailability in rat (dose 6 mg/kg),,In vivo,,CHEMBL622120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6647,50597,,,,10116.0,,10728,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,In vivo,,CHEMBL622121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6640,50597,,,,10116.0,,10729,Oral bioavailability in rat,,In vivo,,CHEMBL622122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,10730,Oral bioavailability in rat,,In vivo,,CHEMBL622123
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6641,50597,,,,10116.0,,10731,Oral bioavailability in rat,,In vivo,,CHEMBL622124
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6642,50597,,,,10116.0,,10732,Bioavailability in rat,,In vivo,,CHEMBL622125
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,10733,Oral bioavailability,,In vivo,,CHEMBL622126
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6141,50597,,,,10116.0,,10734,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,In vivo,,CHEMBL620455
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4390,50597,,,,10116.0,,10735,Oral bioavailability in rat,,In vivo,,CHEMBL620456
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,10736,Oral bioavailability in rat,,In vivo,,CHEMBL620457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5472,50597,,,,10116.0,,10737,Oral bioavailability was evaluated; Not tested,,In vivo,,CHEMBL620458
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5438,50597,,,,10116.0,,10738,Oral bioavailability,,In vivo,,CHEMBL620459
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4883,50597,,,,10116.0,,10739,Oral bioavailability in rat by oral dosing,,In vivo,,CHEMBL620460
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1908,50597,,,,10116.0,,10740,Oral bioavailability in rat (dose 10 mg/kg p.o.),,In vivo,,CHEMBL620461
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10741,Oral bioavailability in rat (Sprague-Dawley),,In vivo,,CHEMBL620462
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10742,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,In vivo,,CHEMBL620463
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10743,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,In vivo,,CHEMBL620464
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10744,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,In vivo,,CHEMBL620465
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10745,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,In vivo,,CHEMBL620466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10746,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,In vivo,,CHEMBL620467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4853,50597,,,,10116.0,,10747,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,In vivo,,CHEMBL620468
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,,,10116.0,,10748,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,In vivo,,CHEMBL620469
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12873,50597,,,,10116.0,,10749,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,In vivo,,CHEMBL620470
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3169,50597,,,,10116.0,,10750,Oral bioavailability in rat,,In vivo,,CHEMBL620471
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6305,50597,,,,10116.0,,10751,Oral bioavailability in rat,,In vivo,,CHEMBL620472
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4762,50597,,,,10116.0,,10752,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,In vivo,,CHEMBL620473
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17847,50597,,,,10116.0,,10753,Oral bioavailability in rat,,In vivo,,CHEMBL620474
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6211,50597,,,,10116.0,,10754,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,In vivo,,CHEMBL620475
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6011,50597,,,,10116.0,,10755,Oral bioavailability in rat,,In vivo,,CHEMBL620476
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6317,50597,,,,10116.0,,10756,Oral bioavailability in rat,,In vivo,,CHEMBL620477
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,10757,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,In vivo,,CHEMBL620478
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,10758,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,In vivo,,CHEMBL618768
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,10759,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,In vivo,,CHEMBL618769
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6644,50597,,,,10116.0,,10760,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,In vivo,,CHEMBL618770
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6113,50597,,,,10116.0,,10761,Oral bioavailability (dose 20 mg/kg p.o.),,In vivo,,CHEMBL618771
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5937,50597,,,,10116.0,,10762,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,In vivo,,CHEMBL618772
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5711,50597,,,,10116.0,,10763,Oral bioavailability in rat at 10 mg/kg of the compound,,In vivo,,CHEMBL618773
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10764,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,In vivo,,CHEMBL875842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10765,Bioavailability in rat (dose 3 mg/kg i.v.),,In vivo,,CHEMBL618774
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10766,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,In vivo,,CHEMBL618775
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17717,50597,,,,10116.0,,10767,Oral bioavailability in rat (dose 60 mg/kg p.o.),,In vivo,,CHEMBL618776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4722,50597,,,,10116.0,,10768,Percent bioavailability (F) in rats after iv administration,,In vivo,,CHEMBL618777
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4722,50597,,,,10116.0,,10769,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,In vivo,,CHEMBL618778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4353,50597,,,,10116.0,,10770,Bioavailability in rat (dose 5 uM/kg p.o.),,In vivo,,CHEMBL618779
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15662,50597,,,,10116.0,,10771,Oral bioavailability,,In vivo,,CHEMBL618780
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,10772,Bioavailability in rat (dose 2 mg/kg p.o.),,In vivo,,CHEMBL618781
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,4756,50597,,,,10116.0,,10773,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,In vivo,,CHEMBL618782
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3436,50597,,,,10116.0,,10774,Oral bioavailability in rat (dose 20 mg/kg),,In vivo,,CHEMBL618783
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17800,50597,,,,10116.0,,10775,Oral bioavailability in rat,,In vivo,,CHEMBL618784
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15762,50597,,,,10116.0,,10776,Percent oral bioavailability evaluated in rat,,In vivo,,CHEMBL618785
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5089,50597,,,,10116.0,,10777,Oral bioavailability in rat,,In vivo,,CHEMBL618786
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5089,50597,,,,10116.0,,10778,Percent oral bioavailability in rat; Not determined,,In vivo,,CHEMBL618787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3185,50597,,,,10116.0,,10779,Oral bioavailability in rat,,In vivo,,CHEMBL618788
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5145,50597,,,,10116.0,,10780,Bioavailability in rat,,In vivo,,CHEMBL618789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3457,50597,,,,10116.0,,10781,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,In vivo,,CHEMBL618790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3457,50597,,,,10116.0,,10782,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,In vivo,,CHEMBL618791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5983,50597,,,,10116.0,,10783,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,In vivo,,CHEMBL875843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5739,50597,,,,10116.0,,10784,Oral bioavailability in rat (dose 20 mg/kg p.o.),,In vivo,,CHEMBL618792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,3579,50597,,,,10116.0,,10785,Cmax at a dose of 30 mg/kg in rat,,In vivo,,CHEMBL623395
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17788,22224,,,,314293.0,,10786,Cmax in monkeys at a dose of 1 mg/kg,,In vivo,,CHEMBL623396
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14956,50597,,,,10116.0,,10787,Cmax in rat,,In vivo,,CHEMBL623397
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17788,50597,,,,10116.0,,10788,Cmax in rats at a dose of 1 mg/kg,,In vivo,,CHEMBL623398
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9750,50594,,,,10090.0,,10789,Cmax was measured in mice after an oral dose of 50 mg/kg.,,In vivo,,CHEMBL623399
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,,,,,10790,"Cmax value at a dose of 12.7 uM/kg, po",,In vivo,,CHEMBL623400
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,,,,,10791,"Cmax value at a dose of 6.3 uM/kg, iv",,In vivo,,CHEMBL623401
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,,,,,10792,"Cmax value at a dose of 7.1 uM/kg, iv",,In vivo,,CHEMBL623402
Autocuration,BAO_0000218,,A,,1,,0,U,,12703,22224,,,,,,10793,Cmax value of compound was determined after 1 hr,,In vivo,,CHEMBL623403
Autocuration,BAO_0000218,,A,,1,,0,U,,15778,22224,,,,,,10794,Cmax value of the compound,,In vivo,,CHEMBL623404
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12818,50597,,,,10116.0,,10795,Cmax value administered intraintestinal in rats.,,In vivo,,CHEMBL625997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14964,50597,,,,10116.0,,10796,Cmax value administered perorally was determined in rat; Not determined,,In vivo,,CHEMBL625998
Autocuration,BAO_0000218,,A,,1,,0,U,,15808,22224,,,,,,10797,Cmax value at the dose of 2.3 mg/kg,,In vivo,,CHEMBL625999
Autocuration,BAO_0000218,,A,,1,,0,U,,15808,22224,,,,,,10798,Cmax value at the dose of 5 mg/kg,,In vivo,,CHEMBL626000
Autocuration,BAO_0000218,,A,,1,,0,U,,15778,22224,,,,,,10799,Cmax value in the period of 8 hr after dosing. ,,In vivo,,CHEMBL626001
Autocuration,BAO_0000218,,A,,1,,0,U,,3715,22224,,,,,,10800,Cmax value at a oral dose of 20 mg/kg; Not tested,,In vivo,,CHEMBL626002
Autocuration,BAO_0000218,,A,,1,,0,U,,3715,22224,,,,,,10801,Cmax value at a oral dose of 20 mg/kg,,In vivo,,CHEMBL626003
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,1446,50597,,,,10116.0,,10802,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,In vivo,,CHEMBL626004
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,15240,50512,,,,10141.0,,10803,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,In vivo,,CHEMBL626005
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15240,50597,,,,10116.0,,10804,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,In vivo,,CHEMBL626006
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14810,50597,,1969.0,Plasma,10116.0,,10805,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,In vivo,,CHEMBL626007
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14239,50594,,1969.0,Plasma,10090.0,,10806,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,In vivo,,CHEMBL626008
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12555,50588,,2107.0,Liver,9615.0,,10807,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,In vivo,,CHEMBL626009
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,10754,50588,,,,9615.0,,10808,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,In vivo,,CHEMBL626010
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,10809,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,In vivo,,CHEMBL626011
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,10810,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,In vivo,,CHEMBL626012
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,10811,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,In vivo,,CHEMBL626013
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,10812,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,In vivo,,CHEMBL626014
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10754,50594,,178.0,Blood,10090.0,,10813,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,In vivo,,CHEMBL877496
Intermediate,BAO_0000218,,F,,1,Canis lupus familiaris,1,N,,14600,50588,,,,9615.0,,10814,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,In vivo,,CHEMBL626015
Intermediate,BAO_0000218,,F,,1,Canis lupus familiaris,1,N,,14600,50588,,,,9615.0,,10815,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,In vivo,,CHEMBL626016
Intermediate,BAO_0000218,,F,,1,Canis lupus familiaris,1,N,,14600,50588,,,,9615.0,,10816,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,In vivo,,CHEMBL626017
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13543,50588,,1969.0,Plasma,9615.0,,10817,Bioavailability as maximal plasma concentration in dogs,,In vivo,,CHEMBL626018
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13543,50588,,1969.0,Plasma,9615.0,,10818,Bioavailability as maximal plasma concentration in dogs,,In vivo,,CHEMBL626692
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13543,50597,,1969.0,Plasma,10116.0,,10819,Bioavailability as maximal plasma concentration in rats,,In vivo,,CHEMBL626693
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,13543,22224,,1969.0,Plasma,10116.0,,10820,Bioavailability as maximal plasma concentration in rats,,In vivo,,CHEMBL626694
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14600,50588,,178.0,Blood,9615.0,,10821,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,In vivo,,CHEMBL626695
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14600,50588,,178.0,Blood,9615.0,,10822,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,In vivo,,CHEMBL626696
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14600,50588,,178.0,Blood,9615.0,,10823,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,In vivo,,CHEMBL626697
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14600,50588,,178.0,Blood,9615.0,,10824,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,In vivo,,CHEMBL626859
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14600,50588,,178.0,Blood,9615.0,,10825,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,In vivo,,CHEMBL626860
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14600,50588,,178.0,Blood,9615.0,,10826,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,In vivo,,CHEMBL626861
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14681,50597,,,,10116.0,,10827,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,In vivo,,CHEMBL626296
Autocuration,BAO_0000218,,A,,1,,0,U,,15905,22224,,,,,,10828,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,In vivo,,CHEMBL626297
Autocuration,BAO_0000218,,A,,1,,0,U,,15905,22224,,1969.0,Plasma,,,10829,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,In vivo,,CHEMBL626298
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13304,50597,,1969.0,Plasma,10116.0,,10830,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,In vivo,,CHEMBL626299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,10831,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,In vivo,,CHEMBL626300
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,10832,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,In vivo,,CHEMBL626301
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,10833,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,In vivo,,CHEMBL626962
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,10834,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,In vivo,,CHEMBL626963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,10835,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,In vivo,,CHEMBL626964
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,1969.0,Plasma,9541.0,,10836,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,In vivo,,CHEMBL626965
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,1969.0,Plasma,10090.0,,10837,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,In vivo,,CHEMBL626966
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,1969.0,Plasma,10090.0,,10838,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,In vivo,,CHEMBL626967
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,1969.0,Plasma,9541.0,,10839,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,In vivo,,CHEMBL626968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10840,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,,,CHEMBL626969
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10841,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,,,CHEMBL627126
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10842,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,,,CHEMBL631276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10843,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,,,CHEMBL631277
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10844,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,,,CHEMBL631278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10845,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,,,CHEMBL874457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10846,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,,,CHEMBL631279
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10847,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,,,CHEMBL631280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10848,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,,,CHEMBL631281
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10849,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,,,CHEMBL631968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10850,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,,,CHEMBL631969
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10851,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,,,CHEMBL631970
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10852,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,,,CHEMBL631971
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10853,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,,,CHEMBL631972
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10854,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,,,CHEMBL630435
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10855,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,,,CHEMBL630436
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10856,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,,,CHEMBL630437
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10857,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,,,CHEMBL630438
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,948.0,Heart,10116.0,,10858,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,,,CHEMBL630439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10859,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,,,CHEMBL630440
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10860,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,,,CHEMBL630441
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10861,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,,,CHEMBL630442
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10862,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,,,CHEMBL625234
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10863,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,,,CHEMBL625235
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10864,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,,,CHEMBL625236
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10865,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,,,CHEMBL625237
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10866,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,,,CHEMBL626125
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10867,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,,,CHEMBL626126
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10868,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,,,CHEMBL626127
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10869,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,,,CHEMBL626128
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10870,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,,,CHEMBL626129
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10871,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,,,CHEMBL626130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10872,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,,,CHEMBL626131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10873,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,,,CHEMBL626132
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10874,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,,,CHEMBL626752
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10875,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,,,CHEMBL626753
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10876,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,,,CHEMBL626754
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2113.0,Kidney,10116.0,,10877,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,,,CHEMBL626755
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,10878,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,,,CHEMBL626756
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,10879,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,,,CHEMBL626757
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,10880,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,,,CHEMBL626758
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,10881,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,,,CHEMBL626759
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,10882,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,,,CHEMBL626760
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10883,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL626394
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10884,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,,,CHEMBL626395
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10885,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,,CHEMBL626396
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10886,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL626397
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10887,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,,CHEMBL626398
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10888,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL626399
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10889,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,,,CHEMBL874653
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10890,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL626400
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10891,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,,CHEMBL626401
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10892,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL626402
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10893,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL626403
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10894,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL626404
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10895,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,,,CHEMBL626405
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10896,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL625529
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10897,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,,CHEMBL625530
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10898,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL625531
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10899,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL625532
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10900,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL625533
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10901,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,,,CHEMBL875474
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10902,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL625534
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10903,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,,CHEMBL625535
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10904,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL625536
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10905,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL625537
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10906,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL625538
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10907,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,,,CHEMBL625539
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10908,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL625540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10909,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,CHEMBL625541
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10910,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL625542
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10911,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL625543
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,10912,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL625544
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10913,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,,,CHEMBL625545
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10914,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,,CHEMBL625546
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10915,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,,,CHEMBL625547
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10916,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL625548
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10917,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL625549
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10918,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,,CHEMBL625550
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10919,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL625551
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10920,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL875475
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10921,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL625552
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10922,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,,CHEMBL625553
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10923,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL625554
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10924,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,,CHEMBL625555
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10925,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL625556
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10926,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,,,CHEMBL624986
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10927,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,,CHEMBL624987
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,10928,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL624988
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10929,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,In vivo,,CHEMBL624989
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10930,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,In vivo,,CHEMBL624990
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10931,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,In vivo,,CHEMBL874391
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10932,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,In vivo,,CHEMBL624991
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10933,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,In vivo,,CHEMBL624992
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10934,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,In vivo,,CHEMBL624993
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10935,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,In vivo,,CHEMBL624994
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10936,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,In vivo,,CHEMBL624995
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10937,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,In vivo,,CHEMBL624996
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10938,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,In vivo,,CHEMBL624997
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10939,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,In vivo,,CHEMBL624998
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10940,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,In vivo,,CHEMBL624999
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10941,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,In vivo,,CHEMBL882955
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10942,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,In vivo,,CHEMBL625000
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10943,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,In vivo,,CHEMBL625001
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10944,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,In vivo,,CHEMBL625089
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10945,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,In vivo,,CHEMBL625090
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10946,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,In vivo,,CHEMBL625091
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10947,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,In vivo,,CHEMBL625092
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10948,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,In vivo,,CHEMBL625093
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10949,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,In vivo,,CHEMBL625094
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,10950,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,In vivo,,CHEMBL625095
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,2249,50588,,,,9615.0,,10951,Compound was evaluated for its bioavailability in the dogs,,In vivo,,CHEMBL625096
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2249,50597,,,,10116.0,,10952,Compound was evaluated for its bioavailability in the rats,,In vivo,,CHEMBL625097
Autocuration,BAO_0000218,,A,,1,,0,U,,17515,22224,,,,,,10953,Compound was evaluated for oral bioavailability,,In vivo,,CHEMBL882956
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14541,50597,,,,10116.0,,10954,Compound was evaluated for percentage of Oral bioavailability in rats,,In vivo,,CHEMBL625098
Autocuration,BAO_0000218,,A,,1,Cavia porcellus,0,U,,12797,22224,,,,10141.0,,10955,Bioavailability in guinea pig,,In vivo,,CHEMBL625099
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12797,50597,,,,10116.0,,10956,Compound was evaluated for the oral bioavailability in rat,,In vivo,,CHEMBL625100
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12797,50588,,,,9615.0,,10957,Compound was evaluated for the oral bioavailability in dog,,In vivo,,CHEMBL625101
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12797,50597,,,,10116.0,,10958,Compound was evaluated for the oral bioavailability in rat,,In vivo,,CHEMBL874396
Autocuration,BAO_0000218,,F,,1,Canis lupus familiaris,0,U,,11727,22224,,,,9615.0,,10959,Bioavailability in dog (dosed i.v.),,In vivo,,CHEMBL625102
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13249,50588,,,,9615.0,,10960,Compound was tested for in vivo bioavailability in dog,,In vivo,,CHEMBL625103
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,13249,100712,,,,10026.0,,10961,Compound was tested for in vivo bioavailability in hamsters,,In vivo,,CHEMBL625104
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,13249,22224,,,,314293.0,,10962,Compound was tested for in vivo bioavailability in monkey,,In vivo,,CHEMBL625105
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13249,50597,,,,10116.0,,10963,Compound was tested for in vivo bioavailability in rat,,In vivo,,CHEMBL625106
Autocuration,BAO_0000218,,A,,1,Mus musculus,0,U,,9552,22224,,,,10090.0,,10964,Oral bioavailability in mouse,,In vivo,,CHEMBL625107
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9552,50594,,,,10090.0,,10965,Compound was tested for percent of oral bioavailability in mice; 56-74,,In vivo,,CHEMBL625108
Autocuration,BAO_0000218,,A,,1,Mus musculus,0,U,,14839,22224,,,,10090.0,,10966,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,In vivo,,CHEMBL625109
Autocuration,BAO_0000218,,A,,1,Macaca fascicularis,0,U,,14839,22224,,,,9541.0,,10967,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,In vivo,,CHEMBL625110
Autocuration,BAO_0000218,,A,,1,Macaca fascicularis,0,U,,14839,22224,,,,9541.0,,10968,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,In vivo,,CHEMBL625111
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,10969,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,In vivo,,CHEMBL625112
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,10970,Oral bioavailability in nude mice,,In vivo,,CHEMBL875334
Autocuration,BAO_0000218,,A,,1,Primates,0,U,,11219,22224,,,,9443.0,,10971,Bioavailability in monkey (i.d. dosing),,In vivo,,CHEMBL628617
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,9552,22224,,,,10116.0,,10972,Bioavailability in rat,,In vivo,,CHEMBL628618
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,10973,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,In vivo,,CHEMBL628619
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,10974,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,In vivo,,CHEMBL628620
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,10975,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,In vivo,,CHEMBL628621
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,10976,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,In vivo,,CHEMBL628622
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,,,9541.0,,10977,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,In vivo,,CHEMBL628623
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,1969.0,Plasma,9541.0,,10978,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,In vivo,,CHEMBL628624
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,1969.0,Plasma,10090.0,,10979,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,In vivo,,CHEMBL628625
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14839,100710,,1969.0,Plasma,9541.0,,10980,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,In vivo,,CHEMBL628626
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,1969.0,Plasma,10090.0,,10981,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,In vivo,,CHEMBL627041
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,1969.0,Plasma,10090.0,,10982,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,In vivo,,CHEMBL627042
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,1969.0,Plasma,10090.0,,10983,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,In vivo,,CHEMBL627043
Autocuration,BAO_0000218,,A,,1,,0,U,,13932,22224,,1969.0,Plasma,,,10984,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,In vivo,,CHEMBL627044
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11637,50594,,1969.0,Plasma,10090.0,,10985,Cmax in mouse plasma,,In vivo,,CHEMBL627045
Autocuration,BAO_0000218,,A,,1,,0,U,,11637,22224,,1969.0,Plasma,,,10986,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,In vivo,,CHEMBL627046
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13960,50597,,1969.0,Plasma,10116.0,,10987,Maximal plasma concentration in rat,,In vivo,,CHEMBL627047
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15905,50597,,1969.0,Plasma,10116.0,,10988,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,In vivo,,CHEMBL627048
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,10989,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,In vivo,,CHEMBL627049
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,10990,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,In vivo,,CHEMBL627050
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,10991,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,In vivo,,CHEMBL627051
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,10992,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,In vivo,,CHEMBL627052
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,10993,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,In vivo,,CHEMBL627053
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,10994,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,In vivo,,CHEMBL627054
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,10995,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,In vivo,,CHEMBL627055
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,10996,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,In vivo,,CHEMBL627056
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,10997,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,In vivo,,CHEMBL627057
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,10998,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,In vivo,,CHEMBL627058
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,10999,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,In vivo,,CHEMBL626211
Autocuration,BAO_0000218,,A,,1,,0,U,,10291,22224,,,,,,11000,Maximum Concentration of the compound.,,In vivo,,CHEMBL626212
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,11001,Maximum Concentration was measured after iv administration into Beagle dog,,In vivo,,CHEMBL626213
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,11002,Maximum Concentration was measured after iv administration into Beagle dog.,,In vivo,,CHEMBL626214
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,11003,Maximum Concentration was measured after po administration into Beagle dog,,In vivo,,CHEMBL626215
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14599,50588,,,,9615.0,,11004,Maximum Concentration was measured after po administration into Beagle dog.,,In vivo,,CHEMBL626216
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,178.0,Blood,,,11005,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,In vivo,,CHEMBL626217
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,178.0,Blood,,,11006,Maximum blood level reached after an iv dose of 12.2 uM/kg,,In vivo,,CHEMBL626218
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,178.0,Blood,,,11007,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,In vivo,,CHEMBL626219
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,178.0,Blood,,,11008,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,In vivo,,CHEMBL626220
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,178.0,Blood,,,11009,Maximum blood level reached after an oral dose of 5.0 mg/kg,,In vivo,,CHEMBL626221
Autocuration,BAO_0000218,,A,,1,,0,U,,12767,22224,,178.0,Blood,,,11010,Maximum blood level reached at dose of 10.6 uM/kg orally,,In vivo,,CHEMBL626222
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14706,50512,,,,10141.0,,11011,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,In vivo,,CHEMBL626223
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14706,50512,,,,10141.0,,11012,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,In vivo,,CHEMBL626224
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,955.0,Brain,10116.0,,11013,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,In vivo,,CHEMBL626225
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,955.0,Brain,10116.0,,11014,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,In vivo,,CHEMBL626226
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,955.0,Brain,10116.0,,11015,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,In vivo,,CHEMBL626227
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,955.0,Brain,10116.0,,11016,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,In vivo,,CHEMBL626228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,11017,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,In vivo,,CHEMBL626229
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,11018,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,In vivo,,CHEMBL626921
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,11019,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,In vivo,,CHEMBL876793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,,,10116.0,,11020,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,In vivo,,CHEMBL625309
Intermediate,BAO_0000218,,A,,1,Bacillus subtilis,1,N,,10524,50278,,,,1423.0,,11021,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,In vivo,,CHEMBL625310
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,11871,22224,,,,314293.0,,11022,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,In vivo,,CHEMBL625311
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11871,50597,,,,10116.0,,11023,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,In vivo,,CHEMBL625312
Autocuration,BAO_0000218,,A,,1,,0,U,,3437,22224,,,,,,11024,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,In vivo,,CHEMBL625313
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12038,50594,,,,10090.0,,11025,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,In vivo,,CHEMBL625314
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12038,50597,,,,10116.0,,11026,Maximum concentration in male rats after iv administration of 20 mg/kg,,In vivo,,CHEMBL625315
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11027,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,,,CHEMBL625316
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11028,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,,,CHEMBL625317
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11029,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,,,CHEMBL625318
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11030,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,,,CHEMBL625319
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11031,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,,,CHEMBL625320
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11032,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,,,CHEMBL625321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11033,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,,,CHEMBL625322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11034,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,,,CHEMBL876801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11035,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,,,CHEMBL625323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11036,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,,,CHEMBL625324
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11037,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,,,CHEMBL625325
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11038,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,,,CHEMBL625326
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11039,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,,,CHEMBL625327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2107.0,Liver,10116.0,,11040,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,,,CHEMBL625328
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11041,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,,,CHEMBL625329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11042,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,,,CHEMBL625330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11043,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,,,CHEMBL627774
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11044,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,,,CHEMBL627775
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11045,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,,,CHEMBL627949
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11046,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,,,CHEMBL627950
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11047,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,,,CHEMBL627951
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11048,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,,,CHEMBL627952
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11049,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,,,CHEMBL627953
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11050,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,,,CHEMBL627954
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11051,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,,,CHEMBL627955
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11052,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,,,CHEMBL627956
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11053,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,,,CHEMBL876802
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11054,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,,,CHEMBL627957
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11055,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,,,CHEMBL627958
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11056,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,,,CHEMBL627959
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11057,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,,,CHEMBL627960
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11058,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,,,CHEMBL627961
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,2048.0,Lung,10116.0,,11059,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,,,CHEMBL627962
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,,,10116.0,,11060,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,,CHEMBL627963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,,,10116.0,,11061,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624759
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,,,10116.0,,11062,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624760
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,,,10116.0,,11063,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624761
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,,,10116.0,,11064,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL877607
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,2107.0,Liver,10116.0,,11065,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,,CHEMBL624762
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,2107.0,Liver,10116.0,,11066,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624763
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,2107.0,Liver,10116.0,,11067,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624764
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,2107.0,Liver,10116.0,,11068,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624765
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,2107.0,Liver,10116.0,,11069,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL624766
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11070,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL624767
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11071,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,,,CHEMBL624768
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11072,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,,CHEMBL624769
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11073,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL624770
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11074,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,,CHEMBL624771
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11075,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL624772
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11076,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,,,CHEMBL624773
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11077,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL624774
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11078,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,,CHEMBL624775
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11079,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL624776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11080,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL624777
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11081,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL624778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11082,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,,,CHEMBL624779
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11083,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL624780
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11084,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL624781
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11085,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL877608
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11086,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,,CHEMBL624782
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11087,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL624783
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11088,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,,,CHEMBL624784
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11089,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL624785
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11090,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,,CHEMBL624786
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11091,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL624787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11092,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL628676
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11093,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,,,CHEMBL621842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11094,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL621843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11095,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,CHEMBL623873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11096,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL623874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11097,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL623875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,11098,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL623876
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11099,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,,,CHEMBL623877
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11100,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,,CHEMBL623878
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11101,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,,,CHEMBL623879
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11102,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL623880
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11103,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL623881
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11104,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,,CHEMBL623957
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11105,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL623958
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11106,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL623959
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11107,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL623960
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11108,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,,CHEMBL623961
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11109,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL623962
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11110,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,,CHEMBL624676
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11111,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL624677
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11112,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,,,CHEMBL624678
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11113,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,,CHEMBL624679
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11114,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL624680
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,11115,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,In vivo,,CHEMBL624849
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,11116,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,In vivo,,CHEMBL624850
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,11117,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,In vivo,,CHEMBL874399
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,11118,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,In vivo,,CHEMBL624851
Autocuration,BAO_0000218,,A,,1,,0,U,,11732,22224,,,,,,11119,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,In vivo,,CHEMBL624852
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,13359,22224,,,,10116.0,,11120,Oral bioavailability in rat (dose 10 mg/kg),,In vivo,,CHEMBL624853
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,16618,22224,,,,10116.0,,11121,Oral bioavailability in rat (Sprague-Dawley),,In vivo,,CHEMBL624854
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,13960,22224,,,,10116.0,,11122,Oral bioavailability in rat,,In vivo,,CHEMBL624855
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,13917,22224,,,,10116.0,,11123,Oral bioavailability in rats was determined in vivo,,In vivo,,CHEMBL624856
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,14266,22224,,,,9615.0,,11124,Oral bioavailability in dog,,In vivo,,CHEMBL882957
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12359,22224,,,,314293.0,,11125,Oral bioavailability of compound in monkey,,In vivo,,CHEMBL624857
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12359,50597,,,,10116.0,,11126,Oral bioavailability of compound in rat,,In vivo,,CHEMBL622202
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12359,22224,,,,10116.0,,11127,Bioavailability in rat of PMEA prodrug,,In vivo,,CHEMBL622203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12359,50597,,,,10116.0,,11128,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,In vivo,,CHEMBL625522
Autocuration,BAO_0000218,,A,,1,Macaca mulatta,0,U,,10791,22224,,,,9544.0,,11129,Serum conc at 3 hours following 25 mg/kg dose,,In vivo,,CHEMBL622868
Autocuration,BAO_0000218,,A,,1,Macaca mulatta,0,U,,10791,22224,,1088.0,Urine,9544.0,,11130,Urine conc 0-5 hours following 25 mg/kg dose,,In vivo,,CHEMBL622869
Autocuration,BAO_0000218,,A,,1,Macaca mulatta,0,U,,10791,22224,,1088.0,Urine,9544.0,,11131,Urine conc 0-24 hours following 25 mg/kg dose,,In vivo,,CHEMBL622870
Autocuration,BAO_0000218,,A,,1,Chlorocebus aethiops,0,U,,138,22224,,,,9534.0,,11132,Oral bioavailability in African green monkeys; 20-25,,In vivo,,CHEMBL622871
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14521,100710,,,,9541.0,,11133,Oral bioavailability in cynomolgus monkey.,,In vivo,,CHEMBL620560
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,13953,22224,,,,9615.0,,11134,Oral bioavailability in dog,,In vivo,,CHEMBL620561
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12836,50588,,,,9615.0,,11135,Oral bioavailability in dog at 10 mg/kg oral dose,,In vivo,,CHEMBL620562
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,12836,100712,,,,10026.0,,11136,Oral bioavailability in hamster at 10 mg/kg oral dose,,In vivo,,CHEMBL620563
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12836,50597,,,,10116.0,,11137,Oral bioavailability in rat at 10 mg/kg oral dose,,In vivo,,CHEMBL620564
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,14521,22224,,,,10116.0,,11138,Oral bioavailability in rat,,In vivo,,CHEMBL872265
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,13953,22224,,,,10116.0,,11139,Oral bioavailability in rat,,In vivo,,CHEMBL620565
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,6799,22224,,,,9347.0,,11140,Oral bioavailability,,In vivo,,CHEMBL620566
Autocuration,BAO_0000218,,A,,1,,0,U,,11311,22224,,,,,,11141,Oral bioavailability was determined; range 49-102%,,In vivo,,CHEMBL620567
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,4013,50588,,,,9615.0,,11142,Oral bioavailability was determined in dogs,,In vivo,,CHEMBL620568
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,4013,22224,,,,10116.0,,11143,Oral bioavailability in rat,,In vivo,,CHEMBL620569
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,17591,22224,,,,9347.0,,11144,Oral bioavailability,,In vivo,,CHEMBL620570
Autocuration,BAO_0000218,,A,,1,,0,U,,17591,22224,,,,,,11145,Oral bioavailability was determined; Not orally available,,In vivo,,CHEMBL620571
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15011,50594,,,,10090.0,,11146,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,In vivo,,CHEMBL620572
Autocuration,BAO_0000218,,A,,1,Mus musculus,0,U,,15011,22224,,,,10090.0,,11147,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,In vivo,,CHEMBL620573
Autocuration,BAO_0000218,,A,,1,Mus musculus,0,U,,15011,22224,,,,10090.0,,11148,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,In vivo,,CHEMBL620574
Autocuration,BAO_0000218,,A,,1,Macaca mulatta,0,U,,9552,22224,,,,9544.0,,11149,Oral bioavailability in Rhesus monkey,,In vivo,,CHEMBL620575
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,9552,22224,,,,9615.0,,11150,Oral bioavailability in dog (female mongrel),,In vivo,,CHEMBL620576
Autocuration,BAO_0000218,,A,,1,,0,U,,3639,22224,,,,,,11151,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,In vivo,,CHEMBL875846
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,13397,22224,,,,9615.0,,11152,Oral bioavailability in dog,,In vivo,,CHEMBL620577
Autocuration,BAO_0000218,,A,,1,,0,U,,3031,22224,,,,,,11153,Percentage Bioavailability was evaluated.,,In vivo,,CHEMBL620578
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12818,22224,,,,10116.0,,11154,Bioavailability in rat administered i.d.,,In vivo,,CHEMBL620579
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,4847,22224,,,,9347.0,,11155,Bioavailability,,In vivo,,CHEMBL621248
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,12421,22224,,,,9615.0,,11156,Bioavailability in dog (male Beagle) i.v. administration,,In vivo,,CHEMBL625390
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,11966,22224,,,,10116.0,,11157,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,In vivo,,CHEMBL625391
Autocuration,BAO_0000218,,A,,1,Primates,0,U,,11218,22224,,,,9443.0,,11158,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,In vivo,,CHEMBL872266
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,13129,22224,,,,10116.0,,11159,Oral bioavailability in rat (Sprague-Dawley) (male),,In vivo,,CHEMBL625392
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12350,50597,,,,10116.0,,11160,The oral bioavailability was measured on rats after oral administration,,In vivo,,CHEMBL625393
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2231,50597,,,,10116.0,,11161,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,In vivo,,CHEMBL625394
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,2231,50797,,,,9544.0,,11162,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,In vivo,,CHEMBL625395
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12187,22224,,,,10116.0,,11163,Bioavailability in rat (dose 10 mg/kg i.d.),,In vivo,,CHEMBL625396
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,12421,22224,,,,9615.0,,11164,Bioavailability in dog (male Beagle) i.v. administration,,In vivo,,CHEMBL625397
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11165,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625398
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,178.0,Blood,10090.0,,11166,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625399
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2037.0,Cerebellum,10090.0,,11167,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL626074
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11168,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL626075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2231,50597,,1969.0,Plasma,10116.0,,11169,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,In vivo,,CHEMBL626076
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,2231,50797,,1969.0,Plasma,9544.0,,11170,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,In vivo,,CHEMBL626077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12178,50597,,178.0,Blood,10116.0,,11171,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,In vivo,,CHEMBL626078
Autocuration,BAO_0000218,,A,,1,,0,U,,12178,22224,,178.0,Blood,,,11172,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,In vivo,,CHEMBL625846
Autocuration,BAO_0000218,,A,,1,,0,U,,12178,22224,,178.0,Blood,,,11173,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,In vivo,,CHEMBL625847
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15633,50597,,,,10116.0,,11174,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,In vivo,,CHEMBL625848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14258,50597,,1969.0,Plasma,10116.0,,11175,Maximum concentration of compound in plasma administered orally to rats,,In vivo,,CHEMBL625849
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,11176,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,In vivo,,CHEMBL626023
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,11177,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,In vivo,,CHEMBL626024
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,11178,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,In vivo,,CHEMBL626025
Autocuration,BAO_0000218,,A,,1,,0,U,,5566,22224,,,,,,11179,Maximum concentration after 10 mg/kg by oral administration,,In vivo,,CHEMBL626026
Autocuration,BAO_0000218,,A,,1,,0,U,,16935,22224,,,,,,11180,Maximum concentration at a dose of 1.5 mg/kg,,In vivo,,CHEMBL626027
Autocuration,BAO_0000218,,A,,1,,0,U,,16935,22224,,,,,,11181,Maximum concentration at a dose of 2.0 mg/kg,,In vivo,,CHEMBL626028
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,11182,Maximum concentration in dog plasma,,In vivo,,CHEMBL626029
Autocuration,BAO_0000218,,A,,1,,0,U,,12536,22224,,1969.0,Plasma,,,11183,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,In vivo,,CHEMBL626030
Autocuration,BAO_0000218,,A,,1,,0,U,,12536,22224,,1969.0,Plasma,,,11184,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,In vivo,,CHEMBL626031
Autocuration,BAO_0000218,,A,,1,,0,U,,12536,22224,,1969.0,Plasma,,,11185,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,In vivo,,CHEMBL626032
Autocuration,BAO_0000218,,A,,1,,0,U,,12536,22224,,1969.0,Plasma,,,11186,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,In vivo,,CHEMBL626033
Autocuration,BAO_0000218,,A,,1,,0,U,,12536,22224,,1969.0,Plasma,,,11187,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,In vivo,,CHEMBL626034
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9994,50588,,1969.0,Plasma,9615.0,,11188,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,In vivo,,CHEMBL626035
Autocuration,BAO_0000218,,A,,1,,0,U,,1434,22224,,1969.0,Plasma,,,11189,Maximum concentration in plasma at Tmax,,In vivo,,CHEMBL626036
Expert,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12836,50588,,1969.0,Plasma,9615.0,,11190,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,In vivo,,CHEMBL626037
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,12836,100712,,1969.0,Plasma,10026.0,,11191,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,In vivo,,CHEMBL626038
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12836,50597,,1969.0,Plasma,10116.0,,11192,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,In vivo,,CHEMBL626039
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12545,50597,,1969.0,Plasma,10116.0,,11193,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,In vivo,,CHEMBL626040
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,13856,50592,,1969.0,Plasma,9986.0,,11194,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,In vivo,,CHEMBL626041
Autocuration,BAO_0000218,,A,,1,,0,U,,3550,22224,,,,,,11195,Maximum concentration was calculated,,In vivo,,CHEMBL626042
Autocuration,BAO_0000218,,A,,1,,0,U,,2632,22224,,,,,,11196,Maximum concentration was calculated.,,In vivo,,CHEMBL626043
Autocuration,BAO_0000218,,A,,1,,0,U,,5566,22224,,,,,,11197,Maximum concentration at a peroral dose of 10 mg/kg,,In vivo,,CHEMBL626044
Autocuration,BAO_0000218,,A,,1,,0,U,,11883,22224,,,,,,11198,Maximum concentration of the drug at 10 uM/dg administered perorally,,In vivo,,CHEMBL626045
Autocuration,BAO_0000218,,A,,1,,0,U,,11883,22224,,,,,,11199,Maximum concentration of the drug at 2 uM/dg administered intravenously,,In vivo,,CHEMBL626046
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14122,50588,,1969.0,Plasma,9615.0,,11200,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,In vivo,,CHEMBL626047
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,14122,100712,,1969.0,Plasma,10026.0,,11201,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,In vivo,,CHEMBL626048
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14122,50597,,1969.0,Plasma,10116.0,,11202,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,In vivo,,CHEMBL626049
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12542,50597,,1969.0,Plasma,10116.0,,11203,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,In vivo,,CHEMBL626050
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12542,50588,,1969.0,Plasma,9615.0,,11204,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,In vivo,,CHEMBL874541
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,12542,100712,,1969.0,Plasma,10026.0,,11205,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,In vivo,,CHEMBL622826
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,12542,100712,,1969.0,Plasma,10026.0,,11206,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,In vivo,,CHEMBL622827
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12542,50597,,1969.0,Plasma,10116.0,,11207,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,In vivo,,CHEMBL622828
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14080,50597,,1969.0,Plasma,10116.0,,11208,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,In vivo,,CHEMBL622829
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11911,50597,,,,10116.0,,11209,Maximum concentration reached following intravenous administration in male rat,,In vivo,,CHEMBL876806
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13204,50588,,,,9615.0,,11210,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,In vivo,,CHEMBL622830
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13204,50597,,,,10116.0,,11211,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,In vivo,,CHEMBL622831
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14346,50588,,,,9615.0,,11212,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,In vivo,,CHEMBL626794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,11213,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL626795
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,11214,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL626796
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,,,10116.0,,11215,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL626797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14127,50597,,,,10116.0,,11216,Maximum drug concentration is determined after oral dosing in rats.,,In vivo,,CHEMBL626798
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14339,50588,,,,9615.0,,11217,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,In vivo,,CHEMBL626799
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14339,50588,,,,9615.0,,11218,Maximum observed concentration in oral (5 mg/kg) fed dogs,,In vivo,,CHEMBL626800
Autocuration,BAO_0000218,,A,,1,,0,U,,13494,22224,,1969.0,Plasma,,,11219,Maximum plasma concentration,,In vivo,,CHEMBL626801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14925,50597,,1969.0,Plasma,10116.0,,11220,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,In vivo,,CHEMBL876816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14474,50597,,1969.0,Plasma,10116.0,,11221,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,In vivo,,CHEMBL626802
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14474,50588,,1969.0,Plasma,9615.0,,11222,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,In vivo,,CHEMBL626803
Autocuration,BAO_0000218,,A,,1,,0,U,,13917,22224,,1969.0,Plasma,,,11223,Maximum plasma concentration following oral administration of 30 umol/kg,,In vivo,,CHEMBL626804
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,1969.0,Plasma,10116.0,,11224,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,,,CHEMBL626805
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,1969.0,Plasma,10116.0,,11225,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,,CHEMBL626309
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,1969.0,Plasma,10116.0,,11226,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626310
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,1969.0,Plasma,10116.0,,11227,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626311
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,1969.0,Plasma,10116.0,,11228,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626312
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,995.0,Uterus,10116.0,,11229,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626313
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,995.0,Uterus,10116.0,,11230,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,,CHEMBL626314
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,995.0,Uterus,10116.0,,11231,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626315
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,995.0,Uterus,10116.0,,11232,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626316
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9796,50597,,995.0,Uterus,10116.0,,11233,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,,CHEMBL626317
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11234,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,,,CHEMBL626318
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11235,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,,,CHEMBL626319
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11236,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,,,CHEMBL626320
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11237,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,,,CHEMBL875053
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11238,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,,,CHEMBL626321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11239,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,,,CHEMBL626322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11240,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,,,CHEMBL626323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11241,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,,,CHEMBL626324
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11242,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,,,CHEMBL626325
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11243,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,,,CHEMBL626326
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11244,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,,,CHEMBL626327
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8363,50597,,,,10116.0,,11245,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,,,CHEMBL626328
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11246,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,,,CHEMBL626329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11247,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,,,CHEMBL626330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11248,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL626331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11249,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL626332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11250,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,,,CHEMBL626333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11251,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL626334
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11252,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL626335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,178.0,Blood,10116.0,,11253,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL624798
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11254,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,,,CHEMBL624799
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11255,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,,,CHEMBL624800
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11256,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,,,CHEMBL624801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11257,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,,,CHEMBL624802
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11258,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,,,CHEMBL624803
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11259,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,,,CHEMBL624804
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11260,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,,,CHEMBL624805
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,955.0,Brain,10116.0,,11261,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,,,CHEMBL624806
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11262,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,,,CHEMBL624807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11263,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL624808
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11264,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL624809
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11265,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,,,CHEMBL624810
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11266,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL877618
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11267,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,,,CHEMBL624811
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11268,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL624812
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11269,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL624813
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11270,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,,,CHEMBL624814
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11271,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL624815
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11272,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL624816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11273,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,,,CHEMBL624817
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11274,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL624818
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11275,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,,,CHEMBL624819
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11276,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,,CHEMBL624820
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11277,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL624821
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11278,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,,CHEMBL624822
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,11279,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL624823
Intermediate,BAO_0000218,,A,,1,Escherichia coli,1,N,,15599,50212,,,,562.0,,11280,Observed diffusion coefficient in organic solvent for Escherichia coli,,,,CHEMBL624824
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,178.0,Blood,10116.0,,11281,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL624825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,178.0,Blood,10116.0,,11282,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624826
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2081.0,Cardiac atrium,10116.0,,11283,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL876817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2081.0,Cardiac atrium,10116.0,,11284,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624827
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,,,10116.0,,11285,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL624828
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,,,10116.0,,11286,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624829
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2107.0,Liver,10116.0,,11287,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL624830
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2107.0,Liver,10116.0,,11288,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624831
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2081.0,Cardiac atrium,10116.0,,11289,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL624832
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2081.0,Cardiac atrium,10116.0,,11290,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624833
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,,,10116.0,,11291,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624834
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,,,10116.0,,11292,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL624835
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2106.0,Spleen,10116.0,,11293,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,CHEMBL624836
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9614,50597,,2106.0,Spleen,10116.0,,11294,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,CHEMBL624837
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,178.0,Blood,10116.0,,11295,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,,,CHEMBL624838
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,178.0,Blood,10116.0,,11296,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,,,CHEMBL622188
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,948.0,Heart,10116.0,,11297,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,,,CHEMBL622189
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,948.0,Heart,10116.0,,11298,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,,,CHEMBL622190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,948.0,Heart,10116.0,,11299,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,,,CHEMBL625170
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2113.0,Kidney,10116.0,,11300,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,,CHEMBL625171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2113.0,Kidney,10116.0,,11301,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,,CHEMBL625172
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2113.0,Kidney,10116.0,,11302,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,,,CHEMBL625173
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2107.0,Liver,10116.0,,11303,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,,,CHEMBL625174
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2107.0,Liver,10116.0,,11304,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,,,CHEMBL625175
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2107.0,Liver,10116.0,,11305,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,,,CHEMBL625176
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2048.0,Lung,10116.0,,11306,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,,CHEMBL625177
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2048.0,Lung,10116.0,,11307,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,,,CHEMBL625178
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2048.0,Lung,10116.0,,11308,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,,,CHEMBL625179
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9071,50597,,2048.0,Lung,10116.0,,11309,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,,CHEMBL625180
Autocuration,BAO_0000218,,A,,1,,0,U,,10677,22224,,,,,,11310,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,,CHEMBL625181
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9750,50594,,1088.0,Urine,10090.0,,11311,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,,,CHEMBL625182
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11312,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,CHEMBL625183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11313,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,CHEMBL875848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11314,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,CHEMBL622260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11315,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,CHEMBL622261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11316,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,CHEMBL622262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11317,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,,CHEMBL622263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11318,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,,CHEMBL622418
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2107.0,Liver,10116.0,,11319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,,CHEMBL622419
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11320,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623388
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2107.0,Liver,10090.0,,11321,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623389
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11322,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623390
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11323,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623391
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,178.0,Blood,10090.0,,11324,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623392
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2037.0,Cerebellum,10090.0,,11325,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623393
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11326,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL623394
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11327,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL618885
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2107.0,Liver,10090.0,,11328,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL618886
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11329,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL618887
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11330,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619535
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,178.0,Blood,10090.0,,11331,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619536
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2037.0,Cerebellum,10090.0,,11332,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619537
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11333,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619705
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11334,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619706
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2107.0,Liver,10090.0,,11335,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619707
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11336,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL619708
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11337,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625219
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,178.0,Blood,10090.0,,11338,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625220
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2037.0,Cerebellum,10090.0,,11339,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625221
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11340,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625222
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11341,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625223
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,2107.0,Liver,10090.0,,11342,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625224
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13256,50594,,,,10090.0,,11343,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,In vivo,,CHEMBL625225
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,178.0,Blood,10116.0,,11344,Biodistribution in Rat blood after 24 hours of iv administration,,In vivo,,CHEMBL625226
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,178.0,Blood,10116.0,,11345,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,In vivo,,CHEMBL625227
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,178.0,Blood,10116.0,,11346,Biodistribution in Rat blood after 30 minutes of iv administration,,In vivo,,CHEMBL625228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,178.0,Blood,10116.0,,11347,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL875354
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,178.0,Blood,10116.0,,11348,Biodistribution in Rat blood after 5 minutes of iv administration,,In vivo,,CHEMBL625229
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,178.0,Blood,10116.0,,11349,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL625230
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,948.0,Heart,10116.0,,11350,Biodistribution in Rat heart after 24 hours of iv administration,,In vivo,,CHEMBL625231
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,948.0,Heart,10116.0,,11351,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,In vivo,,CHEMBL625900
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,948.0,Heart,10116.0,,11352,Biodistribution in Rat heart after 30 minutes of iv administration,,In vivo,,CHEMBL625901
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,948.0,Heart,10116.0,,11353,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL625902
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,948.0,Heart,10116.0,,11354,Biodistribution in Rat heart after 5 minutes of iv administration,,In vivo,,CHEMBL625903
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,948.0,Heart,10116.0,,11355,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL625904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11356,Biodistribution in Rat liver after 24 hours of iv administration,,In vivo,,CHEMBL625905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11357,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,In vivo,,CHEMBL627861
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11358,Biodistribution in Rat liver after 30 minutes of iv administration,,In vivo,,CHEMBL627862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11359,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL627863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11360,Biodistribution in Rat liver after 30 minutes of iv administration,,In vivo,,CHEMBL627769
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13249,50588,,1969.0,Plasma,9615.0,,11361,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,In vivo,,CHEMBL627770
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,13622,100710,,,,9541.0,,11362,Cmax in cynomolgus monkey (PO dose),,In vivo,,CHEMBL627771
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13622,50597,,,,10116.0,,11363,Cmax in rat (PO dose),,In vivo,,CHEMBL627772
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13622,50597,,,,10116.0,,11364,Cmax in rat (PO dose),,In vivo,,CHEMBL627773
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13494,50597,,1969.0,Plasma,10116.0,,11365,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,In vivo,,CHEMBL621922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12170,50597,,1969.0,Plasma,10116.0,,11366,Cmax in rat plasma after oral dose (10 mg/kg),,In vivo,,CHEMBL621923
Autocuration,BAO_0000218,,A,,1,,0,U,,12170,22224,,1969.0,Plasma,,,11367,Cmax in plasma after oral dose (10 mg/kg),,In vivo,,CHEMBL621924
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17025,50588,,1969.0,Plasma,9615.0,,11368,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,In vivo,,CHEMBL621925
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17025,22224,,1969.0,Plasma,314293.0,,11369,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,In vivo,,CHEMBL621926
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,1969.0,Plasma,9986.0,,11370,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,In vivo,,CHEMBL621927
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17025,50597,,1969.0,Plasma,10116.0,,11371,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,In vivo,,CHEMBL621928
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14187,50597,,1969.0,Plasma,10116.0,,11372,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,In vivo,,CHEMBL621929
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14816,50594,,1969.0,Plasma,10090.0,,11373,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,In vivo,,CHEMBL621930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17820,50597,,1969.0,Plasma,10116.0,,11374,Maximum plasma concentration after oral dosing in rat,,In vivo,,CHEMBL621931
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11375,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621932
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11376,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621933
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14691,50588,,1969.0,Plasma,9615.0,,11377,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,In vivo,,CHEMBL621934
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14691,50588,,1969.0,Plasma,9615.0,,11378,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,In vivo,,CHEMBL621935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13375,50597,,1969.0,Plasma,10116.0,,11379,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,In vivo,,CHEMBL621936
Autocuration,BAO_0000218,,A,,1,,0,U,,6236,22224,,1969.0,Plasma,,,11380,Maximum plasma concentration was determined,,In vivo,,CHEMBL621937
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11381,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621938
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11382,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621939
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11383,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621940
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11384,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621941
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11385,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL621942
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11386,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL626178
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11387,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL626179
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,1969.0,Plasma,,,11388,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,In vivo,,CHEMBL626180
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13622,50597,,1969.0,Plasma,10116.0,,11389,Plasma Cmax in rat (PO dose),,In vivo,,CHEMBL626181
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,11390,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,In vivo,,CHEMBL626182
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,11391,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,In vivo,,CHEMBL626183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,11392,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,In vivo,,CHEMBL626184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,,,10116.0,,11393,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,In vivo,,CHEMBL626185
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14925,50588,,1969.0,Plasma,9615.0,,11394,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,In vivo,,CHEMBL626186
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14925,50588,,1969.0,Plasma,9615.0,,11395,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,In vivo,,CHEMBL877589
Autocuration,BAO_0000218,,A,,1,,0,U,,11883,22224,,,,,,11396,Maximum concentration of the drug at 1 uM/dg administered intravenously,,In vivo,,CHEMBL626187
Autocuration,BAO_0000218,,A,,1,,0,U,,11883,22224,,,,,,11397,Maximum concentration of the drug at 20 uM/dg administered perorally,,In vivo,,CHEMBL626188
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,,,,,11398,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,In vivo,,CHEMBL626189
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,178.0,Blood,,,11399,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,In vivo,,CHEMBL626855
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,178.0,Blood,,,11400,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,In vivo,,CHEMBL623781
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,178.0,Blood,,,11401,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,In vivo,,CHEMBL623782
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16360,50597,,1969.0,Plasma,10116.0,,11402,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,In vivo,,CHEMBL623783
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,3673,50588,,1969.0,Plasma,9615.0,,11403,Cmax in dog plasma after 1mg/kg oral dose,,In vivo,,CHEMBL623784
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14431,50588,,1969.0,Plasma,9615.0,,11404,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,In vivo,,CHEMBL623785
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14431,50597,,1969.0,Plasma,10116.0,,11405,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,In vivo,,CHEMBL623786
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14964,50597,,,,10116.0,,11406,Oral maximum concentration in rat,,In vivo,,CHEMBL623787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14964,50597,,,,10116.0,,11407,Oral maximum concentration in rat,,In vivo,,CHEMBL623788
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14209,50594,,1969.0,Plasma,10090.0,,11408,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,In vivo,,CHEMBL623789
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11355,50594,,178.0,Blood,10090.0,,11409,Peak concentration in blood after intravenous administration to mice,,In vivo,,CHEMBL623790
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11355,50594,,178.0,Blood,10090.0,,11410,Peak concentration in blood after peroral administration to mice,,In vivo,,CHEMBL623791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11966,50597,,1969.0,Plasma,10116.0,,11411,Peak concentration in rat plasma was determined,,In vivo,,CHEMBL623792
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8918,22224,,1969.0,Plasma,314293.0,,11412,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,In vivo,,CHEMBL623793
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8918,50594,,1969.0,Plasma,10090.0,,11413,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,In vivo,,CHEMBL623794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8918,50597,,1969.0,Plasma,10116.0,,11414,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,In vivo,,CHEMBL623795
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11415,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL623796
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11416,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,,,CHEMBL623797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11417,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL623798
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11418,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL623799
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11419,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,,,CHEMBL624490
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11420,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL624491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11421,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL624492
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11422,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,,,CHEMBL624493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11423,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL877595
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11424,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,,,CHEMBL624494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11425,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL624495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,160.0,Intestine,10116.0,,11426,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL624681
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11427,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,,,CHEMBL624682
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11428,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL624683
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11429,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL624684
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11430,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,,,CHEMBL624685
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11431,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL624686
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11432,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,,,CHEMBL624687
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11433,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL624688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11434,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL627161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11435,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,,,CHEMBL622127
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11436,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL622128
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11437,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL874384
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11438,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,,,CHEMBL624898
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11439,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL624899
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11440,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,,,CHEMBL624900
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11441,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL624901
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11442,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL624902
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11443,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,,,CHEMBL624903
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11444,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL624904
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11445,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL624905
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11446,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,,,CHEMBL624906
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11447,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL624907
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11448,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,,,CHEMBL624908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11449,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL624909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11450,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL624910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11451,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,,,CHEMBL624911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11452,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL874388
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11453,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL624912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11454,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,,,CHEMBL622930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11455,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL623121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11456,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,,,CHEMBL623122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11457,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL623123
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2385.0,Muscle tissue,10116.0,,11458,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL623124
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11459,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,,,CHEMBL623125
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11460,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL623126
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11461,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL623127
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11462,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,,,CHEMBL623128
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11463,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL623129
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11464,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,,,CHEMBL623130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11465,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL623131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11466,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL623132
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2107.0,Liver,10116.0,,11467,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,,CHEMBL623133
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11468,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,CHEMBL623134
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11469,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,CHEMBL874389
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11470,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,CHEMBL623135
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11471,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,CHEMBL623136
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11472,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,CHEMBL623137
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11473,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,CHEMBL623138
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11474,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,,CHEMBL623139
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11475,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,,CHEMBL623140
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2107.0,Liver,10116.0,,11476,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,,CHEMBL623141
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2107.0,Liver,10116.0,,11477,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,,CHEMBL623142
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11478,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,CHEMBL623143
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14571,50594,,1088.0,Urine,10090.0,,11479,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,,,CHEMBL623144
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14571,50597,,1088.0,Urine,10116.0,,11480,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,,,CHEMBL623405
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11481,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,CHEMBL624074
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11482,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,CHEMBL624075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11483,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,CHEMBL624076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11484,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,CHEMBL624077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11485,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,CHEMBL624078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11486,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,,CHEMBL624079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11487,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,,CHEMBL624261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11488,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,,CHEMBL624262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11489,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,,CHEMBL624263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11490,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,CHEMBL624264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11491,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,CHEMBL624265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11492,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,CHEMBL624266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11493,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,CHEMBL624267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11494,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,CHEMBL624268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11495,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,CHEMBL875227
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11496,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,,CHEMBL624269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,2113.0,Kidney,10116.0,,11497,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,,CHEMBL624270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11498,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,,CHEMBL624271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11499,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,,CHEMBL624272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8319,50597,,,,10116.0,,11500,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,CHEMBL624273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12064,50597,,1088.0,Urine,10116.0,,11501,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,,,CHEMBL624274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12064,50597,,1088.0,Urine,10116.0,,11502,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,,,CHEMBL624275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12064,50597,,1088.0,Urine,10116.0,,11503,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,,,CHEMBL624276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12038,50597,,1088.0,Urine,10116.0,,11504,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,,,CHEMBL624277
Autocuration,BAO_0000019,,A,,1,,0,U,,14314,22224,,,,,,11505,% dose converted to 2-amino-5-chlorophenyl sulfate,,,,CHEMBL624278
Autocuration,BAO_0000019,,A,,1,,0,U,,14314,22224,,,,,,11506,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,,CHEMBL624279
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1988.0,Feces,10116.0,,11507,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,,CHEMBL624280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1988.0,Feces,10116.0,,11508,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,,CHEMBL624281
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1988.0,Feces,10116.0,,11509,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,,CHEMBL622933
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1988.0,Feces,10116.0,,11510,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,,CHEMBL622934
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11511,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL622935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11512,Biodistribution in Rat liver after 5 minutes of iv administration,,In vivo,,CHEMBL622936
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2107.0,Liver,10116.0,,11513,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL875228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2048.0,Lung,10116.0,,11514,Biodistribution in Rat lung after 24 hours of iv administration,,In vivo,,CHEMBL622937
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2048.0,Lung,10116.0,,11515,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,In vivo,,CHEMBL622938
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2048.0,Lung,10116.0,,11516,Biodistribution in Rat lung after 30 minutes of iv administration,,In vivo,,CHEMBL619736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2048.0,Lung,10116.0,,11517,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL625117
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2048.0,Lung,10116.0,,11518,Biodistribution in Rat lung after 5 minutes of iv administration,,In vivo,,CHEMBL625118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8829,50597,,2048.0,Lung,10116.0,,11519,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,In vivo,,CHEMBL625119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14972,50597,,2037.0,Cerebellum,10116.0,,11520,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,In vivo,,CHEMBL625120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14972,50597,,,,10116.0,,11521,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,In vivo,,CHEMBL625121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14972,50597,,10000006.0,Thalamus,10116.0,,11522,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,In vivo,,CHEMBL625122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,178.0,Blood,10116.0,,11523,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL622204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,178.0,Blood,10116.0,,11524,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL877503
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,178.0,Blood,10116.0,,11525,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL627127
Autocuration,BAO_0000218,,A,,1,,0,U,,14608,22224,,10000000.0,Hippocampus,,,11526,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL627128
Autocuration,BAO_0000218,,A,,1,,0,U,,14608,22224,,10000000.0,Hippocampus,,,11527,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL627129
Autocuration,BAO_0000218,,A,,1,,0,U,,14608,22224,,10000000.0,Hippocampus,,,11528,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL627130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,955.0,Brain,10116.0,,11529,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL627131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,955.0,Brain,10116.0,,11530,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL627132
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,955.0,Brain,10116.0,,11531,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL627133
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2037.0,Cerebellum,10116.0,,11532,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL627134
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2037.0,Cerebellum,10116.0,,11533,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL627135
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2037.0,Cerebellum,10116.0,,11534,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL627136
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,,,10116.0,,11535,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL628435
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,,,10116.0,,11536,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL628436
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,,,10116.0,,11537,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL628437
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,948.0,Heart,10116.0,,11538,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL628438
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,948.0,Heart,10116.0,,11539,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL628439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,948.0,Heart,10116.0,,11540,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL628440
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,10000000.0,Hippocampus,10116.0,,11541,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL628441
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,10000000.0,Hippocampus,10116.0,,11542,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL628442
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,10000000.0,Hippocampus,10116.0,,11543,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL628443
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2113.0,Kidney,10116.0,,11544,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL628444
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2113.0,Kidney,10116.0,,11545,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL628445
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2113.0,Kidney,10116.0,,11546,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL877504
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2107.0,Liver,10116.0,,11547,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL628446
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2107.0,Liver,10116.0,,11548,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL626874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2107.0,Liver,10116.0,,11549,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL626875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2048.0,Lung,10116.0,,11550,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL626876
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2048.0,Lung,10116.0,,11551,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL626877
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2048.0,Lung,10116.0,,11552,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL626878
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2385.0,Muscle tissue,10116.0,,11553,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL626879
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8918,22224,,1969.0,Plasma,314293.0,,11554,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,In vivo,,CHEMBL626880
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8918,50594,,1969.0,Plasma,10090.0,,11555,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,In vivo,,CHEMBL626881
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8918,50597,,1969.0,Plasma,10116.0,,11556,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,In vivo,,CHEMBL626882
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14470,50588,,1969.0,Plasma,9615.0,,11557,Peak plasma concentration was measured in dogs,,In vivo,,CHEMBL626883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,11558,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,In vivo,,CHEMBL626884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14886,50597,,,,10116.0,,11559,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,In vivo,,CHEMBL626885
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14886,50597,,,,10116.0,,11560,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,In vivo,,CHEMBL626886
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14886,50597,,,,10116.0,,11561,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,In vivo,,CHEMBL626887
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,11562,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,In vivo,,CHEMBL626888
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13465,50588,,,,9615.0,,11563,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,In vivo,,CHEMBL626889
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,13465,22224,,,,314293.0,,11564,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,In vivo,,CHEMBL626761
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13465,50588,,,,9615.0,,11565,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,In vivo,,CHEMBL626762
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13465,50588,,,,9615.0,,11566,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,In vivo,,CHEMBL626763
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13465,50597,,,,10116.0,,11567,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,In vivo,,CHEMBL626764
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13465,50597,,,,10116.0,,11568,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,In vivo,,CHEMBL626765
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13465,50588,,,,9615.0,,11569,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,In vivo,,CHEMBL626766
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13465,50597,,,,10116.0,,11570,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,In vivo,,CHEMBL626767
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13465,50597,,,,10116.0,,11571,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,In vivo,,CHEMBL626768
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13465,50588,,,,9615.0,,11572,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,In vivo,,CHEMBL626769
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13465,50588,,,,9615.0,,11573,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,In vivo,,CHEMBL874463
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,13465,22224,,,,314293.0,,11574,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,In vivo,,CHEMBL626770
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,13465,22224,,,,314293.0,,11575,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,In vivo,,CHEMBL626771
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13465,50597,,,,10116.0,,11576,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,In vivo,,CHEMBL626772
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14731,100710,,,,9541.0,,11577,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,In vivo,,CHEMBL626773
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14731,50594,,,,10090.0,,11578,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,In vivo,,CHEMBL626774
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13376,50588,,,,9615.0,,11579,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,In vivo,,CHEMBL626775
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13376,50588,,,,9615.0,,11580,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,In vivo,,CHEMBL626776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14443,50597,,,,10116.0,,11581,Maximum concentration (Cmax) in rat when administered orally,,In vivo,,CHEMBL626777
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,13465,22224,,1969.0,Plasma,314293.0,,11582,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,In vivo,,CHEMBL626778
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,16359,22224,,,,10116.0,,11583,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,In vivo,,CHEMBL626779
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,16359,22224,,,,10116.0,,11584,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,In vivo,,CHEMBL626780
Autocuration,BAO_0000218,,A,,1,,0,U,,15618,22224,,1969.0,Plasma,,,11585,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,In vivo,,CHEMBL626781
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14554,50597,,,,10116.0,,11586,Pharmacokinetic profile Cmax was evaluated in rats,,In vivo,,CHEMBL632164
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,11537,50588,,,,9615.0,,11587,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,In vivo,,CHEMBL632165
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11537,50594,,,,10090.0,,11588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,In vivo,,CHEMBL632166
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,11537,50588,,,,9615.0,,11589,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,In vivo,,CHEMBL632167
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11537,50594,,,,10090.0,,11590,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,In vivo,,CHEMBL632168
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,2021,22224,,1969.0,Plasma,10116.0,,11591,Cmax in rat plasma,,In vivo,,CHEMBL632169
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,5932,50588,,1969.0,Plasma,9615.0,,11592,Cmax in dog plasma after 30mg/kg oral dose,,In vivo,,CHEMBL632170
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5932,50597,,1969.0,Plasma,10116.0,,11593,Cmax in rat plasma after 30mg/kg oral dose,,In vivo,,CHEMBL632171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17320,50597,,1969.0,Plasma,10116.0,,11594,Plasma level in rats at 30 mg/kg,,In vivo,,CHEMBL632172
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15831,50594,,1969.0,Plasma,10090.0,,11595,Tested for maximum plasma concentration in mice,,In vivo,,CHEMBL632173
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,11596,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,In vivo,,CHEMBL632174
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,11597,The Cmax values in female wistar rats.,,In vivo,,CHEMBL632175
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15343,50588,,1969.0,Plasma,9615.0,,11598,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,In vivo,,CHEMBL632176
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15343,50597,,1969.0,Plasma,10116.0,,11599,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,In vivo,,CHEMBL632177
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14856,50597,,1969.0,Plasma,10116.0,,11600,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,In vivo,,CHEMBL632178
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13129,50597,,,,10116.0,,11601,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,In vivo,,CHEMBL632179
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13098,50597,,178.0,Blood,10116.0,,11602,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,In vivo,,CHEMBL632180
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13098,50597,,178.0,Blood,10116.0,,11603,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,In vivo,,CHEMBL632181
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13098,50597,,178.0,Blood,10116.0,,11604,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,In vivo,,CHEMBL632182
Autocuration,BAO_0000218,,A,,1,Mus musculus,0,U,,15478,22224,,178.0,Blood,10090.0,,11605,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,In vivo,,CHEMBL632183
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15341,50588,,,,9615.0,,11606,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,In vivo,,CHEMBL632184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,11607,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,In vivo,,CHEMBL874470
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11608,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,,,CHEMBL631302
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11609,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL631303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11610,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL631304
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11611,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,,,CHEMBL631305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11612,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL631306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11613,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,,,CHEMBL631307
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11614,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL631308
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,,,10116.0,,11615,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL625557
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11616,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,,,CHEMBL625558
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11617,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL625559
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11618,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL625560
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11619,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,,,CHEMBL625561
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11620,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL625562
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11621,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,,,CHEMBL875320
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11622,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL625563
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,2106.0,Spleen,10116.0,,11623,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL625564
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11624,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,,,CHEMBL625565
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11625,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,,,CHEMBL625566
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11626,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,,,CHEMBL625567
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11627,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,,,CHEMBL625568
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11628,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,,,CHEMBL628217
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11629,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,,,CHEMBL628218
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11630,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,,,CHEMBL628219
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8684,50597,,995.0,Uterus,10116.0,,11631,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,,,CHEMBL628220
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11632,Distribution in the blood after 120 min of intravenous administration,,,,CHEMBL628221
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11633,Distribution in the blood after 15 min of intravenous administration,,,,CHEMBL628222
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11634,Distribution in the blood after 30 min of intravenous administration,,,,CHEMBL628223
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11635,Distribution in the blood after 5 min of intravenous administration,,,,CHEMBL628224
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11636,Distribution in the blood after 60 min of intravenous administration,,,,CHEMBL628225
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11637,Distribution in the blood after 90 min of intravenous administration,,,,CHEMBL628226
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11638,Distribution in the bone after 120 min of intravenous administration,,,,CHEMBL628227
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11639,Distribution in the bone after 15 min of intravenous administration,,,,CHEMBL875481
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11640,Distribution in the bone after 30 min of intravenous administration,,,,CHEMBL628228
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11641,Distribution in the bone after 5 min of intravenous administration,,,,CHEMBL628229
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11642,Distribution in the bone after 60 min of intravenous administration,,,,CHEMBL628230
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11643,Distribution in the bone after 90 min of intravenous administration,,,,CHEMBL628231
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11644,Distribution in the heart after 120 min of intravenous administration,,,,CHEMBL628232
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11645,Distribution in the heart after 15 min of intravenous administration,,,,CHEMBL628233
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11646,Distribution in the heart after 30 min of intravenous administration,,,,CHEMBL628234
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11647,Distribution in the heart after 5 min of intravenous administration,,,,CHEMBL628235
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11648,Distribution in the heart after 60 min of intravenous administration,,,,CHEMBL628236
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11649,Distribution in the heart after 90 min of intravenous administration,,,,CHEMBL628237
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11650,Distribution in the kidneys after 120 min of intravenous administration,,,,CHEMBL628238
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11651,Distribution in the kidneys after 15 min of intravenous administration,,,,CHEMBL628239
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11652,Distribution in the kidneys after 30 min of intravenous administration,,,,CHEMBL628240
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11653,Distribution in the kidneys after 5 min of intravenous administration,,,,CHEMBL628241
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11654,Distribution in the kidneys after 60 min of intravenous administration,,,,CHEMBL628242
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11655,Distribution in the kidneys after 90 min of intravenous administration,,,,CHEMBL875482
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11656,Distribution in the liver after 120 min of intravenous administration,,,,CHEMBL628243
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11657,Distribution in the liver after 15 min of intravenous administration,,,,CHEMBL628244
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11658,Distribution in the liver after 30 min of intravenous administration,,,,CHEMBL628245
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11659,Distribution in the liver after 5 min of intravenous administration,,,,CHEMBL628246
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11660,Distribution in the liver after 60 min of intravenous administration,,,,CHEMBL628247
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11661,Distribution in the liver after 90 min of intravenous administration,,,,CHEMBL628248
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11662,Distribution in the lung after 120 min of intravenous administration,,,,CHEMBL628249
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,11663,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,,,CHEMBL625452
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,11664,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,,,CHEMBL625453
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,11665,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,,,CHEMBL625454
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14839,50594,,,,10090.0,,11666,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,,,CHEMBL623844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12178,50597,,,,10116.0,,11667,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,,,CHEMBL623845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12178,50597,,,,10116.0,,11668,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,,,CHEMBL623846
Autocuration,BAO_0000218,,A,,1,,0,U,,12178,22224,,,,,,11669,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,,CHEMBL623847
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,11670,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,CHEMBL623848
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,11671,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,CHEMBL623849
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,11672,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,CHEMBL623850
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,11673,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,CHEMBL623851
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,11674,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,,CHEMBL623852
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,12187,50506,,,,9669.0,,11675,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,,CHEMBL624551
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,12187,50506,,,,9669.0,,11676,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,,CHEMBL624552
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,11677,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,,CHEMBL624553
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,11678,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,,,CHEMBL624554
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12187,50597,,,,10116.0,,11679,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,,CHEMBL624555
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12187,50597,,,,10116.0,,11680,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,,CHEMBL624741
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14122,50588,,,,9615.0,,11681,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,,,CHEMBL624742
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,14122,100712,,,,10026.0,,11682,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,,,CHEMBL624743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14122,50597,,,,10116.0,,11683,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,,,CHEMBL877606
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,,,,,11684,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,,CHEMBL624744
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,178.0,Blood,,,11685,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,,CHEMBL624745
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,178.0,Blood,,,11686,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,,CHEMBL624746
Autocuration,BAO_0000218,,A,,1,,0,U,,13391,22224,,178.0,Blood,,,11687,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,,CHEMBL624747
Autocuration,BAO_0000019,,A,,1,,0,U,,16360,22224,,,,,,11688,Oral absorption expressed as Area under curve was determined,,,,CHEMBL624748
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,3673,50588,,,,9615.0,,11689,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,,,CHEMBL622504
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14122,50588,,,,9615.0,,11690,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,,,CHEMBL622505
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,14122,100712,,,,10026.0,,11691,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,,CHEMBL622506
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,14122,100712,,,,10026.0,,11692,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,,CHEMBL622507
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14122,50597,,,,10116.0,,11693,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,,,CHEMBL622508
Autocuration,BAO_0000019,,A,,1,,0,U,,13889,22224,,,,,,11694,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,,CHEMBL622509
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,11695,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,CHEMBL622510
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17279,50597,,,,10116.0,,11696,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,,,CHEMBL622511
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14548,100710,,,,9541.0,,11697,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,,CHEMBL622512
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14548,100710,,,,9541.0,,11698,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,,CHEMBL622513
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14548,100710,,,,9541.0,,11699,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,,,CHEMBL622514
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14548,50588,,,,9615.0,,11700,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,,CHEMBL622515
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14548,50588,,,,9615.0,,11701,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,,,CHEMBL622516
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14548,50597,,,,10116.0,,11702,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,,CHEMBL622517
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14548,50597,,,,10116.0,,11703,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,,,CHEMBL622518
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14548,50597,,,,10116.0,,11704,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,,,CHEMBL622519
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2385.0,Muscle tissue,10116.0,,11705,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL622520
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2385.0,Muscle tissue,10116.0,,11706,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL622521
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14608,50594,,14.0,Zone of skin,10090.0,,11707,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL625113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,14.0,Zone of skin,10116.0,,11708,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL625114
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,14.0,Zone of skin,10116.0,,11709,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL874397
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2106.0,Spleen,10116.0,,11710,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL625115
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2106.0,Spleen,10116.0,,11711,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL625116
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2106.0,Spleen,10116.0,,11712,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL623932
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2435.0,Striatum,10116.0,,11713,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL623933
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2435.0,Striatum,10116.0,,11714,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL623934
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2435.0,Striatum,10116.0,,11715,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL623935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2046.0,Thyroid gland,10116.0,,11716,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,In vivo,,CHEMBL623936
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2046.0,Thyroid gland,10116.0,,11717,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,In vivo,,CHEMBL623937
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14608,50597,,2046.0,Thyroid gland,10116.0,,11718,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,In vivo,,CHEMBL623938
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11719,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL623939
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11720,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,,CHEMBL623940
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11721,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,CHEMBL623941
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11722,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL627216
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11723,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL623942
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,955.0,Brain,10090.0,,11724,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL618793
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,955.0,Brain,10090.0,,11725,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618794
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,955.0,Brain,10090.0,,11726,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL618795
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11727,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618796
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11728,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL618797
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2113.0,Kidney,10090.0,,11729,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,,CHEMBL618798
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2113.0,Kidney,10090.0,,11730,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL618799
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2113.0,Kidney,10090.0,,11731,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,,CHEMBL618800
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2113.0,Kidney,10090.0,,11732,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,CHEMBL618801
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2113.0,Kidney,10090.0,,11733,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618802
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2113.0,Kidney,10090.0,,11734,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL618803
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2107.0,Liver,10090.0,,11735,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,,CHEMBL618804
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2107.0,Liver,10090.0,,11736,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL618805
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2107.0,Liver,10090.0,,11737,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,,CHEMBL618806
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2107.0,Liver,10090.0,,11738,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,CHEMBL618807
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2107.0,Liver,10090.0,,11739,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618808
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2107.0,Liver,10090.0,,11740,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL618809
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2385.0,Muscle tissue,10090.0,,11741,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL618810
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2385.0,Muscle tissue,10090.0,,11742,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,,CHEMBL618811
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2385.0,Muscle tissue,10090.0,,11743,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,CHEMBL875844
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2385.0,Muscle tissue,10090.0,,11744,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618812
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2385.0,Muscle tissue,10090.0,,11745,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL618813
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11746,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL618814
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11747,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618815
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11748,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL618816
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11749,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL618817
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11750,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL620544
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,11751,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,In vivo,,CHEMBL626230
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,11752,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,In vivo,,CHEMBL626231
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,11753,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,In vivo,,CHEMBL626232
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14906,50588,,1969.0,Plasma,9615.0,,11754,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,In vivo,,CHEMBL626233
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14906,50597,,1969.0,Plasma,10116.0,,11755,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,In vivo,,CHEMBL626234
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14906,50597,,1969.0,Plasma,10116.0,,11756,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,In vivo,,CHEMBL875341
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,1969.0,Plasma,9606.0,,11757,The maximum plasma concentration (100 mg/kg) administered orally in human,,In vivo,,CHEMBL626235
Autocuration,BAO_0000218,,A,,1,Callithrix,0,U,,14215,22224,,1969.0,Plasma,9481.0,,11758,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,In vivo,,CHEMBL626236
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,14215,22224,,1969.0,Plasma,314293.0,,11759,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,In vivo,,CHEMBL626237
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14215,50588,,1969.0,Plasma,9615.0,,11760,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,In vivo,,CHEMBL626238
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,1969.0,Plasma,9606.0,,11761,The maximum plasma concentration (200 mg/kg) administered orally in human,,In vivo,,CHEMBL622412
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14215,50597,,1969.0,Plasma,10116.0,,11762,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,In vivo,,CHEMBL623114
Autocuration,BAO_0000218,,A,,1,Callithrix,0,U,,14215,22224,,1969.0,Plasma,9481.0,,11763,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,In vivo,,CHEMBL623115
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,14215,22224,,1969.0,Plasma,314293.0,,11764,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,In vivo,,CHEMBL623116
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,14215,22224,,1969.0,Plasma,9615.0,,11765,The maximum plasma concentration (30 mg/kg) administered orally in dog,,In vivo,,CHEMBL623117
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,1969.0,Plasma,9606.0,,11766,The maximum plasma concentration (400 mg/kg) administered orally in human,,In vivo,,CHEMBL623118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14215,50597,,1969.0,Plasma,10116.0,,11767,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,In vivo,,CHEMBL623119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14215,50597,,1969.0,Plasma,10116.0,,11768,The maximum plasma concentration (50 mg/kg) administered orally in rat,,In vivo,,CHEMBL623120
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,1969.0,Plasma,9606.0,,11769,The maximum plasma concentration (800 mg/kg) administered orally in human,,In vivo,,CHEMBL623286
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14067,50597,,1969.0,Plasma,10116.0,,11770,The maximum plasma concentration was measured on rats,,In vivo,,CHEMBL623287
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12350,50597,,1969.0,Plasma,10116.0,,11771,The maximum plasma concentration was measured on rats after oral administration,,In vivo,,CHEMBL623288
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14813,50597,,1969.0,Plasma,10116.0,,11772,Plasma drug Cmax in rat (PO dose),,In vivo,,CHEMBL623289
Autocuration,BAO_0000218,,A,,1,,0,U,,12536,22224,,,,,,11773,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,In vivo,,CHEMBL623290
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14169,50588,,1969.0,Plasma,9615.0,,11774,maximum Plasma concentration in Dog was determined after Peroral administration,,In vivo,,CHEMBL623291
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14169,50597,,1969.0,Plasma,10116.0,,11775,maximum Plasma concentration in Rats was determined after Peroral administration,,In vivo,,CHEMBL623292
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15604,50588,,1969.0,Plasma,9615.0,,11776,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,In vivo,,CHEMBL623293
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,15604,22224,,1969.0,Plasma,314293.0,,11777,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,In vivo,,CHEMBL623294
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15604,50597,,1969.0,Plasma,10116.0,,11778,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,In vivo,,CHEMBL623295
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14387,50594,,,,10090.0,,11779,maximum concentration was measured when administered through oral route in mice,,In vivo,,CHEMBL623296
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15115,50594,,,,10090.0,,11780,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,,,CHEMBL875349
Autocuration,BAO_0000019,,A,,1,Simiiformes,0,U,,15115,22224,,,,314293.0,,11781,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,,,CHEMBL623297
Autocuration,BAO_0000019,,A,,1,Simiiformes,0,U,,15115,22224,,,,314293.0,,11782,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,,,CHEMBL623298
Autocuration,BAO_0000019,,A,,1,Simiiformes,0,U,,15115,22224,,,,314293.0,,11783,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,,,CHEMBL623299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16359,50597,,,,10116.0,,11784,Pharmacokinetic parameter was evaluated in rats,,,,CHEMBL623300
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12829,50594,,,,10090.0,,11785,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,,CHEMBL623301
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12829,50594,,,,10090.0,,11786,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,,,CHEMBL623302
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12829,50594,,,,10090.0,,11787,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,,CHEMBL623303
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12829,50594,,,,10090.0,,11788,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,,,CHEMBL623304
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12829,50594,,,,10090.0,,11789,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,,,CHEMBL623305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,11790,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,,,CHEMBL623306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,11791,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,,,CHEMBL623307
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15137,50597,,1969.0,Plasma,10116.0,,11792,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,,,CHEMBL623308
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15137,50594,,1969.0,Plasma,10090.0,,11793,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,,,CHEMBL623309
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13509,50594,,,,10090.0,,11794,Plasma Concentration after 120 min of oral administration to mice,,,,CHEMBL623310
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13509,50594,,,,10090.0,,11795,Plasma Concentration after 30 min of oral administration to mice,,,,CHEMBL623311
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,13509,100710,,,,9541.0,,11796,Plasma Concentration after 60 min of oral administration to mice,,,,CHEMBL623312
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13509,50594,,,,10090.0,,11797,Plasma Concentration after 60 min of oral administration to mice; Not determined,,,,CHEMBL875350
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13509,50594,,,,10090.0,,11798,Plasma Concentration after 90 min of oral administration to mice,,,,CHEMBL628635
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12064,50597,,,,10116.0,,11799,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,,,CHEMBL628636
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12064,50597,,,,10116.0,,11800,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,,,CHEMBL628637
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12064,50597,,,,10116.0,,11801,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,,,CHEMBL628058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11802,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,,,CHEMBL628059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11803,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,,,CHEMBL628060
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11804,Distribution in the lung after 15 min of intravenous administration,,,,CHEMBL628061
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11805,Distribution in the lung after 30 min of intravenous administration,,,,CHEMBL628062
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11806,Distribution in the lung after 5 min of intravenous administration,,,,CHEMBL628063
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11807,Distribution in the lung after 60 min of intravenous administration,,,,CHEMBL628064
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,,,,,11808,Distribution in the lung after 90 min of intravenous administration,,,,CHEMBL628065
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2385.0,Muscle tissue,,,11809,Distribution in the muscle after 120 min of intravenous administration,,,,CHEMBL628066
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2385.0,Muscle tissue,,,11810,Distribution in the muscle after 15 min of intravenous administration,,,,CHEMBL628067
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8926,50594,,2385.0,Muscle tissue,10090.0,,11811,Distribution in the muscle after 30 min of intravenous administration,,,,CHEMBL874646
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2385.0,Muscle tissue,,,11812,Distribution in the muscle after 5 min of intravenous administration,,,,CHEMBL628068
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2385.0,Muscle tissue,,,11813,Distribution in the muscle after 60 min of intravenous administration,,,,CHEMBL628069
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2385.0,Muscle tissue,,,11814,Distribution in the muscle after 90 min of intravenous administration,,,,CHEMBL628070
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2106.0,Spleen,,,11815,Distribution in the spleen after 120 min of intravenous administration,,,,CHEMBL628071
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2106.0,Spleen,,,11816,Distribution in the spleen after 15 min of intravenous administration,,,,CHEMBL628072
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2106.0,Spleen,,,11817,Distribution in the spleen after 30 min of intravenous administration,,,,CHEMBL628073
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2106.0,Spleen,,,11818,Distribution in the spleen after 5 min of intravenous administration,,,,CHEMBL628074
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2106.0,Spleen,,,11819,Distribution in the spleen after 60 min of intravenous administration,,,,CHEMBL628075
Autocuration,BAO_0000019,,A,,1,,0,U,,8926,22224,,2106.0,Spleen,,,11820,Distribution in the spleen after 90 min of intravenous administration,,,,CHEMBL628076
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,1235.0,Adrenal cortex,10116.0,,11821,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,,CHEMBL628077
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,178.0,Blood,10116.0,,11822,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,,,CHEMBL628078
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,2107.0,Liver,10116.0,,11823,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,,,CHEMBL628079
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,992.0,Female gonad,10116.0,,11824,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,,,CHEMBL628080
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,2046.0,Thyroid gland,10116.0,,11825,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,,,CHEMBL628081
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,1235.0,Adrenal cortex,10116.0,,11826,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,,CHEMBL628082
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,178.0,Blood,10116.0,,11827,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,,,CHEMBL874647
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,2107.0,Liver,10116.0,,11828,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,,,CHEMBL626406
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,992.0,Female gonad,10116.0,,11829,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,,,CHEMBL626407
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7570,50597,,2046.0,Thyroid gland,10116.0,,11830,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,,,CHEMBL626408
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11831,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,,,CHEMBL626409
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11832,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,,,CHEMBL626410
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11833,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,,,CHEMBL626411
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11834,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,,,CHEMBL626412
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11835,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,,,CHEMBL626413
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11836,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,,,CHEMBL626414
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11837,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,,,CHEMBL626415
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11838,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,,,CHEMBL626416
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11839,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,,,CHEMBL627062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11840,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,,,CHEMBL627063
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11841,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,,,CHEMBL627064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11842,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,,,CHEMBL627227
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11843,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,,,CHEMBL627228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11844,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,,,CHEMBL627229
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11845,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,,,CHEMBL625792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11846,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,,,CHEMBL625793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11847,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,,,CHEMBL625794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,178.0,Blood,10116.0,,11848,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,,,CHEMBL625795
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,,,10090.0,,11849,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,,,CHEMBL625796
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13376,50588,,,,9615.0,,11850,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,,CHEMBL625797
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13376,50588,,,,9615.0,,11851,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,,CHEMBL625798
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11852,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,CHEMBL875613
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11853,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,CHEMBL625799
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11854,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,,CHEMBL625800
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11855,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,,CHEMBL625801
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11856,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,,CHEMBL625802
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11857,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,,CHEMBL625803
Autocuration,BAO_0000019,,A,,1,,0,U,,14380,22224,,,,,,11858,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,,CHEMBL625804
Autocuration,BAO_0000218,,A,,1,,0,U,,14380,22224,,,,,,11859,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,,CHEMBL622530
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11860,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,,,CHEMBL622531
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11861,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,,CHEMBL622532
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11862,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,,CHEMBL623176
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11863,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,,CHEMBL623177
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11864,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,,CHEMBL623178
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11865,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,,,CHEMBL623179
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11866,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,,CHEMBL623180
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11867,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,,CHEMBL623181
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11868,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,,CHEMBL624131
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11869,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,,,CHEMBL624132
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11870,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,,CHEMBL624133
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11871,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,,,CHEMBL624846
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11872,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,,CHEMBL624847
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11873,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,,CHEMBL624848
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11874,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,,CHEMBL625012
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11875,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,,CHEMBL625013
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11876,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,,,CHEMBL625014
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11877,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,,,CHEMBL625015
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11878,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,,CHEMBL625016
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11879,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,,,CHEMBL625017
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11880,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,,CHEMBL625018
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11881,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,,,CHEMBL625019
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11882,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,,,CHEMBL625020
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,11883,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,,,CHEMBL625021
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,11884,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,CHEMBL625022
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14731,50594,,,,10090.0,,11885,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,,,CHEMBL625023
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14731,100710,,,,9541.0,,11886,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,,,CHEMBL625024
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14731,100710,,,,9541.0,,11887,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,,CHEMBL627626
Autocuration,BAO_0000218,,A,,1,,0,U,,13758,22224,,955.0,Brain,,,11888,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,,CHEMBL627627
Autocuration,BAO_0000218,,A,,1,,0,U,,13758,22224,,1977.0,Serum,,,11889,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,,CHEMBL627628
Autocuration,BAO_0000218,,A,,1,,0,U,,13758,22224,,955.0,Brain,,,11890,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,,CHEMBL627629
Autocuration,BAO_0000218,,A,,1,,0,U,,13758,22224,,1977.0,Serum,,,11891,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,,CHEMBL627630
Autocuration,BAO_0000019,,A,,1,,0,U,,16359,22224,,,,,,11892,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,,CHEMBL627631
Autocuration,BAO_0000218,,A,,1,,0,U,,16359,22224,,,,,,11893,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,,CHEMBL629515
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2106.0,Spleen,10090.0,,11894,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL629516
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2106.0,Spleen,10090.0,,11895,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL629517
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,2106.0,Spleen,10090.0,,11896,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL629518
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11897,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,CHEMBL877499
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11898,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,CHEMBL629519
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11899,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,CHEMBL629520
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15383,50594,,,,10090.0,,11900,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,CHEMBL629521
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11901,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,,,CHEMBL629522
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11902,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,,,CHEMBL629523
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11903,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,,,CHEMBL629524
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11904,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,,,CHEMBL629525
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11905,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,,,CHEMBL629526
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11906,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,,,CHEMBL629527
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11907,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,,,CHEMBL629528
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11908,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,,,CHEMBL629529
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11909,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,,,CHEMBL629530
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11910,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,,,CHEMBL629531
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11911,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,,,CHEMBL628656
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,11912,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,,,CHEMBL628657
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11913,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL628658
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11914,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL628659
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11915,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL877500
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11916,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL628660
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11917,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL628661
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11918,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL628662
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11919,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL628663
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,11920,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL628664
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11921,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL628665
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11922,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL628666
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11923,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL628667
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11924,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL628668
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11925,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL628669
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11926,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL628670
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,178.0,Blood,10116.0,,11927,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL628671
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,10000001.0,Bone,10116.0,,11928,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL628672
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,10000001.0,Bone,10116.0,,11929,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL630300
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,10000001.0,Bone,10116.0,,11930,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL629787
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,10000001.0,Bone,10116.0,,11931,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL629788
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,11932,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL629789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,11933,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL629790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,11934,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL629791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,11935,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL629792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,11936,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL629793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,11937,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL629794
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11938,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,,,CHEMBL874459
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11939,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,,,CHEMBL629795
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11940,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,,,CHEMBL629796
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11941,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,,,CHEMBL629797
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10677,50597,,,,10116.0,,11942,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,,,CHEMBL629798
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2369.0,Adrenal gland,10116.0,,11943,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629799
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2369.0,Adrenal gland,10116.0,,11944,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629800
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2369.0,Adrenal gland,10116.0,,11945,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2369.0,Adrenal gland,10116.0,,11946,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,In vivo,,CHEMBL629802
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2369.0,Adrenal gland,10116.0,,11947,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629803
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,178.0,Blood,10116.0,,11948,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629804
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,178.0,Blood,10116.0,,11949,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629805
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,178.0,Blood,10116.0,,11950,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629806
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,178.0,Blood,10116.0,,11951,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,178.0,Blood,10116.0,,11952,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629808
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,955.0,Brain,10116.0,,11953,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629809
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,955.0,Brain,10116.0,,11954,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629810
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,955.0,Brain,10116.0,,11955,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629811
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,955.0,Brain,10116.0,,11956,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629812
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,955.0,Brain,10116.0,,11957,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629813
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,955.0,Brain,10116.0,,11958,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL874460
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,,,10116.0,,11959,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629814
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,,,10116.0,,11960,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629815
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,,,10116.0,,11961,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,,,10116.0,,11962,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL629817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2113.0,Kidney,10116.0,,11963,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626643
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2113.0,Kidney,10116.0,,11964,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626644
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2113.0,Kidney,10116.0,,11965,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626806
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2113.0,Kidney,10116.0,,11966,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626807
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2107.0,Liver,10116.0,,11967,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2107.0,Liver,10116.0,,11968,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2107.0,Liver,10116.0,,11969,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2107.0,Liver,10116.0,,11970,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2048.0,Lung,10116.0,,11971,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2048.0,Lung,10116.0,,11972,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2048.0,Lung,10116.0,,11973,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2048.0,Lung,10116.0,,11974,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2385.0,Muscle tissue,10116.0,,11975,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2385.0,Muscle tissue,10116.0,,11976,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11977,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,,,CHEMBL627271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11978,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,,,CHEMBL627946
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11979,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,,,CHEMBL875472
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11980,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,,,CHEMBL627947
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11981,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,,,CHEMBL627948
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11982,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,,,CHEMBL628113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11983,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,,,CHEMBL628114
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11984,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,,,CHEMBL628115
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11985,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,,,CHEMBL628116
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11986,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,,,CHEMBL628117
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11987,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,,,CHEMBL628118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11988,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,,,CHEMBL628119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11989,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,,,CHEMBL628120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11990,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,,,CHEMBL628121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11991,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,,,CHEMBL628122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11992,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,,,CHEMBL627297
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11993,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,,,CHEMBL627298
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11994,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,,,CHEMBL627299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11995,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,,,CHEMBL627300
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11996,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,,,CHEMBL627301
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11997,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,,,CHEMBL627302
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11998,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,,,CHEMBL627303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,11999,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,,,CHEMBL627304
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12000,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,,,CHEMBL627305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12001,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,,CHEMBL627306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12002,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,,,CHEMBL623982
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12003,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,,,CHEMBL623983
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12004,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,,,CHEMBL623984
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12005,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,,,CHEMBL623985
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12006,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,,,CHEMBL623986
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12007,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,,,CHEMBL623987
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12008,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,,,CHEMBL623988
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12009,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,,,CHEMBL623989
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12010,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,,,CHEMBL622215
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12011,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,,,CHEMBL622216
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,,,10116.0,,12012,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,,,CHEMBL877481
Autocuration,BAO_0000218,,A,,1,,0,U,,16359,22224,,,,,,12013,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,,CHEMBL622217
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13701,50594,,,,10090.0,,12014,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,,CHEMBL622218
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14554,50597,,,,10116.0,,12015,Pharmacokinetic profile AUC was evaluated in rats,,,,CHEMBL622219
Autocuration,BAO_0000019,,A,,1,,0,U,,6241,22224,,,,,,12016,Pharmacokinetic property (Area under curve),,,,CHEMBL622220
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,11537,50588,,,,9615.0,,12017,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,,,CHEMBL622221
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11537,50594,,,,10090.0,,12018,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,,,CHEMBL622222
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,11537,50588,,,,9615.0,,12019,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,,,CHEMBL622223
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11537,50594,,,,10090.0,,12020,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,,,CHEMBL622224
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,12021,Plasma concentration (AUC) was determined,,,,CHEMBL622225
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,12022,Plasma concentration (AUC) was determined; Not detectable,,,,CHEMBL622226
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,9562,50512,,,,10141.0,,12023,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,,,CHEMBL624154
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10363,50597,,,,10116.0,,12024,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,,,CHEMBL624155
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10363,50597,,,,10116.0,,12025,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,,CHEMBL624156
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10363,50597,,,,10116.0,,12026,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,,,CHEMBL624157
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10363,50597,,,,10116.0,,12027,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,,,CHEMBL624158
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,12028,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,,,CHEMBL624159
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,12029,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,,,CHEMBL624160
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,12030,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,,,CHEMBL624161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,12031,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,,,CHEMBL624162
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13317,50588,,,,9615.0,,12032,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,,,CHEMBL624163
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,12033,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL624164
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,12034,The AUC(0-infinity) values in female wistar rats.,,,,CHEMBL624165
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,12035,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL624166
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,12036,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,,,CHEMBL624167
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,12037,The AUC(0-t)values in female wistar rats.,,,,CHEMBL624168
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14067,50597,,,,10116.0,,12038,The Area under the concentration time curve of compound was measured on rats,,,,CHEMBL624169
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,,,9606.0,,12039,The area under curve (100 mg/kg) administered orally in humans,,,,CHEMBL624170
Autocuration,BAO_0000218,,A,,1,Callithrix,0,U,,14215,22224,,,,9481.0,,12040,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,,,CHEMBL624171
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,14215,22224,,,,314293.0,,12041,The area under curve (12.5 mg/kg) administered intravenously in monkey,,,,CHEMBL624172
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14215,50588,,,,9615.0,,12042,The area under curve (15 mg/kg) administered intravenously in dog,,,,CHEMBL624173
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,,,9606.0,,12043,The area under curve (200 mg/kg) administered orally in humans,,,,CHEMBL877488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14215,50597,,,,10116.0,,12044,The area under curve (25 mg/kg) administered intravenously in rat,,,,CHEMBL624174
Autocuration,BAO_0000218,,A,,1,Callithrix,0,U,,14215,22224,,,,9481.0,,12045,The area under curve (25 mg/kg) administered orally in marmoset,,,,CHEMBL624175
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,14215,22224,,,,314293.0,,12046,The area under curve (25 mg/kg) administered orally in monkey,,,,CHEMBL624176
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14215,50588,,,,9615.0,,12047,The area under curve (30 mg/kg) administered orally in dog,,,,CHEMBL624177
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,,,9606.0,,12048,The area under curve (400 mg/kg) administered orally in humans,,,,CHEMBL624178
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14215,50597,,,,10116.0,,12049,The area under curve (50 mg/kg) administered orally in fasted rat,,,,CHEMBL624179
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14215,50597,,,,10116.0,,12050,The area under curve (50 mg/kg) administered orally in rat,,,,CHEMBL627689
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14215,50587,,,,9606.0,,12051,The area under curve (800 mg/kg) administered orally in humans,,,,CHEMBL627690
Autocuration,BAO_0000019,,A,,1,,0,U,,11324,22224,,,,,,12052,The compound was evaluated for area under the curve,,,,CHEMBL627691
Autocuration,BAO_0000019,,A,,1,Callithrix,0,U,,11324,22224,,,,9481.0,,12053,The compound was evaluated for area under the curve in marmosets,,,,CHEMBL627692
Autocuration,BAO_0000019,,A,,1,Callithrix,0,U,,11324,22224,,,,9481.0,,12054,The compound was evaluated for area under the curve in marmosets,,,,CHEMBL627693
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13875,50597,,,,10116.0,,12055,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,,CHEMBL627694
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13875,50597,,,,10116.0,,12056,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,,,CHEMBL627695
Autocuration,BAO_0000218,,A,,1,,0,U,,13875,22224,,,,,,12057,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,,CHEMBL627696
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13875,50597,,,,10116.0,,12058,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,,CHEMBL627697
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13875,50597,,,,10116.0,,12059,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,,CHEMBL627698
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13875,50597,,,,10116.0,,12060,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,,,CHEMBL627699
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13807,50597,,,,10116.0,,12061,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,,,CHEMBL627700
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14127,50597,,,,10116.0,,12062,Total drug exposure is determined after oral dosing in rats.,,,,CHEMBL627701
Autocuration,BAO_0000218,,A,,1,,0,U,,15116,22224,,,,,,12063,Total drug exposure (5 mg/kg) when administered intravenously,,,,CHEMBL627702
Autocuration,BAO_0000218,,A,,1,,0,U,,15116,22224,,,,,,12064,Total drug exposure (5 mg/kg) when administered orally,,,,CHEMBL627703
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,15604,22224,,,,314293.0,,12065,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,,CHEMBL626873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15604,50597,,,,10116.0,,12066,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,,CHEMBL629583
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15604,50588,,,,9615.0,,12067,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,,CHEMBL629584
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15604,50588,,,,9615.0,,12068,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,,CHEMBL629585
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,12069,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL629586
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,955.0,Brain,10116.0,,12070,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL629587
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12071,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL629588
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12072,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL629589
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12073,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL629590
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12074,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL629591
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12075,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL629592
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12076,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL629593
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12077,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL629594
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12078,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL629595
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12079,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL630290
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12080,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL627137
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12081,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL627138
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12082,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL627139
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12083,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL627140
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,948.0,Heart,10116.0,,12084,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL627141
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12085,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL627142
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12086,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL627143
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12087,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL874449
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12088,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL627144
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12089,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL627145
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12090,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL627146
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2113.0,Kidney,10116.0,,12091,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL627147
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12092,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL627148
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12093,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL627149
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12094,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL632160
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12095,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL632161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12096,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL632162
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12097,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL632163
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12098,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL874469
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2048.0,Lung,10116.0,,12099,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL627182
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12100,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,In vivo,,CHEMBL627183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12101,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL627184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12102,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL627185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12103,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL627186
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12104,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL627187
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12105,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL627188
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2385.0,Muscle tissue,10116.0,,12106,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL627189
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,,,10116.0,,12107,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL627190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12108,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,In vivo,,CHEMBL627191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12109,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,In vivo,,CHEMBL627192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12110,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,In vivo,,CHEMBL627193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2385.0,Muscle tissue,10116.0,,12111,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL874590
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2385.0,Muscle tissue,10116.0,,12112,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2385.0,Muscle tissue,10116.0,,12113,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627195
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,992.0,Female gonad,10116.0,,12114,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627196
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,992.0,Female gonad,10116.0,,12115,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627197
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,992.0,Female gonad,10116.0,,12116,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627198
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,992.0,Female gonad,10116.0,,12117,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,In vivo,,CHEMBL627199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,992.0,Female gonad,10116.0,,12118,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,1969.0,Plasma,10116.0,,12119,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,1969.0,Plasma,10116.0,,12120,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,1969.0,Plasma,10116.0,,12121,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,1969.0,Plasma,10116.0,,12122,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2106.0,Spleen,10116.0,,12123,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2106.0,Spleen,10116.0,,12124,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627206
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2106.0,Spleen,10116.0,,12125,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2106.0,Spleen,10116.0,,12126,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2046.0,Thyroid gland,10116.0,,12127,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2046.0,Thyroid gland,10116.0,,12128,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2046.0,Thyroid gland,10116.0,,12129,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,2046.0,Thyroid gland,10116.0,,12130,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,995.0,Uterus,10116.0,,12131,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL627213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,995.0,Uterus,10116.0,,12132,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626599
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,995.0,Uterus,10116.0,,12133,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626600
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10911,50597,,995.0,Uterus,10116.0,,12134,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,In vivo,,CHEMBL626601
Autocuration,BAO_0000019,,A,,1,,0,U,,8081,22224,,,,,,12135,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,,CHEMBL627484
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,17248,100710,,1969.0,Plasma,9541.0,,12136,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,,,CHEMBL627485
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,17248,100710,,1969.0,Plasma,9541.0,,12137,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,,,CHEMBL628147
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,17248,100710,,1969.0,Plasma,9541.0,,12138,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,,,CHEMBL628148
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17248,50588,,1969.0,Plasma,9615.0,,12139,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,,,CHEMBL628149
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17248,50588,,1969.0,Plasma,9615.0,,12140,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,,,CHEMBL628150
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17248,50588,,1969.0,Plasma,9615.0,,12141,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,,,CHEMBL628318
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17248,50588,,1969.0,Plasma,9615.0,,12142,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,,,CHEMBL628319
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,,,9615.0,,12143,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,,CHEMBL875609
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12144,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,,CHEMBL628320
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12145,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,,CHEMBL628321
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12146,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,,CHEMBL628322
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12147,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,,CHEMBL628323
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12148,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,,CHEMBL628324
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12149,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,,CHEMBL628325
Autocuration,BAO_0000019,,A,,1,,0,U,,7040,22224,,,,,,12150,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,,CHEMBL628326
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,1236.0,Adrenal medulla,9615.0,,12151,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,,,CHEMBL628327
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,1236.0,Adrenal medulla,9615.0,,12152,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,,,CHEMBL628328
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,178.0,Blood,9615.0,,12153,"Concentration of compound in blood of dog 1, after administering intravenously",,,,CHEMBL628329
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12154,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,,,CHEMBL628330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12155,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,,,CHEMBL628331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12156,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,,,CHEMBL628332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12157,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,,,CHEMBL628333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12158,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,,,CHEMBL628334
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12159,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,,,CHEMBL628335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12160,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,,,CHEMBL628336
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12161,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,,CHEMBL628337
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12162,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,,,CHEMBL628338
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12163,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,,,CHEMBL875610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12164,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,,,CHEMBL628339
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12165,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,,,CHEMBL628340
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12166,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,,,CHEMBL628341
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12167,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,,,CHEMBL622214
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12168,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,,,CHEMBL623167
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12169,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,,,CHEMBL623168
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12170,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,,,CHEMBL623169
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2107.0,Liver,10116.0,,12171,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,,,CHEMBL623170
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12172,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,,,CHEMBL627224
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12173,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,,,CHEMBL875634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12174,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,,,CHEMBL627225
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12175,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,,,CHEMBL627226
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12176,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,,,CHEMBL626083
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12177,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,,,CHEMBL626084
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12178,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,,,CHEMBL626085
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12179,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,,,CHEMBL626086
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12180,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,,,CHEMBL626087
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12181,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,,,CHEMBL626088
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12182,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,,,CHEMBL626089
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12183,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,,,CHEMBL626090
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12184,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,,,CHEMBL626091
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12185,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,,,CHEMBL626092
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12186,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,,,CHEMBL626093
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12187,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,,,CHEMBL626094
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12188,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,,,CHEMBL626095
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2048.0,Lung,10116.0,,12189,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,,,CHEMBL626096
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,15604,22224,,,,314293.0,,12190,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,,CHEMBL626097
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15604,50597,,,,10116.0,,12191,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,,CHEMBL626098
Autocuration,BAO_0000218,,A,,1,,0,U,,1806,22224,,1969.0,Plasma,,,12192,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,,CHEMBL626099
Autocuration,BAO_0000218,,A,,1,,0,U,,1806,22224,,1969.0,Plasma,,,12193,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,,CHEMBL626100
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17237,50588,,1969.0,Plasma,9615.0,,12194,AUC 0-inf in dog,,,,CHEMBL626101
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,17237,50512,,1969.0,Plasma,10141.0,,12195,AUC 0-inf in guinea pig,,,,CHEMBL626102
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17237,50588,,1969.0,Plasma,9615.0,,12196,AUC 0-t in dog,,,,CHEMBL626103
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,17237,50512,,1969.0,Plasma,10141.0,,12197,AUC 0-t in guinea pig,,,,CHEMBL628391
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15194,50597,,,,10116.0,,12198,The compound was tested for brain to plasma partition in rat,,,,CHEMBL628392
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15194,50597,,,,10116.0,,12199,The compound was tested for brain to plasma partition in rat.,,,,CHEMBL628393
Autocuration,BAO_0000019,,A,,1,,0,U,,8787,22224,,178.0,Blood,,,12200,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,,CHEMBL628394
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17025,50588,,,,9615.0,,12201,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,,,CHEMBL628395
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17025,22224,,,,314293.0,,12202,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,,,CHEMBL628396
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,,,9986.0,,12203,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,,CHEMBL628397
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17025,50597,,,,10116.0,,12204,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,,,CHEMBL628398
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,4236,50797,,,,9544.0,,12205,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,,,CHEMBL628399
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15343,50588,,,,9615.0,,12206,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,,,CHEMBL628400
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15343,50597,,,,10116.0,,12207,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,,,CHEMBL874907
Autocuration,BAO_0000019,,A,,1,,0,U,,17720,22224,,,,,,12208,Area under curve of the compound was determined,,,,CHEMBL628401
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17788,22224,,1969.0,Plasma,314293.0,,12209,AUC in monkeys at a dose of 1 mg/kg,,,,CHEMBL628402
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17788,50597,,1969.0,Plasma,10116.0,,12210,AUC in rats at a dose of 1 mg/kg,,,,CHEMBL628403
Autocuration,BAO_0000019,,A,,1,,0,U,,8778,22224,,,,,,12211,Compound was evaluated for the overall absorbance loss at pH of 2,,,,CHEMBL628404
Autocuration,BAO_0000019,,A,,1,,0,U,,8778,22224,,,,,,12212,Compound was evaluated for the overall absorbance loss at pH of 4,,,,CHEMBL628405
Autocuration,BAO_0000019,,A,,1,,0,U,,8778,22224,,,,,,12213,Compound was evaluated for the overall absorbance loss at pH of 7,,,,CHEMBL628406
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2249,50597,,,,10116.0,,12214,Compound was evaluated for its absorption in the rats,,,,CHEMBL628407
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8881,50597,,1088.0,Urine,10116.0,,12215,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,,CHEMBL628408
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8881,50597,,1088.0,Urine,10116.0,,12216,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,,,CHEMBL629171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8881,50597,,1088.0,Urine,10116.0,,12217,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,,CHEMBL629172
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8881,50597,,1088.0,Urine,10116.0,,12218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,,,CHEMBL629173
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12219,In vitro percent permeability into rat ileum,,,,CHEMBL629174
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12220,In vitro percent permeability into rat ileum; Range is 10-17,,,,CHEMBL629175
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12221,In vitro percent permeability into rat ileum; Range is 10-18,,,,CHEMBL629176
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12222,In vitro percent permeability into rat ileum; Range is 10-19,,,,CHEMBL629177
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12223,In vitro percent permeability into rat ileum; Range is 12-15,,,,CHEMBL629178
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12224,In vitro percent permeability into rat ileum; Range is 13-19,,,,CHEMBL631869
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12225,In vitro percent permeability into rat ileum; Range is 14-17,,,,CHEMBL631870
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12226,In vitro percent permeability into rat ileum; Range is 15-18,,,,CHEMBL631871
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12227,In vitro percent permeability into rat ileum; Range is 2-5,,,,CHEMBL631872
Autocuration,BAO_0000221,,A,,1,,0,U,,15286,22224,,2116.0,Ileum,,,12228,In vitro percent permeability into rat ileum; Range is 23-42,,,,CHEMBL875775
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12229,In vitro percent permeability into rat ileum; Range is 28-36,,,,CHEMBL631873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12230,In vitro percent permeability into rat ileum; Range is 29-35,,,,CHEMBL631874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12231,In vitro percent permeability into rat ileum; Range is 46-66,,,,CHEMBL631875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12232,In vitro percent permeability into rat ileum; Range is 50-68,,,,CHEMBL631876
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12233,In vitro percent permeability into rat ileum; Range is 78-81,,,,CHEMBL631877
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12234,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,,,CHEMBL631878
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12235,In vitro percent permeability into rat ileum; nd indicates not detected,,,,CHEMBL631879
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12236,In vitro percent permeability into rat ileum; nt indicates not detected,,,,CHEMBL631880
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15286,50597,,,,10116.0,,12237,In vitro percent permeability into rat ileum; nt indicates not tested,,,,CHEMBL631881
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13770,50597,,,,10116.0,,12238,Compound was tested for oral absorption in bile-duct cannulated rats,,,,CHEMBL631882
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13770,50597,,,,10116.0,,12239,Compound was tested for oral absorption in bile-duct cannulated rats.,,,,CHEMBL630749
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,5202,50587,,,,9606.0,,12240,Oral absorption using Caco-2 cell monolayers.,,,,CHEMBL630750
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14920,50587,,,,9606.0,,12241,Percent of the drug absorbed after administration to humans was determined,,,,CHEMBL630253
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12242,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,,CHEMBL630254
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12243,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,,CHEMBL630255
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12244,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,,CHEMBL630256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12245,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,In vivo,,CHEMBL875781
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12246,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,In vivo,,CHEMBL630257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13751,50597,,2107.0,Liver,10116.0,,12247,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,In vivo,,CHEMBL630258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15807,50597,,,,10116.0,,12248,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,,,CHEMBL630259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15807,50597,,2435.0,Striatum,10116.0,,12249,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,,,CHEMBL630260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15807,50597,,2435.0,Striatum,10116.0,,12250,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,,,CHEMBL630261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12251,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,,,CHEMBL630262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12252,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,,,CHEMBL630263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12253,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,,,CHEMBL630264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12254,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,,,CHEMBL630265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12255,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,,,CHEMBL630266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2113.0,Kidney,10116.0,,12256,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,,,CHEMBL630267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2113.0,Kidney,10116.0,,12257,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,,,CHEMBL630268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12258,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,,,CHEMBL630269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12259,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,,,CHEMBL630270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2048.0,Lung,10116.0,,12260,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,,,CHEMBL630141
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2048.0,Lung,10116.0,,12261,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,,,CHEMBL630142
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2385.0,Muscle tissue,10116.0,,12262,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,,,CHEMBL630143
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2385.0,Muscle tissue,10116.0,,12263,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,,,CHEMBL630144
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2367.0,Prostate gland,10116.0,,12264,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,,,CHEMBL630145
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2367.0,Prostate gland,10116.0,,12265,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,,,CHEMBL630146
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12266,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,,,CHEMBL630147
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12267,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,,,CHEMBL630148
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12268,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,,,CHEMBL630149
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2106.0,Spleen,10116.0,,12269,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,,,CHEMBL630150
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2106.0,Spleen,10116.0,,12270,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,,,CHEMBL630151
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2046.0,Thyroid gland,10116.0,,12271,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,,,CHEMBL632031
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2046.0,Thyroid gland,10116.0,,12272,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,,,CHEMBL632032
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12273,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,,,CHEMBL632033
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12274,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,,,CHEMBL632034
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2385.0,Muscle tissue,10116.0,,12275,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,,,CHEMBL632035
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,,,10116.0,,12276,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,,,CHEMBL632036
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14950,50597,,2046.0,Thyroid gland,10116.0,,12277,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,,,CHEMBL632037
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12278,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,,CHEMBL632038
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12279,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,,CHEMBL632039
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12280,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,,CHEMBL632040
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12281,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,,CHEMBL632041
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,178.0,Blood,9615.0,,12282,"Concentration of compound in blood of dog 2, after administering intravenously",,,,CHEMBL632042
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,,,9615.0,,12283,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,,,CHEMBL632043
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,,,9615.0,,12284,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,,,CHEMBL632044
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2107.0,Liver,9615.0,,12285,"Concentration of compound in liver of dog 1, after administering intravenously",,,,CHEMBL632045
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2107.0,Liver,9615.0,,12286,"Concentration of compound in liver of dog 2, after administering intravenously",,,,CHEMBL632046
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2048.0,Lung,9615.0,,12287,"Concentration of compound in lung of dog 1, after administering intravenously",,,,CHEMBL632047
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2048.0,Lung,9615.0,,12288,"Concentration of compound in lung of dog 2, after administering intravenously",,,,CHEMBL632048
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2385.0,Muscle tissue,9615.0,,12289,"Concentration of compound in muscle of dog 1, after administering intravenously",,,,CHEMBL632049
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2385.0,Muscle tissue,9615.0,,12290,"Concentration of compound in muscle of dog 2, after administering intravenously",,,,CHEMBL876418
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2106.0,Spleen,9615.0,,12291,"Concentration of compound in spleen of dog 1,after administering intravenously",,,,CHEMBL632050
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9614,50588,,2106.0,Spleen,9615.0,,12292,"Concentration of compound in spleen of dog 2, after administering intravenously",,,,CHEMBL632051
Autocuration,BAO_0000218,,F,,1,,0,U,,10353,22224,,,,,,12293,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,,CHEMBL632052
Autocuration,BAO_0000218,,F,,1,,0,U,,10353,22224,,,,,,12294,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,,CHEMBL632053
Autocuration,BAO_0000218,,A,,1,,0,U,,10353,22224,,,,,,12295,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,CHEMBL632054
Autocuration,BAO_0000218,,F,,1,,0,U,,10353,22224,,,,,,12296,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,CHEMBL632055
Autocuration,BAO_0000218,,F,,1,,0,U,,10353,22224,,,,,,12297,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,,CHEMBL631181
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12298,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,,CHEMBL631182
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12299,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,CHEMBL631183
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12300,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL631184
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12301,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL629774
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12302,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,CHEMBL629775
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12303,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL876549
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12304,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL628172
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12305,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,CHEMBL628173
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12306,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,,CHEMBL628174
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12307,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,,CHEMBL628175
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12308,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL628176
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12309,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL628177
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12310,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL628178
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12311,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,CHEMBL628179
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12312,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,CHEMBL628180
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12313,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,,CHEMBL628181
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12314,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL628182
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12315,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,CHEMBL628183
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12316,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,,CHEMBL628184
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12317,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL628185
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12318,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL875617
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12319,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,CHEMBL628186
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12320,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL628187
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12321,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL628188
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12322,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,CHEMBL628189
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12323,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,,CHEMBL628190
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12324,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL628191
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12325,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,,CHEMBL626513
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12326,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,,,CHEMBL626514
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12327,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,,,CHEMBL626515
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12328,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,,,CHEMBL626516
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12329,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,,,CHEMBL626517
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12330,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,,,CHEMBL626518
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12331,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,,,CHEMBL626519
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12332,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,,,CHEMBL626520
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12333,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,,,CHEMBL626521
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12334,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,,,CHEMBL626522
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12335,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,,,CHEMBL626523
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12336,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,,,CHEMBL626524
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12337,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,,,CHEMBL626688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12338,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,,,CHEMBL626689
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12339,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,,,CHEMBL626690
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12340,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,,,CHEMBL626691
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12341,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,,,CHEMBL627319
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12342,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,,,CHEMBL624052
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8608,50597,,2046.0,Thyroid gland,10116.0,,12343,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,,,CHEMBL624053
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,,,10116.0,,12344,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL624054
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,,,10116.0,,12345,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL624055
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,,,10116.0,,12346,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL624056
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12347,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL624057
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12348,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL622281
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12349,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL622282
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12350,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL622283
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12351,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL622284
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12352,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL622285
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8085,50597,,995.0,Uterus,10116.0,,12353,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,CHEMBL622286
Autocuration,BAO_0000100,,P,,1,,0,U,,7657,22224,,,,,,12354,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,,CHEMBL622287
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8935,50594,,,,10090.0,,12355,Partition coefficient (logD7.4),,,,CHEMBL622288
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,,,10090.0,,12356,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,,CHEMBL622289
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,12357,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,,CHEMBL622290
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,,,10090.0,,12358,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,,CHEMBL622291
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,12359,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,,CHEMBL622292
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,,,10090.0,,12360,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,,CHEMBL622293
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,12361,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,,CHEMBL622294
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,,,10090.0,,12362,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,,CHEMBL622295
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13792,50597,,955.0,Brain,10116.0,,12363,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,,CHEMBL622296
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12364,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,,,CHEMBL874409
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12365,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,,CHEMBL622297
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12366,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,,CHEMBL622298
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12367,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,,CHEMBL622299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12368,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,,CHEMBL622300
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12369,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,,CHEMBL622301
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12370,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,,CHEMBL622302
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12371,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,,CHEMBL622303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12372,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,,CHEMBL622304
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12373,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,,,CHEMBL622305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12374,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,,CHEMBL622306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12375,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,,,CHEMBL626864
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12376,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,,CHEMBL626865
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12377,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,,,CHEMBL626866
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12378,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,,CHEMBL626867
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12379,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,,CHEMBL626868
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12380,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,,,CHEMBL626869
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12381,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,,CHEMBL626870
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12382,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,,,CHEMBL626871
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12383,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,,CHEMBL626872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12384,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,,CHEMBL632185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14103,50597,,1969.0,Plasma,10116.0,,12385,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,,,CHEMBL632186
Autocuration,BAO_0000019,,A,,1,,0,U,,12904,22224,,,,,,12386,Amount of acetic acid produced by the compound,,,,CHEMBL629310
Autocuration,BAO_0000019,,A,,1,,0,U,,12904,22224,,,,,,12387,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,,CHEMBL629311
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9663,50597,,,,10116.0,,12388,Log of (Cbrain/Cblood) in rats,,,,CHEMBL629312
Autocuration,BAO_0000221,,A,,1,,0,U,,7652,22224,,,,,,12389,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,CHEMBL629313
Autocuration,BAO_0000221,,A,,1,,0,U,,7652,22224,,,,,,12390,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,CHEMBL629314
Autocuration,BAO_0000221,,A,,1,,0,U,,7652,22224,,,,,,12391,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,CHEMBL629315
Autocuration,BAO_0000219,,B,,1,,0,U,,7652,22224,,,,,,12392,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,,CHEMBL629316
Autocuration,BAO_0000221,,A,,1,,0,U,,7652,22224,,,,,,12393,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,CHEMBL629317
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12394,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,CHEMBL629318
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12395,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,,CHEMBL877497
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12396,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,,CHEMBL629319
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12397,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,CHEMBL629320
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12398,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,,CHEMBL629496
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12399,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,,CHEMBL629497
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12400,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,,CHEMBL629498
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12401,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,,CHEMBL629499
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12402,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,CHEMBL629500
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12403,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,,CHEMBL629501
Autocuration,BAO_0000019,,A,,1,,0,U,,7652,22224,,,,,,12404,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,,CHEMBL629502
Autocuration,BAO_0000218,,F,,1,,0,U,,8267,22224,,,,,,12405,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,In vivo,,CHEMBL629503
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8267,50588,,,,9615.0,,12406,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,,,CHEMBL629504
Autocuration,BAO_0000019,,A,,1,,0,U,,14479,22224,,,,,,12407,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,,CHEMBL629505
Autocuration,BAO_0000019,,A,,1,,0,U,,17515,22224,,,,,,12408,Compound was evaluated for total body clearance,,,,CHEMBL629506
Autocuration,BAO_0000019,,A,,1,,0,U,,17515,22224,,,,,,12409,Compound was evaluated for volume of distribution at steady state,,,,CHEMBL629507
Autocuration,BAO_0000019,,A,,1,,0,U,,8142,22224,,,,,,12410,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,,CHEMBL877498
Autocuration,BAO_0000019,,A,,1,,0,U,,14849,22224,,,,,,12411,Percentage of the diamine which is monoprotonated at pH 7.4,,,,CHEMBL629508
Autocuration,BAO_0000019,,A,,1,,0,U,,7653,22224,,,,,,12412,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,,CHEMBL629509
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12413,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,,CHEMBL629510
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12414,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,,CHEMBL629511
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12415,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,,CHEMBL629512
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12416,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,,CHEMBL629513
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12417,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,,CHEMBL629514
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12418,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,,CHEMBL628447
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12419,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,,CHEMBL628448
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12420,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,,CHEMBL628449
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12421,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,,CHEMBL631119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12422,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,,CHEMBL631120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12423,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,,CHEMBL631121
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12424,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,,,CHEMBL874458
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12425,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,,CHEMBL631122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12426,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,,CHEMBL631123
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12427,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,,CHEMBL631124
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12428,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,,CHEMBL631125
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12429,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,,CHEMBL631290
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12430,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,,CHEMBL631291
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12431,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,,CHEMBL631292
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12432,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,,CHEMBL631293
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12433,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,,CHEMBL631294
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12434,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,,CHEMBL631295
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12435,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,,CHEMBL631296
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8631,50597,,178.0,Blood,10116.0,,12436,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,,CHEMBL631297
Autocuration,BAO_0000218,,A,,1,,0,U,,10263,22224,,,,,,12437,Maximum biodistribution (Bmax) was determined.,,,,CHEMBL631298
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12364,50594,,,,10090.0,,12438,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,,,CHEMBL631299
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12364,50594,,,,10090.0,,12439,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,,,CHEMBL631300
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12364,50594,,,,10090.0,,12440,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,,,CHEMBL631301
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12364,50594,,,,10090.0,,12441,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,,,CHEMBL630291
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12442,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,CHEMBL630292
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12443,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,,CHEMBL630293
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12444,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,,CHEMBL630294
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12445,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,,CHEMBL630295
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12446,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,,CHEMBL630296
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12447,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,,CHEMBL626782
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12448,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,,CHEMBL626783
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12449,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,CHEMBL626784
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12450,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,,CHEMBL626785
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12451,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,,CHEMBL626786
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12452,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL626787
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12453,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,CHEMBL626788
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12454,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL625927
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12455,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL625928
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12456,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,,CHEMBL625929
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12457,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,,CHEMBL625930
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12458,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,,,CHEMBL625931
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12459,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,,,CHEMBL627230
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12460,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627231
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12461,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,,CHEMBL627232
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12462,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,,CHEMBL627233
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12463,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL875470
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12464,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627234
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12465,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627235
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12466,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627236
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12467,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627237
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12468,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627238
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12469,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627239
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12470,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627240
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12471,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627241
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12472,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627242
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12473,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,,,CHEMBL627243
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12474,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,,CHEMBL627244
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12475,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627245
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12476,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627246
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12477,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627247
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12478,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627248
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12479,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627249
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12480,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL625569
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12481,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL625570
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12482,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL625571
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12483,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,,CHEMBL625572
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12484,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,,CHEMBL625573
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12485,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,,,CHEMBL625574
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12486,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,,CHEMBL626245
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12487,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL626246
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12488,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL626247
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12489,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,CHEMBL626248
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12490,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,CHEMBL626249
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12491,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL626420
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12492,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,CHEMBL626421
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12493,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,CHEMBL626422
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12494,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL626423
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12495,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL626424
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12023,50588,,,,9615.0,,12496,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,,,CHEMBL626425
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12023,50597,,,,10116.0,,12497,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,,,CHEMBL875476
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12023,100710,,,,9541.0,,12498,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,,,CHEMBL626426
Autocuration,BAO_0000100,,P,,1,,0,U,,10580,22224,,,,,,12499,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,CHEMBL626427
Autocuration,BAO_0000100,,P,,1,,0,U,,10580,22224,,,,,,12500,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,CHEMBL626428
Autocuration,BAO_0000019,,A,,1,,0,U,,16032,22224,,,,,,12501,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,,CHEMBL626429
Autocuration,BAO_0000019,,A,,1,,0,U,,16032,22224,,1088.0,Urine,,,12502,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,,CHEMBL625025
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12503,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,CHEMBL625026
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12504,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL625027
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12505,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,CHEMBL874410
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12506,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL625028
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12507,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL625029
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12508,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL625030
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12509,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL625031
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12510,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL625032
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12511,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL625033
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12512,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL625034
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12513,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL624872
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12514,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL624873
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12515,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL624874
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12516,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL624875
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12517,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL624876
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12518,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL624877
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12519,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL624878
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12520,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL624879
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12521,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL624880
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12522,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,,,CHEMBL624881
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12523,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,,,CHEMBL624882
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12524,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,CHEMBL624883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12525,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL624884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12526,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,CHEMBL624885
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12527,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL624886
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12528,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL624887
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12529,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL624888
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12530,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL624889
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12531,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL624890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12532,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL621964
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12533,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL621965
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12534,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,CHEMBL621966
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12535,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL621967
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12536,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,CHEMBL622164
Autocuration,BAO_0000019,,A,,1,,0,U,,7653,22224,,,,,,12537,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,,CHEMBL623097
Autocuration,BAO_0000019,,A,,1,,0,U,,7653,22224,,,,,,12538,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,,CHEMBL623098
Autocuration,BAO_0000019,,A,,1,,0,U,,7653,22224,,,,,,12539,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,,CHEMBL623099
Autocuration,BAO_0000019,,A,,1,,0,U,,7653,22224,,,,,,12540,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,,CHEMBL623100
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12541,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,,,CHEMBL628673
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12542,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,,,CHEMBL628674
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12543,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,,,CHEMBL628675
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12544,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,,,CHEMBL627644
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12545,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,,,CHEMBL627645
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12546,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,,,CHEMBL627646
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12547,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,,,CHEMBL627647
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9104,50597,,,,10116.0,,12548,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,,,CHEMBL627648
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12902,50597,,,,10116.0,,12549,Free level in rat plasma,,,,CHEMBL627649
Autocuration,BAO_0000019,,A,,1,,0,U,,6614,22224,,,,,,12550,Level reaching in blood plasma of rat or human was determined,,,,CHEMBL628313
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9663,50597,,,,10116.0,,12551,Log (Cbrain/Cblood) in rats,,,,CHEMBL628314
Autocuration,BAO_0000019,,A,,1,,0,U,,17658,22224,,,,,,12552,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,,CHEMBL628315
Autocuration,BAO_0000019,,A,,1,,0,U,,17658,22224,,,,,,12553,Mean percentage of compound transport through membrane; expressed as membrane transport,,,,CHEMBL628316
Autocuration,BAO_0000218,,A,,1,,0,U,,14314,22224,,,,,,12554,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,,CHEMBL628317
Autocuration,BAO_0000019,,A,,1,,0,U,,7385,22224,,,,,,12555,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,,CHEMBL628473
Autocuration,BAO_0000019,,A,,1,,0,U,,7385,22224,,,,,,12556,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,,CHEMBL628474
Autocuration,BAO_0000019,,A,,1,,0,U,,7385,22224,,,,,,12557,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,,CHEMBL628475
Autocuration,BAO_0000019,,A,,1,,0,U,,1329,22224,,,,,,12558,Net water uptake by a carrier mediated transport (%cm) mechanism,,,,CHEMBL628476
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,12559,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,,CHEMBL628477
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,12187,50506,,,,9669.0,,12560,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,,CHEMBL628478
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,12187,50506,,,,9669.0,,12561,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,,CHEMBL628479
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,12562,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,,CHEMBL628480
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,12563,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,,,CHEMBL628481
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12187,50597,,,,10116.0,,12564,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,,CHEMBL628482
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12187,50597,,,,10116.0,,12565,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,,CHEMBL628483
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9278,50597,,1969.0,Plasma,10116.0,,12566,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,,CHEMBL628484
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9278,50597,,1969.0,Plasma,10116.0,,12567,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,,CHEMBL628485
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,9278,100710,,1969.0,Plasma,9541.0,,12568,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,,,CHEMBL628486
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,9278,50587,,1969.0,Plasma,9606.0,,12569,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,,,CHEMBL628487
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9278,50597,,1969.0,Plasma,10116.0,,12570,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,,CHEMBL628488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9278,50597,,1969.0,Plasma,10116.0,,12571,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,,CHEMBL628489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9278,50597,,1969.0,Plasma,10116.0,,12572,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,,CHEMBL628490
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,12573,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,CHEMBL628491
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,12574,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,CHEMBL877507
Autocuration,BAO_0000218,,A,,1,,0,U,,12186,22224,,,,,,12575,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,CHEMBL628492
Autocuration,BAO_0000019,,A,,1,Simiiformes,0,U,,12041,22224,,,,314293.0,,12576,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,,,CHEMBL628493
Autocuration,BAO_0000019,,A,,1,Simiiformes,0,U,,12041,22224,,,,314293.0,,12577,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,,,CHEMBL628494
Autocuration,BAO_0000019,,A,,1,Simiiformes,0,U,,12041,22224,,,,314293.0,,12578,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,,,CHEMBL628495
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,6737,50587,,,,9606.0,,12579,Permeability in Caco-2 assay at 10E-6,,,,CHEMBL628496
Autocuration,BAO_0000218,,A,,1,,0,U,,13758,22224,,955.0,Brain,,,12580,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,,CHEMBL628497
Autocuration,BAO_0000218,,A,,1,,0,U,,13758,22224,,955.0,Brain,,,12581,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,,CHEMBL628498
Autocuration,BAO_0000019,,A,,1,,0,U,,5676,22224,,,,,,12582,Plasma protein binding was determined,,,,CHEMBL628499
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12583,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,,CHEMBL627656
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12584,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,CHEMBL627657
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12585,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,,CHEMBL626808
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12586,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,,CHEMBL626809
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12587,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,,CHEMBL626810
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12588,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,CHEMBL626811
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12589,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,,CHEMBL874465
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12590,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,,CHEMBL626812
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12591,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,,CHEMBL626813
Autocuration,BAO_0000218,,A,,1,,0,U,,14793,22224,,,,,,12592,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,,CHEMBL626814
Autocuration,BAO_0000019,,A,,1,,0,U,,14000,22224,,,,,,12593,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,,CHEMBL626815
Autocuration,BAO_0000019,,A,,1,,0,U,,5948,22224,,,,,,12594,Partition coefficient (logP),,,,CHEMBL628566
Autocuration,BAO_0000100,,P,,1,,0,U,,13824,22229,,,,,,12595,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,CHEMBL628567
Autocuration,BAO_0000100,,P,,1,,0,U,,10778,22229,,,,,,12596,Calculated partition coefficient (clogP),,,,CHEMBL628568
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17237,50588,,,,9615.0,,12597,C max in dog,,In vivo,,CHEMBL628569
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,17237,50512,,,,10141.0,,12598,C max in guinea pig,,In vivo,,CHEMBL628570
Autocuration,BAO_0000218,,A,,1,,0,U,,2809,22224,,,,,,12599,C max value was evaluated,,In vivo,,CHEMBL628571
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12600,Cmax value after oral dose of 0.1 mg//kg,,In vivo,,CHEMBL628572
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12601,Cmax value after oral dose of 0.3 mg/kg,,In vivo,,CHEMBL628573
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12602,Cmax value after oral dose of 1 mg/kg,,In vivo,,CHEMBL628574
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12603,Cmax value after oral dose of 10 mg/kg,,In vivo,,CHEMBL628575
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12604,Cmax value after oral dose of 23.4 mg/kg,,In vivo,,CHEMBL628576
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12605,Cmax value after oral dose of 3 mg/kg,,In vivo,,CHEMBL628577
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,12606,Cmax value after oral dose of 3.87 mg/kg,,In vivo,,CHEMBL628578
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12768,50588,,,,9615.0,,12607,Cmax value in female Beagle dogs,,In vivo,,CHEMBL874466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12768,50597,,,,10116.0,,12608,Cmax value in male rats,,In vivo,,CHEMBL628579
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12780,50597,,1969.0,Plasma,10116.0,,12609,Cmax value in rat plasma when administered 20 mg/kg perorally,,In vivo,,CHEMBL628580
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,1969.0,Plasma,9615.0,,12610,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,In vivo,,CHEMBL628581
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,1969.0,Plasma,9615.0,,12611,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,In vivo,,CHEMBL628582
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17025,50588,,,,9615.0,,12612,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,,,CHEMBL628583
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17025,22224,,,,314293.0,,12613,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,,,CHEMBL625782
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,,,9986.0,,12614,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,,,CHEMBL625783
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17025,50597,,,,10116.0,,12615,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,,,CHEMBL625784
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,4236,50797,,1969.0,Plasma,9544.0,,12616,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,,,CHEMBL625785
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15791,50597,,,,10116.0,,12617,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,,,CHEMBL625786
Autocuration,BAO_0000019,,A,,1,,0,U,,11149,22224,,,,,,12618,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,,CHEMBL874467
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,,,9615.0,,12619,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,,CHEMBL625787
Intermediate,BAO_0000218,,A,,1,Human immunodeficiency virus,1,N,,15778,50677,,,,12721.0,,12620,cytotoxicity against HIV protease enzyme.,,,,CHEMBL625964
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,12621,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,,,CHEMBL625965
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12745,50594,,,,10090.0,,12622,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,,,CHEMBL625966
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13941,50588,,1969.0,Plasma,9615.0,,12623,The plasma clearance in dog.,,In vivo,,CHEMBL625967
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13941,50597,,1969.0,Plasma,10116.0,,12624,The plasma clearance in rat.,,In vivo,,CHEMBL625968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16449,50597,,1969.0,Plasma,10116.0,,12625,Clearance from plasma in male Sprague-Dawley rats,,In vivo,,CHEMBL625969
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,16449,100710,,1969.0,Plasma,9541.0,,12626,Clearance from plasma in male cynomolgus monkeys,,In vivo,,CHEMBL625970
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,12627,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,In vivo,,CHEMBL625971
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,12628,Clearance of compound in dog plasma,,In vivo,,CHEMBL625972
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14224,50587,,1969.0,Plasma,9606.0,,12629,Clearance of compound in human plasma,,In vivo,,CHEMBL625973
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14317,50588,,,,9615.0,,12630,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,In vivo,,CHEMBL625974
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14317,50588,,,,9615.0,,12631,Clearance of compound when administered intravenously as an individual dose to a single dog.,,In vivo,,CHEMBL625975
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14224,50588,,1969.0,Plasma,9615.0,,12632,"Clearance (10 mg/kg, intravenously) in dog plasma",,In vivo,,CHEMBL625976
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17237,50588,,,,9615.0,,12633,Clearance value in dog,,In vivo,,CHEMBL625977
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,17237,50512,,,,10141.0,,12634,Clearance value in guinea pig,,In vivo,,CHEMBL625978
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14187,50597,,,,10116.0,,12635,Clearance values in rats after iv administration.,,In vivo,,CHEMBL874468
Autocuration,BAO_0000218,,A,,1,,0,U,,4806,22224,,1969.0,Plasma,,,12636,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,In vivo,,CHEMBL625421
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,15025,50592,,,,9986.0,,12637,In vivo clearance (5 mg/kg) was determined in rabbits,,In vivo,,CHEMBL625422
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13197,50597,,,,10116.0,,12638,Plasma Clearance rate was determined for the compound in rats,,In vivo,,CHEMBL625423
Autocuration,BAO_0000218,,A,,1,Saimiri,0,U,,13197,22224,,,,9520.0,,12639,Plasma Clearance rate was determined for the compound in squirrel monkeys,,In vivo,,CHEMBL625424
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13960,50597,,,,10116.0,,12640,Plasma clearance in rat,,In vivo,,CHEMBL625425
Autocuration,BAO_0000218,,A,,1,,0,U,,17820,22224,,,,,,12641,Plasma clearance of the compound,,In vivo,,CHEMBL625426
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14706,50512,,,,10141.0,,12642,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,In vivo,,CHEMBL625427
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,14706,50512,,,,10141.0,,12643,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,In vivo,,CHEMBL625428
Autocuration,BAO_0000218,,A,,1,,0,U,,6504,22224,,,,,,12644,Plasma clearance was determined,,In vivo,,CHEMBL625429
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14925,50588,,,,9615.0,,12645,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,In vivo,,CHEMBL625430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13197,50597,,,,10116.0,,12646,Plasma clearance rate was determined for the compound in rats,,In vivo,,CHEMBL625431
Autocuration,BAO_0000218,,A,,1,Saimiri,0,U,,13197,22224,,,,9520.0,,12647,Plasma clearance rate was determined for the compound in squirrel monkeys,,In vivo,,CHEMBL627307
Autocuration,BAO_0000218,,A,,1,,0,U,,3437,22224,,,,,,12648,Slow clearance (CL) was determined,,In vivo,,CHEMBL627308
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12649,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL627309
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12650,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,CHEMBL627310
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12651,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,CHEMBL627311
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12652,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL627312
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12653,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,CHEMBL627313
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12654,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,CHEMBL627314
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12655,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL627315
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12656,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL627316
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12657,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,CHEMBL627317
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12658,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,CHEMBL627318
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12659,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,CHEMBL627999
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12660,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,CHEMBL628000
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12661,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,CHEMBL628001
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12662,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL628002
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12663,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,CHEMBL625610
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12664,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL625611
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12665,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,CHEMBL625612
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12666,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,CHEMBL625613
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12667,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,CHEMBL875479
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12668,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,CHEMBL625614
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12669,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,CHEMBL625615
Autocuration,BAO_0000218,,A,,1,,0,U,,9196,22224,,,,,,12670,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,CHEMBL626302
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12671,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL626303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8374,50597,,178.0,Blood,10116.0,,12672,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,,CHEMBL627420
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12673,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,,,CHEMBL627421
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12674,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,,,CHEMBL625695
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12675,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,,,CHEMBL625696
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,955.0,Brain,10090.0,,12676,Distribution of compound in mice brain was measured after 1 hr,,,,CHEMBL875606
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,955.0,Brain,10090.0,,12677,Distribution of compound in mice brain was measured after 24 hr r,,,,CHEMBL625697
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,955.0,Brain,10090.0,,12678,Distribution of compound in mice brain was measured after 2 hr,,,,CHEMBL625698
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,955.0,Brain,10090.0,,12679,Distribution of compound in mice brain was measured after 3 hr,,,,CHEMBL625699
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,955.0,Brain,10090.0,,12680,Distribution of compound in mice brain was measured after 6 hr,,,,CHEMBL625700
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,12681,Distribution of compound in mice liver was measured after 1 hr,,,,CHEMBL625701
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,12682,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,,,CHEMBL625702
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,12683,Distribution of compound in mice liver was measured after 2 hr,,,,CHEMBL625703
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,12684,Distribution of compound in mice liver was measured after 3 hr,,,,CHEMBL625704
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,12685,Distribution of compound in mice liver was measured after 6 hr,,,,CHEMBL625705
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1236.0,Adrenal medulla,9615.0,,12686,Distribution in dog adrenal medulla 30 min after administration.,,,,CHEMBL625706
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1236.0,Adrenal medulla,9615.0,,12687,Distribution in dog adrenal medulla 72 hours after administration.,,,,CHEMBL625707
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12688,Distribution in female dog Ovary 24 hours after administration.,,,,CHEMBL625708
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12689,Distribution in female dog Ovary 72 hours after administration.,,,,CHEMBL625709
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12690,Distribution in female dog adipose 24 hours after administration.,,,,CHEMBL624180
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12691,Distribution in female dog adipose 72 hours after administration.,,,,CHEMBL624181
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1235.0,Adrenal cortex,9615.0,,12692,Distribution in female dog adrenal cortex 72 hours after administration.,,,,CHEMBL624182
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1235.0,Adrenal cortex,9615.0,,12693,Distribution in female dog adrenal cortex 72 hours after administration.,,,,CHEMBL624183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12694,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL624184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12695,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL877489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12696,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL624185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12697,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL624186
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12698,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL624187
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12699,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL624188
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12700,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,CHEMBL624189
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12701,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL624190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12702,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL624191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12703,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,CHEMBL624192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12704,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL624193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12705,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL624194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12706,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL624891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12707,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL624892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12708,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL624893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12709,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL627632
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12710,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,CHEMBL627633
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12711,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL627634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12712,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL627635
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12713,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,CHEMBL627636
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12714,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL626816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12715,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL626817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12716,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL626818
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12717,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL626819
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12718,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL626820
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12719,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL626821
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12720,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,CHEMBL626822
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12721,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,CHEMBL626823
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12722,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,CHEMBL626824
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12723,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,CHEMBL626825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12724,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,CHEMBL626826
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12725,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,CHEMBL626827
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12726,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,CHEMBL626828
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12727,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,CHEMBL626829
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12728,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL626830
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12729,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL627150
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12730,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL627151
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12731,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,CHEMBL627152
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12732,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,CHEMBL627153
Autocuration,BAO_0000019,,A,,1,,0,U,,12904,22224,,,,,,12733,Rate of acetate production by the compound was determined,,,,CHEMBL627154
Autocuration,BAO_0000019,,A,,1,,0,U,,12904,22224,,,,,,12734,Rate of acetate production by the compound was determined; Not determined,,,,CHEMBL627155
Autocuration,BAO_0000019,,A,,1,,0,U,,3730,22224,,,,,,12735,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,,CHEMBL627156
Autocuration,BAO_0000019,,A,,1,,0,U,,3627,22224,,,,,,12736,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,,CHEMBL627157
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,13799,50592,,,,9986.0,,12737,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,,CHEMBL627158
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,13799,50592,,1969.0,Plasma,9986.0,,12738,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,,CHEMBL627159
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13799,50594,,,,10090.0,,12739,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,,CHEMBL627160
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13799,50597,,,,10116.0,,12740,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,,CHEMBL628540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13799,50597,,1969.0,Plasma,10116.0,,12741,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,,CHEMBL628541
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13799,50597,,1969.0,Plasma,10116.0,,12742,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,,CHEMBL628542
Autocuration,BAO_0000100,,P,,1,,0,U,,6629,22229,,,,,,12743,Solubility after at a pH 1.2,,,,CHEMBL628543
Autocuration,BAO_0000100,,P,,1,,0,U,,6629,22229,,,,,,12744,Solubility after at pH 1.2,,,,CHEMBL628544
Autocuration,BAO_0000100,,P,,1,,0,U,,6629,22229,,,,,,12745,Solubility after injection of water,,,,CHEMBL628545
Autocuration,BAO_0000019,,A,,1,,0,U,,14000,22224,,,,,,12746,Statistical significance of IC 50 values; Expressed as R value,,,,CHEMBL628546
Autocuration,BAO_0000019,,A,,1,,0,U,,8267,22224,,,,,,12747,Systemic availability with respect to methyldopa was determined,,,,CHEMBL874455
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13799,50597,,,,10116.0,,12748,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,,,CHEMBL628547
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13799,50597,,1969.0,Plasma,10116.0,,12749,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,,,CHEMBL628548
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12750,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,,,CHEMBL628549
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12751,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,,,CHEMBL628550
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12752,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,,,CHEMBL628551
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12753,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,,,CHEMBL628552
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12754,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,,,CHEMBL628553
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12755,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,,,CHEMBL628554
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12756,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,,,CHEMBL628555
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12757,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,,,CHEMBL628556
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,2113.0,Kidney,9986.0,,12758,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,,,CHEMBL628557
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12759,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,,,CHEMBL628558
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12760,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,,,CHEMBL628559
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12761,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,,,CHEMBL628560
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12762,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,,,CHEMBL874456
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12763,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,,,CHEMBL628561
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12764,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,,,CHEMBL628562
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12765,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,,,CHEMBL628563
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12766,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,,,CHEMBL628564
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12767,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,,,CHEMBL628565
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12768,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,,,CHEMBL631248
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,12769,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,,,CHEMBL631249
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,2113.0,Kidney,9986.0,,12770,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,,,CHEMBL627214
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12771,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,,,CHEMBL874591
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12772,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,,,CHEMBL627215
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,12773,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,,,CHEMBL625471
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,,,9986.0,,12774,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,,,CHEMBL625472
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,,,9986.0,,12775,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,,,CHEMBL625473
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13317,50588,,,,9615.0,,12776,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,In vivo,,CHEMBL625474
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15341,50588,,,,9615.0,,12777,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,In vivo,,CHEMBL625475
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,12778,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,In vivo,,CHEMBL625476
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,12779,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,In vivo,,CHEMBL625477
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15341,50597,,,,10116.0,,12780,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,In vivo,,CHEMBL625478
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12801,50597,,,esophageal tunica muscularis mucosae,10116.0,,12781,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,In vitro,,CHEMBL625479
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12801,50597,,,esophageal tunica muscularis mucosae,10116.0,,12782,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,In vitro,,CHEMBL625480
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14856,50597,,1969.0,Plasma,10116.0,,12783,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,In vivo,,CHEMBL625481
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,12784,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,In vivo,,CHEMBL625482
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,12785,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,In vivo,,CHEMBL625483
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,12786,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,In vivo,,CHEMBL625484
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14062,50597,,,,10116.0,,12787,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,In vivo,,CHEMBL625485
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14346,50588,,1969.0,Plasma,9615.0,,12788,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,In vivo,,CHEMBL625486
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,1969.0,Plasma,10116.0,,12789,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL625487
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,1969.0,Plasma,10116.0,,12790,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL625488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,1969.0,Plasma,10116.0,,12791,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL625489
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,1969.0,Plasma,10116.0,,12792,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL625490
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14346,50588,,1969.0,Plasma,9615.0,,12793,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,In vivo,,CHEMBL625491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14346,50597,,1969.0,Plasma,10116.0,,12794,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,In vivo,,CHEMBL625492
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,15711,50587,,1969.0,Plasma,9606.0,,12795,plasma clearance in human,,In vivo,,CHEMBL625493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14886,50597,,,,10116.0,,12796,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,In vivo,,CHEMBL625494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14886,50597,,,,10116.0,,12797,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,In vivo,,CHEMBL625495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14886,50597,,,,10116.0,,12798,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,In vivo,,CHEMBL625496
Autocuration,BAO_0000100,,P,,1,,0,U,,4115,22229,,,,,,12799,1-Octanol/water partition coefficient measured at 7.4,,,,CHEMBL625497
Autocuration,BAO_0000100,,P,,1,,0,U,,13733,22229,,,,,,12800,Calculated partition coefficient (clogP),,,,CHEMBL625498
Autocuration,BAO_0000019,,A,,1,,0,U,,12102,22224,,,,,,12801,Partition coefficient (logP),,,,CHEMBL625499
Autocuration,BAO_0000100,,P,,1,,0,U,,12676,22229,,,,,,12802,Calculated partition coefficient (clogP),,,,CHEMBL625500
Autocuration,BAO_0000100,,P,,1,,0,U,,13733,22229,,,,,,12803,Calculated partition coefficient (clogP),,,,CHEMBL625501
Autocuration,BAO_0000100,,P,,1,,0,U,,13740,22229,,,,,,12804,Calculated partition coefficient (clogP),,,,CHEMBL625502
Autocuration,BAO_0000100,,P,,1,,0,U,,12766,22229,,,,,,12805,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,,CHEMBL625503
Autocuration,BAO_0000100,,P,,1,,0,U,,2764,22229,,,,,,12806,Calculated partition coefficient (clogP),,,,CHEMBL625504
Autocuration,BAO_0000100,,P,,1,,0,U,,12355,22229,,,,,,12807,Calculated partition coefficient (clogP),,,,CHEMBL625505
Autocuration,BAO_0000100,,P,,1,,0,U,,11314,22229,,,,,,12808,Calculated partition coefficient of the compound,,,,CHEMBL625506
Autocuration,BAO_0000019,,A,,1,,0,U,,12706,22224,,,,,,12809,Partition coefficient (logP),,,,CHEMBL625507
Autocuration,BAO_0000100,,P,,1,,0,U,,12645,22229,,,,,,12810,Calculated partition coefficient (clogP),,,,CHEMBL625508
Autocuration,BAO_0000100,,P,,1,,0,U,,13668,22229,,,,,,12811,Calculated partition coefficient (clogP),,,,CHEMBL625509
Autocuration,BAO_0000100,,P,,1,,0,U,,12819,22229,,,,,,12812,Calculated partition coefficient (clogP),,,,CHEMBL625510
Autocuration,BAO_0000100,,P,,1,,0,U,,13668,22229,,,,,,12813,Calculated partition coefficient (clogP),,,,CHEMBL883125
Autocuration,BAO_0000100,,P,,1,,0,U,,13017,22229,,,,,,12814,Calculated partition coefficient (clogP),,,,CHEMBL625511
Autocuration,BAO_0000019,,A,,1,,0,U,,2448,22224,,,,,,12815,Partition coefficient of the compound,,,,CHEMBL874650
Autocuration,BAO_0000019,,A,,1,,0,U,,11526,22224,,,,,,12816,Partition coefficient of the compound,,,,CHEMBL625512
Autocuration,BAO_0000019,,A,,1,,0,U,,12426,22224,,,,,,12817,Partition coefficient of compound was determined,,,,CHEMBL625513
Autocuration,BAO_0000019,,A,,1,,0,U,,2448,22224,,,,,,12818,Partition coefficient was determined,,,,CHEMBL625514
Autocuration,BAO_0000100,,P,,1,,0,U,,12001,22229,,,,,,12819,Calculated partition coefficient (clogP),,,,CHEMBL625515
Autocuration,BAO_0000100,,P,,1,,0,U,,12426,22229,,,,,,12820,partition coefficient of compound was determined,,,,CHEMBL625516
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13204,50588,,,,9615.0,,12821,The total body administered intravenously in dog,,In vivo,,CHEMBL625517
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13204,50597,,,,10116.0,,12822,The total body administered intravenously in rats,,In vivo,,CHEMBL625518
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13889,50594,,,,10090.0,,12823,Time taken for the administration to female NIH mice weighing 25-30 g.,,,,CHEMBL625519
Autocuration,BAO_0000019,,A,,1,,0,U,,13889,22224,,,,,,12824,Time taken for the administration,,,,CHEMBL625520
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,17025,50588,,,,9615.0,,12825,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,In vivo,,CHEMBL874651
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,17025,22224,,,,314293.0,,12826,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,In vivo,,CHEMBL625521
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,,,9986.0,,12827,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,In vivo,,CHEMBL623171
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,17025,50597,,,,10116.0,,12828,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,In vivo,,CHEMBL623853
Autocuration,BAO_0000019,,A,,1,,0,U,,15067,22224,,,,,,12829,Plasma clearance for the compound was determined.,,,,CHEMBL623854
Autocuration,BAO_0000100,,P,,1,,0,U,,3091,22224,,,,,,12830,CLog P value of the compound,,,,CHEMBL874405
Autocuration,BAO_0000100,,P,,1,,0,U,,15592,22229,,,,,,12831,Calculated partition coefficient (clogP),,,,CHEMBL623855
Autocuration,BAO_0000100,,P,,1,,0,U,,14738,22229,,,,,,12832,Calculated partition coefficient (clogP),,,,CHEMBL623856
Autocuration,BAO_0000100,,P,,1,,0,U,,14738,22224,,,,,,12833,ClogP value of the compound; nd ='no data',,,,CHEMBL623857
Autocuration,BAO_0000100,,P,,1,,0,U,,14738,22224,,,,,,12834,ClogP value of the compound; nd ='not determined',,,,CHEMBL623858
Autocuration,BAO_0000100,,P,,1,,0,U,,6076,22224,,,,,,12835,CLog P was determined,,,,CHEMBL623859
Autocuration,BAO_0000100,,P,,1,,0,U,,17840,22229,,,,,,12836,Calculated partition coefficient (clogP),,,,CHEMBL839829
Autocuration,BAO_0000019,,A,,1,,0,U,,13589,22224,,,,,,12837,CLogP was calculated,,,,CHEMBL623860
Autocuration,BAO_0000019,,A,,1,,0,U,,17655,22224,,,,,,12838,CLogP value was determined,,,,CHEMBL623861
Autocuration,BAO_0000019,,A,,1,,0,U,,5867,22224,,,,,,12839,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,,CHEMBL623862
Autocuration,BAO_0000100,,P,,1,,0,U,,5867,22229,,,,,,12840,Calculated partition coefficient (clogP),,,,CHEMBL874406
Autocuration,BAO_0000100,,P,,1,,0,U,,10783,22229,,,,,,12841,Calculated partition coefficient (clogP),,,,CHEMBL623863
Autocuration,BAO_0000100,,P,,1,,0,U,,14849,22229,,,,,,12842,Calculated partition coefficient (clogP),,,,CHEMBL624021
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1236.0,Adrenal medulla,9615.0,,12843,Distribution in female dog adrenal medulla 24 hours after administration.,,,,CHEMBL624022
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1236.0,Adrenal medulla,9615.0,,12844,Distribution in female dog adrenal medulla 72 hours after administration.,,,,CHEMBL624023
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12845,Distribution in female dog bile 24 hours after administration.,,,,CHEMBL624024
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12846,Distribution in female dog bile 72 hr after administration.,,,,CHEMBL624025
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12847,Distribution in female dog blood 24 hours after administration.,,,,CHEMBL624026
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12848,Distribution in female dog blood 72 hours after administration.,,,,CHEMBL624027
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12849,Distribution in female dog heart 24 hours after administration.,,,,CHEMBL624028
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12850,Distribution in female dog heart 72 hours after administration.,,,,CHEMBL624029
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12851,Distribution in female dog kidney 24 hours after administration.,,,,CHEMBL624030
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12852,Distribution in female dog kidney 72 hours after administration.,,,,CHEMBL624031
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,160.0,Intestine,9615.0,,12853,Distribution in female dog large intestine 24 hours after administration.,,,,CHEMBL624032
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,160.0,Intestine,9615.0,,12854,Distribution in female dog large intestine 72 hours after administration.,,,,CHEMBL874407
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12855,Distribution in female dog liver 24 hours after administration.,,,,CHEMBL624033
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12856,Distribution in female dog liver 72 hours after administration.,,,,CHEMBL624034
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12857,Distribution in female dog lung 24 hours after administration.,,,,CHEMBL624035
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12858,Distribution in female dog lung 72 hours after administration.,,,,CHEMBL624036
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,2385.0,Muscle tissue,9615.0,,12859,Distribution in female dog muscle 24 hours after administration.,,,,CHEMBL624037
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,2385.0,Muscle tissue,9615.0,,12860,Distribution in female dog muscle 72 hours after administration.,,,,CHEMBL624038
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12861,Distribution in female dog pancreas 24 hours after administration.,,,,CHEMBL624039
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,,,9615.0,,12862,Distribution in female dog pancreas 72 hours after administration.,,,,CHEMBL624040
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,160.0,Intestine,9615.0,,12863,Distribution in female dog small intestine 24 hours after administration.,,,,CHEMBL624041
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,160.0,Intestine,9615.0,,12864,Distribution in female dog small intestine 72 hours after administration.,,,,CHEMBL624042
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,2106.0,Spleen,9615.0,,12865,Distribution in female dog spleen 24 hours after administration.,,,,CHEMBL624043
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,2106.0,Spleen,9615.0,,12866,Distribution in female dog spleen 72 hours after administration.,,,,CHEMBL624044
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,945.0,Stomach,9615.0,,12867,Distribution in female dog stomach 24 hours after administration.,,,,CHEMBL624045
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,945.0,Stomach,9615.0,,12868,Distribution in female dog stomach 72 hours after administration.,,,,CHEMBL624046
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,2046.0,Thyroid gland,9615.0,,12869,Distribution in female dog thyroid 24 hours after administration.,,,,CHEMBL624047
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,2046.0,Thyroid gland,9615.0,,12870,Distribution in female dog thyroid 72 hours after administration.,,,,CHEMBL624048
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1088.0,Urine,9615.0,,12871,Distribution in female dog urine 24 hours after administration.,,,,CHEMBL874408
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8170,50588,,1088.0,Urine,9615.0,,12872,Distribution in female dog urine 72 hr after administration.,,,,CHEMBL624049
Autocuration,BAO_0000218,,A,,1,,0,U,,14283,22224,,1969.0,Plasma,,,12873,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,,CHEMBL624050
Autocuration,BAO_0000019,,A,,1,,0,U,,5623,22224,,,,,,12874,Plasma concentration at 7 hr after intravenous dosing,,,,CHEMBL624051
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12875,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,,,CHEMBL623278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12876,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,,,CHEMBL623279
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12877,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,,,CHEMBL623280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12878,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,,,CHEMBL623963
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12879,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,,,CHEMBL623964
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12880,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,,,CHEMBL623965
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12881,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,,,CHEMBL623966
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12882,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,,,CHEMBL874415
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12883,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,,,CHEMBL623967
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12884,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,,,CHEMBL623968
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12885,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,,,CHEMBL623969
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12886,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,,,CHEMBL628409
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12887,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,,,CHEMBL628410
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12888,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,,,CHEMBL628411
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,12889,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,,,CHEMBL628412
Autocuration,BAO_0000019,,A,,1,,0,U,,12553,22224,,,,,,12890,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,,CHEMBL628413
Autocuration,BAO_0000019,,A,,1,,0,U,,14548,22224,,1969.0,Plasma,,,12891,The concentration in plasmat; Not determined,,,,CHEMBL628414
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,12892,Tissue level at 10 mg/kg/po in wistar rats in blood,,,,CHEMBL628415
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,12893,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,,,CHEMBL628416
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,12894,Tissue level at 10 mg/kg/po in wistar rats in heart,,,,CHEMBL628417
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,2107.0,Liver,10116.0,,12895,Tissue level at 10 mg/kg/po in wistar rats in liver,,,,CHEMBL874908
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,12896,Tissue level at 10 mg/kg/po in wistar rats in plasma,,,,CHEMBL628418
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,2385.0,Muscle tissue,10116.0,,12897,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,,,CHEMBL628419
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,12898,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,,,CHEMBL628420
Autocuration,BAO_0000019,,A,,1,,0,U,,1629,22224,,,,,,12899,Water solubility at 37 degree C.,,,,CHEMBL628421
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,12900,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,CHEMBL626726
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,12901,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,CHEMBL626727
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12902,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL626728
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12903,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL626729
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12904,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL626730
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12905,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL626731
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,178.0,Blood,10116.0,,12906,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL626732
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12907,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL626733
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12908,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL626734
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12909,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL626735
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12910,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL874909
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,948.0,Heart,10116.0,,12911,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL626736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12912,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL626737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12913,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL630999
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12914,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL631000
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12915,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL631001
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2113.0,Kidney,10116.0,,12916,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL631002
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12917,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL631003
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12918,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL631004
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12919,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL631005
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12920,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL631006
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2107.0,Liver,10116.0,,12921,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL631007
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12922,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL631008
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12923,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL631009
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12924,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL631010
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12925,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL631011
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2048.0,Lung,10116.0,,12926,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL631012
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12927,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL630271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12928,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL630272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12929,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL630273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12930,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL630274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,2046.0,Thyroid gland,10116.0,,12931,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL630275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12932,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,,,CHEMBL875782
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12933,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,,,CHEMBL630276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12934,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,,,CHEMBL630277
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12935,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,,,CHEMBL630278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8594,50597,,,,10116.0,,12936,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,,,CHEMBL630279
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,,,,,12937,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,,CHEMBL630280
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,,,,,12938,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,CHEMBL630281
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,,,9986.0,,12939,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,,,CHEMBL630282
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,,,9986.0,,12940,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,,,CHEMBL630283
Autocuration,BAO_0000019,,A,,1,,0,U,,5797,22224,,,,,,12941,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,,CHEMBL630284
Autocuration,BAO_0000019,,A,,1,,0,U,,7849,22224,,,,,,12942,Alkylating activity was determined,,,,CHEMBL630285
Autocuration,BAO_0000251,,A,,1,,0,U,,14220,22224,,,,,,12943,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Microsomes,,,CHEMBL630286
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,8650,50592,,,,9986.0,,12944,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,,,CHEMBL630069
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,8650,50592,,,,9986.0,,12945,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,,,CHEMBL630070
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,8650,50592,,,,9986.0,,12946,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,,,CHEMBL630071
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,8650,50592,,,,9986.0,,12947,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,,,CHEMBL630072
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,8650,50592,,,,9986.0,,12948,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,,,CHEMBL875110
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7116,50597,,,,10116.0,,12949,Compound was tested for antidiuretic activity in rats,,,,CHEMBL630073
Autocuration,BAO_0000019,,A,,1,,0,U,,14131,22224,,,,,,12950,Compound was tested for inactivation kinetic values,,,,CHEMBL630074
Autocuration,BAO_0000218,,A,,1,,0,U,,7415,22224,,,,,,12951,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,In vivo,,CHEMBL630075
Autocuration,BAO_0000019,,A,,1,,0,U,,13178,22224,,,,,,12952,Dissociation rate calculated from the first-order equation using the t1/2 value,,,,CHEMBL630076
Autocuration,BAO_0000100,,P,,1,,0,U,,8815,22229,,,,,,12953,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,,CHEMBL630077
Autocuration,BAO_0000100,,P,,1,,0,U,,1450,22229,,,,,,12954,Aqueous solubility was measured,,,,CHEMBL630078
Autocuration,BAO_0000100,,P,,1,,0,U,,1450,22229,,,,,,12955,Aqueous solubility was measured at a pH 4,,,,CHEMBL630079
Autocuration,BAO_0000100,,P,,1,,0,U,,1450,22229,,,,,,12956,Aqueous solubility (pH 7),,,,CHEMBL630080
Autocuration,BAO_0000100,,P,,1,,0,U,,1450,22229,,,,,,12957,Aqueous solubility was measured at a pH 9,,,,CHEMBL630081
Autocuration,BAO_0000019,,A,,1,,0,U,,12711,22224,,,,,,12958,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,,CHEMBL630082
Autocuration,BAO_0000019,,A,,1,,0,U,,12711,22224,,,,,,12959,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,CHEMBL630083
Autocuration,BAO_0000019,,A,,1,,0,U,,12711,22224,,,,,,12960,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,CHEMBL630084
Autocuration,BAO_0000100,,P,,1,,0,U,,15032,22229,,,,,,12961,Aqueous solubility of the compound,,,,CHEMBL629198
Autocuration,BAO_0000100,,P,,1,,0,U,,9964,22229,,,,,,12962,Aqueous solubility at 37 degree Celsius at pH 7.38,,,,CHEMBL629199
Autocuration,BAO_0000100,,P,,1,,0,U,,14962,22229,,,,,,12963,Aqueous solubility in pH 7.4 phosphate buffer,,,,CHEMBL629200
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12487,50588,,,,9615.0,,12964,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,,,CHEMBL629201
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12487,50588,,,,9615.0,,12965,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,,,CHEMBL629202
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10026,50587,,,,9606.0,,12966,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,,,CHEMBL875111
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10026,50587,,,,9606.0,,12967,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,,,CHEMBL629203
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10026,50587,,,,9606.0,,12968,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,,,CHEMBL629204
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10026,50587,,,,9606.0,,12969,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,,,CHEMBL629205
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10026,50587,,,,9606.0,,12970,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,,,CHEMBL629206
Autocuration,BAO_0000019,,A,,1,,0,U,,10026,22224,,,,,,12971,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,,CHEMBL631185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,,,10116.0,,12972,Compound was evaluated for the average bile flow rat in rats,,,,CHEMBL631186
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,,,9986.0,,12973,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,,CHEMBL631187
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,17025,50592,,,,9986.0,,12974,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,,CHEMBL631188
Autocuration,BAO_0000019,,A,,1,,0,U,,10184,22224,,,,,,12975,Average half life period was determined,,,,CHEMBL876419
Autocuration,BAO_0000019,,A,,1,,0,U,,10184,22224,,,,,,12976,Average half life period was determined,,,,CHEMBL631189
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12977,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,,CHEMBL631190
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12978,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,,CHEMBL631191
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12979,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,,,CHEMBL631192
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12980,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,,,CHEMBL632400
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12981,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,,CHEMBL630564
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12982,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,,CHEMBL630565
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12983,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,,,CHEMBL630566
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12984,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,,,CHEMBL631229
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,12985,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,,,CHEMBL631230
Autocuration,BAO_0000100,,P,,1,,0,U,,6030,22229,,,,,,12986,Calculated partition coefficient (clogP),,,,CHEMBL876428
Autocuration,BAO_0000100,,P,,1,,0,U,,6147,22229,,,,,,12987,Calculated partition coefficient (clogP),,,,CHEMBL631231
Autocuration,BAO_0000100,,P,,1,,0,U,,14556,22229,,,,,,12988,Calculated partition coefficient (clogP) (MacLogP),,,,CHEMBL631232
Autocuration,BAO_0000019,,A,,1,,0,U,,768,22224,,,,,,12989,Hydrophilicity was determined,,,,CHEMBL631233
Autocuration,BAO_0000100,,P,,1,,0,U,,14452,22229,,,,,,12990,Calculated partition coefficient (clogP),,,,CHEMBL631234
Autocuration,BAO_0000019,,A,,1,,0,U,,5237,22224,,,,,,12991,Increased absorption was determined,,,,CHEMBL883126
Autocuration,BAO_0000100,,P,,1,,0,U,,14378,22224,,,,,,12992,Lipophilicity value was evaluated,,,,CHEMBL631235
Autocuration,BAO_0000100,,P,,1,,0,U,,14418,22224,,,,,,12993,Log P value of the compound.,,,,CHEMBL631236
Autocuration,BAO_0000019,,A,,1,,0,U,,5249,22224,,,,,,12994,Partition coefficient of compound was determined,,,,CHEMBL631237
Autocuration,BAO_0000100,,P,,1,,0,U,,14621,22229,,,,,,12995,Calculated partition coefficient (clogP),,,,CHEMBL631238
Autocuration,BAO_0000100,,P,,1,,0,U,,12542,22229,,,,,,12996,Calculated partition coefficient (clogP),,,,CHEMBL876429
Autocuration,BAO_0000019,,A,,1,,0,U,,12542,22224,,,,,,12997,Partition coefficient was measured by medchem software; Not calculated,,,,CHEMBL631414
Autocuration,BAO_0000100,,P,,1,,0,U,,12542,22224,,,,,,12998,Partition coefficient was measured by octanol-water using standard shake-flask method,,,,CHEMBL631415
Autocuration,BAO_0000100,,P,,1,,0,U,,15462,22229,,,,,,12999,Calculated partition coefficient (clogP),,,,CHEMBL631416
Autocuration,BAO_0000019,,A,,1,,0,U,,14884,22224,,,,,,13000,Partition coefficient (logP),,,,CHEMBL631417
Autocuration,BAO_0000100,,P,,1,,0,U,,16526,22229,,,,,,13001,Calculated partition coefficient (clogP),,,,CHEMBL631418
Autocuration,BAO_0000100,,P,,1,,0,U,,13693,22229,,,,,,13002,The Octanol/Water partition coefficient CLogP,,,,CHEMBL631419
Autocuration,BAO_0000019,,A,,1,,0,U,,13693,22224,,,,,,13003,The pharmacokinetic parameter C Log p was reported,,,,CHEMBL631420
Autocuration,BAO_0000100,,P,,1,,0,U,,13779,22229,,,,,,13004,Calculated partition coefficient (clogP),,,,CHEMBL631421
Autocuration,BAO_0000100,,P,,1,,0,U,,14772,22229,,,,,,13005,Calculated partition coefficient (clogP),,,,CHEMBL631422
Autocuration,BAO_0000100,,P,,1,,0,U,,14393,22229,,,,,,13006,Calculated partition coefficient (clogP),,,,CHEMBL631423
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,13007,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,In vivo,,CHEMBL876430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,13008,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,In vivo,,CHEMBL631424
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13744,50588,,1969.0,Plasma,9615.0,,13009,Compound was administered intravenously in dog to evaluate plasma clearance values,,In vivo,,CHEMBL631425
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,13744,22224,,1969.0,Plasma,314293.0,,13010,Compound was administered intravenously in monkey to evaluate plasma clearance values,,In vivo,,CHEMBL631426
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13744,50594,,1969.0,Plasma,10090.0,,13011,Compound was administered intravenously in mouse to evaluate plasma clearance values,,In vivo,,CHEMBL631427
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13207,50588,,1969.0,Plasma,9615.0,,13012,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,In vivo,,CHEMBL631428
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,5669,50797,,2107.0,Liver,9544.0,,13013,Intrinsic clearance in Rhesus liver microsome,Microsomes,In vitro,,CHEMBL631429
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,5669,50588,,2107.0,Liver,9615.0,,13014,Intrinsic clearance in dog liver microsome,Microsomes,In vitro,,CHEMBL631430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,2107.0,Liver,10116.0,,13015,Intrinsic clearance in rat liver microsome,Microsomes,In vitro,,CHEMBL631431
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,4853,50797,,1969.0,Plasma,9544.0,,13016,Low plasma clearance was calculated in rhesus monkey,,In vivo,,CHEMBL631432
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,16452,50588,,,,9615.0,,13017,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,In vivo,,CHEMBL631433
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,13018,Plasma clearance after intravenous dose of 0.3 mg/kg,,In vivo,,CHEMBL631434
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,13019,Plasma clearance after intravenous dose of 1 mg/kg,,In vivo,,CHEMBL631435
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,13020,Plasma clearance after intravenous dose of 3 mg/kg,,In vivo,,CHEMBL631436
Autocuration,BAO_0000218,,A,,1,,0,U,,11954,22224,,,,,,13021,Plasma clearance after intravenous dose of 3.87 mg/kg,,In vivo,,CHEMBL631437
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,13022,Plasma clearance after peroral administration at 10 mpk in Rat,,In vivo,,CHEMBL631438
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,5669,50797,,,,9544.0,,13023,Plasma clearance after peroral administration at 10 mpk in Rhesus,,In vivo,,CHEMBL876431
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,5669,50588,,,,9615.0,,13024,Plasma clearance after peroral administration at 10 mpk in dog,,In vivo,,CHEMBL631439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13662,50597,,,,10116.0,,13025,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,In vivo,,CHEMBL631440
Autocuration,BAO_0000019,,A,,1,,0,U,,8272,22224,,,,,,13026,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,,CHEMBL631441
Autocuration,BAO_0000019,,A,,1,,0,U,,13410,22224,,,,,,13027,Critical Micellar concentration was determined,,,,CHEMBL631442
Autocuration,BAO_0000019,,A,,1,,0,U,,13410,22224,,,,,,13028,Critical Micellar concentration of the compound. was determined,,,,CHEMBL626525
Autocuration,BAO_0000019,,A,,1,,0,U,,12628,22224,,,,,,13029,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,,CHEMBL627168
Autocuration,BAO_0000019,,A,,1,,0,U,,9675,22224,,,,,,13030,Critical micellar concentration was measured in water by the dye solubilization method,,,,CHEMBL875618
Autocuration,BAO_0000019,,B,,1,,0,U,,12628,22224,,,,,,13031,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,,CHEMBL626612
Autocuration,BAO_0000019,,A,,1,,0,U,,12766,22224,,,,,,13032,CMR value (relative to BAY K 8644),,,,CHEMBL626613
Autocuration,BAO_0000019,,A,,1,,0,U,,7849,22224,,,,,,13033,Carbamoylating activity was determined,,,,CHEMBL626614
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,13034,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,,,CHEMBL626615
Autocuration,BAO_0000019,,A,,1,,0,U,,2040,22224,,,,,,13035,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,,CHEMBL626616
Autocuration,BAO_0000019,,A,,1,,0,U,,2040,22224,,,,,,13036,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,,CHEMBL626617
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14180,50588,,1969.0,Plasma,9615.0,,13037,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,In vivo,,CHEMBL626618
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14180,50597,,1969.0,Plasma,10116.0,,13038,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,In vivo,,CHEMBL626619
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14474,50588,,,,9615.0,,13039,"Clearance rate at 0.46 mg/kg, iv, in dogs",,In vivo,,CHEMBL626620
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14474,50597,,,,10116.0,,13040,"Clearance rate at 5.5 mg/kg, iv, in rat",,In vivo,,CHEMBL626621
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14548,100710,,,,9541.0,,13041,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,In vivo,,CHEMBL626622
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14548,100710,,,,9541.0,,13042,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,In vivo,,CHEMBL626623
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,14548,50588,,,,9615.0,,13043,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,In vivo,,CHEMBL626624
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14548,50597,,,,10116.0,,13044,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,In vivo,,CHEMBL626625
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6125,50597,,2107.0,Liver,10116.0,,13045,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,Ex vivo,,CHEMBL626626
Autocuration,BAO_0000218,,A,,1,,0,U,,6874,22224,,,,,,13046,Tested for the total clearance of the compound,,In vivo,,CHEMBL626627
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15343,50588,,,,9615.0,,13047,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,In vivo,,CHEMBL626628
Autocuration,BAO_0000218,,A,,1,,0,U,,6236,22224,,,,,,13048,Total body clearance was determined,,In vivo,,CHEMBL626629
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13049,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,,CHEMBL626630
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13050,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,,CHEMBL626631
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,13051,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,CHEMBL626632
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,13052,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,CHEMBL626633
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,13053,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,,CHEMBL626634
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,13054,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,CHEMBL626635
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,13055,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,CHEMBL626636
Autocuration,BAO_0000100,,P,,1,,0,U,,8194,22229,,,,,,13056,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,CHEMBL626637
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13057,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,,,CHEMBL626638
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13058,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,,,CHEMBL626639
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13059,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,,,CHEMBL626640
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13060,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,,,CHEMBL626641
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13061,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,,,CHEMBL627272
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13062,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,,,CHEMBL627273
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13063,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,,,CHEMBL627441
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13064,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,,,CHEMBL628355
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13065,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,,,CHEMBL628356
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13066,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,,,CHEMBL628357
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13067,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,,,CHEMBL628358
Intermediate,BAO_0000218,,A,,1,Pneumocystis carinii,1,N,,13273,50339,,,,4754.0,,13068,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,,,CHEMBL622307
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,13069,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,,CHEMBL622527
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,13070,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,,CHEMBL622528
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,13071,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,,CHEMBL622529
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,13072,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,,CHEMBL622992
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,13073,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,,CHEMBL622993
Autocuration,BAO_0000019,,A,,1,,0,U,,13118,22224,,,,,,13074,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,,CHEMBL622994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10633,50597,,,,10116.0,,13075,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,,,CHEMBL622995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10633,50597,,,,10116.0,,13076,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,,,CHEMBL622996
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10633,50597,,,,10116.0,,13077,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,,,CHEMBL622997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10633,50597,,,,10116.0,,13078,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,,,CHEMBL622998
Autocuration,BAO_0000218,,A,,1,,0,U,,5767,22224,,,,,,13079,Cp max following ip administration at 1 mg/kg,,,,CHEMBL622999
Autocuration,BAO_0000218,,A,,1,,0,U,,3302,22224,,1969.0,Plasma,,,13080,Maximum concentration in plasma was reported at 0.5 hour,,In vivo,,CHEMBL623000
Autocuration,BAO_0000218,,A,,1,,0,U,,3302,22224,,1969.0,Plasma,,,13081,Maximum concentration in plasma was reported at 2 hour,,In vivo,,CHEMBL623001
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12467,50594,,,,10090.0,,13082,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,,,CHEMBL623002
Autocuration,BAO_0000100,,P,,1,,0,U,,11778,22229,,,,,,13083,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,,CHEMBL623003
Autocuration,BAO_0000019,,A,,1,,0,U,,4321,22224,,,,,,13084,Steady state concentration was evaluated,,,,CHEMBL623004
Autocuration,BAO_0000019,,A,,1,,0,U,,14884,22224,,,,,,13085,Partition coefficient (logP),,,,CHEMBL623005
Autocuration,BAO_0000019,,A,,1,,0,U,,15234,22224,,,,,,13086,Partition coefficient (logD7.4),,,,CHEMBL623006
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2107.0,Liver,10116.0,,13087,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,In vivo,,CHEMBL623007
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,10000001.0,Bone,10116.0,,13088,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,In vivo,,CHEMBL623008
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2037.0,Cerebellum,10116.0,,13089,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,In vivo,,CHEMBL876654
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13090,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,In vivo,,CHEMBL623009
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13091,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,In vivo,,CHEMBL623010
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,948.0,Heart,10116.0,,13092,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,In vivo,,CHEMBL623011
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,160.0,Intestine,10116.0,,13093,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,In vivo,,CHEMBL623012
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,,,,,13094,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,,CHEMBL623013
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,,,,,13095,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,CHEMBL623014
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,1088.0,Urine,,,13096,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,,CHEMBL623015
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,1088.0,Urine,,,13097,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,,CHEMBL623016
Autocuration,BAO_0000019,,A,,1,,0,U,,8151,22224,,1088.0,Urine,,,13098,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,,CHEMBL624858
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,13099,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,,,CHEMBL624859
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,13100,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,CHEMBL624860
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,13101,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,,CHEMBL624861
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,13102,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,,CHEMBL624862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,13103,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,,,CHEMBL624863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8151,50597,,,,10116.0,,13104,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,,CHEMBL876655
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13105,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,,CHEMBL624864
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13106,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,,CHEMBL624865
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13107,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,,CHEMBL624866
Expert,BAO_0000218,,F,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13108,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,,,CHEMBL624867
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13109,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,,CHEMBL624868
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13110,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,,,CHEMBL628450
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13111,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,,CHEMBL628451
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13112,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,,CHEMBL628452
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13113,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,,CHEMBL628453
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13114,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,,,CHEMBL628454
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13115,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,,CHEMBL628455
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13116,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,,CHEMBL628456
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13117,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,,CHEMBL628457
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13118,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,,,CHEMBL877505
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13119,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,,,CHEMBL628458
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13120,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,,CHEMBL628459
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13121,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,,CHEMBL628460
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13122,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,,CHEMBL628461
Autocuration,BAO_0000218,,B,,1,,0,U,,6996,22224,,,,,,13123,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,,CHEMBL628462
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13124,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,CHEMBL628463
Expert,BAO_0000218,,F,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13125,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,,,CHEMBL625666
Autocuration,BAO_0000218,,B,,1,,0,U,,6996,22224,,,,,,13126,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,CHEMBL625667
Expert,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13127,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,CHEMBL625668
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13128,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,CHEMBL625669
Autocuration,BAO_0000019,,A,,1,,0,U,,7114,22224,,,,,,13129,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,,CHEMBL625670
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7114,50597,,,,10116.0,,13130,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,,,CHEMBL625671
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13131,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,,,CHEMBL625672
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13132,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,,,CHEMBL625673
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13133,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,,,CHEMBL625674
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13134,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,,,CHEMBL625675
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13135,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,,CHEMBL627637
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13136,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,,,CHEMBL627638
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13137,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,,,CHEMBL627639
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13138,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,,,CHEMBL627640
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13139,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,,,CHEMBL627641
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13140,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,,CHEMBL627642
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,13141,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,,CHEMBL877506
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8613,50594,,,,10090.0,,13142,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,,CHEMBL627275
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13143,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,,,CHEMBL627643
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13144,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,,CHEMBL631246
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13145,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,,CHEMBL631247
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13146,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,,CHEMBL629532
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13147,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,,,CHEMBL629533
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13148,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,,CHEMBL629534
Intermediate,BAO_0000218,,A,,1,Mustela putorius furo,1,N,,11219,50506,,,,9669.0,,13149,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,,,CHEMBL629535
Autocuration,BAO_0000019,,A,,1,,0,U,,14837,22224,,,,,,13150,Pharmacokinetic parameter :drug bound to plasma was reported,,,,CHEMBL625932
Autocuration,BAO_0000019,,A,,1,,0,U,,14837,22224,,,,,,13151,compound was evaluated for drug bound in plasma,,,,CHEMBL625933
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15343,50597,,,,10116.0,,13152,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,,,CHEMBL625934
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,13761,22224,,,,9347.0,,13153,Bioavailability,,,,CHEMBL625935
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14810,50597,,,,10116.0,,13154,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,,,CHEMBL625936
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14810,50597,,,,10116.0,,13155,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,,,CHEMBL625937
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13249,50588,,,,9615.0,,13156,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,,CHEMBL625938
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9267,50597,,1970.0,Bile,10116.0,,13157,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,,,CHEMBL625939
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9267,50597,,1970.0,Bile,10116.0,,13158,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,,,CHEMBL625940
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9267,50597,,1970.0,Bile,10116.0,,13159,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,,,CHEMBL874464
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9267,50597,,1970.0,Bile,10116.0,,13160,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,,,CHEMBL625941
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9267,50597,,1970.0,Bile,10116.0,,13161,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,,,CHEMBL625942
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9267,50597,,1970.0,Bile,10116.0,,13162,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,,,CHEMBL625943
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,15549,50587,,1977.0,Serum,9606.0,,13163,In vitro protein binding in human serum at 5 ug/ml,,,,CHEMBL625944
Autocuration,BAO_0000019,,A,,1,,0,U,,10929,22224,,,,,,13164,Serum protein binding ability was measured,,,,CHEMBL625945
Autocuration,BAO_0000019,,A,,1,,0,U,,15444,22224,,,,,,13165,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,,CHEMBL625946
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,12860,22224,,,,9615.0,,13166,Oral bioavailability in dog,,In vivo,,CHEMBL625947
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12170,50597,,,,10116.0,,13167,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,In vivo,,CHEMBL625948
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13168,Absolute oral bioavailability at an iv dose of 14 mg/kg,,In vivo,,CHEMBL625949
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13169,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,In vivo,,CHEMBL625950
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,15173,22224,,,,9347.0,,13170,Oral bioavailability (dose 15 mg/kg i.v.),,In vivo,,CHEMBL625951
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13171,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,In vivo,,CHEMBL625952
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13172,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,In vivo,,CHEMBL625953
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13173,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,In vivo,,CHEMBL625954
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13174,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,In vivo,,CHEMBL882959
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,11767,50588,,,,9615.0,,13175,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,In vivo,,CHEMBL625955
Autocuration,BAO_0000218,,A,,1,Mustela putorius furo,0,U,,11219,22224,,,,9669.0,,13176,Bioavailability in ferret,,In vivo,,CHEMBL625956
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,12186,100710,,,,9541.0,,13177,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,In vivo,,CHEMBL625957
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13178,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,,CHEMBL625958
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13179,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,,CHEMBL625959
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13180,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,,CHEMBL626642
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13181,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,,CHEMBL631330
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13182,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,,CHEMBL631331
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13183,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,,CHEMBL631332
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13184,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,,CHEMBL631333
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13185,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,,CHEMBL632018
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13186,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,,CHEMBL632019
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13187,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,,CHEMBL632020
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13188,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,,CHEMBL632021
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13189,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,,CHEMBL632022
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13190,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,,CHEMBL632023
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13191,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,,CHEMBL632024
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13192,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,,CHEMBL874472
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13193,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,,CHEMBL632025
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13194,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,,CHEMBL632026
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13195,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,,CHEMBL632027
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13196,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,,CHEMBL632028
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13197,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,,CHEMBL626430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13198,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,,CHEMBL626431
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13199,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,,CHEMBL626432
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13200,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,,CHEMBL626433
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13201,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,,CHEMBL626434
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13202,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,,CHEMBL627280
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13203,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,,CHEMBL627281
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13204,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,,CHEMBL627282
Autocuration,BAO_0000019,,A,,1,,0,U,,7199,22224,,,,,,13205,Total body clearance was measured at given dose,,,,CHEMBL627283
Autocuration,BAO_0000218,,A,,1,,0,U,,7199,22224,,,,,,13206,Total body clearance was measured at given dose.,,,,CHEMBL627284
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7095,50597,,,,10116.0,,13207,Metabolic clearance from the body in rat,,,,CHEMBL627285
Autocuration,BAO_0000218,,A,,1,,0,U,,7095,22224,,,,,,13208,Renal clearance from the body,,In vivo,,CHEMBL627286
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7095,50597,,,,10116.0,,13209,Renal clearance from the body in rat,,In vivo,,CHEMBL875477
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12528,50597,,,,10116.0,,13210,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,In vivo,,CHEMBL627287
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12528,50588,,,,9615.0,,13211,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,In vivo,,CHEMBL627288
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7095,50597,,,,10116.0,,13212,Total clearance from the body in rat,,,,CHEMBL627289
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14223,50597,,1969.0,Plasma,10116.0,,13213,Clearance into cortex from rat plasma or PBS,,In vivo,,CHEMBL627290
Autocuration,BAO_0000218,,A,,1,,0,U,,13569,22224,,,,,,13214,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,In vivo,,CHEMBL627291
Autocuration,BAO_0000218,,A,,1,,0,U,,13569,22224,,,,,,13215,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,In vivo,,CHEMBL627292
Autocuration,BAO_0000218,,A,,1,,0,U,,13569,22224,,,,,,13216,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,In vivo,,CHEMBL627293
Autocuration,BAO_0000218,,A,,1,,0,U,,13569,22224,,,,,,13217,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,In vivo,,CHEMBL627294
Autocuration,BAO_0000218,,A,,1,,0,U,,13569,22224,,,,,,13218,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,In vivo,,CHEMBL875478
Autocuration,BAO_0000218,,A,,1,,0,U,,13979,22224,,,,,,13219,Clearance was determined,,In vivo,,CHEMBL627295
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14315,50594,,,,10090.0,,13220,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,In vivo,,CHEMBL627296
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,14315,50592,,,,9986.0,,13221,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,In vivo,,CHEMBL626119
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14315,50597,,,,10116.0,,13222,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,In vivo,,CHEMBL626120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12174,50597,,,,10116.0,,13223,Clearance in rat after iv dose (100 ug/kg),,In vivo,,CHEMBL626121
Autocuration,BAO_0000218,,A,,1,Cavia porcellus,0,U,,12797,22224,,,,10141.0,,13224,Clearance in guinea pig,,In vivo,,CHEMBL626122
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12797,50597,,,,10116.0,,13225,Compound was evaluated for clearance in rat,,In vivo,,CHEMBL626123
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12797,50588,,,,9615.0,,13226,Compound was evaluated for the clearance in dog,,In vivo,,CHEMBL623456
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12797,50597,,,,10116.0,,13227,Compound was evaluated for the clearance in rat,,In vivo,,CHEMBL623457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11500,50597,,,,10116.0,,13228,Compound was tested in vivo for clearance after iv administration in the rat,,In vivo,,CHEMBL623458
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13229,IV clearance determined at an iv dose of 14 mg/kg,,In vivo,,CHEMBL623459
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13230,IV clearance determined at an iv dose of 15.2 mg/kg,,In vivo,,CHEMBL875484
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13231,IV clearance determined at an iv dose of 15 mg/kg,,In vivo,,CHEMBL623460
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13232,IV clearance determined at an peroral dose of 30 mg/kg.,,In vivo,,CHEMBL623461
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13233,IV clearance determined at an peroral dose of 30.2 mg/kg.,,In vivo,,CHEMBL623462
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13234,IV clearance determined at an peroral dose of 30.3 mg/kg.,,In vivo,,CHEMBL627386
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2113.0,Kidney,10116.0,,13235,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,In vivo,,CHEMBL627387
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2107.0,Liver,10116.0,,13236,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,In vivo,,CHEMBL627388
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2048.0,Lung,10116.0,,13237,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,In vivo,,CHEMBL627389
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2385.0,Muscle tissue,10116.0,,13238,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,In vivo,,CHEMBL627390
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,1969.0,Plasma,10116.0,,13239,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,In vivo,,CHEMBL627391
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13240,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,In vivo,,CHEMBL627392
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2106.0,Spleen,10116.0,,13241,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,In vivo,,CHEMBL627393
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,3126.0,Trachea,10116.0,,13242,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,In vivo,,CHEMBL627394
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,10000001.0,Bone,10116.0,,13243,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,In vivo,,CHEMBL627395
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2037.0,Cerebellum,10116.0,,13244,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,In vivo,,CHEMBL875485
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13245,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,In vivo,,CHEMBL627396
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13246,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,In vivo,,CHEMBL627397
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,948.0,Heart,10116.0,,13247,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,In vivo,,CHEMBL627398
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,10000001.0,Bone,10116.0,,13248,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,In vivo,,CHEMBL627399
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2113.0,Kidney,10116.0,,13249,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,In vivo,,CHEMBL627400
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2107.0,Liver,10116.0,,13250,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,In vivo,,CHEMBL627401
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2048.0,Lung,10116.0,,13251,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,In vivo,,CHEMBL627402
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2385.0,Muscle tissue,10116.0,,13252,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,In vivo,,CHEMBL627403
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,1969.0,Plasma,10116.0,,13253,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,In vivo,,CHEMBL627404
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13254,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,In vivo,,CHEMBL623101
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2106.0,Spleen,10116.0,,13255,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,In vivo,,CHEMBL877480
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,3126.0,Trachea,10116.0,,13256,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,In vivo,,CHEMBL623102
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,10000001.0,Bone,10116.0,,13257,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,In vivo,,CHEMBL623103
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2037.0,Cerebellum,10116.0,,13258,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,In vivo,,CHEMBL623104
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13259,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,In vivo,,CHEMBL623105
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13260,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,In vivo,,CHEMBL623106
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,948.0,Heart,10116.0,,13261,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,In vivo,,CHEMBL623107
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,160.0,Intestine,10116.0,,13262,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,In vivo,,CHEMBL623108
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2113.0,Kidney,10116.0,,13263,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,In vivo,,CHEMBL623109
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2107.0,Liver,10116.0,,13264,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,In vivo,,CHEMBL623110
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2048.0,Lung,10116.0,,13265,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,In vivo,,CHEMBL623111
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2385.0,Muscle tissue,10116.0,,13266,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,In vivo,,CHEMBL625060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,1969.0,Plasma,10116.0,,13267,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,In vivo,,CHEMBL625061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13268,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,In vivo,,CHEMBL625062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2106.0,Spleen,10116.0,,13269,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,In vivo,,CHEMBL625063
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,3126.0,Trachea,10116.0,,13270,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,In vivo,,CHEMBL625064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,10000001.0,Bone,10116.0,,13271,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,In vivo,,CHEMBL625065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2037.0,Cerebellum,10116.0,,13272,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,In vivo,,CHEMBL625066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13273,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,In vivo,,CHEMBL625067
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13274,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,In vivo,,CHEMBL625068
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,948.0,Heart,10116.0,,13275,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,In vivo,,CHEMBL622159
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,160.0,Intestine,10116.0,,13276,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,In vivo,,CHEMBL622160
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2113.0,Kidney,10116.0,,13277,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,In vivo,,CHEMBL622161
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2048.0,Lung,10116.0,,13278,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,In vivo,,CHEMBL622162
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2385.0,Muscle tissue,10116.0,,13279,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,In vivo,,CHEMBL622163
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,1969.0,Plasma,10116.0,,13280,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,In vivo,,CHEMBL622313
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,,,10116.0,,13281,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,In vivo,,CHEMBL622314
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,2106.0,Spleen,10116.0,,13282,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,In vivo,,CHEMBL622315
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14198,50597,,3126.0,Trachea,10116.0,,13283,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,In vivo,,CHEMBL622316
Intermediate,BAO_0000218,,A,,1,Escherichia coli,1,N,,15599,50212,,,,562.0,,13284,Normal diffusion coefficient in water for Escherichia coli,,,,CHEMBL877486
Autocuration,BAO_0000019,,A,,1,,0,U,,8204,22224,,,,,,13285,Average max percent decrease in RVR (renal vascular resistance) was determined,,,,CHEMBL622317
Autocuration,BAO_0000019,,A,,1,,0,U,,8204,22224,,,,,,13286,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,,CHEMBL622318
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13287,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,,CHEMBL622319
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13288,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,,CHEMBL622320
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13289,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,,CHEMBL622321
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13290,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,,CHEMBL622322
Autocuration,BAO_0000019,,A,,1,,0,U,,7114,22224,,,,,,13291,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,,CHEMBL622323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7114,50597,,,,10116.0,,13292,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,,,CHEMBL622324
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13293,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,,CHEMBL622325
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13294,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,,CHEMBL622326
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13295,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,,,CHEMBL877487
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13296,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,,CHEMBL622327
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13297,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,,,CHEMBL622328
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13298,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,,CHEMBL622329
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13299,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,,CHEMBL622330
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13300,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,,CHEMBL622331
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13301,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,,CHEMBL622332
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13302,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,,,CHEMBL622333
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13303,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,,CHEMBL627658
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13304,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,,,CHEMBL630428
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13305,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,,CHEMBL630429
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13306,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,,,CHEMBL630430
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13307,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,,,CHEMBL630431
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13308,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,,CHEMBL630432
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13309,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,,CHEMBL630433
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13310,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,,CHEMBL630434
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13311,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,,CHEMBL629372
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13312,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,,,CHEMBL629553
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13313,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,,CHEMBL629554
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13314,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,,CHEMBL874447
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13315,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,,CHEMBL629555
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13316,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,,CHEMBL629556
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13317,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,,,CHEMBL629557
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13318,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,,CHEMBL629558
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13319,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,,CHEMBL629559
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13320,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,,CHEMBL629560
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13321,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,,CHEMBL629561
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13322,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,,CHEMBL629562
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13323,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,,CHEMBL629563
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13324,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,,CHEMBL629564
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13325,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,,CHEMBL629565
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13326,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,,CHEMBL629566
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13327,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,,CHEMBL629567
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13328,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,,CHEMBL629568
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13329,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,,,CHEMBL629569
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13330,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,,CHEMBL629570
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13331,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,,CHEMBL629571
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12170,22224,,,,10116.0,,13332,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,In vivo,,CHEMBL629572
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12170,22224,,,,10116.0,,13333,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,In vivo,,CHEMBL629573
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,4985,22224,,,,9347.0,,13334,Bioavailability (dose 20 mg/kg),,In vivo,,CHEMBL629574
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,15145,22224,,,,9615.0,,13335,Bioavailability in dog,,In vivo,,CHEMBL629575
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,14080,22224,,,,10116.0,,13336,Bioavailability in rat (Sprague-Dawley) (male),,In vivo,,CHEMBL874448
Autocuration,BAO_0000218,,A,,1,Primates,0,U,,11219,22224,,,,9443.0,,13337,Bioavailability in monkey (dose 10 mg/kg i.d.),,In vivo,,CHEMBL629576
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,15145,22224,,,,10116.0,,13338,Bioavailability in rat,,In vivo,,CHEMBL629577
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,15145,22224,,,,10116.0,,13339,Bioavailability in rat,,In vivo,,CHEMBL629578
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,1202,22224,,,,9615.0,,13340,Bioavailability in dog (dose 3.0 mg/kg p.o.),,In vivo,,CHEMBL629579
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,1202,22224,,,,9615.0,,13341,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,In vivo,,CHEMBL882958
Intermediate,BAO_0000218,,A,,1,Pan troglodytes,1,N,,1202,50505,,,,9598.0,,13342,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,In vivo,,CHEMBL629580
Autocuration,BAO_0000218,,A,,1,Eutheria,0,U,,4026,22224,,,,9347.0,,13343,Bioavailability,,In vivo,,CHEMBL629581
Autocuration,BAO_0000218,,A,,1,Saimiri,0,U,,1492,22224,,,,9520.0,,13344,Bioavailability in squirrel monkey,,In vivo,,CHEMBL629582
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12793,50588,,,,9615.0,,13345,Bioavailability was evaluated in dog,,In vivo,,CHEMBL628522
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,12793,100712,,,,10026.0,,13346,Bioavailability was evaluated in hamster,,In vivo,,CHEMBL625432
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12793,22224,,,,10116.0,,13347,Bioavailability in rat,,In vivo,,CHEMBL625433
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,13348,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,In vivo,,CHEMBL625434
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14793,50597,,1969.0,Plasma,10116.0,,13349,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,In vivo,,CHEMBL625435
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,14793,22224,,,,10116.0,,13350,Bioavailability in rat (dose 10 mg/kg p.o.),,In vivo,,CHEMBL625436
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,14731,100710,,,,9541.0,,13351,Bioavailability was measured in cynomolgus monkeys.,,In vivo,,CHEMBL874588
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14731,50594,,,,10090.0,,13352,Bioavailability was measured in nude mice.,,In vivo,,CHEMBL625437
Autocuration,BAO_0000218,,A,,1,Mustela putorius furo,0,U,,12187,22224,,,,9669.0,,13353,Bioavailability in ferret (dose 10 mg/kg i.d.),,In vivo,,CHEMBL625438
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,13354,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,In vivo,,CHEMBL625439
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,13355,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,In vivo,,CHEMBL625440
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,12187,22224,,,,314293.0,,13356,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,In vivo,,CHEMBL625441
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,12187,22224,,,,10116.0,,13357,Bioavailability in rat (dose 10 mg/kg i.d.),,In vivo,,CHEMBL625442
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12187,50597,,,,10116.0,,13358,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,In vivo,,CHEMBL625443
Autocuration,BAO_0000218,,A,,1,,0,U,,17431,22224,,,,,,13359,Bioavailability was determined; extremely poor,,In vivo,,CHEMBL625444
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13318,50594,,,,10090.0,,13360,% bioavailability in mice after oral administration of prodrug,,In vivo,,CHEMBL625445
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13361,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,In vivo,,CHEMBL625446
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13362,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,In vivo,,CHEMBL882960
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13363,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,In vivo,,CHEMBL625447
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13364,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,In vivo,,CHEMBL625448
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13365,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,In vivo,,CHEMBL625449
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13366,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,In vivo,,CHEMBL874589
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13367,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,In vivo,,CHEMBL625450
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13368,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,In vivo,,CHEMBL625451
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13369,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,In vivo,,CHEMBL626584
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13370,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,In vivo,,CHEMBL626585
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13371,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,In vivo,,CHEMBL626586
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13372,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,In vivo,,CHEMBL626587
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13373,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,In vivo,,CHEMBL626588
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13374,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,In vivo,,CHEMBL626589
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13375,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,In vivo,,CHEMBL626590
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13376,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,In vivo,,CHEMBL626591
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13377,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,In vivo,,CHEMBL627181
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13378,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,In vivo,,CHEMBL628083
Autocuration,BAO_0000218,,A,,1,,0,U,,15173,22224,,,,,,13379,IV clearance determined at an peroral dose of 15 mg/kg.,,In vivo,,CHEMBL628084
Expert,BAO_0000218,,F,,1,Hymenolepis nana,1,N,,7732,50064,,,,102285.0,,13380,Mouse oral clearance was measured against Hymenolepiasis nana.,,In vivo,,CHEMBL628085
Expert,BAO_0000218,,F,,1,Heligmosomoides polygyrus,1,N,,7732,50545,,,,6339.0,,13381,Mouse oral clearance was measured against Nematospiroides dubius,,In vivo,,CHEMBL628086
Autocuration,BAO_0000218,,F,,1,,0,U,,7732,22224,,,,,,13382,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,In vivo,,CHEMBL628087
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,7732,50594,,,,10090.0,,13383,Mouse oral clearance was measured against N. nana; NT is Not Tested,,In vivo,,CHEMBL628088
Autocuration,BAO_0000218,,B,,1,,0,U,,7732,22224,,,,,,13384,Mouse oral clearance was measured against N. nana; NT is Not Tested,,In vivo,,CHEMBL628089
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13385,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL628090
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13386,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL628091
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13387,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL628092
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13388,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL628093
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13389,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL875607
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13390,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL625710
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13391,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL625711
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13392,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL625712
Autocuration,BAO_0000218,,A,,1,,0,U,,8328,22224,,,,,,13393,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,In vivo,,CHEMBL625713
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,13376,50588,,,,9615.0,,13394,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,In vivo,,CHEMBL625714
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,13477,50797,,,,9544.0,,13395,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,In vivo,,CHEMBL625715
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,13396,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,In vivo,,CHEMBL625716
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13477,50597,,,,10116.0,,13397,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,In vivo,,CHEMBL625717
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13313,50597,,,,10116.0,,13398,Plasma clearance was determined for the compound in rats,,In vivo,,CHEMBL625718
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,13399,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,In vivo,,CHEMBL625719
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,13400,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,In vivo,,CHEMBL625720
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,13401,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,In vivo,,CHEMBL625721
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12504,50597,,,,10116.0,,13402,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,In vivo,,CHEMBL625722
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13129,50597,,,,10116.0,,13403,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,In vivo,,CHEMBL625723
Intermediate,BAO_0000218,,A,,1,Heligmosomoides polygyrus,1,N,,7732,50545,,,,6339.0,,13404,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,In vivo,,CHEMBL625724
Intermediate,BAO_0000218,,A,,1,Heligmosomoides polygyrus,1,N,,7732,50545,,,,6339.0,,13405,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,In vivo,,CHEMBL625725
Intermediate,BAO_0000218,,A,,1,Heligmosomoides polygyrus,1,N,,7732,50545,,,,6339.0,,13406,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,In vivo,,CHEMBL625726
Intermediate,BAO_0000218,,A,,1,Heligmosomoides polygyrus,1,N,,7732,50545,,,,6339.0,,13407,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,In vivo,,CHEMBL875608
Intermediate,BAO_0000218,,A,,1,Heligmosomoides polygyrus,1,N,,7732,50545,,,,6339.0,,13408,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,In vivo,,CHEMBL625727
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,9278,22224,,1088.0,Urine,10116.0,,13409,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,In vivo,,CHEMBL625728
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,9278,22224,,,,10116.0,,13410,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,In vivo,,CHEMBL625729
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,9278,22224,,,,10116.0,,13411,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,In vivo,,CHEMBL625730
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,9278,22224,,1088.0,Urine,10116.0,,13412,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,In vivo,,CHEMBL625731
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,9278,22224,,1088.0,Urine,10116.0,,13413,Urinary clearance was determined in rat at 25 mg/kg os dosage,,In vivo,,CHEMBL626417
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,9278,50587,,1088.0,Urine,9606.0,,13414,Urinary clearance was determined at 100 mg/kg oral dosage in human,,In vivo,,CHEMBL626418
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9278,50588,,1088.0,Urine,9615.0,,13415,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,In vivo,,CHEMBL626419
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,5932,50588,,1969.0,Plasma,9615.0,,13416,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,In vivo,,CHEMBL626592
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5932,50597,,1969.0,Plasma,10116.0,,13417,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,In vivo,,CHEMBL626593
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5182,50597,,,,10116.0,,13418,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,In vivo,,CHEMBL626594
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,10499,50588,,,,9615.0,,13419,Clearance rate in dogs,,In vivo,,CHEMBL625035
Autocuration,BAO_0000019,,A,,1,,0,U,,6051,22224,,,,,,13420,Compound was measured for intrinsic clearance,,In vitro,,CHEMBL625036
Autocuration,BAO_0000100,,P,,1,,0,U,,17508,22229,,,,,,13421,Calculated partition coefficient (clogP),,,,CHEMBL625037
Autocuration,BAO_0000100,,P,,1,,0,U,,6228,22229,,,,,,13422,Calculated partition coefficient (clogP),,,,CHEMBL625038
Autocuration,BAO_0000100,,P,,1,,0,U,,6231,22229,,,,,,13423,Calculated partition coefficient (clogP),,,,CHEMBL625039
Autocuration,BAO_0000100,,P,,1,,0,U,,17740,22229,,,,,,13424,Calculated partition coefficient (clogP),,,,CHEMBL625040
Autocuration,BAO_0000100,,P,,1,,0,U,,6495,22229,,,,,,13425,Calculated partition coefficient (clogP),,,,CHEMBL625041
Autocuration,BAO_0000100,,P,,1,,0,U,,2171,22229,,,,,,13426,Calculated partition coefficient (clogP),,,,CHEMBL625042
Autocuration,BAO_0000019,,A,,1,,0,U,,3255,22224,,,,,,13427,Partition coefficient of the compound,,,,CHEMBL874411
Autocuration,BAO_0000019,,A,,1,,0,U,,6821,22224,,,,,,13428,Permeability,,,,CHEMBL625043
Autocuration,BAO_0000100,,P,,1,,0,U,,2685,22229,,,,,,13429,Calculated partition coefficient (clogP),,,,CHEMBL625044
Autocuration,BAO_0000019,,A,,1,,0,U,,17584,22224,,,,,,13430,Partition coefficient (logD),,,,CHEMBL625045
Autocuration,BAO_0000100,,P,,1,,0,U,,13824,22229,,,,,,13431,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,CHEMBL625046
Autocuration,BAO_0000100,,P,,1,,0,U,,13824,22229,,,,,,13432,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,CHEMBL625047
Autocuration,BAO_0000100,,P,,1,,0,U,,16479,22229,,,,,,13433,Calculated partition coefficient (clogP),,,,CHEMBL625048
Autocuration,BAO_0000100,,P,,1,,0,U,,11997,22229,,,,,,13434,Calculated partition coefficient (clogP),,,,CHEMBL625049
Autocuration,BAO_0000100,,P,,1,,0,U,,2988,22229,,,,,,13435,Calculated logarithm of partition coefficient (P) was determined,,,,CHEMBL625050
Autocuration,BAO_0000100,,P,,1,,0,U,,931,22229,,,,,,13436,Calculated partition coefficient (clogP),,,,CHEMBL625051
Autocuration,BAO_0000100,,P,,1,,0,U,,4381,22229,,,,,,13437,Calculated partition coefficient (clogP),,,,CHEMBL874412
Autocuration,BAO_0000100,,P,,1,,0,U,,4397,22229,,,,,,13438,Calculated partition coefficient (clogP),,,,CHEMBL625052
Autocuration,BAO_0000100,,P,,1,,0,U,,5889,22229,,,,,,13439,Calculated partition coefficient (clogP),,,,CHEMBL625053
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13440,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,,CHEMBL623250
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13441,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,,CHEMBL623251
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13442,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,,CHEMBL623252
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13443,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,,CHEMBL623253
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13444,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,,CHEMBL623254
Autocuration,BAO_0000019,,A,,1,,0,U,,6154,22224,,,,,,13445,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,,CHEMBL623255
Autocuration,BAO_0000019,,A,,1,,0,U,,6887,22224,,,,,,13446,Percent degradation of compound at a pH of 1 over a 18 hr period,,,,CHEMBL626831
Autocuration,BAO_0000019,,A,,1,,0,U,,6887,22224,,,,,,13447,Percent degradation of compound at pH of 1 over an 18 hr period,,,,CHEMBL877494
Autocuration,BAO_0000019,,A,,1,,0,U,,14116,22224,,,,,,13448,Delta Logarithm of Partition Coefficient value was determined.,,,,CHEMBL626832
Autocuration,BAO_0000019,,A,,1,,0,U,,11137,22224,,,,,,13449,Delta logPoct-cyc,,,,CHEMBL626833
Autocuration,BAO_0000100,,P,,1,,0,U,,7230,22224,,,,,,13450,Lipophilicity estimated on reversed phase TLC,,,,CHEMBL626834
Autocuration,BAO_0000019,,A,,1,,0,U,,15741,22224,,,,,,13451,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,,CHEMBL626835
Autocuration,BAO_0000019,,A,,1,,0,U,,9663,22224,,,,,,13452,Delta logPoct-cyc,,,,CHEMBL626836
Autocuration,BAO_0000100,,P,,1,,0,U,,9663,22229,,,,,,13453,Change in logarithm of partition coefficient of the compound,,,,CHEMBL626837
Autocuration,BAO_0000019,,A,,1,,0,U,,13807,22224,,,,,,13454,Delta logD (pH 6.5),,,,CHEMBL626838
Autocuration,BAO_0000100,,P,,1,,0,U,,13807,22224,,,,,,13455,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,,CHEMBL626839
Autocuration,BAO_0000019,,A,,1,,0,U,,17425,22224,,,,,,13456,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,,CHEMBL626840
Autocuration,BAO_0000019,,A,,1,,0,U,,12143,22224,,,,,,13457,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,,CHEMBL626841
Autocuration,BAO_0000219,,A,,1,,0,U,,12608,22224,,,,,,13458,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,,CHEMBL626842
Autocuration,BAO_0000219,,A,,1,,0,U,,12608,22224,,,,,,13459,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,,CHEMBL626843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13460,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,,,CHEMBL626844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13461,Amount of deuterium retained was reported after normal workup in rats,,,,CHEMBL877495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13462,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,,,CHEMBL626845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13463,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,,,CHEMBL626846
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13464,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,,CHEMBL626847
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13465,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,,CHEMBL628677
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8649,50597,,,,10116.0,,13466,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,,,CHEMBL628678
Autocuration,BAO_0000019,,A,,1,,0,U,,9659,22224,,,,,,13467,Compound was subjected to electrochemical oxidation,,,,CHEMBL628679
Autocuration,BAO_0000019,,A,,1,,0,U,,9659,22224,,,,,,13468,Compound was subjected to photochemical oxidation,,,,CHEMBL628680
Autocuration,BAO_0000019,,A,,1,,0,U,,9659,22224,,,,,,13469,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,,CHEMBL628681
Autocuration,BAO_0000019,,A,,1,,0,U,,9659,22224,,,,,,13470,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,,CHEMBL628682
Autocuration,BAO_0000019,,A,,1,,0,U,,9659,22224,,,,,,13471,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,,CHEMBL628683
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9607,50597,,,,10116.0,,13472,Percent diffusion through fuzzy rat skin after 48 h of incubation,,,,CHEMBL628684
Autocuration,BAO_0000100,,P,,1,,0,U,,7057,22229,,,,,,13473,Dissociation constant (pKa),,,,CHEMBL877501
Autocuration,BAO_0000100,,P,,1,,0,U,,7057,22224,,,,,,13474,Dissociation constant value of the compound; ND means not determined.,,,,CHEMBL628685
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,178.0,Blood,10116.0,,13475,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,,,CHEMBL628686
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,178.0,Blood,10116.0,,13476,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,,CHEMBL628687
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,,,10116.0,,13477,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,,,CHEMBL628688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,,,10116.0,,13478,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,,CHEMBL628689
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,2107.0,Liver,10116.0,,13479,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,,,CHEMBL628690
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,2107.0,Liver,10116.0,,13480,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,,CHEMBL629363
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,2106.0,Spleen,10116.0,,13481,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,,,CHEMBL629364
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,2106.0,Spleen,10116.0,,13482,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,,CHEMBL629365
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,,,10116.0,,13483,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,,,CHEMBL629366
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,1088.0,Urine,10116.0,,13484,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,,,CHEMBL629367
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,1988.0,Feces,10116.0,,13485,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,,CHEMBL629368
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7911,50597,,1088.0,Urine,10116.0,,13486,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,,CHEMBL877502
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,2037.0,Cerebellum,10090.0,,13487,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,,,CHEMBL629369
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,13488,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,,,CHEMBL629370
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13489,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,,,CHEMBL629371
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13490,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,,CHEMBL626276
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13491,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,,CHEMBL626277
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13492,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,,CHEMBL631250
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13493,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,,CHEMBL631251
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13494,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,,CHEMBL631252
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13495,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,,,CHEMBL631253
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13496,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,,CHEMBL631254
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13497,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,,CHEMBL631255
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13498,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,,CHEMBL631256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13499,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,,CHEMBL631257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13500,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,,,CHEMBL628009
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13501,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,,CHEMBL628010
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13502,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,,CHEMBL628011
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13503,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,,,CHEMBL628012
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13504,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,,CHEMBL628013
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13505,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,,CHEMBL628014
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13506,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,,,CHEMBL628015
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13507,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,,CHEMBL628016
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13508,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,,,CHEMBL874461
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13509,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,,CHEMBL628017
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13510,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,,CHEMBL628018
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13511,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,,CHEMBL628019
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13512,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,,CHEMBL628020
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13513,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,,CHEMBL628021
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13514,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,,CHEMBL628022
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8133,50588,,1088.0,Urine,9615.0,,13515,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,,CHEMBL628023
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13516,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,,CHEMBL628024
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13517,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,,,CHEMBL628025
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13518,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,,CHEMBL628026
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13519,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,,CHEMBL628027
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,8133,22224,,1088.0,Urine,314293.0,,13520,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,,CHEMBL628028
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13521,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,,CHEMBL628029
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13522,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,,,CHEMBL628030
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13523,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,,CHEMBL628031
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13524,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,,,CHEMBL628032
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13525,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,,CHEMBL628033
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13526,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,,,CHEMBL628034
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13527,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,,CHEMBL628035
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13528,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,,,CHEMBL628036
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13529,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,,CHEMBL874462
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13530,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,In vivo,,CHEMBL628037
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13531,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,In vivo,,CHEMBL628123
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13532,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,In vivo,,CHEMBL628124
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13533,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,In vivo,,CHEMBL628125
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13534,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,In vivo,,CHEMBL628126
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13535,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,In vivo,,CHEMBL628127
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13536,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,In vivo,,CHEMBL628128
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13537,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,In vivo,,CHEMBL628129
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13538,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,In vivo,,CHEMBL628130
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13539,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,In vivo,,CHEMBL628131
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13540,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,In vivo,,CHEMBL628132
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13541,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,In vivo,,CHEMBL628133
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13542,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,In vivo,,CHEMBL628134
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13543,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,In vivo,,CHEMBL628135
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13544,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,In vivo,,CHEMBL628136
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13545,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,In vivo,,CHEMBL628137
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13546,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,In vivo,,CHEMBL628138
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13547,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,In vivo,,CHEMBL628139
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13548,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,In vivo,,CHEMBL628140
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13549,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,In vivo,,CHEMBL628141
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13550,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,In vivo,,CHEMBL628142
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13551,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,In vivo,,CHEMBL628143
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13552,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,In vivo,,CHEMBL628144
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13553,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,In vivo,,CHEMBL628145
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13554,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,In vivo,,CHEMBL628146
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13555,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,In vivo,,CHEMBL625355
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13556,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,In vivo,,CHEMBL625356
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13557,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,In vivo,,CHEMBL625357
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13558,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,In vivo,,CHEMBL625527
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13559,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,In vivo,,CHEMBL875473
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,,,9615.0,,13560,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,In vivo,,CHEMBL625528
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9025,50597,,,,10116.0,,13561,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,In vivo,,CHEMBL626304
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,9025,50588,,1637.0,Artery,9615.0,,13562,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,In vivo,,CHEMBL624138
Autocuration,BAO_0000100,,P,,1,,0,U,,6448,22229,,,,,,13563,Calculated partition coefficient (clogP),,,,CHEMBL624139
Autocuration,BAO_0000100,,P,,1,,0,U,,17221,22229,,,,,,13564,Calculated partition coefficient (clogP),,,,CHEMBL624140
Autocuration,BAO_0000100,,P,,1,,0,U,,6545,22229,,,,,,13565,Calculated partition coefficient (clogP),,,,CHEMBL624141
Autocuration,BAO_0000100,,P,,1,,0,U,,577,22229,,,,,,13566,Calculated partition coefficient (clogP),,,,CHEMBL624142
Autocuration,BAO_0000100,,P,,1,,0,U,,6285,22229,,,,,,13567,Calculated partition coefficient (clogP),,,,CHEMBL624143
Autocuration,BAO_0000100,,P,,1,,0,U,,6500,22229,,,,,,13568,Calculated partition coefficient (clogP),,,,CHEMBL624144
Autocuration,BAO_0000100,,P,,1,,0,U,,6716,22229,,,,,,13569,Calculated partition coefficient (clogP),,,,CHEMBL624145
Autocuration,BAO_0000100,,P,,1,,0,U,,13658,22229,,,,,,13570,Calculated partition coefficient (clogP),,,,CHEMBL624146
Autocuration,BAO_0000100,,P,,1,,0,U,,6549,22229,,,,,,13571,Calculated partition coefficient (clogP),,,,CHEMBL624147
Autocuration,BAO_0000100,,P,,1,,0,U,,14685,22229,,,,,,13572,Calculated partition coefficient (clogP) (MacLogP),,,,CHEMBL883123
Autocuration,BAO_0000019,,A,,1,,0,U,,6893,22224,,,,,,13573,Partition coefficient (logP),,,,CHEMBL624148
Autocuration,BAO_0000019,,A,,1,,0,U,,3687,22224,,,,,,13574,Kinetic parameter was determined,,,,CHEMBL874416
Autocuration,BAO_0000100,,P,,1,,0,U,,4207,22229,,,,,,13575,Calculated partition coefficient (clogP),,,,CHEMBL624149
Autocuration,BAO_0000100,,P,,1,,0,U,,4626,22229,,,,,,13576,Calculated partition coefficient (clogP),,,,CHEMBL624150
Autocuration,BAO_0000100,,P,,1,,0,U,,1021,22224,,,,,,13577,Lipophilicity was determined,,,,CHEMBL624151
Autocuration,BAO_0000100,,P,,1,,0,U,,3777,22224,,,,,,13578,Lipophilicity was determined,,,,CHEMBL624152
Autocuration,BAO_0000100,,P,,1,,0,U,,17533,22224,,,,,,13579,Lipophilicity was determined,,,,CHEMBL622139
Autocuration,BAO_0000100,,P,,1,,0,U,,6524,22229,,,,,,13580,Calculated partition coefficient (clogP),,,,CHEMBL622140
Autocuration,BAO_0000100,,P,,1,,0,U,,17533,22224,,,,,,13581,Lipophilicity was determined,,,,CHEMBL622141
Autocuration,BAO_0000100,,P,,1,,0,U,,6480,22224,,,,,,13582,Lipophilicity in octanol-water,,,,CHEMBL622142
Autocuration,BAO_0000100,,P,,1,,0,U,,17606,22229,,,,,,13583,Calculated partition coefficient (clogP),,,,CHEMBL622143
Autocuration,BAO_0000100,,P,,1,,0,U,,6863,22229,,,,,,13584,Octanol-water partition coefficient was determined,,,,CHEMBL622144
Autocuration,BAO_0000019,,A,,1,,0,U,,1356,22224,,,,,,13585,Partition coefficient (logP),,,,CHEMBL877473
Autocuration,BAO_0000100,,P,,1,,0,U,,3326,22229,,,,,,13586,Calculated partition coefficient (clogP),,,,CHEMBL622145
Autocuration,BAO_0000019,,A,,1,,0,U,,1356,22224,,,,,,13587,Partition coefficient was determined; ND means not determined,,,,CHEMBL622146
Autocuration,BAO_0000100,,P,,1,,0,U,,12984,22229,,,,,,13588,Calculated partition coefficient (clogP),,,,CHEMBL622147
Autocuration,BAO_0000019,,A,,1,,0,U,,17363,22224,,,,,,13589,Partition coefficient of the compound,,,,CHEMBL622148
Autocuration,BAO_0000019,,A,,1,,0,U,,6827,22224,,,,,,13590,Permeability was determined,,,,CHEMBL883124
Autocuration,BAO_0000100,,P,,1,,0,U,,261,22229,,,,,,13591,The compound was evaluated for the partition coefficient,,,,CHEMBL622149
Autocuration,BAO_0000019,,A,,1,,0,U,,2685,22224,,,,,,13592,Partition coefficient (logP),,,,CHEMBL622150
Autocuration,BAO_0000100,,P,,1,,0,U,,414,22224,,,,,,13593,The lipophilicity was reported,,,,CHEMBL622151
Autocuration,BAO_0000100,,P,,1,,0,U,,15769,22229,,,,,,13594,logarithm of the octanol-water partition coefficient for the compound,,,,CHEMBL622152
Autocuration,BAO_0000019,,A,,1,,0,U,,17248,22224,,,,,,13595,Clogp value was determined,,,,CHEMBL622153
Autocuration,BAO_0000218,,A,,1,,0,U,,16935,22224,,,,,,13596,Clp at a dose of 1.5 mg/kg,,In vivo,,CHEMBL877474
Autocuration,BAO_0000218,,A,,1,,0,U,,16935,22224,,,,,,13597,Clp at a dose of 2.0 mg/kg,,In vivo,,CHEMBL622154
Autocuration,BAO_0000218,,A,,1,,0,U,,14832,22224,,1969.0,Plasma,,,13598,"Clp, plasma clearance at a dose of 10 mg/kg",,In vivo,,CHEMBL622155
Autocuration,BAO_0000218,,A,,1,,0,U,,14832,22224,,1969.0,Plasma,,,13599,"Clp, plasma clearance at a dose of 50 mg/kg",,In vivo,,CHEMBL622156
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2399,50597,,1969.0,Plasma,10116.0,,13600,Compound was tested for plasma clearance in rat,,In vivo,,CHEMBL622157
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,2399,50597,,1969.0,Plasma,10116.0,,13601,Compound was tested for plasma clearance in rat; Not determined,,In vivo,,CHEMBL622158
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6227,50597,,,,10116.0,,13602,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,In vivo,,CHEMBL622807
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,6227,50797,,,,9544.0,,13603,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,In vivo,,CHEMBL622808
Autocuration,BAO_0000218,,A,,1,,0,U,,5623,22224,,,,,,13604,Plasma clearance by iv administration at a dose 0.003 ug/mL,,In vivo,,CHEMBL622809
Autocuration,BAO_0000218,,A,,1,,0,U,,4854,22224,,,,,,13605,Plasma clearance determined,,In vivo,,CHEMBL622810
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,4493,100712,,,,10026.0,,13606,Plasma clearance after iv administration at 3 mg/kg in hamster,,In vivo,,CHEMBL876653
Intermediate,BAO_0000218,,A,,1,Cricetinae,1,N,,4493,100712,,,,10026.0,,13607,Plasma clearance after iv administration at 4 mg/kg in hamster,,In vivo,,CHEMBL622811
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14956,50597,,,,10116.0,,13608,Rate of clearance in rat was determined,,In vivo,,CHEMBL622986
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,1969.0,Plasma,10116.0,,13609,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,In vivo,,CHEMBL622987
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,1969.0,Plasma,10116.0,,13610,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,In vivo,,CHEMBL622988
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,1969.0,Plasma,10116.0,,13611,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,In vivo,,CHEMBL622989
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15372,50597,,1969.0,Plasma,10116.0,,13612,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,In vivo,,CHEMBL622990
Autocuration,BAO_0000218,,A,,1,Simiiformes,0,U,,15604,22224,,1969.0,Plasma,314293.0,,13613,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,In vivo,,CHEMBL622991
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15604,50597,,1969.0,Plasma,10116.0,,13614,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,In vivo,,CHEMBL622227
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15604,50588,,1969.0,Plasma,9615.0,,13615,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,In vivo,,CHEMBL622228
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14964,50597,,,,10116.0,,13616,Clpl value in rat,,In vivo,,CHEMBL622229
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,15240,50512,,,,10141.0,,13617,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,In vivo,,CHEMBL622230
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16449,50597,,,,10116.0,,13618,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,In vivo,,CHEMBL622231
Intermediate,BAO_0000218,,A,,1,Macaca fascicularis,1,N,,16449,100710,,,,9541.0,,13619,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,In vivo,,CHEMBL622232
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13620,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,In vivo,,CHEMBL622233
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13621,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,In vivo,,CHEMBL622234
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13622,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,In vivo,,CHEMBL622235
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13623,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,In vivo,,CHEMBL622236
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13624,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,In vivo,,CHEMBL622237
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13625,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,In vivo,,CHEMBL877482
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13626,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,In vivo,,CHEMBL622238
Autocuration,BAO_0000218,,A,,1,,0,U,,12902,22224,,,,,,13627,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,In vivo,,CHEMBL622239
Autocuration,BAO_0000218,,A,,1,,0,U,,11149,22224,,178.0,Blood,,,13628,Cmax was calculated as maximum concentration reached in the blood,,In vivo,,CHEMBL622240
Autocuration,BAO_0000218,,A,,1,,0,U,,11149,22224,,178.0,Blood,,,13629,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,In vivo,,CHEMBL622241
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,13630,Cmax was determine after peroral administration at 10 mpk in Rat,,In vivo,,CHEMBL631013
Intermediate,BAO_0000218,,A,,1,Macaca mulatta,1,N,,5669,50797,,,,9544.0,,13631,Cmax was determine after peroral administration at 10 mpk in Rhesus,,In vivo,,CHEMBL631014
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,5669,50588,,,,9615.0,,13632,Cmax was determine after peroral administration at 10 mpk in dog,,In vivo,,CHEMBL631015
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,13633,Cmax was determine after peroral administration at 160 mpk in Rat,,In vivo,,CHEMBL631016
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,13634,Cmax was determine after peroral administration at 20 mpk in Rat,,In vivo,,CHEMBL631017
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,5669,50597,,,,10116.0,,13635,Cmax was determine after peroral administration at 50 mpk in Rat,,In vivo,,CHEMBL631018
Autocuration,BAO_0000218,,A,,1,,0,U,,4236,22224,,,,,,13636,Cmax was determined,,In vivo,,CHEMBL631019
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,13637,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,,,CHEMBL875761
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,13638,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,,,CHEMBL631020
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,13639,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,,,CHEMBL631669
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,955.0,Brain,10090.0,,13640,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,,,CHEMBL631670
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13792,50594,,2435.0,Striatum,10090.0,,13641,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,,,CHEMBL631671
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13642,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,,,CHEMBL631672
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13643,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,,,CHEMBL631673
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13644,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,,,CHEMBL631856
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13645,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,,,CHEMBL631857
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13646,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,,,CHEMBL631858
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13647,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,,,CHEMBL631859
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13648,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,,,CHEMBL631860
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13649,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,,,CHEMBL631861
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13650,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,,,CHEMBL631862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13651,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,,,CHEMBL631863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13652,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,,,CHEMBL631864
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13653,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,,,CHEMBL631865
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13654,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,,,CHEMBL631866
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13655,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,,,CHEMBL629360
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13656,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,,,CHEMBL629361
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13657,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,,,CHEMBL629362
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13658,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,,,CHEMBL630740
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13659,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,,,CHEMBL630741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,178.0,Blood,10116.0,,13660,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,,,CHEMBL630742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13661,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,,,CHEMBL630743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13662,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,,,CHEMBL630744
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13663,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,,,CHEMBL630745
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13664,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,,,CHEMBL630746
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13665,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,,,CHEMBL630747
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13666,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,,,CHEMBL630748
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13667,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,,,CHEMBL632056
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13668,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,,,CHEMBL632057
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13669,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,,,CHEMBL632058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13670,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,,,CHEMBL632059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13671,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,,,CHEMBL632060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13672,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,,,CHEMBL632061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13673,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,,,CHEMBL629207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13674,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,,,CHEMBL629208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13675,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,,,CHEMBL629209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13676,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,,,CHEMBL629210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13677,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,,,CHEMBL629211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13678,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,,,CHEMBL629212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8418,50597,,,,10116.0,,13679,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,,,CHEMBL629213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13680,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,,CHEMBL629214
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13681,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,,,CHEMBL629215
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8133,50597,,1088.0,Urine,10116.0,,13682,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,,,CHEMBL635154
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13683,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,CHEMBL629216
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13684,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,,,CHEMBL629217
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13685,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL629218
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13686,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,,CHEMBL629219
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13687,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL629220
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13688,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL629221
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13689,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL631127
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13690,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,,,CHEMBL631128
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13691,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL631129
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13692,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,,CHEMBL631130
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13693,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL631131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13694,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL631132
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13695,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL631133
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13696,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,,,CHEMBL631134
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13697,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL875120
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13698,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,,CHEMBL631135
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13699,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL631136
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13700,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL631137
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13701,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL631138
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13702,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,,,CHEMBL631139
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13703,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL631140
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13704,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,CHEMBL631141
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13705,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,,CHEMBL631142
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13706,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,,CHEMBL631143
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6996,50597,,,,10116.0,,13707,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,CHEMBL631144
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13708,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,,,CHEMBL631145
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13709,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,,CHEMBL631146
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13710,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,,,CHEMBL631147
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13711,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL631148
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13712,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL631149
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13713,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,,CHEMBL631150
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13714,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL631151
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13715,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL631152
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13716,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL631443
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13717,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,,CHEMBL631444
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13718,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL631445
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13719,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,,CHEMBL631446
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13720,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,,,CHEMBL631447
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13721,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,,CHEMBL631448
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13722,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,,,CHEMBL631449
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13723,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,,CHEMBL631450
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,6996,50588,,,,9615.0,,13724,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,,CHEMBL629724
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,14.0,Zone of skin,10090.0,,13725,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL629725
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,14.0,Zone of skin,10090.0,,13726,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL629726
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,2106.0,Spleen,10090.0,,13727,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL629727
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,2106.0,Spleen,10090.0,,13728,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630404
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,2106.0,Spleen,10090.0,,13729,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630405
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,2106.0,Spleen,10090.0,,13730,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630406
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,945.0,Stomach,10090.0,,13731,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630407
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,945.0,Stomach,10090.0,,13732,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630573
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,945.0,Stomach,10090.0,,13733,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630574
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,945.0,Stomach,10090.0,,13734,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630575
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,,,10090.0,,13735,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630576
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,,,10090.0,,13736,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630577
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,,,10090.0,,13737,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630578
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,9716,50594,,,,10090.0,,13738,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,In vivo,,CHEMBL630579
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,2113.0,Kidney,10090.0,,13739,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,,,CHEMBL630580
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,2113.0,Kidney,10090.0,,13740,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,,,CHEMBL630581
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,2113.0,Kidney,10090.0,,13741,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,,,CHEMBL630582
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13742,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,,,CHEMBL630583
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13743,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,,,CHEMBL630584
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13744,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,,,CHEMBL630585
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13745,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,,,CHEMBL630586
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13746,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,,,CHEMBL630587
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13747,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,,,CHEMBL630588
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13748,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,,,CHEMBL630589
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,12192,50594,,,,10090.0,,13749,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,,,CHEMBL630590
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1988.0,Feces,,,13750,Removal of 238-Plutonium(IV) in feces at 24 h,,,,CHEMBL630591
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1988.0,Feces,,,13751,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,,CHEMBL630592
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,,,,,13752,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,,CHEMBL630593
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,,,,,13753,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,,CHEMBL630594
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13754,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,,CHEMBL630595
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13755,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,,CHEMBL630596
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13756,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,,CHEMBL630597
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13757,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,,CHEMBL630598
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13758,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,,CHEMBL630599
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13759,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,,CHEMBL630600
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13760,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,,CHEMBL630601
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13761,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,,CHEMBL630602
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13762,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,,CHEMBL630603
Autocuration,BAO_0000019,,A,,1,,0,U,,12192,22224,,1088.0,Urine,,,13763,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,,CHEMBL630604
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,13764,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL624869
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,13765,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL624870
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,13766,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL623189
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,13767,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623190
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,13768,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623191
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13769,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623192
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13770,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623193
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13771,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL623194
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13772,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623195
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13773,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623196
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,,,10116.0,,13774,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,,,CHEMBL623197
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,,,10116.0,,13775,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,,CHEMBL623198
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,,,10116.0,,13776,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,,CHEMBL623199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13777,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,,,CHEMBL623200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13778,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,,,CHEMBL623201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13779,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,,,CHEMBL623202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13780,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,,,CHEMBL623203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13781,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,,,CHEMBL623204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13782,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,,,CHEMBL623205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13783,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,,CHEMBL623206
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13784,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,,,CHEMBL623207
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13785,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,,,CHEMBL623208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13786,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,,CHEMBL623209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,2385.0,Muscle tissue,10116.0,,13787,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,,CHEMBL623210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,,,10116.0,,13788,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,,CHEMBL623211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11836,50597,,995.0,Uterus,10116.0,,13789,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,,CHEMBL623212
Autocuration,BAO_0000019,,A,,1,,0,U,,12640,22224,,,,,,13790,Tested in vitro for intrinsic activity relative to quinpirole,,,,CHEMBL623213
Autocuration,BAO_0000019,,A,,1,,0,U,,14218,22224,,,,,,13791,"Relative ion enhancement, determined in pulsed ultrafiltration",,,,CHEMBL623214
Autocuration,BAO_0000019,,A,,1,,0,U,,11296,22224,,,,,,13792,% ionization at the pH 7.4 at 37 degree Centigrade,,,,CHEMBL623215
Autocuration,BAO_0000019,,A,,1,,0,U,,10929,22224,,,,,,13793,Percentage ionization was measured,,,,CHEMBL623216
Intermediate,BAO_0000218,,A,,1,Bos taurus,1,N,,13841,50591,,,,9913.0,,13794,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,,,CHEMBL623217
Autocuration,BAO_0000019,,A,,1,,0,U,,10431,22224,,,,,,13795,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,,CHEMBL623218
Autocuration,BAO_0000019,,A,,1,,0,U,,10431,22224,,,,,,13796,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,,CHEMBL623913
Autocuration,BAO_0000019,,A,,1,,0,U,,10431,22224,,,,,,13797,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,,CHEMBL623914
Autocuration,BAO_0000100,,P,,1,,0,U,,8826,22229,,,,,,13798,Compound was evaluated for the partition coefficient in octanol/water,,,,CHEMBL623915
Autocuration,BAO_0000100,,P,,1,,0,U,,8826,22229,,,,,,13799,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,,CHEMBL624080
Autocuration,BAO_0000019,,A,,1,,0,U,,9884,22224,,,,,,13800,Equilibrium constant measured by the pulse radiolysis at pH 7,,,,CHEMBL624081
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,9827,50587,,,,9606.0,,13801,In vitro hydrolytic rate constant determined in human blood,,,,CHEMBL624082
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10009,50587,,,,9606.0,,13802,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,,,CHEMBL625054
Autocuration,BAO_0000019,,A,,1,,0,U,,10009,22224,,,,,,13803,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,,CHEMBL877485
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,13804,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,,,CHEMBL625055
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,13805,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,,,CHEMBL625056
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,10009,50587,,,,9606.0,,13806,In vitro oxidation of compound in presence of human plasma,,,,CHEMBL625057
Autocuration,BAO_0000019,,A,,1,,0,U,,10009,22224,,,,,,13807,In vitro oxidation of compound in presence of hydrogen peroxide,,,,CHEMBL625058
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,13808,In vitro oxidation of compound in presence of mouse brain homogenate,,,,CHEMBL625059
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,10009,50594,,,,10090.0,,13809,In vitro oxidation of compound in presence of mouse liver homogenate,,,,CHEMBL629536
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13810,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,,CHEMBL629537
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13811,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,,CHEMBL629538
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13812,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,,CHEMBL629539
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13813,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,,CHEMBL874445
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13814,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,,CHEMBL629540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13815,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,,CHEMBL629541
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13816,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,,CHEMBL629542
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13817,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,,CHEMBL630243
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13818,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,,CHEMBL630244
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13819,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,,CHEMBL630245
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13820,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,,CHEMBL630246
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13821,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,,CHEMBL630247
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13822,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,,CHEMBL630248
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,178.0,Blood,10116.0,,13823,Biodistribution in rat blood at 240 minutes after dose administration.,,In vivo,,CHEMBL630249
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,178.0,Blood,10116.0,,13824,Biodistribution in rat blood at 30 minutes after dose administration.,,In vivo,,CHEMBL630250
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,178.0,Blood,10116.0,,13825,Biodistribution in rat blood at 360 minutes after dose administration.,,In vivo,,CHEMBL630251
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,178.0,Blood,10116.0,,13826,Biodistribution in rat blood at 3 hr after dose administration.,,In vivo,,CHEMBL630252
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,178.0,Blood,10116.0,,13827,Biodistribution in rat blood at 60 minutes after dose administration.,,In vivo,,CHEMBL630408
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13828,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,In vivo,,CHEMBL630409
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13829,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,In vivo,,CHEMBL874446
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13830,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,In vivo,,CHEMBL630410
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13831,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,In vivo,,CHEMBL630411
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13832,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,In vivo,,CHEMBL630412
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13833,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,In vivo,,CHEMBL630413
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13834,Biodistribution in rat cerebellum at 3 hr after dose administration.,,In vivo,,CHEMBL630414
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2037.0,Cerebellum,10116.0,,13835,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,In vivo,,CHEMBL630415
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13836,Biodistribution in rat cortex at 120 minutes after dose administration.,,In vivo,,CHEMBL630416
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13837,Biodistribution in rat cortex at 1440 minutes after dose administration.,,In vivo,,CHEMBL630417
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13838,Biodistribution in rat cortex at 15 minutes after dose administration.,,In vivo,,CHEMBL630418
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13839,Biodistribution in rat cortex at 240 minutes after dose administration.,,In vivo,,CHEMBL630419
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13840,Biodistribution in rat cortex at 30 minutes after dose administration.,,In vivo,,CHEMBL630420
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13841,Biodistribution in rat cortex at 360 minutes after dose administration.,,In vivo,,CHEMBL630421
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13842,Biodistribution in rat cortex at 3 hr after dose administration.,,In vivo,,CHEMBL630422
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,13843,Biodistribution in rat cortex at 60 minutes after dose administration.,,In vivo,,CHEMBL630423
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13844,Biodistribution in rat heart at 120 minutes after dose administration.,,In vivo,,CHEMBL630424
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13845,Biodistribution in rat heart at 15 minutes after dose administration.,,In vivo,,CHEMBL630425
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13846,Biodistribution in rat heart at 240 minutes after dose administration.,,In vivo,,CHEMBL629462
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13847,Biodistribution in rat heart at 30 minutes after dose administration.,,In vivo,,CHEMBL630426
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13848,Biodistribution in rat heart at 360 minutes after dose administration.,,In vivo,,CHEMBL630427
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13849,Biodistribution in rat heart at 3 hr after dose administration.,,In vivo,,CHEMBL625877
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,948.0,Heart,10116.0,,13850,Biodistribution in rat heart at 60 minutes after dose administration.,,In vivo,,CHEMBL625878
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,10000000.0,Hippocampus,10116.0,,13851,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,In vivo,,CHEMBL625879
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,10000000.0,Hippocampus,10116.0,,13852,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,In vivo,,CHEMBL625880
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,10000000.0,Hippocampus,10116.0,,13853,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,In vivo,,CHEMBL625881
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,10000000.0,Hippocampus,10116.0,,13854,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,In vivo,,CHEMBL625882
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,10000000.0,Hippocampus,10116.0,,13855,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,In vivo,,CHEMBL625883
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13856,Biodistribution in rat kidney at 120 minutes after dose administration.,,In vivo,,CHEMBL625884
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13857,Biodistribution in rat kidney at 1440 minutes after dose administration.,,In vivo,,CHEMBL625885
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13858,Biodistribution in rat kidney at 15 minutes after dose administration.,,In vivo,,CHEMBL628649
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13859,Biodistribution in rat kidney at 240 minutes after dose administration.,,In vivo,,CHEMBL628650
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13860,Biodistribution in rat kidney at 30 minutes after dose administration.,,In vivo,,CHEMBL628651
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13861,Biodistribution in rat kidney at 360 minutes after dose administration.,,In vivo,,CHEMBL628652
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2113.0,Kidney,10116.0,,13862,Biodistribution in rat kidney at 60 minutes after dose administration.,,In vivo,,CHEMBL628653
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13863,Biodistribution in rat liver at 120 minutes after dose administration.,,In vivo,,CHEMBL628654
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13864,Biodistribution in rat liver at 1440 minutes after dose administration.,,In vivo,,CHEMBL628655
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13865,Biodistribution in rat liver at 15 minutes after dose administration.,,In vivo,,CHEMBL625238
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13866,Biodistribution in rat liver at 240 minutes after dose administration.,,In vivo,,CHEMBL625239
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13867,Biodistribution in rat liver at 30 minutes after dose administration.,,In vivo,,CHEMBL625240
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13868,Biodistribution in rat liver at 360 minutes after dose administration.,,In vivo,,CHEMBL625241
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2107.0,Liver,10116.0,,13869,Biodistribution in rat liver at 60 minutes after dose administration.,,In vivo,,CHEMBL625242
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,13870,Biodistribution in rat lung at 120 minutes after dose administration.,,In vivo,,CHEMBL874587
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,13871,Biodistribution in rat lung at 1440 minutes after dose administration.,,In vivo,,CHEMBL625405
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,13872,Biodistribution in rat lung at 15 minutes after dose administration.,,In vivo,,CHEMBL625406
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,13873,Biodistribution in rat lung at 240 minutes after dose administration.,,In vivo,,CHEMBL625407
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,13874,Biodistribution in rat lung at 30 minutes after dose administration.,,In vivo,,CHEMBL625408
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,13875,Biodistribution in rat lung at 360 minutes after dose administration.,,In vivo,,CHEMBL625409
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13876,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,,,CHEMBL625410
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13877,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,,,CHEMBL625411
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13878,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,,,CHEMBL625412
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13879,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,,,CHEMBL625413
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13880,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,,,CHEMBL625414
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13881,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,,,CHEMBL625415
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12361,50597,,1515.0,Thoracic aorta,10116.0,,13882,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,,,CHEMBL625416
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12712,50597,,1088.0,Urine,10116.0,,13883,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,,,CHEMBL625417
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,1988.0,Feces,10116.0,,13884,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,,,CHEMBL625418
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,1088.0,Urine,10116.0,,13885,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,,,CHEMBL625419
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,,,10116.0,,13886,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,,,CHEMBL625420
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,,,10116.0,,13887,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,,,CHEMBL626996
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,1988.0,Feces,10116.0,,13888,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,,,CHEMBL626997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,1088.0,Urine,10116.0,,13889,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,,,CHEMBL626998
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,,,10116.0,,13890,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,,,CHEMBL626999
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,,,10090.0,,13891,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,,,CHEMBL627000
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,,,10090.0,,13892,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,,,CHEMBL627001
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,,,10090.0,,13893,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,,,CHEMBL627002
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,,,10090.0,,13894,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,,,CHEMBL627003
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13895,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,,,CHEMBL627004
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13896,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,,,CHEMBL627005
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13897,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,,,CHEMBL874594
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13898,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,,,CHEMBL627006
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13899,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,,,CHEMBL627007
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13900,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,,,CHEMBL627884
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13901,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,,,CHEMBL627885
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13902,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,,,CHEMBL627886
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13903,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,,,CHEMBL627887
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13904,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,,,CHEMBL627888
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13905,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,,,CHEMBL628057
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8050,50594,,1088.0,Urine,10090.0,,13906,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,,,CHEMBL627405
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13907,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,,CHEMBL627406
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13908,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,,CHEMBL627407
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13909,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,,CHEMBL627408
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13910,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,,CHEMBL627409
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13911,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,,CHEMBL875486
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13912,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,,CHEMBL627410
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13913,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,,CHEMBL627411
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13914,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,,CHEMBL627412
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13915,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,,CHEMBL627413
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13916,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,,CHEMBL627414
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13917,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,,CHEMBL627415
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13918,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,,,CHEMBL627416
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13919,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,,CHEMBL627417
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13920,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,,CHEMBL627418
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13921,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,,CHEMBL627419
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13922,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,,CHEMBL627320
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,13923,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,,CHEMBL627321
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,13924,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627322
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,13925,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627323
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,13926,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL627491
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,13927,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627492
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,13928,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,13929,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627494
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,13930,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,13931,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL627496
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,13932,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627497
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,13933,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,13934,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627499
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,13935,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL627500
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,13936,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL627501
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,13937,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625616
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,13938,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625617
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,13939,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625618
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,13940,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625619
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,13941,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL625620
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,13942,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625621
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,13943,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625622
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13944,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625788
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13945,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13946,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL625790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13947,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL625791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13948,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL622334
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2046.0,Thyroid gland,10116.0,,13949,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL622335
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2046.0,Thyroid gland,10116.0,,13950,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL622336
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2046.0,Thyroid gland,10116.0,,13951,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL622337
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2046.0,Thyroid gland,10116.0,,13952,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL622338
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2046.0,Thyroid gland,10116.0,,13953,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL622339
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13954,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL624153
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13955,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL628430
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13956,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL628431
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13957,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL628432
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,13958,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL628433
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13959,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,In vivo,,CHEMBL628434
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13960,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,In vivo,,CHEMBL626789
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13961,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,In vivo,,CHEMBL626790
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13962,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,In vivo,,CHEMBL626791
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13963,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,In vivo,,CHEMBL626792
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,13964,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,In vivo,,CHEMBL626793
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13965,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,,CHEMBL627436
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13966,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,,CHEMBL627437
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13967,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,,CHEMBL627438
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13968,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,,CHEMBL627439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13969,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,,CHEMBL627440
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13970,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,,CHEMBL627602
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13971,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,,CHEMBL627603
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13972,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,,CHEMBL627604
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13973,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,,CHEMBL627605
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13974,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,,CHEMBL627606
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13975,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,,CHEMBL627607
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13976,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,,CHEMBL627608
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13977,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,,CHEMBL627609
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13978,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,,CHEMBL627610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13979,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,,CHEMBL627611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,13980,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,,CHEMBL627612
Autocuration,BAO_0000100,,P,,1,,0,U,,8362,22229,,,,,,13981,Octanol:water partition coefficient is evaluated,,,,CHEMBL627613
Autocuration,BAO_0000100,,P,,1,,0,U,,8257,22224,,,,,,13982,Partition coefficient in 1-octanol/water system,,,,CHEMBL627614
Autocuration,BAO_0000100,,P,,1,,0,U,,8257,22224,,,,,,13983,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,,CHEMBL627615
Autocuration,BAO_0000100,,P,,1,,0,U,,9468,22224,,,,,,13984,Partition coefficient in octanol/water system was determined,,,,CHEMBL627616
Autocuration,BAO_0000100,,P,,1,,0,U,,9468,22224,,,,,,13985,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,,CHEMBL627617
Autocuration,BAO_0000019,,A,,1,,0,U,,10568,22224,,,,,,13986,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,,CHEMBL627618
Autocuration,BAO_0000019,,A,,1,,0,U,,10568,22224,,,,,,13987,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,,CHEMBL627619
Autocuration,BAO_0000019,,A,,1,,0,U,,15359,22224,,,,,,13988,Pseudo-first-order rate constant of the compound,,,,CHEMBL627620
Autocuration,BAO_0000019,,A,,1,,0,U,,15359,22224,,,,,,13989,Pseudo-first-order rate constant with 1-min time point,,,,CHEMBL627621
Autocuration,BAO_0000019,,A,,1,,0,U,,15359,22224,,,,,,13990,Pseudo-first-order rate constant without 1-min time point,,,,CHEMBL627622
Autocuration,BAO_0000019,,A,,1,,0,U,,10431,22224,,,,,,13991,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,,CHEMBL627623
Autocuration,BAO_0000019,,A,,1,,0,U,,10431,22224,,,,,,13992,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,,CHEMBL627624
Autocuration,BAO_0000019,,A,,1,,0,U,,10431,22224,,,,,,13993,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,,CHEMBL627625
Autocuration,BAO_0000019,,A,,1,,0,U,,15704,22224,,,,,,13994,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,,CHEMBL628523
Autocuration,BAO_0000019,,A,,1,,0,U,,15287,22224,,,,,,13995,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,,CHEMBL628524
Autocuration,BAO_0000019,,A,,1,,0,U,,7516,22224,,,,,,13996,The efflux rate constant of the compound,,,,CHEMBL628525
Autocuration,BAO_0000019,,A,,1,,0,U,,12973,22224,,,,,,13997,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,CHEMBL625732
Autocuration,BAO_0000019,,A,,1,,0,U,,12973,22224,,,,,,13998,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,CHEMBL625733
Autocuration,BAO_0000019,,F,,1,,0,U,,12973,22224,,,,,,13999,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,CHEMBL625734
Autocuration,BAO_0000019,,A,,1,,0,U,,12973,22224,,,,,,14000,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,,CHEMBL625913
Autocuration,BAO_0000019,,A,,1,,0,U,,8696,22224,,,,,,14001,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,,CHEMBL625914
Autocuration,BAO_0000019,,A,,1,,0,U,,15052,22224,,,,,,14002,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,,CHEMBL625915
Autocuration,BAO_0000019,,A,,1,,0,U,,15052,22224,,,,,,14003,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,,CHEMBL625916
Autocuration,BAO_0000019,,A,,1,,0,U,,10503,22224,,,,,,14004,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,,CHEMBL625917
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14005,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625918
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14006,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625919
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14007,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625920
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14008,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL874453
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14009,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625921
Autocuration,BAO_0000019,,A,,1,,0,U,,10503,22224,,,,,,14010,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,,CHEMBL625922
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14011,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625923
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14012,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625924
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14013,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625925
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14014,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL625926
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2048.0,Lung,10116.0,,14015,Biodistribution in rat lung at 60 minutes after dose administration.,,In vivo,,CHEMBL627704
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,14016,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,In vivo,,CHEMBL627705
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,14017,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,In vivo,,CHEMBL627706
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,14018,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,In vivo,,CHEMBL627707
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,14019,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,In vivo,,CHEMBL627708
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,14020,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,In vivo,,CHEMBL628361
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,,,10116.0,,14021,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,In vivo,,CHEMBL628362
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14022,Biodistribution in rat striatum at 120 minutes after dose administration.,,In vivo,,CHEMBL628363
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14023,Biodistribution in rat striatum at 1440 minutes after dose administration.,,In vivo,,CHEMBL628364
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14024,Biodistribution in rat striatum at 15 minutes after dose administration.,,In vivo,,CHEMBL628365
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14025,Biodistribution in rat striatum at 240 minutes after dose administration.,,In vivo,,CHEMBL874454
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14026,Biodistribution in rat striatum at 30 minutes after dose administration.,,In vivo,,CHEMBL628531
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14027,Biodistribution in rat striatum at 360 minutes after dose administration.,,In vivo,,CHEMBL628532
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14028,Biodistribution in rat striatum at 3 hr after dose administration.,,In vivo,,CHEMBL628533
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2435.0,Striatum,10116.0,,14029,Biodistribution in rat striatum at 60 minutes after dose administration.,,In vivo,,CHEMBL628534
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14030,Biodistribution in rat thyroid at 120 minutes after dose administration.,,In vivo,,CHEMBL628535
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14031,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,In vivo,,CHEMBL628536
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14032,Biodistribution in rat thyroid at 15 minutes after dose administration.,,In vivo,,CHEMBL628537
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14033,Biodistribution in rat thyroid at 240 minutes after dose administration.,,In vivo,,CHEMBL628538
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14034,Biodistribution in rat thyroid at 30 minutes after dose administration.,,In vivo,,CHEMBL628539
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14035,Biodistribution in rat thyroid at 360 minutes after dose administration.,,In vivo,,CHEMBL630297
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,2046.0,Thyroid gland,10116.0,,14036,Biodistribution in rat thyroid at 60 minutes after dose administration.,,In vivo,,CHEMBL630298
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14037,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,In vivo,,CHEMBL630299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14038,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,In vivo,,CHEMBL628094
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14039,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,In vivo,,CHEMBL628095
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14040,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,In vivo,,CHEMBL874648
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14041,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,In vivo,,CHEMBL628096
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14042,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,In vivo,,CHEMBL628097
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13100,50597,,955.0,Brain,10116.0,,14043,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,In vivo,,CHEMBL628098
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14044,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,,CHEMBL628099
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14045,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,CHEMBL628100
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14046,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,,CHEMBL628101
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14047,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,,CHEMBL628102
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14048,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,,CHEMBL628103
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14049,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,CHEMBL628104
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14050,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,,CHEMBL628105
Autocuration,BAO_0000019,,A,,1,,0,U,,13331,22224,,,,,,14051,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,,CHEMBL628106
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10086,50597,,1088.0,Urine,10116.0,,14052,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,,CHEMBL628107
Autocuration,BAO_0000218,,F,,1,,0,U,,10086,22224,,1088.0,Urine,,,14053,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,,CHEMBL628108
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10086,50597,,1088.0,Urine,10116.0,,14054,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,,CHEMBL628109
Autocuration,BAO_0000218,,F,,1,,0,U,,10086,22224,,1088.0,Urine,,,14055,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,,CHEMBL625299
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10086,50597,,1088.0,Urine,10116.0,,14056,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,,,CHEMBL625300
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10086,50597,,1088.0,Urine,10116.0,,14057,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,,,CHEMBL625301
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10086,50597,,1088.0,Urine,10116.0,,14058,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,,,CHEMBL625302
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10086,50597,,1088.0,Urine,10116.0,,14059,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,,,CHEMBL874649
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13248,50597,,,,10116.0,,14060,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,,,CHEMBL625303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13248,50597,,,,10116.0,,14061,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,,,CHEMBL625463
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14527,50587,,2107.0,Liver,9606.0,,14062,In vitro metabolism in human liver microsomes,,,,CHEMBL625464
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,3008,50587,,,,9606.0,,14063,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,,,CHEMBL625465
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14064,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,,CHEMBL625466
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14065,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,,CHEMBL625467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14066,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,,CHEMBL625468
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14067,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,,,CHEMBL625469
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14068,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,,CHEMBL625470
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14069,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,,CHEMBL632418
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14070,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,,CHEMBL627250
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14071,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,,,CHEMBL627251
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14072,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,,,CHEMBL627252
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14073,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,,CHEMBL627253
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14074,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,,,CHEMBL627254
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14075,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,,CHEMBL875471
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14076,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,,,CHEMBL627255
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14077,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,,CHEMBL627256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14078,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,,,CHEMBL627257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14079,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,,CHEMBL627258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14080,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,,,CHEMBL627259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14081,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,,CHEMBL627260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14082,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,,,CHEMBL623256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14083,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,,CHEMBL874413
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14084,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,,,CHEMBL623257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14085,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,,CHEMBL623258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14086,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,,,CHEMBL623259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14087,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,,,CHEMBL623260
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14088,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,,CHEMBL623261
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14089,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,,,CHEMBL623262
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14090,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,,,CHEMBL623263
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14091,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,,CHEMBL623264
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14092,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,,CHEMBL623265
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14093,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,,CHEMBL623266
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14094,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,,,CHEMBL623267
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14095,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,,,CHEMBL623268
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14096,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,,CHEMBL623269
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14097,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,,CHEMBL623270
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14098,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,,CHEMBL623271
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14099,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,,,CHEMBL623272
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14100,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,,CHEMBL623273
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14101,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,,,CHEMBL623274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14102,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,,CHEMBL874414
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14103,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,,,CHEMBL623275
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14104,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,,CHEMBL629150
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14105,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,,CHEMBL623276
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14106,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,,CHEMBL623277
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14107,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,,,CHEMBL623112
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14108,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,,,CHEMBL623113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14109,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,,CHEMBL623800
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14110,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,,CHEMBL623801
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14111,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,In vivo,,CHEMBL623802
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,995.0,Uterus,10116.0,,14112,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623803
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,995.0,Uterus,10116.0,,14113,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623970
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,995.0,Uterus,10116.0,,14114,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL623971
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,178.0,Blood,10116.0,,14115,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,In vivo,,CHEMBL623972
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,178.0,Blood,10116.0,,14116,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,In vivo,,CHEMBL623973
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,178.0,Blood,10116.0,,14117,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,In vivo,,CHEMBL623974
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,178.0,Blood,10116.0,,14118,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,In vivo,,CHEMBL623975
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,955.0,Brain,10116.0,,14119,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,In vivo,,CHEMBL623976
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,955.0,Brain,10116.0,,14120,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,In vivo,,CHEMBL623977
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,955.0,Brain,10116.0,,14121,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,In vivo,,CHEMBL623978
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,955.0,Brain,10116.0,,14122,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,In vivo,,CHEMBL623979
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,,,10116.0,,14123,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,In vivo,,CHEMBL623980
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,,,10116.0,,14124,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,In vivo,,CHEMBL623981
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,,,10116.0,,14125,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,In vivo,,CHEMBL626278
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14045,50597,,,,10116.0,,14126,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,In vivo,,CHEMBL626279
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14127,Biodistribution in mice bladder plus excreted urine was determined,,In vivo,,CHEMBL626280
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14128,"Percentage biodistribution in mouse blood, 10 minutes post injection",,,,CHEMBL626281
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14129,"Percentage biodistribution in mouse blood, 30 minutes post injection",,,,CHEMBL626282
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14130,"Percentage biodistribution in mouse blood, 5 minutes post injection",,,,CHEMBL626283
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14131,"Percentage biodistribution in mouse blood, 60 minutes post injection",,,,CHEMBL626284
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,955.0,Brain,10090.0,,14132,"Percentage biodistribution in mouse brain, 10 minutes post injection",,,,CHEMBL626285
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,955.0,Brain,10090.0,,14133,"Percentage biodistribution in mouse brain, 30 minutes post injection",,,,CHEMBL626286
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,955.0,Brain,10090.0,,14134,"Percentage biodistribution in mouse brain, 5 minutes post injection",,,,CHEMBL626287
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,955.0,Brain,10090.0,,14135,"Percentage biodistribution in mouse brain, 60 minutes post injection",,,,CHEMBL626288
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14136,"Percentage biodistribution in mouse heart, 10 minutes post injection",,,,CHEMBL626289
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14137,"Percentage biodistribution in mouse heart, 30 minutes post injection",,,,CHEMBL626290
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14138,"Percentage biodistribution in mouse heart, 5 minutes post injection",,,,CHEMBL626291
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14139,"Percentage biodistribution in mouse heart, 60 minutes post injection",,,,CHEMBL839888
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,160.0,Intestine,10090.0,,14140,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,,,CHEMBL626292
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,160.0,Intestine,10090.0,,14141,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,,,CHEMBL626293
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,160.0,Intestine,10090.0,,14142,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,,,CHEMBL626294
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,160.0,Intestine,10090.0,,14143,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,,,CHEMBL626295
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2107.0,Liver,10090.0,,14144,"Percentage biodistribution in mouse liver, 10 minutes post injection",,,,CHEMBL627659
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2107.0,Liver,10090.0,,14145,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,,,CHEMBL627660
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2107.0,Liver,10090.0,,14146,"Percentage biodistribution in mouse liver, 5 minutes post injection",,,,CHEMBL627661
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2107.0,Liver,10090.0,,14147,Biodistribution in mice liver at 60 minutes of post injection,,In vivo,,CHEMBL627662
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2048.0,Lung,10090.0,,14148,Biodistribution in mice lungs at 10 min of post injection,,In vivo,,CHEMBL627663
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14149,"Percentage biodistribution in mouse lung, 30 minutes post injection",,,,CHEMBL627664
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,,,10090.0,,14150,"Percentage biodistribution in mousee lung, 5 minutes post injection",,,,CHEMBL627665
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2048.0,Lung,10090.0,,14151,Biodistribution in mice lungs at 60 min of post injection,,In vivo,,CHEMBL627666
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,2106.0,Spleen,10090.0,,14152,Percentage biodistribution in mouse spleen,,,,CHEMBL627667
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14045,50594,,945.0,Stomach,10090.0,,14153,Percentage biodistribution in mouse stomach,,,,CHEMBL627668
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,11745,50594,,1088.0,Urine,10090.0,,14154,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,,,CHEMBL627669
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1255.0,Urinary bladder,,,14155,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,In vivo,,CHEMBL627670
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,178.0,Blood,,,14156,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,In vivo,,CHEMBL627671
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1474.0,Bone element,,,14157,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,In vivo,,CHEMBL627672
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14158,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,In vivo,,CHEMBL627673
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2113.0,Kidney,,,14159,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,In vivo,,CHEMBL627674
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2107.0,Liver,,,14160,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,In vivo,,CHEMBL627675
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2048.0,Lung,,,14161,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,In vivo,,CHEMBL627676
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14162,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,In vivo,,CHEMBL627677
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14163,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,,CHEMBL627678
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7095,50597,,1977.0,Serum,10116.0,,14164,Affinity for protein binding expressed as association constant in fresh rat serum,,,,CHEMBL627679
Autocuration,BAO_0000019,,A,,1,,0,U,,12185,22224,,,,,,14165,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,CHEMBL627680
Autocuration,BAO_0000019,,A,,1,,0,U,,12185,22224,,,,,,14166,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,CHEMBL627681
Autocuration,BAO_0000019,,A,,1,,0,U,,12185,22224,,,,,,14167,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,CHEMBL627682
Autocuration,BAO_0000019,,A,,1,,0,U,,12185,22224,,,,,,14168,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,CHEMBL627683
Autocuration,BAO_0000019,,A,,1,,0,U,,12686,22224,,,,,,14169,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,,CHEMBL627684
Autocuration,BAO_0000019,,A,,1,,0,U,,12686,22224,,,,,,14170,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,CHEMBL874441
Autocuration,BAO_0000019,,A,,1,,0,U,,12686,22224,,,,,,14171,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,,CHEMBL627685
Autocuration,BAO_0000019,,A,,1,,0,U,,12686,22224,,,,,,14172,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,CHEMBL627686
Autocuration,BAO_0000019,,A,,1,,0,U,,8057,22224,,,,,,14173,Apparent rate constant Koff for inactivation of dTMP synthase.,,,,CHEMBL627687
Autocuration,BAO_0000019,,A,,1,,0,U,,15778,22224,,,,,,14174,The irreversible inhibitor activity by second order rate equation.,,,,CHEMBL627688
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12375,50597,,,,10116.0,,14175,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,,,CHEMBL628038
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12375,50597,,,,10116.0,,14176,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,,,CHEMBL628039
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12375,50597,,,,10116.0,,14177,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,,,CHEMBL628040
Autocuration,BAO_0000019,,A,,1,,0,U,,13588,22224,,,,,,14178,Dissociation rate calculated from the first-order equation using t1/2 value,,,,CHEMBL628041
Autocuration,BAO_0000019,,A,,1,,0,U,,15039,22224,,,,,,14179,The compound was tested for Binding constant against DNA,,,,CHEMBL630226
Autocuration,BAO_0000019,,A,,1,,0,U,,9500,22224,,,,,,14180,First order rate constant for cyclization of the compound,,,,CHEMBL628042
Autocuration,BAO_0000019,,A,,1,,0,U,,10014,22224,,,,,,14181,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,CHEMBL625232
Autocuration,BAO_0000019,,A,,1,,0,U,,10014,22224,,,,,,14182,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,CHEMBL625233
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14183,Hydrolysis rate constant was determined,,,,CHEMBL625979
Autocuration,BAO_0000019,,A,,1,,0,U,,10026,22224,,,,,,14184,Observed first order rate constant,,,,CHEMBL625980
Autocuration,BAO_0000019,,A,,1,,0,U,,10281,22224,,,,,,14185,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,CHEMBL625981
Autocuration,BAO_0000019,,A,,1,,0,U,,10281,22224,,,,,,14186,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,CHEMBL625982
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14187,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,,CHEMBL625983
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14188,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625984
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14189,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625985
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14190,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625986
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14191,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625987
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14192,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625988
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14193,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625989
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14194,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625990
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14195,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625991
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14196,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625992
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14197,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL625993
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14198,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL631973
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14199,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632143
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14200,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632144
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14201,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632145
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14202,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632146
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14203,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632147
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14204,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632148
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14205,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632149
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14206,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632150
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14207,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL632151
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,3008,50587,,,,9606.0,,14208,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,,,CHEMBL632152
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,4509,50587,,,,9606.0,,14209,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,,CHEMBL632153
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,4509,50587,,,,9606.0,,14210,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,,CHEMBL632154
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14211,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,,,CHEMBL632155
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14212,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,,,CHEMBL632156
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14213,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,,,CHEMBL632157
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14214,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,,,CHEMBL632158
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14215,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,,,CHEMBL632159
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14216,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,,,CHEMBL626305
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14217,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,,,CHEMBL626306
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,,,CHEMBL626307
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14219,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,,,CHEMBL626308
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14220,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,,,CHEMBL626479
Intermediate,BAO_0000218,,A,,1,Human herpesvirus 1,1,N,,8613,50602,,,,10298.0,,14221,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,,,CHEMBL626480
Autocuration,BAO_0000100,,P,,1,,0,U,,6021,22229,,,,,,14222,Calculated partition coefficient (clogP) (MlogP),,,,CHEMBL626481
Autocuration,BAO_0000019,,A,,1,,0,U,,9348,22224,,,,,,14223,Equipotent potent ratio relative to carbachol (nicotinic activity),,,,CHEMBL626482
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,,,9615.0,,14224,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,,,CHEMBL626483
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,,,9615.0,,14225,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,,,CHEMBL626484
Autocuration,BAO_0000100,,P,,1,,0,U,,15592,22229,,,,,,14226,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,,CHEMBL626485
Autocuration,BAO_0000100,,P,,1,,0,U,,15592,22229,,,,,,14227,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,,CHEMBL626486
Autocuration,BAO_0000100,,P,,1,,0,U,,15592,22229,,,,,,14228,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,,CHEMBL626487
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,15592,50588,,1969.0,Plasma,9615.0,,14229,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,In vivo,,CHEMBL626488
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7095,50597,,1977.0,Serum,10116.0,,14230,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,,,CHEMBL626489
Autocuration,BAO_0000019,,A,,1,,0,U,,16618,22224,,,,,,14231,Area under the MAP curve measured over 5 min; ND means Not determined,,,,CHEMBL626490
Autocuration,BAO_0000100,,P,,1,,0,U,,16835,22224,,,,,,14232,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,,CHEMBL626491
Autocuration,BAO_0000100,,P,,1,,0,U,,15284,22229,,,,,,14233,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,,CHEMBL626492
Autocuration,BAO_0000019,,A,,1,,0,U,,15750,22224,,,,,,14234,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,,CHEMBL626493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16618,50597,,,,10116.0,,14235,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,In vivo,,CHEMBL626494
Autocuration,BAO_0000218,,A,,1,,0,U,,16618,22224,,,,,,14236,Half life after oral tested,,In vivo,,CHEMBL626495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15812,50597,,1969.0,Plasma,10116.0,,14237,Half life was determined in plasma of rat; NT indicates not tested,,,,CHEMBL626496
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,16618,50597,,,,10116.0,,14238,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,In vivo,,CHEMBL626497
Autocuration,BAO_0000218,,A,,1,,0,U,,16618,22224,,,,,,14239,Oral bioavailability after oral tested,,In vivo,,CHEMBL626498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13098,50597,,,,10116.0,,14240,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,,,CHEMBL626499
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13098,50597,,,,10116.0,,14241,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,,,CHEMBL626500
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15812,50597,,1969.0,Plasma,10116.0,,14242,half life was determined in plasma of rat; NT indicates not tested,,,,CHEMBL626501
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15812,50597,,1969.0,Plasma,10116.0,,14243,half life was determined in plasma of rat; NT means not tested,,,,CHEMBL626502
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14244,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,,,CHEMBL626503
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14245,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,,,CHEMBL626504
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14246,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,,,CHEMBL626505
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14247,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,,,CHEMBL626506
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14248,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,,,CHEMBL626507
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14249,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,,,CHEMBL626508
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14250,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,,,CHEMBL626509
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14251,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,,,CHEMBL875480
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14252,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,,,CHEMBL626510
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14253,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,,,CHEMBL626511
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14254,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,,,CHEMBL626512
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14255,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,,,CHEMBL628208
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14256,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,,,CHEMBL628209
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14257,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,,,CHEMBL628210
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14258,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,,,CHEMBL628211
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14259,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,,,CHEMBL628212
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14260,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,,,CHEMBL628213
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14261,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,,CHEMBL628214
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14262,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,,CHEMBL628215
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14263,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,,CHEMBL628216
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14264,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,,CHEMBL626595
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14265,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,,CHEMBL626596
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14266,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,,CHEMBL626597
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14267,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,,CHEMBL626598
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14268,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,,CHEMBL622242
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14269,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,,CHEMBL622243
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14270,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,,CHEMBL622244
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14271,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,,CHEMBL622245
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14272,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,,CHEMBL622246
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14273,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,,CHEMBL622247
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14274,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,,CHEMBL622248
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14275,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,,CHEMBL877483
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14276,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,,CHEMBL622249
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14277,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,,CHEMBL622250
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14278,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,,CHEMBL622251
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14279,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,,CHEMBL622252
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14280,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,,CHEMBL622253
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14281,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,,CHEMBL622254
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14282,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,,CHEMBL622255
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14283,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,,CHEMBL622256
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14284,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,,CHEMBL622257
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14285,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,,CHEMBL622258
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14286,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,,CHEMBL622259
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14287,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,,CHEMBL622927
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14288,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,,CHEMBL622928
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14289,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,,CHEMBL622929
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14290,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,,CHEMBL623182
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14291,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,,CHEMBL623183
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14292,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,,,CHEMBL623184
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14293,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,,CHEMBL623185
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14294,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,,CHEMBL877484
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14295,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,,CHEMBL627274
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14296,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,,,CHEMBL623186
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14297,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,,,CHEMBL623187
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14298,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,,CHEMBL623188
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14299,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,,,CHEMBL628055
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14300,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,,CHEMBL628056
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14301,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,,,CHEMBL628200
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14302,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,,CHEMBL628201
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14303,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,,,CHEMBL628202
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14304,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,,CHEMBL628203
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14305,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,,,CHEMBL628204
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14306,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,,CHEMBL628205
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14307,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,,,CHEMBL628206
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14308,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,In vivo,,CHEMBL628207
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14309,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,In vivo,,CHEMBL627220
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14310,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,In vivo,,CHEMBL627221
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14311,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,In vivo,,CHEMBL627222
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14312,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,In vivo,,CHEMBL627223
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14313,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,In vivo,,CHEMBL632062
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2106.0,Spleen,,,14314,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,In vivo,,CHEMBL632063
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1255.0,Urinary bladder,,,14315,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,In vivo,,CHEMBL632064
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,178.0,Blood,,,14316,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,In vivo,,CHEMBL632065
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1474.0,Bone element,,,14317,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,In vivo,,CHEMBL632066
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14318,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,In vivo,,CHEMBL632067
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2113.0,Kidney,,,14319,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,In vivo,,CHEMBL629188
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2107.0,Liver,,,14320,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,In vivo,,CHEMBL629189
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2048.0,Lung,,,14321,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,In vivo,,CHEMBL629190
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14322,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,In vivo,,CHEMBL629191
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14323,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,In vivo,,CHEMBL629192
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14324,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,In vivo,,CHEMBL629193
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14325,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,In vivo,,CHEMBL629194
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14326,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,In vivo,,CHEMBL629195
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14327,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,In vivo,,CHEMBL629373
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2106.0,Spleen,,,14328,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,In vivo,,CHEMBL629374
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14329,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,In vivo,,CHEMBL629375
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1255.0,Urinary bladder,,,14330,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,In vivo,,CHEMBL629376
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,178.0,Blood,,,14331,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,In vivo,,CHEMBL629377
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1474.0,Bone element,,,14332,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,In vivo,,CHEMBL629378
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14333,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,In vivo,,CHEMBL629379
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2113.0,Kidney,,,14334,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,In vivo,,CHEMBL629151
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2107.0,Liver,,,14335,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,In vivo,,CHEMBL629152
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2048.0,Lung,,,14336,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,In vivo,,CHEMBL629153
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14337,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,In vivo,,CHEMBL629154
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14338,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,In vivo,,CHEMBL629155
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14339,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,In vivo,,CHEMBL629156
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14340,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,In vivo,,CHEMBL629157
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14341,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,In vivo,,CHEMBL629158
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14342,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,In vivo,,CHEMBL629159
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14343,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,In vivo,,CHEMBL629160
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2106.0,Spleen,,,14344,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,In vivo,,CHEMBL629161
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1255.0,Urinary bladder,,,14345,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,In vivo,,CHEMBL629162
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,178.0,Blood,,,14346,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,In vivo,,CHEMBL629163
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1474.0,Bone element,,,14347,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,In vivo,,CHEMBL629164
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14348,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,In vivo,,CHEMBL629165
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2107.0,Liver,,,14349,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,In vivo,,CHEMBL629166
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2048.0,Lung,,,14350,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,In vivo,,CHEMBL629167
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14351,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,In vivo,,CHEMBL629168
Autocuration,BAO_0000019,,A,,1,,0,U,,2193,22224,,,,,,14352,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,,CHEMBL629169
Autocuration,BAO_0000019,,A,,1,,0,U,,2193,22224,,,,,,14353,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,,CHEMBL629170
Autocuration,BAO_0000019,,A,,1,,0,U,,2193,22224,,,,,,14354,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,,CHEMBL631153
Autocuration,BAO_0000019,,A,,1,,0,U,,2193,22224,,,,,,14355,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,,CHEMBL875121
Autocuration,BAO_0000019,,A,,1,,0,U,,2193,22224,,,,,,14356,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,,CHEMBL631154
Autocuration,BAO_0000019,,A,,1,,0,U,,2193,22224,,,,,,14357,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,,CHEMBL631155
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14358,Hydrolysis rate constant was determined,,,,CHEMBL631156
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14359,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,,CHEMBL631157
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14360,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,CHEMBL631158
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14361,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,CHEMBL631159
Autocuration,BAO_0000019,,A,,1,,0,U,,10026,22224,,,,,,14362,Observed second order rate constant,,,,CHEMBL631160
Autocuration,BAO_0000019,,A,,1,,0,U,,10281,22224,,,,,,14363,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,CHEMBL631161
Autocuration,BAO_0000019,,A,,1,,0,U,,10014,22224,,,,,,14364,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,CHEMBL631162
Autocuration,BAO_0000019,,A,,1,,0,U,,10014,22224,,,,,,14365,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,CHEMBL630313
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14366,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,CHEMBL630314
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14367,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,CHEMBL630315
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14368,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630316
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14369,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630986
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14370,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630987
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14371,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630988
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14372,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630989
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14373,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630990
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14374,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630991
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14375,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630992
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14376,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630993
Autocuration,BAO_0000019,,A,,1,,0,U,,13028,22224,,,,,,14377,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,CHEMBL630994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10014,50597,,,,10116.0,,14378,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,,,CHEMBL630995
Autocuration,BAO_0000019,,A,,1,,0,U,,9962,22224,,,,,,14379,Association constant for compound at 31 degree C was determined,,,,CHEMBL629252
Autocuration,BAO_0000019,,A,,1,,0,U,,12029,22224,,,,,,14380,Calculated antagonist equilibrium dissociation constant of the compound,,,,CHEMBL629253
Autocuration,BAO_0000019,,A,,1,,0,U,,12029,22224,,,,,,14381,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,,CHEMBL629944
Intermediate,BAO_0000218,,A,,1,Cavia porcellus,1,N,,10583,50512,,3126.0,Trachea,10141.0,,14382,Dissociation constants vs LTE4 on guinea pig trachea,,,,CHEMBL629945
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14383,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,,CHEMBL629946
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14384,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,,CHEMBL629947
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14385,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,,CHEMBL629948
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14386,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,,CHEMBL856024
Autocuration,BAO_0000019,,A,,1,,0,U,,7493,22224,,,,,,14387,Affinity constant KD value was derived from TMP,,,,CHEMBL629949
Autocuration,BAO_0000019,,A,,1,,0,U,,8371,22224,,,,,,14388,Apparent dissociation (binding) rate constant was evaluated,,,,CHEMBL629950
Autocuration,BAO_0000100,,P,,1,,0,U,,13114,22224,,,,,,14389,Dissociation constant (KD) of the compound,,,,CHEMBL630127
Autocuration,BAO_0000100,,P,,1,,0,U,,15515,22224,,,,,,14390,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,,CHEMBL630128
Autocuration,BAO_0000100,,P,,1,,0,U,,522,22224,,,,,,14391,Dissociation constant from ESR titration experiments,,,,CHEMBL630129
Autocuration,BAO_0000019,,,,1,,0,U,,13888,22224,,,,,,14392,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,,CHEMBL630130
Autocuration,BAO_0000100,,P,,1,,0,U,,2616,22224,,,,,,14393,Dissociation constant was evaluated.,,,,CHEMBL875234
Autocuration,BAO_0000100,,P,,1,,0,U,,3798,22224,,,,,,14394,Dissociation constant was reported,,,,CHEMBL630131
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,8731,50597,,,,10116.0,,14395,Dissociation constant was determined in rat pituitary cells.,,,,CHEMBL630132
Autocuration,BAO_0000019,,A,,1,,0,U,,11892,22224,,,,,,14396,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,,CHEMBL630133
Autocuration,BAO_0000019,,A,,1,,0,U,,11892,22224,,,,,,14397,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,,CHEMBL630134
Autocuration,BAO_0000019,,A,,1,,0,U,,2582,22224,,,,,,14398,Equilibrium dissociation constant of the compound,,,,CHEMBL630135
Autocuration,BAO_0000019,,A,,1,,0,U,,11892,22224,,,,,,14399,Equilibrium dissociation constant was determined,,,,CHEMBL630136
Autocuration,BAO_0000019,,A,,1,,0,U,,13396,22224,,,,,,14400,Kinetic constant KD was evaluated,,,,CHEMBL630137
Autocuration,BAO_0000019,,A,,1,,0,U,,603,22224,,,,,,14401,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,,CHEMBL630138
Autocuration,BAO_0000019,,A,,1,,0,U,,15673,22224,,,,,,14402,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,,CHEMBL630139
Autocuration,BAO_0000019,,A,,1,,0,U,,10368,22224,,,,,,14403,Rate constant for hydrolysis in aqueous acetone.,,,,CHEMBL630140
Autocuration,BAO_0000019,,A,,1,,0,U,,14228,22224,,,,,,14404,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,,CHEMBL875235
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14405,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,,,CHEMBL876439
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14406,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,,,CHEMBL630605
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14407,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,,,CHEMBL630606
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14408,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,,,CHEMBL630607
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14409,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,,,CHEMBL630608
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14410,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,,,CHEMBL630609
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14411,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,,,CHEMBL630610
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14412,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,,,CHEMBL630611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14413,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,,,CHEMBL629552
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14414,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,,CHEMBL629733
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14415,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,,CHEMBL629734
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14416,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,,CHEMBL629735
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14417,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,,CHEMBL629736
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14418,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,,CHEMBL629737
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14419,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,,CHEMBL629738
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14420,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,,CHEMBL629739
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14421,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,,CHEMBL629740
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14422,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,,CHEMBL629741
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14423,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,,CHEMBL629742
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14424,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,,CHEMBL629743
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14425,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,,CHEMBL629744
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14426,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,,CHEMBL629745
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14427,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,,CHEMBL629746
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14428,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,,CHEMBL629747
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14429,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,,CHEMBL629748
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14430,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,,CHEMBL629749
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14431,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,,CHEMBL629750
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14432,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,,CHEMBL629751
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14433,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,,CHEMBL629752
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14434,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,,CHEMBL629753
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14435,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,,CHEMBL629754
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14436,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,,CHEMBL629755
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14437,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,,CHEMBL629756
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14438,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,,CHEMBL629757
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14439,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,,CHEMBL629758
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14440,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,,CHEMBL629759
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14441,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,,CHEMBL629760
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11510,50597,,,,10116.0,,14442,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,,CHEMBL876443
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8310,50588,,,,9615.0,,14443,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,,,CHEMBL629761
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8310,50588,,,,9615.0,,14444,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,,,CHEMBL629762
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14445,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,CHEMBL629763
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14446,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,,CHEMBL629764
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14447,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,,CHEMBL629765
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14448,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,,,CHEMBL629766
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14449,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,CHEMBL629767
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8310,50588,,,,9615.0,,14450,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,,,CHEMBL629768
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14451,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,,,CHEMBL629769
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8310,50588,,,,9615.0,,14452,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,,,CHEMBL629770
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,8310,50588,,,,9615.0,,14453,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,,,CHEMBL629771
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14454,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,CHEMBL629772
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14455,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,CHEMBL629773
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14456,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,,CHEMBL625455
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14457,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,,,CHEMBL625456
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,8310,50594,,,,10090.0,,14458,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,,,CHEMBL625457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14459,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,,CHEMBL625458
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14460,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,,,CHEMBL625459
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14461,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,,CHEMBL875483
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14462,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,,,CHEMBL634779
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14463,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,,,CHEMBL625460
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14464,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,,CHEMBL626117
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14465,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,,,CHEMBL626118
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14466,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,,,CHEMBL628342
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14467,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,,CHEMBL628343
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14468,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,,CHEMBL628344
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14469,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,,CHEMBL628345
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14470,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,,,CHEMBL628346
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14471,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,,,CHEMBL628347
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14472,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,,CHEMBL628348
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14473,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,,CHEMBL628349
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14474,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,,CHEMBL875611
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14475,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,,,CHEMBL628350
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14476,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,,CHEMBL628351
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14477,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,,,CHEMBL628352
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14478,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,,CHEMBL628353
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14479,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,,,CHEMBL628354
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14480,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,,CHEMBL626667
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14481,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,,CHEMBL626668
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14482,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,,CHEMBL626669
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14483,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,,,CHEMBL626670
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14484,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,,,CHEMBL626671
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14485,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,,CHEMBL626672
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14486,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,,,CHEMBL626673
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14487,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,,CHEMBL626674
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14488,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,,CHEMBL626675
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14489,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,,,CHEMBL626676
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14490,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,,,CHEMBL626677
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14491,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,,CHEMBL626678
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14492,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,,CHEMBL626679
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14493,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,,CHEMBL875612
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14494,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,,CHEMBL626680
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14495,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,,CHEMBL626681
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14496,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,,CHEMBL626682
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14497,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,,CHEMBL626683
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14498,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,,CHEMBL626684
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14499,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,,CHEMBL626685
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14500,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,,CHEMBL626686
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14501,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,,CHEMBL626687
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14502,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,,CHEMBL624978
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14503,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,,CHEMBL624979
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14504,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,,CHEMBL624980
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14505,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,,CHEMBL624981
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14506,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,,CHEMBL624982
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14507,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,In vivo,,CHEMBL627564
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14508,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,In vivo,,CHEMBL627565
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14509,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,In vivo,,CHEMBL627566
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14510,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,In vivo,,CHEMBL627567
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2106.0,Spleen,,,14511,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,In vivo,,CHEMBL627568
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2113.0,Kidney,,,14512,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,In vivo,,CHEMBL627569
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1255.0,Urinary bladder,,,14513,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,In vivo,,CHEMBL627570
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,178.0,Blood,,,14514,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,In vivo,,CHEMBL627571
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,1474.0,Bone element,,,14515,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,In vivo,,CHEMBL627572
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14516,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,In vivo,,CHEMBL627573
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2113.0,Kidney,,,14517,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,In vivo,,CHEMBL627574
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2107.0,Liver,,,14518,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,In vivo,,CHEMBL627575
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2048.0,Lung,,,14519,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,In vivo,,CHEMBL627576
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14520,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,In vivo,,CHEMBL627577
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14521,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,In vivo,,CHEMBL627578
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14522,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,In vivo,,CHEMBL627579
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14523,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,In vivo,,CHEMBL627580
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14524,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,In vivo,,CHEMBL627581
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,,,,,14525,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,In vivo,,CHEMBL627582
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14526,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,In vivo,,CHEMBL627583
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2106.0,Spleen,,,14527,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,In vivo,,CHEMBL627584
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2367.0,Prostate gland,,,14528,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,In vivo,,CHEMBL627585
Autocuration,BAO_0000218,,A,,1,,0,U,,13257,22224,,2385.0,Muscle tissue,,,14529,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,In vivo,,CHEMBL627586
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14530,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,In vivo,,CHEMBL627587
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14531,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL627588
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14532,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,In vivo,,CHEMBL628250
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14533,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628251
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14534,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,In vivo,,CHEMBL628252
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14535,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628253
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14536,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,In vivo,,CHEMBL628254
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14537,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL877493
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14538,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628255
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14539,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628256
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14540,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628257
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14541,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628258
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14542,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628259
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14543,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL628429
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14544,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,In vivo,,CHEMBL626862
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14545,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,In vivo,,CHEMBL626863
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,2037.0,Cerebellum,10116.0,,14546,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,In vivo,,CHEMBL625886
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,2037.0,Cerebellum,10116.0,,14547,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,In vivo,,CHEMBL625887
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14548,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,In vivo,,CHEMBL625888
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14549,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,In vivo,,CHEMBL625889
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14550,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,In vivo,,CHEMBL625890
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14551,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,In vivo,,CHEMBL625891
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14552,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,In vivo,,CHEMBL625892
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14553,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,In vivo,,CHEMBL625893
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,2037.0,Cerebellum,10116.0,,14554,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,In vivo,,CHEMBL625894
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,,,10116.0,,14555,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,In vivo,,CHEMBL625895
Autocuration,BAO_0000019,,A,,1,,0,U,,12404,22224,,,,,,14556,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,CHEMBL625896
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14557,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,,CHEMBL625897
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14558,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,CHEMBL625898
Autocuration,BAO_0000019,,A,,1,,0,U,,568,22224,,,,,,14559,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,CHEMBL625899
Autocuration,BAO_0000019,,A,,1,,0,U,,12404,22224,,,,,,14560,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,CHEMBL626124
Intermediate,BAO_0000218,,A,,1,Escherichia coli,1,N,,7624,50212,,,,562.0,,14561,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,,,CHEMBL628500
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7624,50597,,,,10116.0,,14562,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,,,CHEMBL857856
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7624,50597,,,,10116.0,,14563,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,,,CHEMBL628501
Autocuration,BAO_0000019,,A,,1,,0,U,,4643,22224,,,,,,14564,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,,CHEMBL628502
Autocuration,BAO_0000019,,A,,1,,0,U,,11532,22224,,,,,,14565,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,,CHEMBL628503
Autocuration,BAO_0000019,,A,,1,,0,U,,11018,22224,,,,,,14566,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,,CHEMBL628504
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14567,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,CHEMBL628505
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14568,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,,CHEMBL874452
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14569,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,,CHEMBL628506
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14570,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,CHEMBL628507
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14571,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,,CHEMBL628508
Autocuration,BAO_0000019,,A,,1,,0,U,,8949,22224,,,,,,14572,Michaelis constant (KM) was evaluated,,,,CHEMBL628509
Autocuration,BAO_0000019,,A,,1,,0,U,,12404,22224,,,,,,14573,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,CHEMBL628510
Autocuration,BAO_0000019,,B,,1,,0,U,,7625,22224,,,,,,14574,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,,CHEMBL628511
Autocuration,BAO_0000019,,B,,1,,0,U,,7625,22224,,,,,,14575,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,,CHEMBL628512
Autocuration,BAO_0000019,,B,,1,,0,U,,7625,22224,,,,,,14576,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,,CHEMBL628513
Autocuration,BAO_0000019,,B,,1,,0,U,,7625,22224,,,,,,14577,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,,CHEMBL628514
Autocuration,BAO_0000019,,A,,1,,0,U,,12908,22224,,,,,,14578,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,,CHEMBL628515
Autocuration,BAO_0000019,,A,,1,,0,U,,10368,22224,,,,,,14579,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,,CHEMBL628516
Autocuration,BAO_0000019,,A,,1,,0,U,,13108,22224,,,,,,14580,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,CHEMBL628517
Autocuration,BAO_0000019,,A,,1,,0,U,,13108,22224,,,,,,14581,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,CHEMBL628518
Autocuration,BAO_0000019,,A,,1,,0,U,,15217,22224,,,,,,14582,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,,CHEMBL628519
Autocuration,BAO_0000019,,A,,1,,0,U,,15217,22224,,,,,,14583,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,,CHEMBL628520
Autocuration,BAO_0000019,,A,,1,,0,U,,10933,22224,,,,,,14584,Binding constant was determined,,,,CHEMBL628521
Autocuration,BAO_0000019,,A,,1,,0,U,,2363,22224,,,,,,14585,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,,CHEMBL630443
Autocuration,BAO_0000019,,A,,1,,0,U,,2363,22224,,,,,,14586,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,,CHEMBL630444
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14587,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,,CHEMBL857732
Autocuration,BAO_0000100,,P,,1,,0,U,,14915,22224,,,,,,14588,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,,CHEMBL630445
Autocuration,BAO_0000019,,A,,1,,0,U,,8847,22224,,,,,,14589,Catalytic rate constant of the compound,,,,CHEMBL630446
Autocuration,BAO_0000019,,B,,1,,0,U,,15357,22224,,,,,,14590,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,,CHEMBL630447
Autocuration,BAO_0000019,,A,,1,,0,U,,2869,22224,,,,,,14591,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,,CHEMBL630448
Autocuration,BAO_0000019,,A,,1,,0,U,,3484,22224,,,,,,14592,Catalytic rate constant against phospholipase A2 was determined,,,,CHEMBL630449
Autocuration,BAO_0000019,,A,,1,,0,U,,1373,22224,,,,,,14593,"Compound was evaluated for catalytic constant, Kcat",,,,CHEMBL630450
Autocuration,BAO_0000019,,A,,1,,0,U,,8142,22224,,,,,,14594,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,,CHEMBL630451
Autocuration,BAO_0000019,,A,,1,,0,U,,14131,22224,,,,,,14595,Kcat calculated from 0.693/T1/2,,,,CHEMBL630452
Autocuration,BAO_0000019,,A,,1,,0,U,,17269,22224,,,,,,14596,Kcat was determined,,,,CHEMBL630453
Autocuration,BAO_0000019,,A,,1,,0,U,,3485,22224,,,,,,14597,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,,CHEMBL630454
Autocuration,BAO_0000019,,A,,1,,0,U,,3485,22224,,,,,,14598,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,,CHEMBL630455
Autocuration,BAO_0000019,,A,,1,,0,U,,3485,22224,,,,,,14599,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,,CHEMBL631487
Autocuration,BAO_0000019,,A,,1,,0,U,,5962,22224,,,,,,14600,Kcat value was determined,,,,CHEMBL631488
Autocuration,BAO_0000019,,A,,1,,0,U,,3133,22224,,,,,,14601,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,,CHEMBL876440
Autocuration,BAO_0000019,,A,,1,,0,U,,3133,22224,,,,,,14602,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,,CHEMBL631489
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14603,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,CHEMBL857742
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14604,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,CHEMBL631490
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14605,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,,CHEMBL631491
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14606,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,CHEMBL631492
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14607,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,CHEMBL631493
Autocuration,BAO_0000019,,A,,1,,0,U,,4892,22224,,,,,,14608,Kinetic parameter for rate of conversion to PABA was determined,,,,CHEMBL631494
Autocuration,BAO_0000019,,A,,1,,0,U,,3133,22224,,,,,,14609,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,CHEMBL631495
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1988.0,Feces,10116.0,,14610,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,,CHEMBL631496
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1088.0,Urine,10116.0,,14611,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,,CHEMBL631497
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1088.0,Urine,10116.0,,14612,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,,CHEMBL631498
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1088.0,Urine,10116.0,,14613,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,,CHEMBL629776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1088.0,Urine,10116.0,,14614,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,,CHEMBL629777
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,1088.0,Urine,10116.0,,14615,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,,CHEMBL629778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14616,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,,,CHEMBL630456
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14617,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,,,CHEMBL630457
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14618,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,,,CHEMBL630458
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14619,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,,,CHEMBL630459
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14620,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,,,CHEMBL630460
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14621,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,,,CHEMBL876550
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14622,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,,,CHEMBL630461
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14623,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,,,CHEMBL630462
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14624,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,,,CHEMBL630463
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14625,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,,,CHEMBL630464
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14626,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,,,CHEMBL630465
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14627,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,,,CHEMBL630466
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14628,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,,,CHEMBL630467
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14629,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,,,CHEMBL630633
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14630,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,,,CHEMBL630634
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14631,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,,,CHEMBL630635
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14632,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,,,CHEMBL630636
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,11488,50597,,,,10116.0,,14633,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,,,CHEMBL630637
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14634,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,,CHEMBL630638
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14635,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,,CHEMBL630639
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14636,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,,CHEMBL630640
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14637,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,,CHEMBL876551
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14638,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,,,CHEMBL630641
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14639,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,,CHEMBL630642
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14640,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,,CHEMBL630643
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14641,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,,CHEMBL630644
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14642,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,,CHEMBL630645
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14643,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,,CHEMBL625599
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14644,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,,CHEMBL625600
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14645,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,,CHEMBL625601
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1988.0,Feces,9986.0,,14646,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,,CHEMBL625602
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14647,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,,,CHEMBL627470
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14648,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,,CHEMBL627471
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14649,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,,CHEMBL627472
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14650,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,,CHEMBL627473
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,7132,50592,,1088.0,Urine,9986.0,,14651,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,,CHEMBL627474
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,178.0,Blood,10116.0,,14652,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL627475
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,178.0,Blood,10116.0,,14653,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL627476
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14654,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,,CHEMBL627477
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14655,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,,CHEMBL627478
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14656,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,,CHEMBL627479
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14657,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,,CHEMBL627480
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14658,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,,CHEMBL627481
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14659,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,,CHEMBL627482
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14660,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,,CHEMBL627483
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14661,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,,CHEMBL875636
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14662,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,,CHEMBL625764
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14663,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,,CHEMBL625765
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14664,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,,,CHEMBL625766
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14665,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,,CHEMBL625767
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14666,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,,CHEMBL625768
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14667,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,,CHEMBL625769
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14668,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,,CHEMBL625770
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14669,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,,CHEMBL625771
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14670,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,,,CHEMBL625772
Intermediate,BAO_0000218,,A,,1,Canis lupus familiaris,1,N,,12582,50588,,1088.0,Urine,9615.0,,14671,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,,CHEMBL625773
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14672,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,,CHEMBL625774
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14673,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,,,CHEMBL625775
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14674,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,,CHEMBL625776
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14675,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,,CHEMBL625777
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14676,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,,CHEMBL625778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14677,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,,,CHEMBL625779
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14678,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,,,CHEMBL625780
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14679,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,,CHEMBL625781
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14680,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,,,CHEMBL875637
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14681,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,,CHEMBL626473
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14682,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,,,CHEMBL626474
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14683,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,,CHEMBL626475
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14684,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,,,CHEMBL626476
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14685,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,,CHEMBL634397
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14686,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,,,CHEMBL626477
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14687,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,,CHEMBL631069
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14688,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,,,CHEMBL631070
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14689,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,,CHEMBL631071
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14690,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,,,CHEMBL631072
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14691,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,,CHEMBL631073
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14692,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,,,CHEMBL631074
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14693,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,,,CHEMBL631075
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14694,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,,CHEMBL631725
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14695,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,,,CHEMBL631726
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14696,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,,,CHEMBL631727
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14697,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,,CHEMBL631728
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14698,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,,CHEMBL631729
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14699,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,,,CHEMBL631730
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14700,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,,,CHEMBL631731
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14701,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,,CHEMBL631910
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,10000000.0,Hippocampus,10116.0,,14702,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,In vivo,,CHEMBL631911
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14703,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,In vivo,,CHEMBL631912
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15413,50597,,1898.0,Hypothalamus,10116.0,,14704,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,In vivo,,CHEMBL631913
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14705,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631914
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14706,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631915
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14707,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL875778
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14708,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631916
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14709,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631917
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14710,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631918
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14711,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631919
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14712,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL631920
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14713,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631921
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14714,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631922
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,178.0,Blood,10116.0,,14715,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL631923
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14716,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631924
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14717,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630234
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14718,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630235
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14719,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630236
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14720,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630237
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14721,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630238
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14722,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630239
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14723,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630303
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14724,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630304
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,,,10116.0,,14725,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630305
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14726,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630306
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14727,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630307
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14728,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630308
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14729,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630309
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14730,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL629309
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14731,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL629993
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14732,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL629994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14733,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL629995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14734,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631993
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14735,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631994
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2113.0,Kidney,10116.0,,14736,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631995
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14737,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL631996
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14738,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631997
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14739,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631998
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14740,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631999
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14741,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL632000
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14742,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL632001
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14743,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL874424
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14744,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL632002
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14745,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL632003
Autocuration,BAO_0000019,,A,,1,,0,U,,3133,22224,,,,,,14746,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,CHEMBL632004
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14747,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,,CHEMBL632005
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14748,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,,CHEMBL632006
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14749,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,,CHEMBL632007
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14750,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,,CHEMBL632008
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14751,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,,CHEMBL632009
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14752,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,,CHEMBL632010
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14753,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,,CHEMBL857750
Autocuration,BAO_0000019,,A,,1,,0,U,,2742,22224,,,,,,14754,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,,CHEMBL632011
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14755,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,CHEMBL632012
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14756,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,CHEMBL632013
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14757,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,,CHEMBL632014
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14758,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,CHEMBL629622
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14759,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,CHEMBL629623
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14760,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,,CHEMBL629624
Autocuration,BAO_0000019,,A,,1,,0,U,,17269,22224,,,,,,14761,Ratio of Kcat to that of Km was determined,,,,CHEMBL629625
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14762,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,CHEMBL629626
Autocuration,BAO_0000019,,A,,1,,0,U,,2276,22224,,,,,,14763,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,CHEMBL629627
Autocuration,BAO_0000019,,A,,1,,0,U,,15917,22224,,,,,,14764,"Compound was evaluated for constant, Kd",,,,CHEMBL629628
Autocuration,BAO_0000019,,A,,1,,0,U,,10933,22224,,,,,,14765,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,,CHEMBL629629
Autocuration,BAO_0000019,,A,,1,,0,U,,10933,22224,,,,,,14766,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,,CHEMBL629630
Autocuration,BAO_0000019,,A,,1,,0,U,,14293,22224,,,,,,14767,Dissociation Constant of compound determined,,,,CHEMBL856030
Autocuration,BAO_0000019,,B,,1,,0,U,,6698,22224,,,,,,14768,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,,CHEMBL629631
Autocuration,BAO_0000019,,B,,1,,0,U,,6698,22224,,,,,,14769,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,,CHEMBL629632
Autocuration,BAO_0000100,,P,,1,,0,U,,4318,22224,,,,,,14770,Dissociation constant of compound with Fructose was determined,,,,CHEMBL629633
Autocuration,BAO_0000100,,P,,1,,0,U,,4318,22224,,,,,,14771,Dissociation constant of compound with Fructose was determined; Not determined,,,,CHEMBL629634
Autocuration,BAO_0000100,,P,,1,,0,U,,4318,22224,,,,,,14772,Dissociation constant of compound with Lactulose was determined,,,,CHEMBL629635
Autocuration,BAO_0000100,,P,,1,,0,U,,4318,22224,,,,,,14773,Dissociation constant of compound with Lactulose was determined; Not determined,,,,CHEMBL629636
Autocuration,BAO_0000100,,P,,1,,0,U,,14959,22224,,,,,,14774,Dissociation constant of the Compound,,,,CHEMBL629637
Autocuration,BAO_0000100,,P,,1,,0,U,,5913,22224,,,,,,14775,Dissociation constant by non-linear regression analysis,,,,CHEMBL629638
Autocuration,BAO_0000100,,P,,1,,0,U,,14218,22224,,,,,,14776,Dissociation constant was determined,,,,CHEMBL629639
Autocuration,BAO_0000100,,P,,1,,0,U,,10689,22224,,,,,,14777,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,,CHEMBL629640
Autocuration,BAO_0000100,,P,,1,,0,U,,13925,22224,,,,,,14778,Dissociation constant was determined,,,,CHEMBL629641
Autocuration,BAO_0000100,,P,,1,,0,U,,16359,22224,,,,,,14779,Dissociation constant was determined,,,,CHEMBL631344
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10944,50597,,2385.0,Muscle tissue,10116.0,,14780,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,,,CHEMBL631345
Autocuration,BAO_0000019,,A,,1,,0,U,,11080,22224,,,,,,14781,The dissociation constant determined by fluorescence displacement assay,,,,CHEMBL631346
Autocuration,BAO_0000019,,A,,1,,0,U,,17805,22224,,,,,,14782,kd value surface plasmon resonance (SPR) method,,,,CHEMBL631524
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,10944,50597,,2385.0,Muscle tissue,10116.0,,14783,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,,,CHEMBL631525
Autocuration,BAO_0000019,,F,,1,,0,U,,16645,22224,,,,,,14784,First dissociation constant of the binding of compound to V30M TTR,,,,CHEMBL631526
Autocuration,BAO_0000019,,F,,1,,0,U,,16645,22224,,,,,,14785,Second dissociation constant of the binding of compound to V30M TTR,,,,CHEMBL631527
Autocuration,BAO_0000019,,A,,1,,0,U,,7793,22224,,,,,,14786,"Compound was evaluated for equilibrium constant, Ke",,,,CHEMBL631528
Autocuration,BAO_0000019,,A,,1,,0,U,,12199,22224,,1898.0,Hypothalamus,,,14787,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,,CHEMBL631529
Autocuration,BAO_0000019,,A,,1,,0,U,,12199,22224,,1898.0,Hypothalamus,,,14788,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,,CHEMBL631530
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14789,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,,CHEMBL631531
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14790,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,,CHEMBL631532
Autocuration,BAO_0000019,,A,,1,,0,U,,9680,22224,,,,,,14791,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,,CHEMBL631533
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14792,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,CHEMBL876552
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14793,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,,CHEMBL631534
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14794,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,CHEMBL631535
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14795,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,CHEMBL631536
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14796,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,,,CHEMBL631537
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14797,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,,CHEMBL631538
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14798,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,,,CHEMBL631539
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,13758,50594,,,,10090.0,,14799,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,CHEMBL631540
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,14800,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,CHEMBL625637
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14393,50597,,,,10116.0,,14801,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,CHEMBL625638
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,15078,50597,,,,10116.0,,14802,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,,CHEMBL625639
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,955.0,Brain,10116.0,,14803,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625640
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,955.0,Brain,10116.0,,14804,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625641
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,948.0,Heart,10116.0,,14805,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625642
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,948.0,Heart,10116.0,,14806,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625643
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2113.0,Kidney,10116.0,,14807,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625644
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2113.0,Kidney,10116.0,,14808,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625645
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2107.0,Liver,10116.0,,14809,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625646
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2107.0,Liver,10116.0,,14810,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625647
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2048.0,Lung,10116.0,,14811,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625648
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2048.0,Lung,10116.0,,14812,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625649
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2385.0,Muscle tissue,10116.0,,14813,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625650
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2385.0,Muscle tissue,10116.0,,14814,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625651
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,14.0,Zone of skin,10116.0,,14815,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625652
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,14.0,Zone of skin,10116.0,,14816,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625653
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2106.0,Spleen,10116.0,,14817,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625654
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,2106.0,Spleen,10116.0,,14818,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,In vivo,,CHEMBL625655
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,178.0,Blood,10116.0,,14819,Biodistribution of Compound in rat blood after 15 minutes of administration,,In vivo,,CHEMBL625656
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,178.0,Blood,10116.0,,14820,Biodistribution of Compound in rat blood after 2 minutes of administration,,In vivo,,CHEMBL625657
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,955.0,Brain,10116.0,,14821,Biodistribution of Compound in rat brain after 15 minutes of administration,,In vivo,,CHEMBL625658
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,955.0,Brain,10116.0,,14822,Biodistribution of Compound in rat brain after 2 minutes of administration,,In vivo,,CHEMBL625659
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,948.0,Heart,10116.0,,14823,Biodistribution of Compound in rat heart after 15 minutes of administration,,In vivo,,CHEMBL625660
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,948.0,Heart,10116.0,,14824,Biodistribution of Compound in rat heart after 2 minutes of administration,,In vivo,,CHEMBL625661
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,2107.0,Liver,10116.0,,14825,Biodistribution of Compound in rat liver after 15 minutes of administration,,In vivo,,CHEMBL625662
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,2107.0,Liver,10116.0,,14826,Biodistribution of Compound in rat liver after 2 minutes of administration,,In vivo,,CHEMBL625663
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,2048.0,Lung,10116.0,,14827,Biodistribution of Compound in rat lung after 15 minutes of administration,,In vivo,,CHEMBL875621
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,2048.0,Lung,10116.0,,14828,Biodistribution of Compound in rat lung after 2 minutes of administration,,In vivo,,CHEMBL628382
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,2385.0,Muscle tissue,10116.0,,14829,Biodistribution of Compound in rat muscle after 15 minutes of administration,,In vivo,,CHEMBL628383
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,9712,50597,,2385.0,Muscle tissue,10116.0,,14830,Biodistribution of Compound in rat muscle after 2 minutes of administration,,In vivo,,CHEMBL628384
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,,,10116.0,,14831,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,,,CHEMBL628385
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,,,10116.0,,14832,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,,,CHEMBL875753
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,13925,50597,,,,10116.0,,14833,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,,,CHEMBL628386
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14834,Organ distribution in rat blood 2 minutes after intravenous injection,,,,CHEMBL628387
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14835,Organ distribution in rat blood 2 hr after intravenous injection,,,,CHEMBL628388
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14836,Organ distribution in rat blood 30 minutes after intravenous injection,,,,CHEMBL628389
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14837,Organ distribution in rat blood 30 min after intravenous injection,,,,CHEMBL632756
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14838,Organ distribution in rat brain 2 minutes after intravenous injection,,,,CHEMBL628390
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14839,Organ distribution in rat brain 2 hr after intravenous injection,,,,CHEMBL631811
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14840,Organ distribution in rat brain 30 minutes after intravenous injection,,,,CHEMBL631812
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14841,Organ distribution in rat heart 2 minutes after intravenous injection,,,,CHEMBL631813
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14842,Organ distribution in rat heart 2 hr after intravenous injection,,,,CHEMBL631814
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14843,Organ distribution in rat heart 30 minutes after intravenous injection,,,,CHEMBL631815
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14844,Organ distribution in rat kidney 2 minutes after intravenous injection,,,,CHEMBL631816
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14845,Organ distribution in rat kidney 2 hr after intravenous injection,,,,CHEMBL875758
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14846,Organ distribution in rat kidney 30 minutes after intravenous injection,,,,CHEMBL631817
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,2107.0,Liver,10116.0,,14847,Organ distribution in rat liver 2 minutes after intravenous injection,,,,CHEMBL631818
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,2107.0,Liver,10116.0,,14848,Organ distribution in rat liver 2 hr after intravenous injection,,,,CHEMBL631819
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,2107.0,Liver,10116.0,,14849,Organ distribution in rat liver 30 minutes after intravenous injection,,,,CHEMBL631820
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14850,Organ distribution in rat lung 2 minutes after intravenous injection,,,,CHEMBL631821
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14851,Organ distribution in rat lung 2 hr after intravenous injection,,,,CHEMBL631822
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,,,10116.0,,14852,Organ distribution in rat lung 30 minutes after intravenous injection,,,,CHEMBL631823
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,2385.0,Muscle tissue,10116.0,,14853,Organ distribution in rat muscle 2 minutes after intravenous injection,,,,CHEMBL631824
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,2385.0,Muscle tissue,10116.0,,14854,Organ distribution in rat muscle 2 hr after intravenous injection,,,,CHEMBL631825
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,6941,50597,,2385.0,Muscle tissue,10116.0,,14855,Organ distribution in rat muscle 30 minutes after intravenous injection,,,,CHEMBL631826
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,14856,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,In vivo,,CHEMBL631827
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,14857,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,In vivo,,CHEMBL631828
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,14858,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,In vivo,,CHEMBL631829
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14859,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,,CHEMBL875759
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14860,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,,,CHEMBL631830
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14861,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,,,CHEMBL631831
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14862,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,,CHEMBL631832
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14863,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,,,CHEMBL631833
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14864,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,,CHEMBL631834
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14865,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,,,CHEMBL631835
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14866,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,,CHEMBL631836
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14867,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,,CHEMBL631837
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14868,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,,CHEMBL631838
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14869,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,,,CHEMBL631839
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14870,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,,,CHEMBL631840
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14871,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,,CHEMBL631841
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14872,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,,CHEMBL631842
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14873,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,,CHEMBL631843
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14874,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,,CHEMBL631844
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14875,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,,CHEMBL631845
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14876,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,,CHEMBL631846
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14877,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,,CHEMBL875760
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14878,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,,CHEMBL632199
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14879,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,,CHEMBL631847
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14880,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,,CHEMBL631848
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14881,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,,CHEMBL628707
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14882,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,,CHEMBL628708
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14883,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,,CHEMBL628709
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14884,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,,CHEMBL628710
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14885,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,,CHEMBL628711
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14886,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,,CHEMBL628712
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14887,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,,CHEMBL628713
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12582,50597,,1088.0,Urine,10116.0,,14888,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,,CHEMBL628714
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,7415,50597,,,,10116.0,,14889,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,,,CHEMBL628715
Autocuration,BAO_0000019,,A,,1,,0,U,,7313,22224,,,,,,14890,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,,CHEMBL629179
Autocuration,BAO_0000019,,A,,1,,0,U,,7313,22224,,,,,,14891,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,,CHEMBL629180
Autocuration,BAO_0000019,,A,,1,,0,U,,7313,22224,,,,,,14892,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,,CHEMBL875108
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,1235.0,Adrenal cortex,,,14893,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,,CHEMBL629181
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,1235.0,Adrenal cortex,,,14894,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,,CHEMBL629182
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14895,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,,CHEMBL629183
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14896,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,CHEMBL629184
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,1235.0,Adrenal cortex,,,14897,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,,CHEMBL629185
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,1235.0,Adrenal cortex,,,14898,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,,CHEMBL629186
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14899,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,,CHEMBL629187
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14900,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,CHEMBL629887
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14901,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,,CHEMBL629888
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14902,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,,CHEMBL629889
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,1235.0,Adrenal cortex,,,14903,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,,CHEMBL629890
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14904,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,CHEMBL629891
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14905,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,,CHEMBL629892
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,1235.0,Adrenal cortex,,,14906,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,,CHEMBL629893
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14907,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,,CHEMBL629894
Autocuration,BAO_0000019,,A,,1,,0,U,,7570,22224,,,,,,14908,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,CHEMBL629895
Autocuration,BAO_0000218,,A,,1,Canis lupus familiaris,0,U,,14122,22224,,,,9615.0,,14909,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,In vivo,,CHEMBL875109
Autocuration,BAO_0000218,,A,,1,Macaca fascicularis,0,U,,16449,22224,,,,9541.0,,14910,Absolute bioavailability in male cynomolgus monkeys,,In vivo,,CHEMBL629896
Autocuration,BAO_0000218,,A,,1,Rattus norvegicus,0,U,,16449,22224,,,,10116.0,,14911,Absolute bioavailability in maleSprague-Dawley rats,,In vivo,,CHEMBL629897
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14912,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL629898
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14913,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630057
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2107.0,Liver,10116.0,,14914,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630058
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14915,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630059
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14916,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630060
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14917,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630061
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14918,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630062
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14919,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630063
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14920,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630064
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14921,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630065
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14922,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630066
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14923,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630067
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2048.0,Lung,10116.0,,14924,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630068
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14925,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631113
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14926,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631114
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14927,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL631115
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14928,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL631116
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14929,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630528
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14930,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630529
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14931,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630530
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14932,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630531
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14933,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630532
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2385.0,Muscle tissue,10116.0,,14934,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630533
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,178.0,Blood,10090.0,,14935,Biodistribution in normal mice blood after 120 hr,,In vivo,,CHEMBL630534
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,178.0,Blood,10090.0,,14936,Biodistribution in normal mice blood after 24 hr,,In vivo,,CHEMBL630535
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,178.0,Blood,10090.0,,14937,Biodistribution in normal mice blood after 4 hr,,In vivo,,CHEMBL630536
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,10000001.0,Bone,10090.0,,14938,Biodistribution in normal mice bone after 120 hr,,In vivo,,CHEMBL630537
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,10000001.0,Bone,10090.0,,14939,Biodistribution in normal mice bone after 24 hr,,In vivo,,CHEMBL630538
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,10000001.0,Bone,10090.0,,14940,Biodistribution in normal mice bone after 4 hr,,In vivo,,CHEMBL630539
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,948.0,Heart,10090.0,,14941,Biodistribution in normal mice heart after 120 hr,,In vivo,,CHEMBL630540
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,948.0,Heart,10090.0,,14942,Biodistribution in normal mice heart after 24 hr,,In vivo,,CHEMBL630541
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,948.0,Heart,10090.0,,14943,Biodistribution in normal mice heart after 4 hr,,In vivo,,CHEMBL630542
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2113.0,Kidney,10090.0,,14944,Biodistribution in normal mice kidney after 120 hr,,In vivo,,CHEMBL630543
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2113.0,Kidney,10090.0,,14945,Biodistribution in normal mice kidney after 24 hr,,In vivo,,CHEMBL630544
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2113.0,Kidney,10090.0,,14946,Biodistribution in normal mice kidney after 4 hr,,In vivo,,CHEMBL630545
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2107.0,Liver,10090.0,,14947,Biodistribution in normal mice liver after 120 hr,,In vivo,,CHEMBL630546
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2107.0,Liver,10090.0,,14948,Biodistribution in normal mice liver after 24 hr,,In vivo,,CHEMBL630547
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2107.0,Liver,10090.0,,14949,Biodistribution in normal mice liver after 4 hr,,In vivo,,CHEMBL630548
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2106.0,Spleen,10090.0,,14950,Biodistribution in normal mice spleen after 120 hr,,In vivo,,CHEMBL630549
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2106.0,Spleen,10090.0,,14951,Biodistribution in normal mice spleen after 24 hr,,In vivo,,CHEMBL630550
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,15045,50594,,2106.0,Spleen,10090.0,,14952,Biodistribution in normal mice spleen after 4 hr,,In vivo,,CHEMBL876426
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14953,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630551
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14954,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630552
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14955,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630553
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14956,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630554
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14957,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630555
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14958,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630556
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14959,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630557
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14960,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,In vivo,,CHEMBL630558
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14961,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630559
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2106.0,Spleen,10116.0,,14962,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL630560
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,12017,50597,,2046.0,Thyroid gland,10116.0,,14963,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,In vivo,,CHEMBL876427
Intermediate,BAO_0000218,,A,,1,Rattus norvegicus,1,N,,14941,50597,,,,10116.0,,14964,The Kel values in female wistar rats.,,,,CHEMBL630561
Autocuration,BAO_0000019,,A,,1,,0,U,,4646,22224,,,,,,14965,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,,CHEMBL630562
Autocuration,BAO_0000019,,A,,1,,0,U,,8847,22224,,,,,,14966,Hydrolysis rate constant of the compound,,,,CHEMBL630563
Autocuration,BAO_0000100,,P,,1,,0,U,,11778,22229,,,,,,14967,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,,CHEMBL629673
Autocuration,BAO_0000019,,A,,1,,0,U,,2363,22224,,,,,,14968,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,,CHEMBL629674
Autocuration,BAO_0000019,,A,,1,,0,U,,2363,22224,,,,,,14969,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,,CHEMBL629675
Autocuration,BAO_0000019,,A,,1,,0,U,,2363,22224,,,,,,14970,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,,CHEMBL629676
Autocuration,BAO_0000019,,A,,1,,0,U,,2363,22224,,,,,,14971,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,,CHEMBL629677
Autocuration,BAO_0000019,,A,,1,,0,U,,8371,22224,,,,,,14972,Apparent inactivation rate constant was evaluated,,,,CHEMBL629678
Autocuration,BAO_0000019,,A,,1,,0,U,,14883,22224,,,,,,14973,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,,CHEMBL629679
Autocuration,BAO_0000019,,A,,1,,0,U,,14883,22224,,,,,,14974,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,,CHEMBL629680
Autocuration,BAO_0000019,,A,,1,,0,U,,4643,22224,,,,,,14975,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,,CHEMBL629681
Autocuration,BAO_0000019,,A,,1,,0,U,,3519,22224,,,,,,14976,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,,CHEMBL629682
Autocuration,BAO_0000019,,A,,1,,0,U,,10600,22224,,,,,,14977,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,,CHEMBL629683
Autocuration,BAO_0000019,,F,,1,,0,U,,8501,22224,,,,,,14978,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,,CHEMBL629684
Autocuration,BAO_0000100,,P,,1,,0,U,,8505,22224,,,,,,14979,Dissociation constant was determined,,,,CHEMBL629685
Autocuration,BAO_0000100,,P,,1,,0,U,,9778,22224,,,,,,14980,Dissociation constant was determined,,,,CHEMBL629686
Autocuration,BAO_0000100,,P,,1,,0,U,,9778,22224,,,,,,14981,Dissociation constant at pH 7.4,,,,CHEMBL872932
Autocuration,BAO_0000100,,P,,1,,0,U,,9778,22224,,,,,,14982,Dissociation constant in presence of 1 mM dithiothreitol,,,,CHEMBL629687
Autocuration,BAO_0000019,,A,,1,,0,U,,13007,22224,,,,,,14983,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,CHEMBL872931
Autocuration,BAO_0000019,,A,,1,,0,U,,13007,22224,,,,,,14984,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,CHEMBL628151
Autocuration,BAO_0000019,,A,,1,,0,U,,13007,22224,,,,,,14985,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,CHEMBL628152
Autocuration,BAO_0000019,,A,,1,,0,U,,13007,22224,,,,,,14986,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,CHEMBL628153
Autocuration,BAO_0000019,,A,,1,,0,U,,11482,22224,,,,,,14987,Kinetic constant for aromatization of androstenedione,,,,CHEMBL628154
Autocuration,BAO_0000019,,A,,1,,0,U,,11482,22224,,,,,,14988,Kinetic constant for aromatization of testosterone,,,,CHEMBL628155
Autocuration,BAO_0000019,,A,,1,,0,U,,2303,22224,,,,,,14989,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,,CHEMBL628156
Autocuration,BAO_0000019,,A,,1,,0,U,,11964,22224,,,,,,14990,Local inhibition constant was determined,,,,CHEMBL628157
Intermediate,BAO_0000218,,A,,1,Saccharomyces cerevisiae,1,N,,3140,50347,,,,4932.0,,14991,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,,,CHEMBL857533
Autocuration,BAO_0000100,,P,,1,,0,U,,10650,22224,,,,,,14992,Dissociation constant value of the compound,,,,CHEMBL628158
Autocuration,BAO_0000019,,A,,1,,0,U,,4667,22224,,964.0,Cornea,,,14993,In vitro permeability through cornea without epithelium,,,,CHEMBL628159
Autocuration,BAO_0000019,,A,,1,,0,U,,4667,22224,,964.0,Cornea,,,14994,In vitro permeability through intact cornea,,,,CHEMBL875616
Intermediate,BAO_0000218,,A,,1,Oryctolagus cuniculus,1,N,,9199,50592,,964.0,Cornea,9986.0,,14995,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,,,CHEMBL628160
Autocuration,BAO_0000019,,A,,1,,0,U,,11966,22224,,,,,,14996,Rate of enzyme inactivation for the compound was determined,,,,CHEMBL628161
Autocuration,BAO_0000019,,A,,1,,0,U,,4667,22224,,964.0,Cornea,,,14997,In vitro permeability through cornea without epithelium,,,,CHEMBL628162
Autocuration,BAO_0000019,,A,,1,,0,U,,4667,22224,,964.0,Cornea,,,14998,In vitro permeability through intact cornea,,,,CHEMBL628163
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,14999,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628164
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15000,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628165
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15001,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628166
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15002,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628167
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15003,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628168
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15004,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628169
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15005,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628170
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15006,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628171
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15007,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL627434
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15008,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL627435
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15009,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628110
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15010,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628111
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15011,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628112
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15012,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628260
Autocuration,BAO_0000019,,A,,1,,0,U,,8354,22224,,,,,,15013,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,CHEMBL628261
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15014,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,In vivo,,CHEMBL628262
Intermediate,BAO_0000218,,A,,1,Homo sapiens,1,N,,14439,50587,,,,9606.0,,15015,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,In vivo,,CHEMBL628263
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15016,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,In vivo,,CHEMBL628264
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15017,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,In vivo,,CHEMBL628265
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15018,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,In vivo,,CHEMBL628266
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15019,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,In vivo,,CHEMBL628267
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15020,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,In vivo,,CHEMBL628268
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15021,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,In vivo,,CHEMBL628269
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15022,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,In vivo,,CHEMBL628270
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15023,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,In vivo,,CHEMBL628271
Intermediate,BAO_0000218,,A,,1,Mus musculus,1,N,,14439,50594,,,,10090.0,,15024,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,In vivo,,CHEMBL628272
